{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41219112\", \"sentence_id\": 0, \"text\": \"BACKGROUND AND INTRODUCTION: Over the past 15\u00a0yr, significant progress has been made in the management of prostate cancer (PC), including the development of chemotherapy, androgen receptor pathway inhibitors (ARPIs), and, more recently, radium-223 radioligand therapy.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "41219112", "sentence_id": 0, "text": "BACKGROUND AND INTRODUCTION: Over the past 15\u00a0yr, significant progress has been made in the management of prostate cancer (PC), including the development of chemotherapy, androgen receptor pathway inhibitors (ARPIs), and, more recently, radium-223 radioligand therapy."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41219112\", \"sentence_id\": 1, \"text\": \"However, metastatic PC is still the third leading cancer-related cause of death among men in Europe, with a 5-yr survival rate of \u223c30% and median overall survival (OS) of <3\u00a0yr for castration-resistant PC (CRPC).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "41219112", "sentence_id": 1, "text": "However, metastatic PC is still the third leading cancer-related cause of death among men in Europe, with a 5-yr survival rate of \u223c30% and median overall survival (OS) of <3\u00a0yr for castration-resistant PC (CRPC)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41219112\", \"sentence_id\": 2, \"text\": \"Current strategies are moving towards personalised treatment, with the emergence of PARP inhibitors (PARPi) that exploit a vulnerability in the DNA repair system in patients with alterations in genes involved in homologous recombination.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "41219112", "sentence_id": 2, "text": "Current strategies are moving towards personalised treatment, with the emergence of PARP inhibitors (PARPi) that exploit a vulnerability in the DNA repair system in patients with alterations in genes involved in homologous recombination."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41219112\", \"sentence_id\": 3, \"text\": \"METHODS: We reviewed the literature on PARPi treatment for CRPC and provide a narrative synthesis of the evidence for the rapidly evolving treatment landscape in this setting.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "41219112", "sentence_id": 3, "text": "METHODS: We reviewed the literature on PARPi treatment for CRPC and provide a narrative synthesis of the evidence for the rapidly evolving treatment landscape in this setting."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41219112\", \"sentence_id\": 4, \"text\": \"KEY FINDINGS AND LIMITATIONS: Phase 3 studies evaluating the efficacy of PARPi agents available (olaparib, niraparib, rucaparib, and talazoparib) for the treatment of metastatic CRPC have confirmed their ability to prolong OS, especially in patients carrying BRCA1/2 mutations.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "41219112", "sentence_id": 4, "text": "KEY FINDINGS AND LIMITATIONS: Phase 3 studies evaluating the efficacy of PARPi agents available (olaparib, niraparib, rucaparib, and talazoparib) for the treatment of metastatic CRPC have confirmed their ability to prolong OS, especially in patients carrying BRCA1/2 mutations."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41219112\", \"sentence_id\": 5, \"text\": \"Studies on PARPi + ARPI combinations have shown longer radiological progression-free survival, and better OS with talazoparib + enzalutamide, regardless of mutational status for DNA repair genes, with synergistic activity identified.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "41219112", "sentence_id": 5, "text": "Studies on PARPi + ARPI combinations have shown longer radiological progression-free survival, and better OS with talazoparib + enzalutamide, regardless of mutational status for DNA repair genes, with synergistic activity identified."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41219112\", \"sentence_id\": 6, \"text\": \"However, response to PARPi seems to vary depending on the genes altered, with a greater benefit for patients with mutations in genes encoding the repair effector proteins BRCA1/2, CDK12, and PALB2.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "41219112", "sentence_id": 6, "text": "However, response to PARPi seems to vary depending on the genes altered, with a greater benefit for patients with mutations in genes encoding the repair effector proteins BRCA1/2, CDK12, and PALB2."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41219112\", \"sentence_id\": 7, \"text\": \"CONCLUSIONS AND CLINICAL IMPLICATIONS: Promising results have led to the approval of several PARPi agents as monotherapy or in combination with ARPIs in selected or unselected patients when chemotherapy is not clinically indicated.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "41219112", "sentence_id": 7, "text": "CONCLUSIONS AND CLINICAL IMPLICATIONS: Promising results have led to the approval of several PARPi agents as monotherapy or in combination with ARPIs in selected or unselected patients when chemotherapy is not clinically indicated."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41219112\", \"sentence_id\": 8, \"text\": \"However, some questions remain regarding patient selection and treatment sequencing.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "41219112", "sentence_id": 8, "text": "However, some questions remain regarding patient selection and treatment sequencing."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41216708\", \"sentence_id\": 0, \"text\": \"Advanced urothelial carcinoma (UC) requires new therapeutics beyond chemo- and immunotherapies.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "41216708", "sentence_id": 0, "text": "Advanced urothelial carcinoma (UC) requires new therapeutics beyond chemo- and immunotherapies."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41216708\", \"sentence_id\": 1, \"text\": \"Clinical trials with PARP inhibitors (PARPi), particularly in Cisplatin-treated UC, yielded limited response.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "41216708", "sentence_id": 1, "text": "Clinical trials with PARP inhibitors (PARPi), particularly in Cisplatin-treated UC, yielded limited response."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41216708\", \"sentence_id\": 2, \"text\": \"Biomarker-based patient selection (apart from BRCAness) or combination treatment may increase efficacy.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "41216708", "sentence_id": 2, "text": "Biomarker-based patient selection (apart from BRCAness) or combination treatment may increase efficacy."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41216708\", \"sentence_id\": 3, \"text\": \"To identify the most suitable PARPi for UC, we compared Olaparib with Talazoparib.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "41216708", "sentence_id": 3, "text": "To identify the most suitable PARPi for UC, we compared Olaparib with Talazoparib."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41216708\", \"sentence_id\": 4, \"text\": \"RNA sequencing of PARPi-treated UC lines revealed few common targets and a different impact on immune response.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "41216708", "sentence_id": 4, "text": "RNA sequencing of PARPi-treated UC lines revealed few common targets and a different impact on immune response."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41216708\", \"sentence_id\": 5, \"text\": \"By analysis of experimental and public clinical data, we identified new UC-specific PARPi response predictors SLFN5, SLFN11, and OAS1.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "41216708", "sentence_id": 5, "text": "By analysis of experimental and public clinical data, we identified new UC-specific PARPi response predictors SLFN5, SLFN11, and OAS1."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41216708\", \"sentence_id\": 6, \"text\": \"We investigated a new combination treatment using PLX51107, an epigenetic BET protein inhibitor, to increase PARPi efficacy.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "41216708", "sentence_id": 6, "text": "We investigated a new combination treatment using PLX51107, an epigenetic BET protein inhibitor, to increase PARPi efficacy."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41216708\", \"sentence_id\": 7, \"text\": \"The Talazoparib + PLX51107 combination had a strong synergistic impact on UC cells and organoids, including Cisplatin-resistant cells, allowing dose reduction to spare benign cells.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "41216708", "sentence_id": 7, "text": "The Talazoparib + PLX51107 combination had a strong synergistic impact on UC cells and organoids, including Cisplatin-resistant cells, allowing dose reduction to spare benign cells."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41216708\", \"sentence_id\": 8, \"text\": \"Mechanisms of synergism targeted homologous recombination repair, DNA replication, and apoptosis regulation.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "41216708", "sentence_id": 8, "text": "Mechanisms of synergism targeted homologous recombination repair, DNA replication, and apoptosis regulation."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41216708\", \"sentence_id\": 9, \"text\": \"In conclusion, we suggest Talazoparib treatment of UC to be highly efficacious on all models examined when combined with PLX51107.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "41216708", "sentence_id": 9, "text": "In conclusion, we suggest Talazoparib treatment of UC to be highly efficacious on all models examined when combined with PLX51107."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41216708\", \"sentence_id\": 10, \"text\": \"This new combination treatment allows efficient application of PARPi Talazoparib to all UC patients, independent of Cisplatin pretreatment and genetic BRCAness.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "41216708", "sentence_id": 10, "text": "This new combination treatment allows efficient application of PARPi Talazoparib to all UC patients, independent of Cisplatin pretreatment and genetic BRCAness."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41186828\", \"sentence_id\": 0, \"text\": \"Poly(ADP-ribose) polymerase (PARP) inhibitors (PARPi) have attracted significant attention in triple negative breast cancer (TNBC) treatment.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "41186828", "sentence_id": 0, "text": "Poly(ADP-ribose) polymerase (PARP) inhibitors (PARPi) have attracted significant attention in triple negative breast cancer (TNBC) treatment."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41186828\", \"sentence_id\": 1, \"text\": \"However, the acquired or de novo PARP inhibitor resistance limits treatment success.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "41186828", "sentence_id": 1, "text": "However, the acquired or de novo PARP inhibitor resistance limits treatment success."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41186828\", \"sentence_id\": 2, \"text\": \"Ataxia telangiectasia and Rad3-related (ATR) regulates genome integrity, and thus, the aberrant activation of ATR could play a significant role in the pathogenesis of TNBC and be associated with PARPi resistance in especially homologous recombinant deficiency tumors.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "41186828", "sentence_id": 2, "text": "Ataxia telangiectasia and Rad3-related (ATR) regulates genome integrity, and thus, the aberrant activation of ATR could play a significant role in the pathogenesis of TNBC and be associated with PARPi resistance in especially homologous recombinant deficiency tumors."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41186828\", \"sentence_id\": 3, \"text\": \"We aimed to assess the efficacy of ATR and PARP inhibitors combination in TNBC cells and the reversal of PARPi resistance in resistant cells.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "41186828", "sentence_id": 3, "text": "We aimed to assess the efficacy of ATR and PARP inhibitors combination in TNBC cells and the reversal of PARPi resistance in resistant cells."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41186828\", \"sentence_id\": 4, \"text\": \"HCC1937 and HCC1937-R Talazoparib (TAL) resistant cells were treated with Elimusertib (ELI) alone as ATR inhibitor (ATRi) and ELI and TAL combination.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "41186828", "sentence_id": 4, "text": "HCC1937 and HCC1937-R Talazoparib (TAL) resistant cells were treated with Elimusertib (ELI) alone as ATR inhibitor (ATRi) and ELI and TAL combination."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41186828\", \"sentence_id\": 5, \"text\": \"Then, the cytotoxic, apoptotic and ATR based DNA damage response (DDR) were evaluated by WST-1, Annexin V, AO/PI, cell cycle and western blot analysis.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "41186828", "sentence_id": 5, "text": "Then, the cytotoxic, apoptotic and ATR based DNA damage response (DDR) were evaluated by WST-1, Annexin V, AO/PI, cell cycle and western blot analysis."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41186828\", \"sentence_id\": 6, \"text\": \"Our results showed that the ELI and TAL combination could overcome TAL resistance by downregulating cell cycle checkpoint proteins and ATR-based DDR pathways through synergistic effects (ZIP score\u2009>\u200910).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "41186828", "sentence_id": 6, "text": "Our results showed that the ELI and TAL combination could overcome TAL resistance by downregulating cell cycle checkpoint proteins and ATR-based DDR pathways through synergistic effects (ZIP score\u2009>\u200910)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41186828\", \"sentence_id\": 7, \"text\": \"The overexpression of ATR and associated cell cycle proteins could play a role in PARPi resistance.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "41186828", "sentence_id": 7, "text": "The overexpression of ATR and associated cell cycle proteins could play a role in PARPi resistance."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41186828\", \"sentence_id\": 8, \"text\": \"However, this combination did not exert synergism in TNBC cells despite a higher apoptotic rate and increased DNA damage compared with the drug alone.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "41186828", "sentence_id": 8, "text": "However, this combination did not exert synergism in TNBC cells despite a higher apoptotic rate and increased DNA damage compared with the drug alone."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41186828\", \"sentence_id\": 9, \"text\": \"Therefore, the dual targeting of ATR and PARP is a promising modality to reverse PARPi resistance with the downregulation of ATR-Chk1 based DNA damage response.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "41186828", "sentence_id": 9, "text": "Therefore, the dual targeting of ATR and PARP is a promising modality to reverse PARPi resistance with the downregulation of ATR-Chk1 based DNA damage response."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41186828\", \"sentence_id\": 10, \"text\": \"However, further preclinical and clinical investigations should be required to elucidate the underlying molecular mechanisms behind ATRi and PARPi interactions in TNBC cells.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "41186828", "sentence_id": 10, "text": "However, further preclinical and clinical investigations should be required to elucidate the underlying molecular mechanisms behind ATRi and PARPi interactions in TNBC cells."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41173779\", \"sentence_id\": 0, \"text\": \"BACKGROUND AND OBJECTIVE: The impact of alterations beyond DNA damage response-homologous recombination repair (DDR-HRR) genes on outcomes with poly(ADP-ribose) polymerase inhibitor monotherapy remains unknown.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "41173779", "sentence_id": 0, "text": "BACKGROUND AND OBJECTIVE: The impact of alterations beyond DNA damage response-homologous recombination repair (DDR-HRR) genes on outcomes with poly(ADP-ribose) polymerase inhibitor monotherapy remains unknown."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41173779\", \"sentence_id\": 1, \"text\": \"This study aims to explore the impact of genomic features and co-occurring alterations on treatment outcomes in patients with metastatic castration-resistant prostate cancer (mCRPC) and DDR-HRR alterations in TALAPRO-1.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "41173779", "sentence_id": 1, "text": "This study aims to explore the impact of genomic features and co-occurring alterations on treatment outcomes in patients with metastatic castration-resistant prostate cancer (mCRPC) and DDR-HRR alterations in TALAPRO-1."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41173779\", \"sentence_id\": 2, \"text\": \"METHODS: TALAPRO-1 evaluated talazoparib monotherapy in heavily pretreated patients with mCRPC and DDR-HRR alterations.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "41173779", "sentence_id": 2, "text": "METHODS: TALAPRO-1 evaluated talazoparib monotherapy in heavily pretreated patients with mCRPC and DDR-HRR alterations."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41173779\", \"sentence_id\": 3, \"text\": \"We used tumor and saliva alteration results, and somatic-germline-zygosity prediction to assess genomic alterations.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "41173779", "sentence_id": 3, "text": "We used tumor and saliva alteration results, and somatic-germline-zygosity prediction to assess genomic alterations."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41173779\", \"sentence_id\": 4, \"text\": \"KEY FINDINGS AND LIMITATIONS: Associations between antitumor activity and gene alteration origin, selected non-DDR-HRR gene alteration status, tumor mutational burden, and genomic loss of heterozygosity (gLOH) were explored.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "41173779", "sentence_id": 4, "text": "KEY FINDINGS AND LIMITATIONS: Associations between antitumor activity and gene alteration origin, selected non-DDR-HRR gene alteration status, tumor mutational burden, and genomic loss of heterozygosity (gLOH) were explored."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41173779\", \"sentence_id\": 5, \"text\": \"Objective response rates (ORRs) and median overall survival (OS) with 95% confidence intervals (Clopper-Pearson method) and p values (two-sided Fisher's exact test) were calculated.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "41173779", "sentence_id": 5, "text": "Objective response rates (ORRs) and median overall survival (OS) with 95% confidence intervals (Clopper-Pearson method) and p values (two-sided Fisher's exact test) were calculated."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41173779\", \"sentence_id\": 6, \"text\": \"Commonly altered non-DDR-HRR genes included TMPRSS2, TP53, PTEN, androgen receptor (AR), MYC, and SPOP.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "41173779", "sentence_id": 6, "text": "Commonly altered non-DDR-HRR genes included TMPRSS2, TP53, PTEN, androgen receptor (AR), MYC, and SPOP."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41173779\", \"sentence_id\": 7, \"text\": \"ORRs were 30.0% and 34.5% in men with TP53 and PTEN alterations, respectively, and 28.6% and 26.8% in men without TP53 or PTEN alterations, respectively.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "41173779", "sentence_id": 7, "text": "ORRs were 30.0% and 34.5% in men with TP53 and PTEN alterations, respectively, and 28.6% and 26.8% in men without TP53 or PTEN alterations, respectively."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41173779\", \"sentence_id\": 8, \"text\": \"In tumors bearing ATM alterations, ORR was greater in those with (two of four) versus without PTEN alterations (zero of 13; p\u00a0=\u00a00.044).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "41173779", "sentence_id": 8, "text": "In tumors bearing ATM alterations, ORR was greater in those with (two of four) versus without PTEN alterations (zero of 13; p\u00a0=\u00a00.044)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41173779\", \"sentence_id\": 9, \"text\": \"ORR was significantly higher for gLOH-high than for gLOH-low patients (53.3% vs 12.0%; p\u00a0=\u00a00.0017).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "41173779", "sentence_id": 9, "text": "ORR was significantly higher for gLOH-high than for gLOH-low patients (53.3% vs 12.0%; p\u00a0=\u00a00.0017)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41173779\", \"sentence_id\": 10, \"text\": \"The median OS for gLOH-high patients was 23.7\u00a0mo versus 18.7\u00a0mo for gLOH-low patients (hazard ratio 0.92, 95% confidence interval 0.52-1.64).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "41173779", "sentence_id": 10, "text": "The median OS for gLOH-high patients was 23.7\u00a0mo versus 18.7\u00a0mo for gLOH-low patients (hazard ratio 0.92, 95% confidence interval 0.52-1.64)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41173779\", \"sentence_id\": 11, \"text\": \"Our analyses are retrospective and limited by small subgroup sizes.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "41173779", "sentence_id": 11, "text": "Our analyses are retrospective and limited by small subgroup sizes."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41173779\", \"sentence_id\": 12, \"text\": \"CONCLUSIONS AND CLINICAL IMPLICATIONS: In men with mCRPC, high gLOH status was associated with enhanced responses to talazoparib.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "41173779", "sentence_id": 12, "text": "CONCLUSIONS AND CLINICAL IMPLICATIONS: In men with mCRPC, high gLOH status was associated with enhanced responses to talazoparib."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41158759\", \"sentence_id\": 0, \"text\": \"Despite advances in cancer treatment with targeted therapies and immunotherapies, triple-negative breast cancer (TNBC) has not significantly benefited from these developments.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "41158759", "sentence_id": 0, "text": "Despite advances in cancer treatment with targeted therapies and immunotherapies, triple-negative breast cancer (TNBC) has not significantly benefited from these developments."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41158759\", \"sentence_id\": 1, \"text\": \"Although poly (ADP-ribose) polymerase (PARP) inhibitors (PARPi) are approved for breast cancer, their clinical use is largely limited to the small subset of HER2-negative patients with germline BRCA1/2 mutations, and resistance is frequently observed.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "41158759", "sentence_id": 1, "text": "Although poly (ADP-ribose) polymerase (PARP) inhibitors (PARPi) are approved for breast cancer, their clinical use is largely limited to the small subset of HER2-negative patients with germline BRCA1/2 mutations, and resistance is frequently observed."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41158759\", \"sentence_id\": 2, \"text\": \"Previously, we demonstrated that proton pump inhibitors (PPIs), including lansoprazole and its metabolite, 5-hydroxy lansoprazole sulfide (5HLS), reduce PARP1 expression by inhibiting fatty acid synthase (FASN), a key enzyme in\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "41158759", "sentence_id": 2, "text": "Previously, we demonstrated that proton pump inhibitors (PPIs), including lansoprazole and its metabolite, 5-hydroxy lansoprazole sulfide (5HLS), reduce PARP1 expression by inhibiting fatty acid synthase (FASN), a key enzyme in"}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41077155\", \"sentence_id\": 0, \"text\": \"P-glycoprotein (Pgp), a membrane-bound transporter protein, plays significant roles in the development of multidrug resistance (MDR) and in drug disposition.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "41077155", "sentence_id": 0, "text": "P-glycoprotein (Pgp), a membrane-bound transporter protein, plays significant roles in the development of multidrug resistance (MDR) and in drug disposition."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41077155\", \"sentence_id\": 1, \"text\": \"Understanding the interactions between Pgp and its substrates is therefore crucial for optimal drug design and ultimately clinical success.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "41077155", "sentence_id": 1, "text": "Understanding the interactions between Pgp and its substrates is therefore crucial for optimal drug design and ultimately clinical success."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41077155\", \"sentence_id\": 2, \"text\": \"In this study, we conducted a comparative analysis of the four FDA-approved anti-cancer PARPi and their interactions with Pgp to elucidate the mechanisms driving their Pgp-mediated transport.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "41077155", "sentence_id": 2, "text": "In this study, we conducted a comparative analysis of the four FDA-approved anti-cancer PARPi and their interactions with Pgp to elucidate the mechanisms driving their Pgp-mediated transport."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41077155\", \"sentence_id\": 3, \"text\": \"Through an assessment of PARPi-induced effect on Pgp-coupled ATP hydrolysis, we found that olaparib and talazoparib act as Pgp inducers, increasing Pgp's rate of ATP hydrolysis 3-fold from its basal activity.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "41077155", "sentence_id": 3, "text": "Through an assessment of PARPi-induced effect on Pgp-coupled ATP hydrolysis, we found that olaparib and talazoparib act as Pgp inducers, increasing Pgp's rate of ATP hydrolysis 3-fold from its basal activity."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41077155\", \"sentence_id\": 4, \"text\": \"Rucaparib and niraparib slightly increased Pgp activity at lower concentrations but displayed biphasic kinetic trends and predominantly reduced Pgp ATPase activity below basal levels.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "41077155", "sentence_id": 4, "text": "Rucaparib and niraparib slightly increased Pgp activity at lower concentrations but displayed biphasic kinetic trends and predominantly reduced Pgp ATPase activity below basal levels."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41077155\", \"sentence_id\": 5, \"text\": \"Quenching of Pgp's intrinsic tryptophan residues revealed high binding affinities for the PARPi-Pgp complexes, apart from talazoparib, which displayed relatively lower affinity.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "41077155", "sentence_id": 5, "text": "Quenching of Pgp's intrinsic tryptophan residues revealed high binding affinities for the PARPi-Pgp complexes, apart from talazoparib, which displayed relatively lower affinity."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41077155\", \"sentence_id\": 6, \"text\": \"Indirect conformational analyses via acrylamide quenching of tryptophan residues indicated that olaparib, rucaparib, and niraparib all induce Pgp to move more toward its \\\"outward-open\\\" position, while talazoparib induced a more intermediate conformation.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "41077155", "sentence_id": 6, "text": "Indirect conformational analyses via acrylamide quenching of tryptophan residues indicated that olaparib, rucaparib, and niraparib all induce Pgp to move more toward its \"outward-open\" position, while talazoparib induced a more intermediate conformation."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41077155\", \"sentence_id\": 7, \"text\": \"Saturation transfer double difference (STDD) NMR revealed the PARPi structural basis for Pgp binding.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "41077155", "sentence_id": 7, "text": "Saturation transfer double difference (STDD) NMR revealed the PARPi structural basis for Pgp binding."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41077155\", \"sentence_id\": 8, \"text\": \"Bi-directional transport assays suggested the rate of Pgp-mediated efflux to be olaparib\u00a0>\u00a0talazoparib\u00a0>\u00a0rucaparib\u00a0>\u00a0niraparib.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "41077155", "sentence_id": 8, "text": "Bi-directional transport assays suggested the rate of Pgp-mediated efflux to be olaparib\u00a0>\u00a0talazoparib\u00a0>\u00a0rucaparib\u00a0>\u00a0niraparib."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41077155\", \"sentence_id\": 9, \"text\": \"Overall, our results provide insight for future potential development of PARPi that are less subject to Pgp-mediated transport.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "41077155", "sentence_id": 9, "text": "Overall, our results provide insight for future potential development of PARPi that are less subject to Pgp-mediated transport."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41049440\", \"sentence_id\": 0, \"text\": \"Glioblastoma multiforme (GBM) is characterized by rapid progression, therapeutic resistance, and a profoundly immunosuppressive tumor microenvironment.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "41049440", "sentence_id": 0, "text": "Glioblastoma multiforme (GBM) is characterized by rapid progression, therapeutic resistance, and a profoundly immunosuppressive tumor microenvironment."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41049440\", \"sentence_id\": 1, \"text\": \"Emerging evidence suggests that endoplasmic reticulum (ER)-associated macromolecules play critical roles in tumor adaptation.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "41049440", "sentence_id": 1, "text": "Emerging evidence suggests that endoplasmic reticulum (ER)-associated macromolecules play critical roles in tumor adaptation."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41049440\", \"sentence_id\": 2, \"text\": \"In this study, we performed a multi-omics investigation of orosomucoid-like protein 2 (ORMDL2), a conserved ER membrane protein involved in sphingolipid biosynthesis and ER stress regulation, and uncovered its regulatory functions in GBM progression.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "41049440", "sentence_id": 2, "text": "In this study, we performed a multi-omics investigation of orosomucoid-like protein 2 (ORMDL2), a conserved ER membrane protein involved in sphingolipid biosynthesis and ER stress regulation, and uncovered its regulatory functions in GBM progression."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41049440\", \"sentence_id\": 3, \"text\": \"Transcriptomic analyses across The Cancer Genome Atlas (TCGA), and Chinese Glioma Genome Atlas (CGGA) revealed elevated ORMDL2 expression in GBM tissues which causes poor prognosis.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "41049440", "sentence_id": 3, "text": "Transcriptomic analyses across The Cancer Genome Atlas (TCGA), and Chinese Glioma Genome Atlas (CGGA) revealed elevated ORMDL2 expression in GBM tissues which causes poor prognosis."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41049440\", \"sentence_id\": 4, \"text\": \"The MetaCore pathway and Gene Set Enrichment Analysis (GSEA) identified ORMDL2's involvement in antigen presentation via a major histocompatibility complex I (MHC class I), unfolded protein response (UPR), and mitochondrial apoptotic signaling.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "41049440", "sentence_id": 4, "text": "The MetaCore pathway and Gene Set Enrichment Analysis (GSEA) identified ORMDL2's involvement in antigen presentation via a major histocompatibility complex I (MHC class I), unfolded protein response (UPR), and mitochondrial apoptotic signaling."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41049440\", \"sentence_id\": 5, \"text\": \"Single-cell RNA-sequencing data and the Human Protein Atlas showed ORMDL2 enrichment in tumor stromal cells.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "41049440", "sentence_id": 5, "text": "Single-cell RNA-sequencing data and the Human Protein Atlas showed ORMDL2 enrichment in tumor stromal cells."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41049440\", \"sentence_id\": 6, \"text\": \"Pharmacogenomic correlation via the Genomics in Drug Sensitivity in Cancer (GDSC) and Cancer Therapeutics Response Portal (CTRP) database suggested that ORMDL2 expression was associated with resistance to DNA damage response inhibitors such as etoposide, doxorubicin, talazoparib, and might interact with sphingolipid-targeting compounds.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "41049440", "sentence_id": 6, "text": "Pharmacogenomic correlation via the Genomics in Drug Sensitivity in Cancer (GDSC) and Cancer Therapeutics Response Portal (CTRP) database suggested that ORMDL2 expression was associated with resistance to DNA damage response inhibitors such as etoposide, doxorubicin, talazoparib, and might interact with sphingolipid-targeting compounds."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41049440\", \"sentence_id\": 7, \"text\": \"Collectively, our findings establish ORMDL2 as a multi-functional macromolecular regulator of immune suppression and therapeutic resistance in GBM, providing new mechanistic insights and potential targets for translational medicines.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "41049440", "sentence_id": 7, "text": "Collectively, our findings establish ORMDL2 as a multi-functional macromolecular regulator of immune suppression and therapeutic resistance in GBM, providing new mechanistic insights and potential targets for translational medicines."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40954422\", \"sentence_id\": 0, \"text\": \"Homologous recombination repair (HRR) is a DNA repair pathway that helps maintain genomic stability.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40954422", "sentence_id": 0, "text": "Homologous recombination repair (HRR) is a DNA repair pathway that helps maintain genomic stability."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40954422\", \"sentence_id\": 1, \"text\": \"About one quarter of patients with metastatic castration-resistant prostate cancer (mCRPC) have alterations in HRR genes.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40954422", "sentence_id": 1, "text": "About one quarter of patients with metastatic castration-resistant prostate cancer (mCRPC) have alterations in HRR genes."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40954422\", \"sentence_id\": 2, \"text\": \"For adult patients in the USA with mCRPC harboring HRR gene alterations, the combination of talazoparib plus enzalutamide is an approved treatment option.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40954422", "sentence_id": 2, "text": "For adult patients in the USA with mCRPC harboring HRR gene alterations, the combination of talazoparib plus enzalutamide is an approved treatment option."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40954422\", \"sentence_id\": 3, \"text\": \"The objective of this podcast, featuring two nurse practitioners, is to provide information for oncology nurses and advanced practice providers (APPs) on the use of talazoparib plus enzalutamide and its practical implementation aspects in the clinic.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40954422", "sentence_id": 3, "text": "The objective of this podcast, featuring two nurse practitioners, is to provide information for oncology nurses and advanced practice providers (APPs) on the use of talazoparib plus enzalutamide and its practical implementation aspects in the clinic."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40954422\", \"sentence_id\": 4, \"text\": \"We discuss the importance of testing for HRR gene alterations in mCRPC, appropriate dosing and administration, and our clinical experiences of adverse event monitoring and dose modifications as illustrative examples of the role of oncology nurses and APPs in the treatment of mCRPC with talazoparib plus enzalutamide.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40954422", "sentence_id": 4, "text": "We discuss the importance of testing for HRR gene alterations in mCRPC, appropriate dosing and administration, and our clinical experiences of adverse event monitoring and dose modifications as illustrative examples of the role of oncology nurses and APPs in the treatment of mCRPC with talazoparib plus enzalutamide."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40954422\", \"sentence_id\": 5, \"text\": \"Podcast and Infographic are available for this article.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40954422", "sentence_id": 5, "text": "Podcast and Infographic are available for this article."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40954422\", \"sentence_id\": 6, \"text\": \"Podcast Video (MP4 172565 KB).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40954422", "sentence_id": 6, "text": "Podcast Video (MP4 172565 KB)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40906325\", \"sentence_id\": 0, \"text\": \"As monotherapy, PARP inhibitors have little cytotoxic effect in tumors without homologous recombinant repair (HRR) alterations.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40906325", "sentence_id": 0, "text": "As monotherapy, PARP inhibitors have little cytotoxic effect in tumors without homologous recombinant repair (HRR) alterations."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40906325\", \"sentence_id\": 1, \"text\": \"Supported by preclinical models, we hypothesized that the PARP inhibitor talazoparib in combination with temozolomide chemotherapy could induce DNA damage leading to cell death and tumor response in patients with metastatic castration-resistant prostate cancer (mCRPC) without HRR alterations.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40906325", "sentence_id": 1, "text": "Supported by preclinical models, we hypothesized that the PARP inhibitor talazoparib in combination with temozolomide chemotherapy could induce DNA damage leading to cell death and tumor response in patients with metastatic castration-resistant prostate cancer (mCRPC) without HRR alterations."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40906325\", \"sentence_id\": 2, \"text\": \"In this phase 1b/2 trial (NCT04019327; registration date July 11, 2019), patients with progressive mCRPC without HRR mutations who failed at least one androgen receptor signaling inhibitor were enrolled in escalating doses of intermittent talazoparib plus temozolomide to determine the maximum tolerated dose and recommended phase 2 dose (RP2D) in Phase 1b.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40906325", "sentence_id": 2, "text": "In this phase 1b/2 trial (NCT04019327; registration date July 11, 2019), patients with progressive mCRPC without HRR mutations who failed at least one androgen receptor signaling inhibitor were enrolled in escalating doses of intermittent talazoparib plus temozolomide to determine the maximum tolerated dose and recommended phase 2 dose (RP2D) in Phase 1b."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40906325\", \"sentence_id\": 3, \"text\": \"Phase 2 used a composite endpoint of overall response per RECIST v1.1, 50% decline in prostate-specific antigen (PSA), and/or circulating tumor cells (CTC) conversion from\u2009\u2265\u20091 cell/7.5\u00a0mL to 0.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40906325", "sentence_id": 3, "text": "Phase 2 used a composite endpoint of overall response per RECIST v1.1, 50% decline in prostate-specific antigen (PSA), and/or circulating tumor cells (CTC) conversion from\u2009\u2265\u20091 cell/7.5\u00a0mL to 0."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40906325\", \"sentence_id\": 4, \"text\": \"Sixteen patients were enrolled across 4 dose levels.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40906325", "sentence_id": 4, "text": "Sixteen patients were enrolled across 4 dose levels."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40906325\", \"sentence_id\": 5, \"text\": \"The most common adverse events were thrombocytopenia, neutropenia, anemia, fatigue, and nausea.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40906325", "sentence_id": 5, "text": "The most common adverse events were thrombocytopenia, neutropenia, anemia, fatigue, and nausea."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40906325\", \"sentence_id\": 6, \"text\": \"In phase 1b, one patient receiving talazoparib 1\u00a0mg and temozolomide 75\u00a0mg/m\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40906325", "sentence_id": 6, "text": "In phase 1b, one patient receiving talazoparib 1\u00a0mg and temozolomide 75\u00a0mg/m"}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40874518\", \"sentence_id\": 0, \"text\": \"Pancreatic ductal adenocarcinoma (PDAC) is a highly fatal disease with limited treatment options.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40874518", "sentence_id": 0, "text": "Pancreatic ductal adenocarcinoma (PDAC) is a highly fatal disease with limited treatment options."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40874518\", \"sentence_id\": 1, \"text\": \"PARP inhibitors (PARPi) have shown promise in treating PDAC with homologous recombination deficiency (HRD), but rapid acquisition of resistance limits their efficacy.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40874518", "sentence_id": 1, "text": "PARP inhibitors (PARPi) have shown promise in treating PDAC with homologous recombination deficiency (HRD), but rapid acquisition of resistance limits their efficacy."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40874518\", \"sentence_id\": 2, \"text\": \"Our objective is to investigate mechanisms of resistance to PARPi in BRCA2-mutant PDAC cells and identify potential therapeutic targets to modulate this resistance.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40874518", "sentence_id": 2, "text": "Our objective is to investigate mechanisms of resistance to PARPi in BRCA2-mutant PDAC cells and identify potential therapeutic targets to modulate this resistance."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40874518\", \"sentence_id\": 3, \"text\": \"We developed olaparib- and talazoparib-resistant Capan-1 cell lines and characterised their resistance profiles using viability assays, RNA sequencing and metabolomic profiling.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40874518", "sentence_id": 3, "text": "We developed olaparib- and talazoparib-resistant Capan-1 cell lines and characterised their resistance profiles using viability assays, RNA sequencing and metabolomic profiling."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40874518\", \"sentence_id\": 4, \"text\": \"We also developed a cisplatin-resistant Capan-1 cell line to compare resistance mechanisms between PARPi and platinum agents.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40874518", "sentence_id": 4, "text": "We also developed a cisplatin-resistant Capan-1 cell line to compare resistance mechanisms between PARPi and platinum agents."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40874518\", \"sentence_id\": 5, \"text\": \"Both olaparib- and talazoparib-resistant cells showed cross-resistance to other PARPi and oxaliplatin, but not to gemcitabine or 5-FU.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40874518", "sentence_id": 5, "text": "Both olaparib- and talazoparib-resistant cells showed cross-resistance to other PARPi and oxaliplatin, but not to gemcitabine or 5-FU."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40874518\", \"sentence_id\": 6, \"text\": \"Talazoparib-resistant cells exhibited a similar resistance profile to cisplatin-resistant cells, including decreased PARP1 expression and altered metabolomic profiles.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40874518", "sentence_id": 6, "text": "Talazoparib-resistant cells exhibited a similar resistance profile to cisplatin-resistant cells, including decreased PARP1 expression and altered metabolomic profiles."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40874518\", \"sentence_id\": 7, \"text\": \"RNA sequencing and metabolomic profiling revealed significant enrichment of metabolic pathways, including oxidative phosphorylation and glycolysis, in resistant cells.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40874518", "sentence_id": 7, "text": "RNA sequencing and metabolomic profiling revealed significant enrichment of metabolic pathways, including oxidative phosphorylation and glycolysis, in resistant cells."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40874518\", \"sentence_id\": 8, \"text\": \"Our study highlights the complexity of resistance mechanisms to PARPi in PDAC and identifies potential therapeutic targets in metabolism.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40874518", "sentence_id": 8, "text": "Our study highlights the complexity of resistance mechanisms to PARPi in PDAC and identifies potential therapeutic targets in metabolism."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40874518\", \"sentence_id\": 9, \"text\": \"The differences in the resistance profiles between olaparib and talazoparib suggest that PARP-trapping potency may play a role in resistance development.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40874518", "sentence_id": 9, "text": "The differences in the resistance profiles between olaparib and talazoparib suggest that PARP-trapping potency may play a role in resistance development."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40874518\", \"sentence_id\": 10, \"text\": \"Further research is needed to validate these findings and explore novel therapeutic strategies to overcome resistance to PARPi in PDAC.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40874518", "sentence_id": 10, "text": "Further research is needed to validate these findings and explore novel therapeutic strategies to overcome resistance to PARPi in PDAC."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40873813\", \"sentence_id\": 0, \"text\": \"BACKGROUND: The phase III TALAPRO-2 trial established that combining talazoparib (TALA) with enzalutamide significantly extends progression-free survival (PFS) and overall survival in metastatic castration-resistant prostate cancer (mCRPC) patients.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40873813", "sentence_id": 0, "text": "BACKGROUND: The phase III TALAPRO-2 trial established that combining talazoparib (TALA) with enzalutamide significantly extends progression-free survival (PFS) and overall survival in metastatic castration-resistant prostate cancer (mCRPC) patients."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40873813\", \"sentence_id\": 1, \"text\": \"Given the substantial cost implications of novel targeted therapies, economic evaluation is essential to determine whether the clinical benefits of this regimen justify its expense in the first-line mCRPC setting.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40873813", "sentence_id": 1, "text": "Given the substantial cost implications of novel targeted therapies, economic evaluation is essential to determine whether the clinical benefits of this regimen justify its expense in the first-line mCRPC setting."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40873813\", \"sentence_id\": 2, \"text\": \"OBJECTIVES: To evaluate the cost-effectiveness of talazoparib plus enzalutamide versus enzalutamide monotherapy as first-line treatment for mCRPC, informing clinical decision-making and healthcare resource allocation.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40873813", "sentence_id": 2, "text": "OBJECTIVES: To evaluate the cost-effectiveness of talazoparib plus enzalutamide versus enzalutamide monotherapy as first-line treatment for mCRPC, informing clinical decision-making and healthcare resource allocation."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40873813\", \"sentence_id\": 3, \"text\": \"DESIGN: A Markov model-based cost-effectiveness analysis.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40873813", "sentence_id": 3, "text": "DESIGN: A Markov model-based cost-effectiveness analysis."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40873813\", \"sentence_id\": 4, \"text\": \"METHODS: Based on data from the TALAPRO-2 trial, a dynamic Markov model was constructed to simulate disease progression in mCRPC patients.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40873813", "sentence_id": 4, "text": "METHODS: Based on data from the TALAPRO-2 trial, a dynamic Markov model was constructed to simulate disease progression in mCRPC patients."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40873813\", \"sentence_id\": 5, \"text\": \"From the perspectives of U.S.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40873813", "sentence_id": 5, "text": "From the perspectives of U.S."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40873813\", \"sentence_id\": 6, \"text\": \"and Chinese payers, total costs, quality-adjusted life years (QALYs), and incremental cost-effectiveness ratios (ICER) were considered as the primary outputs in the model.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40873813", "sentence_id": 6, "text": "and Chinese payers, total costs, quality-adjusted life years (QALYs), and incremental cost-effectiveness ratios (ICER) were considered as the primary outputs in the model."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40873813\", \"sentence_id\": 7, \"text\": \"One-way sensitivity analysis and probabilistic sensitivity analysis were used to validate the robustness of the model.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40873813", "sentence_id": 7, "text": "One-way sensitivity analysis and probabilistic sensitivity analysis were used to validate the robustness of the model."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40873813\", \"sentence_id\": 8, \"text\": \"Price reduction analysis provided an evidence-based basis for drug pricing and health insurance negotiations by quantifying the impact of price adjustments on economics.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40873813", "sentence_id": 8, "text": "Price reduction analysis provided an evidence-based basis for drug pricing and health insurance negotiations by quantifying the impact of price adjustments on economics."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40873813\", \"sentence_id\": 9, \"text\": \"RESULTS: In the base-case analysis, the ICERs for talazoparib plus enzalutamide were $646,743.72/QALY and $57,635.76/QALY from the U.S.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40873813", "sentence_id": 9, "text": "RESULTS: In the base-case analysis, the ICERs for talazoparib plus enzalutamide were $646,743.72/QALY and $57,635.76/QALY from the U.S."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40873813\", \"sentence_id\": 10, \"text\": \"and China perspectives, respectively, which were above the willingness-to-pay thresholds ($150,000 in the U.S.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40873813", "sentence_id": 10, "text": "and China perspectives, respectively, which were above the willingness-to-pay thresholds ($150,000 in the U.S."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40873813\", \"sentence_id\": 11, \"text\": \"and $40,334 in China).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40873813", "sentence_id": 11, "text": "and $40,334 in China)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40873813\", \"sentence_id\": 12, \"text\": \"Sensitivity analyses showed that the utility of PFS and drug prices impacted the results most.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40873813", "sentence_id": 12, "text": "Sensitivity analyses showed that the utility of PFS and drug prices impacted the results most."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40873813\", \"sentence_id\": 13, \"text\": \"Price adjustment scenarios showed that China needed a 34.5% price reduction to achieve affordability, whereas the U.S.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40873813", "sentence_id": 13, "text": "Price adjustment scenarios showed that China needed a 34.5% price reduction to achieve affordability, whereas the U.S."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40873813\", \"sentence_id\": 14, \"text\": \"remained unaffordable even with an 80% price reduction.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40873813", "sentence_id": 14, "text": "remained unaffordable even with an 80% price reduction."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40873813\", \"sentence_id\": 15, \"text\": \"CONCLUSION: At current pricing, talazoparib plus enzalutamide as first-line treatment of patients with mCRPC is not cost-effective in either the U.S.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40873813", "sentence_id": 15, "text": "CONCLUSION: At current pricing, talazoparib plus enzalutamide as first-line treatment of patients with mCRPC is not cost-effective in either the U.S."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40873813\", \"sentence_id\": 16, \"text\": \"or China.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40873813", "sentence_id": 16, "text": "or China."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40873813\", \"sentence_id\": 17, \"text\": \"The study supports differentiated pricing strategies to balance clinical benefits with the rational allocation of healthcare resources.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40873813", "sentence_id": 17, "text": "The study supports differentiated pricing strategies to balance clinical benefits with the rational allocation of healthcare resources."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40848312\", \"sentence_id\": 0, \"text\": \"Prostate cancer (PC) is the second most common cancer and the fifth leading cause of cancer mortality in men, worldwide.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40848312", "sentence_id": 0, "text": "Prostate cancer (PC) is the second most common cancer and the fifth leading cause of cancer mortality in men, worldwide."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40848312\", \"sentence_id\": 1, \"text\": \"Genomic analysis identified alterations in DNA damage repair (DDR) pathways, in up to 30% of metastatic castration-resistant prostate cancer (mCRPC).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40848312", "sentence_id": 1, "text": "Genomic analysis identified alterations in DNA damage repair (DDR) pathways, in up to 30% of metastatic castration-resistant prostate cancer (mCRPC)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40848312\", \"sentence_id\": 2, \"text\": \"Homologous recombination repair (HRR) mutations in BRCA1/2 emerged as a relevant biomarker in PC, linked to aggressive behavior, unfavorable outcomes and notable responses to poly-ADP ribose polymerase inhibitors (PARPi).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40848312", "sentence_id": 2, "text": "Homologous recombination repair (HRR) mutations in BRCA1/2 emerged as a relevant biomarker in PC, linked to aggressive behavior, unfavorable outcomes and notable responses to poly-ADP ribose polymerase inhibitors (PARPi)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40848312\", \"sentence_id\": 3, \"text\": \"While PARPi efficacy in BRCA-mutated mCRPC is well established, their role in earlier disease stages is currently under investigation.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40848312", "sentence_id": 3, "text": "While PARPi efficacy in BRCA-mutated mCRPC is well established, their role in earlier disease stages is currently under investigation."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40848312\", \"sentence_id\": 4, \"text\": \"This non-systematic narrative review aims to summarize current evidence on PARPi in PC, outlining approved indications, ongoing clinical trials, and emerging therapeutic strategies across different disease settings.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40848312", "sentence_id": 4, "text": "This non-systematic narrative review aims to summarize current evidence on PARPi in PC, outlining approved indications, ongoing clinical trials, and emerging therapeutic strategies across different disease settings."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40683290\", \"sentence_id\": 0, \"text\": \"BACKGROUND: The primary analysis of this phase 3 trial combining talazoparib with enzalutamide demonstrated significantly improved radiographic progression-free survival (rPFS) versus enzalutamide plus placebo in patients with metastatic castration-resistant prostate cancer unselected for homologous recombination repair (HRR) gene alterations.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40683290", "sentence_id": 0, "text": "BACKGROUND: The primary analysis of this phase 3 trial combining talazoparib with enzalutamide demonstrated significantly improved radiographic progression-free survival (rPFS) versus enzalutamide plus placebo in patients with metastatic castration-resistant prostate cancer unselected for homologous recombination repair (HRR) gene alterations."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40683290\", \"sentence_id\": 1, \"text\": \"Overall survival data were immature at that time.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40683290", "sentence_id": 1, "text": "Overall survival data were immature at that time."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40683290\", \"sentence_id\": 2, \"text\": \"Here we report the final prespecified overall survival analysis, an updated descriptive analysis of rPFS, and safety in the cohort unselected for HRR gene alterations.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40683290", "sentence_id": 2, "text": "Here we report the final prespecified overall survival analysis, an updated descriptive analysis of rPFS, and safety in the cohort unselected for HRR gene alterations."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40683290\", \"sentence_id\": 3, \"text\": \"METHODS: TALAPRO-2 was a randomised, double-blind, placebo-controlled, phase 3 trial.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40683290", "sentence_id": 3, "text": "METHODS: TALAPRO-2 was a randomised, double-blind, placebo-controlled, phase 3 trial."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40683290\", \"sentence_id\": 4, \"text\": \"In the genetically unselected cohort, patients were randomly assigned from 200 centres, including hospitals, cancer centres, and medical centres, in 26 countries in North America, Europe, Israel, South America, South Africa, and the Asia-Pacific region.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40683290", "sentence_id": 4, "text": "In the genetically unselected cohort, patients were randomly assigned from 200 centres, including hospitals, cancer centres, and medical centres, in 26 countries in North America, Europe, Israel, South America, South Africa, and the Asia-Pacific region."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40683290\", \"sentence_id\": 5, \"text\": \"Adult men (aged \u226518 years [\u226520 years in Japan]) with asymptomatic or mildly symptomatic metastatic castration-resistant prostate cancer receiving ongoing androgen deprivation therapy, and with no previous life-prolonging systemic therapy for castration-resistant prostate cancer, were randomly assigned (1:1) to talazoparib 0\u00b75 mg plus enzalutamide 160 mg or enzalutamide plus placebo, administered orally once daily as initial treatment for metastatic castration-resistant prostate cancer, stratified by HRR gene alteration status (HRR-deficient vs HRR-non-deficient or unknown) and previous treatment for castration-sensitive disease (yes vs no).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40683290", "sentence_id": 5, "text": "Adult men (aged \u226518 years [\u226520 years in Japan]) with asymptomatic or mildly symptomatic metastatic castration-resistant prostate cancer receiving ongoing androgen deprivation therapy, and with no previous life-prolonging systemic therapy for castration-resistant prostate cancer, were randomly assigned (1:1) to talazoparib 0\u00b75 mg plus enzalutamide 160 mg or enzalutamide plus placebo, administered orally once daily as initial treatment for metastatic castration-resistant prostate cancer, stratified by HRR gene alteration status (HRR-deficient vs HRR-non-deficient or unknown) and previous treatment for castration-sensitive disease (yes vs no)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40683290\", \"sentence_id\": 6, \"text\": \"The sponsor, patients, and investigators were masked to talazoparib or placebo, and enzalutamide was open label.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40683290", "sentence_id": 6, "text": "The sponsor, patients, and investigators were masked to talazoparib or placebo, and enzalutamide was open label."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40683290\", \"sentence_id\": 7, \"text\": \"The primary endpoint was rPFS by blinded independent central review, and overall survival (time from randomisation to death due to any cause) was an event-based \u03b1-protected key secondary endpoint (\u03b1-threshold at final overall survival analysis was 0\u00b7022 [two-sided])-both assessed in the intention-to-treat population.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40683290", "sentence_id": 7, "text": "The primary endpoint was rPFS by blinded independent central review, and overall survival (time from randomisation to death due to any cause) was an event-based \u03b1-protected key secondary endpoint (\u03b1-threshold at final overall survival analysis was 0\u00b7022 [two-sided])-both assessed in the intention-to-treat population."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40683290\", \"sentence_id\": 8, \"text\": \"Follow-up for overall survival was intended to continue until the planned final analysis.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40683290", "sentence_id": 8, "text": "Follow-up for overall survival was intended to continue until the planned final analysis."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40683290\", \"sentence_id\": 9, \"text\": \"Safety was assessed in patients who received at least one dose of a study drug.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40683290", "sentence_id": 9, "text": "Safety was assessed in patients who received at least one dose of a study drug."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40683290\", \"sentence_id\": 10, \"text\": \"This study is registered with ClinicalTrials.gov, NCT03395197, and is ongoing.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40683290", "sentence_id": 10, "text": "This study is registered with ClinicalTrials.gov, NCT03395197, and is ongoing."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40683290\", \"sentence_id\": 11, \"text\": \"FINDINGS: Between Jan 7, 2019, and Sept 17, 2020, 993 patients were assessed for eligibility, of whom 188 (19%) patients were excluded and 805 (81%) patients were enrolled and randomly assigned (402 [50%] to talazoparib plus enzalutamide, 403 [50%] to enzalutamide plus placebo).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40683290", "sentence_id": 11, "text": "FINDINGS: Between Jan 7, 2019, and Sept 17, 2020, 993 patients were assessed for eligibility, of whom 188 (19%) patients were excluded and 805 (81%) patients were enrolled and randomly assigned (402 [50%] to talazoparib plus enzalutamide, 403 [50%] to enzalutamide plus placebo)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40683290\", \"sentence_id\": 12, \"text\": \"At a median follow-up of 52\u00b75 months (IQR 48\u00b76-56\u00b70), overall survival was significantly improved with talazoparib plus enzalutamide compared with enzalutamide plus placebo (hazard ratio [HR] 0\u00b780 [95% CI 0\u00b766-0\u00b796]; p=0\u00b7016); median overall survival was 45\u00b78 months (95% CI 39\u00b74-50\u00b78) in the talazoparib group compared with 37\u00b70 months (34\u00b71-40\u00b74) in the control group.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40683290", "sentence_id": 12, "text": "At a median follow-up of 52\u00b75 months (IQR 48\u00b76-56\u00b70), overall survival was significantly improved with talazoparib plus enzalutamide compared with enzalutamide plus placebo (hazard ratio [HR] 0\u00b780 [95% CI 0\u00b766-0\u00b796]; p=0\u00b7016); median overall survival was 45\u00b78 months (95% CI 39\u00b74-50\u00b78) in the talazoparib group compared with 37\u00b70 months (34\u00b71-40\u00b74) in the control group."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40683290\", \"sentence_id\": 13, \"text\": \"Overall survival favoured talazoparib plus enzalutamide over enzalutamide plus placebo in HRR-deficient patients (n=169; HR 0\u00b755 [0\u00b736-0\u00b783]; p=0\u00b70035) and to a lesser extent in HRR-non-deficient or unknown patients (n=636; HR 0\u00b788 [0\u00b771-1\u00b708]; p=0\u00b722).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40683290", "sentence_id": 13, "text": "Overall survival favoured talazoparib plus enzalutamide over enzalutamide plus placebo in HRR-deficient patients (n=169; HR 0\u00b755 [0\u00b736-0\u00b783]; p=0\u00b70035) and to a lesser extent in HRR-non-deficient or unknown patients (n=636; HR 0\u00b788 [0\u00b771-1\u00b708]; p=0\u00b722)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40683290\", \"sentence_id\": 14, \"text\": \"Updated rPFS also favoured talazoparib plus enzalutamide (HR 0\u00b767 [0\u00b755-0\u00b781]; p<0\u00b70001); median rPFS was 33\u00b71 months for talazoparib plus enzalutamide versus 19\u00b75 months for enzalutamide plus placebo.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40683290", "sentence_id": 14, "text": "Updated rPFS also favoured talazoparib plus enzalutamide (HR 0\u00b767 [0\u00b755-0\u00b781]; p<0\u00b70001); median rPFS was 33\u00b71 months for talazoparib plus enzalutamide versus 19\u00b75 months for enzalutamide plus placebo."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40683290\", \"sentence_id\": 15, \"text\": \"Safety was consistent with the known profile of talazoparib; common grade 3 or higher adverse events with talazoparib plus enzalutamide were anaemia (195 [49%] vs 18 [4%] patients with enzalutamide plus placebo) and neutropenia (77 [19%] vs six [1%] patients with enzalutamide plus placebo).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40683290", "sentence_id": 15, "text": "Safety was consistent with the known profile of talazoparib; common grade 3 or higher adverse events with talazoparib plus enzalutamide were anaemia (195 [49%] vs 18 [4%] patients with enzalutamide plus placebo) and neutropenia (77 [19%] vs six [1%] patients with enzalutamide plus placebo)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40683290\", \"sentence_id\": 16, \"text\": \"INTERPRETATION: Combining talazoparib with enzalutamide significantly improved overall survival in patients with metastatic castration-resistant prostate cancer, supporting this combination as a standard-of-care initial treatment option for these patients.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40683290", "sentence_id": 16, "text": "INTERPRETATION: Combining talazoparib with enzalutamide significantly improved overall survival in patients with metastatic castration-resistant prostate cancer, supporting this combination as a standard-of-care initial treatment option for these patients."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40683290\", \"sentence_id\": 17, \"text\": \"FUNDING: Pfizer.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40683290", "sentence_id": 17, "text": "FUNDING: Pfizer."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40683287\", \"sentence_id\": 0, \"text\": \"BACKGROUND: Metastatic castration-resistant prostate cancer remains incurable and is particularly aggressive in patients with alterations in DNA damage repair genes involved directly or indirectly in homologous recombination repair (HRR).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40683287", "sentence_id": 0, "text": "BACKGROUND: Metastatic castration-resistant prostate cancer remains incurable and is particularly aggressive in patients with alterations in DNA damage repair genes involved directly or indirectly in homologous recombination repair (HRR)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40683287\", \"sentence_id\": 1, \"text\": \"In the primary analysis of TALAPRO-2, talazoparib plus enzalutamide significantly improved radiographic progression-free survival (rPFS) versus enzalutamide plus placebo in patients with metastatic castration-resistant prostate cancer harbouring HRR gene alterations.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40683287", "sentence_id": 1, "text": "In the primary analysis of TALAPRO-2, talazoparib plus enzalutamide significantly improved radiographic progression-free survival (rPFS) versus enzalutamide plus placebo in patients with metastatic castration-resistant prostate cancer harbouring HRR gene alterations."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40683287\", \"sentence_id\": 2, \"text\": \"At primary analysis, overall survival was immature.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40683287", "sentence_id": 2, "text": "At primary analysis, overall survival was immature."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40683287\", \"sentence_id\": 3, \"text\": \"Here we report final prespecified overall survival analysis, updated rPFS, safety, and patient-reported outcomes in the HRR-deficient cohort of TALAPRO-2.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40683287", "sentence_id": 3, "text": "Here we report final prespecified overall survival analysis, updated rPFS, safety, and patient-reported outcomes in the HRR-deficient cohort of TALAPRO-2."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40683287\", \"sentence_id\": 4, \"text\": \"METHODS: TALAPRO-2 is an ongoing international, randomised, double-blind, placebo-controlled phase 3 trial.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40683287", "sentence_id": 4, "text": "METHODS: TALAPRO-2 is an ongoing international, randomised, double-blind, placebo-controlled phase 3 trial."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40683287\", \"sentence_id\": 5, \"text\": \"The HRR-deficient cohort included randomly assigned patients from 142 hospitals, cancer centres, and medical centres in 26 countries; the study included men aged at least 18 years (\u226520 years in Japan) with asymptomatic or mildly symptomatic metastatic castration-resistant prostate cancer, progressive disease at study entry, and no previous life-prolonging systemic therapy for castration-resistant prostate cancer, but were receiving ongoing androgen deprivation therapy.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40683287", "sentence_id": 5, "text": "The HRR-deficient cohort included randomly assigned patients from 142 hospitals, cancer centres, and medical centres in 26 countries; the study included men aged at least 18 years (\u226520 years in Japan) with asymptomatic or mildly symptomatic metastatic castration-resistant prostate cancer, progressive disease at study entry, and no previous life-prolonging systemic therapy for castration-resistant prostate cancer, but were receiving ongoing androgen deprivation therapy."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40683287\", \"sentence_id\": 6, \"text\": \"Patients were prospectively assessed for tumour HRR gene alterations and randomly assigned (1:1) to once-daily oral talazoparib 0\u00b75 mg plus enzalutamide 160 mg or enzalutamide plus placebo stratified by prior treatment (yes vs no) for castration-sensitive disease.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40683287", "sentence_id": 6, "text": "Patients were prospectively assessed for tumour HRR gene alterations and randomly assigned (1:1) to once-daily oral talazoparib 0\u00b75 mg plus enzalutamide 160 mg or enzalutamide plus placebo stratified by prior treatment (yes vs no) for castration-sensitive disease."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40683287\", \"sentence_id\": 7, \"text\": \"The sponsor, patients, and investigators were masked to talazoparib or placebo, whereas enzalutamide was open label.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40683287", "sentence_id": 7, "text": "The sponsor, patients, and investigators were masked to talazoparib or placebo, whereas enzalutamide was open label."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40683287\", \"sentence_id\": 8, \"text\": \"The primary endpoint was rPFS (time from randomisation to radiographic progression or death, whichever occurred first) by blinded independent central review, and overall survival (time from randomisation to death due to any cause) was a key alpha-protected secondary endpoint, both assessed in the intention-to-treat population.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40683287", "sentence_id": 8, "text": "The primary endpoint was rPFS (time from randomisation to radiographic progression or death, whichever occurred first) by blinded independent central review, and overall survival (time from randomisation to death due to any cause) was a key alpha-protected secondary endpoint, both assessed in the intention-to-treat population."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40683287\", \"sentence_id\": 9, \"text\": \"Follow-up for overall survival was intended to continue until the planned final analysis.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40683287", "sentence_id": 9, "text": "Follow-up for overall survival was intended to continue until the planned final analysis."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40683287\", \"sentence_id\": 10, \"text\": \"For statistical significance at the final overall survival analysis, the two-sided p value from the stratified log-rank test needed to be 0\u00b7024 or less based on a group sequential design with O'Brien-Fleming spending function.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40683287", "sentence_id": 10, "text": "For statistical significance at the final overall survival analysis, the two-sided p value from the stratified log-rank test needed to be 0\u00b7024 or less based on a group sequential design with O'Brien-Fleming spending function."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40683287\", \"sentence_id\": 11, \"text\": \"Safety was assessed in patients who had received at least one study drug dose.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40683287", "sentence_id": 11, "text": "Safety was assessed in patients who had received at least one study drug dose."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40683287\", \"sentence_id\": 12, \"text\": \"The trial is registered with ClinicalTrials.gov, NCT03395197.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40683287", "sentence_id": 12, "text": "The trial is registered with ClinicalTrials.gov, NCT03395197."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40683287\", \"sentence_id\": 13, \"text\": \"FINDINGS: Between Dec 18, 2018, and Jan 20, 2022, 399 patients with HRR-deficient metastatic castration-resistant prostate cancer were randomly assigned (200 [50%] to talazoparib plus enzalutamide and 199 [50%] to enzalutamide plus placebo).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40683287", "sentence_id": 13, "text": "FINDINGS: Between Dec 18, 2018, and Jan 20, 2022, 399 patients with HRR-deficient metastatic castration-resistant prostate cancer were randomly assigned (200 [50%] to talazoparib plus enzalutamide and 199 [50%] to enzalutamide plus placebo)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40683287\", \"sentence_id\": 14, \"text\": \"At a median follow-up of 44\u00b72 months (IQR 36\u00b70-50\u00b78), treatment with talazoparib plus enzalutamide resulted in a statistically significant improvement in overall survival versus enzalutamide (hazard ratio [HR] 0\u00b762 [95% CI 0\u00b748-0\u00b781]; two-sided p=0\u00b70005); median overall survival 45\u00b71 months (95% CI 35\u00b74-not reached) in the talazoparib group versus 31\u00b71 months (27\u00b73-35\u00b74) in the control group.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40683287", "sentence_id": 14, "text": "At a median follow-up of 44\u00b72 months (IQR 36\u00b70-50\u00b78), treatment with talazoparib plus enzalutamide resulted in a statistically significant improvement in overall survival versus enzalutamide (hazard ratio [HR] 0\u00b762 [95% CI 0\u00b748-0\u00b781]; two-sided p=0\u00b70005); median overall survival 45\u00b71 months (95% CI 35\u00b74-not reached) in the talazoparib group versus 31\u00b71 months (27\u00b73-35\u00b74) in the control group."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40683287\", \"sentence_id\": 15, \"text\": \"In the subgroup of patients with BRCA1/2 alterations (n=155 [39%]), median overall survival was not reached for talazoparib plus enzalutamide versus 28\u00b75 months for enzalutamide (HR 0\u00b750 [95% CI 0\u00b732-0\u00b778]; p=0\u00b70017); 4-year overall survival rates were 53% in the talazoparib group versus 23% in the control group.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40683287", "sentence_id": 15, "text": "In the subgroup of patients with BRCA1/2 alterations (n=155 [39%]), median overall survival was not reached for talazoparib plus enzalutamide versus 28\u00b75 months for enzalutamide (HR 0\u00b750 [95% CI 0\u00b732-0\u00b778]; p=0\u00b70017); 4-year overall survival rates were 53% in the talazoparib group versus 23% in the control group."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40683287\", \"sentence_id\": 16, \"text\": \"In patients without BRCA1/2 alterations (n=244 [61%]), median overall survival was 42\u00b74 months for talazoparib plus enzalutamide versus 32\u00b76 months for enzalutamide (HR 0\u00b773 [95% CI 0\u00b752-1\u00b702]; p=0\u00b7066).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40683287", "sentence_id": 16, "text": "In patients without BRCA1/2 alterations (n=244 [61%]), median overall survival was 42\u00b74 months for talazoparib plus enzalutamide versus 32\u00b76 months for enzalutamide (HR 0\u00b773 [95% CI 0\u00b752-1\u00b702]; p=0\u00b7066)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40683287\", \"sentence_id\": 17, \"text\": \"Updated rPFS favoured talazoparib plus enzalutamide versus enzalutamide (HR 0\u00b747 [95% CI 0\u00b736-0\u00b761]; p<0\u00b70001; median rPFS 30\u00b77 vs 12\u00b73 months).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40683287", "sentence_id": 17, "text": "Updated rPFS favoured talazoparib plus enzalutamide versus enzalutamide (HR 0\u00b747 [95% CI 0\u00b736-0\u00b761]; p<0\u00b70001; median rPFS 30\u00b77 vs 12\u00b73 months)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40683287\", \"sentence_id\": 18, \"text\": \"No new safety signals were identified; most common adverse events of grade 3 or higher with talazoparib plus enzalutamide were anaemia (86 [43%] patients) and neutropenia (39 [20%] patients).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40683287", "sentence_id": 18, "text": "No new safety signals were identified; most common adverse events of grade 3 or higher with talazoparib plus enzalutamide were anaemia (86 [43%] patients) and neutropenia (39 [20%] patients)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40683287\", \"sentence_id\": 19, \"text\": \"INTERPRETATION: Talazoparib plus enzalutamide resulted in statistically significant and clinically meaningful improvement in survival versus enzalutamide plus placebo, further supporting this combination as a standard of care in HRR-deficient metastatic castration-resistant prostate cancer.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40683287", "sentence_id": 19, "text": "INTERPRETATION: Talazoparib plus enzalutamide resulted in statistically significant and clinically meaningful improvement in survival versus enzalutamide plus placebo, further supporting this combination as a standard of care in HRR-deficient metastatic castration-resistant prostate cancer."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40683287\", \"sentence_id\": 20, \"text\": \"FUNDING: Pfizer.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40683287", "sentence_id": 20, "text": "FUNDING: Pfizer."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40661990\", \"sentence_id\": 0, \"text\": \"BACKGROUND: Talazoparib plus enzalutamide showed significant improvement of progression-free survival in metastatic castration-resistant prostate cancer (mCRPC) patients with alterations in homologous recombination repair (HRR) genes.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40661990", "sentence_id": 0, "text": "BACKGROUND: Talazoparib plus enzalutamide showed significant improvement of progression-free survival in metastatic castration-resistant prostate cancer (mCRPC) patients with alterations in homologous recombination repair (HRR) genes."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40661990\", \"sentence_id\": 1, \"text\": \"OBJECTIVES: This study aimed to evaluate the cost-effectiveness of HRR status-guided use of talazoparib plus enzalutamide in patients with mCRPC from the U.S.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40661990", "sentence_id": 1, "text": "OBJECTIVES: This study aimed to evaluate the cost-effectiveness of HRR status-guided use of talazoparib plus enzalutamide in patients with mCRPC from the U.S."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40661990\", \"sentence_id\": 2, \"text\": \"payer perspective.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40661990", "sentence_id": 2, "text": "payer perspective."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40661990\", \"sentence_id\": 3, \"text\": \"DESIGN: A partitioned survival model was used to simulate outcomes of a hypothetical cohort of mCRPC patients.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40661990", "sentence_id": 3, "text": "DESIGN: A partitioned survival model was used to simulate outcomes of a hypothetical cohort of mCRPC patients."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40661990\", \"sentence_id\": 4, \"text\": \"METHODS: Three treatment strategies were evaluated: (1) talazoparib plus enzalutamide for HRR-deficient patients and enzalutamide for non-HRR-deficient patients (HRR-guided talazoparib plus enzalutamide), (2) talazoparib plus enzalutamide for patients with or without HRR deficiency (empirical talazoparib plus enzalutamide), and (3) enzalutamide for patients with or without HRR deficiency (empirical enzalutamide).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40661990", "sentence_id": 4, "text": "METHODS: Three treatment strategies were evaluated: (1) talazoparib plus enzalutamide for HRR-deficient patients and enzalutamide for non-HRR-deficient patients (HRR-guided talazoparib plus enzalutamide), (2) talazoparib plus enzalutamide for patients with or without HRR deficiency (empirical talazoparib plus enzalutamide), and (3) enzalutamide for patients with or without HRR deficiency (empirical enzalutamide)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40661990\", \"sentence_id\": 5, \"text\": \"Primary outcomes were direct medical costs, life-years (LYs), quality-adjusted life-years (QALYs), and incremental cost per QALY gained (incremental cost-effectiveness ratio, ICER).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40661990", "sentence_id": 5, "text": "Primary outcomes were direct medical costs, life-years (LYs), quality-adjusted life-years (QALYs), and incremental cost per QALY gained (incremental cost-effectiveness ratio, ICER)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40661990\", \"sentence_id\": 6, \"text\": \"Sensitivity analyses were performed to examine the robustness of model results.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40661990", "sentence_id": 6, "text": "Sensitivity analyses were performed to examine the robustness of model results."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40661990\", \"sentence_id\": 7, \"text\": \"RESULTS: In base-case analysis, the empirical enzalutamide strategy had the lowest cost and QALYs gained (US$752,383; 2.4764 QALYs), followed by HRR-guided talazoparib plus enzalutamide (US$878,517; 2.6490 QALYs), and empirical talazoparib plus enzalutamide (US$1,201,221; 2.8418 QALYs).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40661990", "sentence_id": 7, "text": "RESULTS: In base-case analysis, the empirical enzalutamide strategy had the lowest cost and QALYs gained (US$752,383; 2.4764 QALYs), followed by HRR-guided talazoparib plus enzalutamide (US$878,517; 2.6490 QALYs), and empirical talazoparib plus enzalutamide (US$1,201,221; 2.8418 QALYs)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40661990\", \"sentence_id\": 8, \"text\": \"The ICER of the HRR-guided talazoparib plus enzalutamide group (vs empirical enzalutamide) was US$730,671 per QALY gained, and the ICER of empirical talazoparib plus enzalutamide (vs HRR-guided talazoparib plus enzalutamide) was US$1,673,457 per QALY gained.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40661990", "sentence_id": 8, "text": "The ICER of the HRR-guided talazoparib plus enzalutamide group (vs empirical enzalutamide) was US$730,671 per QALY gained, and the ICER of empirical talazoparib plus enzalutamide (vs HRR-guided talazoparib plus enzalutamide) was US$1,673,457 per QALY gained."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40661990\", \"sentence_id\": 9, \"text\": \"Both ICERs of the HRR-guided strategy and empirical combination therapy were higher than the willingness-to-pay threshold (US$100,000 per QALY) and were not accepted as cost-effective.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40661990", "sentence_id": 9, "text": "Both ICERs of the HRR-guided strategy and empirical combination therapy were higher than the willingness-to-pay threshold (US$100,000 per QALY) and were not accepted as cost-effective."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40661990\", \"sentence_id\": 10, \"text\": \"Sensitivity analyses found drug costs of talazoparib and enzalutamide to be the key influential factors on the cost-effectiveness of HRR-guided therapy.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40661990", "sentence_id": 10, "text": "Sensitivity analyses found drug costs of talazoparib and enzalutamide to be the key influential factors on the cost-effectiveness of HRR-guided therapy."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40661990\", \"sentence_id\": 11, \"text\": \"CONCLUSION: HRR-guided talazoparib plus enzalutamide does not appear to be cost-effective for mCRPC patients from the U.S.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40661990", "sentence_id": 11, "text": "CONCLUSION: HRR-guided talazoparib plus enzalutamide does not appear to be cost-effective for mCRPC patients from the U.S."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40661990\", \"sentence_id\": 12, \"text\": \"payer perspective.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40661990", "sentence_id": 12, "text": "payer perspective."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40543584\", \"sentence_id\": 0, \"text\": \"Mutations in BRCA1 and BRCA2 genes are the leading cause of hereditary breast and ovarian cancer.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40543584", "sentence_id": 0, "text": "Mutations in BRCA1 and BRCA2 genes are the leading cause of hereditary breast and ovarian cancer."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40543584\", \"sentence_id\": 1, \"text\": \"BRCA1/2-mutant cells are defective in repairing damaged DNA by homologous recombination and are characterized by hypersensitivity to PARP inhibitors.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40543584", "sentence_id": 1, "text": "BRCA1/2-mutant cells are defective in repairing damaged DNA by homologous recombination and are characterized by hypersensitivity to PARP inhibitors."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40543584\", \"sentence_id\": 2, \"text\": \"PARP inhibitors can trap PARP proteins on the chromatin, a mechanism that can contribute to the death of BRCA1/2-deficient cells.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40543584", "sentence_id": 2, "text": "PARP inhibitors can trap PARP proteins on the chromatin, a mechanism that can contribute to the death of BRCA1/2-deficient cells."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40543584\", \"sentence_id\": 3, \"text\": \"The FDA has approved multiple PARP inhibitors for the treatment of metastatic breast and ovarian cancers, yet despite the success of PARP inhibitors in treating BRCA1/2-mutant cancers, drug resistance is a major challenge.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40543584", "sentence_id": 3, "text": "The FDA has approved multiple PARP inhibitors for the treatment of metastatic breast and ovarian cancers, yet despite the success of PARP inhibitors in treating BRCA1/2-mutant cancers, drug resistance is a major challenge."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40543584\", \"sentence_id\": 4, \"text\": \"Here, we report that 5hmC enhances PARP1 trapping on the chromatin in olaparib-treated cells.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40543584", "sentence_id": 4, "text": "Here, we report that 5hmC enhances PARP1 trapping on the chromatin in olaparib-treated cells."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40543584\", \"sentence_id\": 5, \"text\": \"Elevated PARP trapping generates replication gaps, leading to the restoration of PARP inhibitor sensitivity in chemoresistant BRCA1/2-deficient cells.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40543584", "sentence_id": 5, "text": "Elevated PARP trapping generates replication gaps, leading to the restoration of PARP inhibitor sensitivity in chemoresistant BRCA1/2-deficient cells."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40543584\", \"sentence_id\": 6, \"text\": \"Our findings suggest that combining 5hmC with olaparib can restore the sensitivity of chemoresistant BRCA1/2-deficient cells.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40543584", "sentence_id": 6, "text": "Our findings suggest that combining 5hmC with olaparib can restore the sensitivity of chemoresistant BRCA1/2-deficient cells."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40498229\", \"sentence_id\": 0, \"text\": \"PARP1, the most prominent member of the PARP family, mediates DNA repair and cellular stress responses.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40498229", "sentence_id": 0, "text": "PARP1, the most prominent member of the PARP family, mediates DNA repair and cellular stress responses."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40498229\", \"sentence_id\": 1, \"text\": \"PARP inhibitors (PARPi) show clinical promise in treating BRCA1/2-mutated or homologous recombination-deficient tumors, particularly in breast and ovarian cancers.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40498229", "sentence_id": 1, "text": "PARP inhibitors (PARPi) show clinical promise in treating BRCA1/2-mutated or homologous recombination-deficient tumors, particularly in breast and ovarian cancers."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40498229\", \"sentence_id\": 2, \"text\": \"However, acquired resistance remains a significant therapeutic challenge.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40498229", "sentence_id": 2, "text": "However, acquired resistance remains a significant therapeutic challenge."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40498229\", \"sentence_id\": 3, \"text\": \"This study developed a PARP1 inhibitor discovery pipeline integrating machine learning with conventional virtual screening methods.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40498229", "sentence_id": 3, "text": "This study developed a PARP1 inhibitor discovery pipeline integrating machine learning with conventional virtual screening methods."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40498229\", \"sentence_id\": 4, \"text\": \"We introduced a novel strategy called fragment replacement to generate new compounds with optimized properties.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40498229", "sentence_id": 4, "text": "We introduced a novel strategy called fragment replacement to generate new compounds with optimized properties."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40498229\", \"sentence_id\": 5, \"text\": \"Using the Maybridge compound library, we developed machine learning models to predict inhibitor activity.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40498229", "sentence_id": 5, "text": "Using the Maybridge compound library, we developed machine learning models to predict inhibitor activity."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40498229\", \"sentence_id\": 6, \"text\": \"The Random Forest classifier demonstrated superior performance (AUC\u2009=\u20090.971, accuracy\u2009=\u20090.915) in tenfold cross-validation.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40498229", "sentence_id": 6, "text": "The Random Forest classifier demonstrated superior performance (AUC\u2009=\u20090.971, accuracy\u2009=\u20090.915) in tenfold cross-validation."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40498229\", \"sentence_id\": 7, \"text\": \"This machine learning-driven approach outperformed conventional virtual screening in terms of efficiency.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40498229", "sentence_id": 7, "text": "This machine learning-driven approach outperformed conventional virtual screening in terms of efficiency."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40498229\", \"sentence_id\": 8, \"text\": \"Subsequently, we conducted virtual screening using 2D fingerprints, shapes, and docking to retain the top-ranked ligands based on a standardized score (Z2-score).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40498229", "sentence_id": 8, "text": "Subsequently, we conducted virtual screening using 2D fingerprints, shapes, and docking to retain the top-ranked ligands based on a standardized score (Z2-score)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40498229\", \"sentence_id\": 9, \"text\": \"XP docking and ADMET prediction were used to select two molecules with strong drug-like properties.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40498229", "sentence_id": 9, "text": "XP docking and ADMET prediction were used to select two molecules with strong drug-like properties."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40498229\", \"sentence_id\": 10, \"text\": \"Fragment replacement was employed to reconstruct 101 new compounds with improved drug-like characteristics and increased activity.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40498229", "sentence_id": 10, "text": "Fragment replacement was employed to reconstruct 101 new compounds with improved drug-like characteristics and increased activity."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40498229\", \"sentence_id\": 11, \"text\": \"After validation, we identified three hits with docking scores between -\u00a011.802kcal/mol and -\u00a010.808kcal/mol, which were superior to the positive control Talazoparib (docking score: -\u00a09.103kcal/mol).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40498229", "sentence_id": 11, "text": "After validation, we identified three hits with docking scores between -\u00a011.802kcal/mol and -\u00a010.808kcal/mol, which were superior to the positive control Talazoparib (docking score: -\u00a09.103kcal/mol)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40498229\", \"sentence_id\": 12, \"text\": \"MD simulations assessed the binding stability of the compounds to proteins, with all three selected compounds exhibiting good binding stability, thus identifying them as potential candidates for development as PARP1 inhibitors.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40498229", "sentence_id": 12, "text": "MD simulations assessed the binding stability of the compounds to proteins, with all three selected compounds exhibiting good binding stability, thus identifying them as potential candidates for development as PARP1 inhibitors."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40494034\", \"sentence_id\": 0, \"text\": \"Triple-negative breast cancer (TNBC) continues to be a very aggressive subtype with few targeted therapy options.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40494034", "sentence_id": 0, "text": "Triple-negative breast cancer (TNBC) continues to be a very aggressive subtype with few targeted therapy options."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40494034\", \"sentence_id\": 1, \"text\": \"Antibody-drug conjugates (ADCs) and poly (ADP-ribose) polymerase inhibitors (PARPis) have been promising therapeutic strategies, each of which targets different vulnerabilities in TNBC cells.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40494034", "sentence_id": 1, "text": "Antibody-drug conjugates (ADCs) and poly (ADP-ribose) polymerase inhibitors (PARPis) have been promising therapeutic strategies, each of which targets different vulnerabilities in TNBC cells."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40494034\", \"sentence_id\": 2, \"text\": \"ADCs like sacituzumab govitecan (SG) and datopotamab deruxtecan (Dato-DXd) target cytotoxic payloads with specificity, whereas PARPis like olaparib, rucaparib, niraparib, and talazoparib cause synthetic lethality in homologous recombination repair (HRR)-deficient tumors.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40494034", "sentence_id": 2, "text": "ADCs like sacituzumab govitecan (SG) and datopotamab deruxtecan (Dato-DXd) target cytotoxic payloads with specificity, whereas PARPis like olaparib, rucaparib, niraparib, and talazoparib cause synthetic lethality in homologous recombination repair (HRR)-deficient tumors."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40494034\", \"sentence_id\": 3, \"text\": \"Recent clinical trials of SEASTAR and PETRA have evaluated ADC-PARPi combinations to enhance anti-tumor activity through DNA damage induction with the prevention of its repair.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40494034", "sentence_id": 3, "text": "Recent clinical trials of SEASTAR and PETRA have evaluated ADC-PARPi combinations to enhance anti-tumor activity through DNA damage induction with the prevention of its repair."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40494034\", \"sentence_id\": 4, \"text\": \"Early data demonstrate enhanced therapeutic outcomes, especially in BRCA-mutated and HRD-positive TNBC.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40494034", "sentence_id": 4, "text": "Early data demonstrate enhanced therapeutic outcomes, especially in BRCA-mutated and HRD-positive TNBC."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40494034\", \"sentence_id\": 5, \"text\": \"Myelosuppression and adaptation of dosing regimens remain challenges to be addressed.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40494034", "sentence_id": 5, "text": "Myelosuppression and adaptation of dosing regimens remain challenges to be addressed."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40494034\", \"sentence_id\": 6, \"text\": \"Future directions include biomarker-driven patient selection, combination with immune checkpoint inhibitors, and advancement in next-generation ADCs.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40494034", "sentence_id": 6, "text": "Future directions include biomarker-driven patient selection, combination with immune checkpoint inhibitors, and advancement in next-generation ADCs."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40494034\", \"sentence_id\": 7, \"text\": \"The synergistic potential of ADC-PARPi combinations provides a new avenue for overcoming TNBC resistance, enhancing treatment outcomes, and widening therapeutic strategies for this challenging disease.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40494034", "sentence_id": 7, "text": "The synergistic potential of ADC-PARPi combinations provides a new avenue for overcoming TNBC resistance, enhancing treatment outcomes, and widening therapeutic strategies for this challenging disease."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40402278\", \"sentence_id\": 0, \"text\": \"US-FDA has approved PARP-1 inhibitors (Talazoparib, Olaparib, Rucaparib, and Niraparib) as the first line of treatment for many cancer types (e.g., breast, ovarian, pancreatic, and prostate) caused by mutations in breast cancer gene 1 and 2 (BRCA1/2).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40402278", "sentence_id": 0, "text": "US-FDA has approved PARP-1 inhibitors (Talazoparib, Olaparib, Rucaparib, and Niraparib) as the first line of treatment for many cancer types (e.g., breast, ovarian, pancreatic, and prostate) caused by mutations in breast cancer gene 1 and 2 (BRCA1/2)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40402278\", \"sentence_id\": 1, \"text\": \"However, developing resistance to PARP-1 inhibitors is a major concern, which limits therapeutic effectiveness.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40402278", "sentence_id": 1, "text": "However, developing resistance to PARP-1 inhibitors is a major concern, which limits therapeutic effectiveness."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40402278\", \"sentence_id\": 2, \"text\": \"In the present study, we identified novel gene signatures implicated in developing resistance to Olaparib.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40402278", "sentence_id": 2, "text": "In the present study, we identified novel gene signatures implicated in developing resistance to Olaparib."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40402278\", \"sentence_id\": 3, \"text\": \"Meta-analysis was performed on publicly available RNA-Seq data related to ovarian and breast cancers from the GEO (Gene Expression Omnibus) database.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40402278", "sentence_id": 3, "text": "Meta-analysis was performed on publicly available RNA-Seq data related to ovarian and breast cancers from the GEO (Gene Expression Omnibus) database."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40402278\", \"sentence_id\": 4, \"text\": \"Differential gene expression analysis, gene ontology, KEGG pathway enrichment, and protein-protein interaction (PPI) networking analyses were performed.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40402278", "sentence_id": 4, "text": "Differential gene expression analysis, gene ontology, KEGG pathway enrichment, and protein-protein interaction (PPI) networking analyses were performed."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40402278\", \"sentence_id\": 5, \"text\": \"A total of 139 Common DEGs (Differentially Expressed Genes) were identified, comprising 69 and 70 genes that were upregulated and downregulated respectively.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40402278", "sentence_id": 5, "text": "A total of 139 Common DEGs (Differentially Expressed Genes) were identified, comprising 69 and 70 genes that were upregulated and downregulated respectively."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40402278\", \"sentence_id\": 6, \"text\": \"KEGG Pathways \\\"P53 signaling pathway\\\" and \\\"Positive regulation of developmental process(BP)\\\", \\\"endoplasmic reticulum lumen(CC),\\\" and \\\"growth factor binding(MF)\\\", were found to be potentially associated with Olaparib resistance.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40402278", "sentence_id": 6, "text": "KEGG Pathways \"P53 signaling pathway\" and \"Positive regulation of developmental process(BP)\", \"endoplasmic reticulum lumen(CC),\" and \"growth factor binding(MF)\", were found to be potentially associated with Olaparib resistance."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40402278\", \"sentence_id\": 7, \"text\": \"Five hub genes were identified using PPI networking of which FN1, CCN2, and JUN may play a significant role in the development of Olaparib resistance and could be promising therapeutic and diagnostic biomarkers for dealing with Olaparib resistance in BRCA1/2 mutant breast and ovarian cancer.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40402278", "sentence_id": 7, "text": "Five hub genes were identified using PPI networking of which FN1, CCN2, and JUN may play a significant role in the development of Olaparib resistance and could be promising therapeutic and diagnostic biomarkers for dealing with Olaparib resistance in BRCA1/2 mutant breast and ovarian cancer."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40336260\", \"sentence_id\": 0, \"text\": \"PURPOSE OF REVIEW: Recent advancements in the understanding of the genetic background of genitourinary cancers allowed for a successful introduction of targeted antitumor agents to prostate cancer (PCa) treatment.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40336260", "sentence_id": 0, "text": "PURPOSE OF REVIEW: Recent advancements in the understanding of the genetic background of genitourinary cancers allowed for a successful introduction of targeted antitumor agents to prostate cancer (PCa) treatment."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40336260\", \"sentence_id\": 1, \"text\": \"Inhibitors of the poly ADP-ribose polymerase enzyme (PARPi) transformed the treatment landscape of metastatic prostate cancer, and being increasingly studied in earlier disease stages.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40336260", "sentence_id": 1, "text": "Inhibitors of the poly ADP-ribose polymerase enzyme (PARPi) transformed the treatment landscape of metastatic prostate cancer, and being increasingly studied in earlier disease stages."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40336260\", \"sentence_id\": 2, \"text\": \"However, they are associated with nonnegligible toxicity, therefore, we aimed to summarize their side-effect profile in patients with PCa.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40336260", "sentence_id": 2, "text": "However, they are associated with nonnegligible toxicity, therefore, we aimed to summarize their side-effect profile in patients with PCa."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40336260\", \"sentence_id\": 3, \"text\": \"RECENT FINDINGS: Hematologic toxicities, particularly anemia, thrombocytopenia, and neutropenia are among the most common and serious adverse events associated with PARPi, highlighting the need for regular blood count monitoring.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40336260", "sentence_id": 3, "text": "RECENT FINDINGS: Hematologic toxicities, particularly anemia, thrombocytopenia, and neutropenia are among the most common and serious adverse events associated with PARPi, highlighting the need for regular blood count monitoring."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40336260\", \"sentence_id\": 4, \"text\": \"Nonhematologic side effects, including fatigue, nausea, vomiting, diarrhea, and constipation, are common, and can be mitigated with supportive interventions like dietary modifications, antiemetics, or stool management techniques.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40336260", "sentence_id": 4, "text": "Nonhematologic side effects, including fatigue, nausea, vomiting, diarrhea, and constipation, are common, and can be mitigated with supportive interventions like dietary modifications, antiemetics, or stool management techniques."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40336260\", \"sentence_id\": 5, \"text\": \"Special attention should be given to patients with therapy-resistant or persistent cytopenia, in whom bone marrow biopsy should be considered, as it can indicate myelodysplastic syndrome and acute myeloid leukemia.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40336260", "sentence_id": 5, "text": "Special attention should be given to patients with therapy-resistant or persistent cytopenia, in whom bone marrow biopsy should be considered, as it can indicate myelodysplastic syndrome and acute myeloid leukemia."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40336260\", \"sentence_id\": 6, \"text\": \"SUMMARY: PARP inhibitors represent a major advancement in the management of metastatic prostate cancer, offering a significant survival benefit in applicable cases.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40336260", "sentence_id": 6, "text": "SUMMARY: PARP inhibitors represent a major advancement in the management of metastatic prostate cancer, offering a significant survival benefit in applicable cases."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40336260\", \"sentence_id\": 7, \"text\": \"However, patients need to be carefully selected and informed, to allow for optimal balancing between the benefits and nonneglectable risks of severe toxicities.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40336260", "sentence_id": 7, "text": "However, patients need to be carefully selected and informed, to allow for optimal balancing between the benefits and nonneglectable risks of severe toxicities."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40336260\", \"sentence_id\": 8, \"text\": \"Better understanding of PARPi toxicity profile can improve personalized decision-making and enhance treatment compliance, through raising patients' awareness about the possible side effects of PARPi.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40336260", "sentence_id": 8, "text": "Better understanding of PARPi toxicity profile can improve personalized decision-making and enhance treatment compliance, through raising patients' awareness about the possible side effects of PARPi."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40315400\", \"sentence_id\": 0, \"text\": \"PURPOSE: To provide evidence-based recommendations for patients with metastatic castration-resistant prostate cancer (mCRPC).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40315400", "sentence_id": 0, "text": "PURPOSE: To provide evidence-based recommendations for patients with metastatic castration-resistant prostate cancer (mCRPC)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40315400\", \"sentence_id\": 1, \"text\": \"METHODS: An Expert Panel including patient representation completed a systematic review of the evidence and made recommendations.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40315400", "sentence_id": 1, "text": "METHODS: An Expert Panel including patient representation completed a systematic review of the evidence and made recommendations."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40315400\", \"sentence_id\": 2, \"text\": \"RESULTS: Depending upon prior treatment received, androgen receptor pathway inhibitors (ARPIs: enzalutamide, abiraterone with prednisone), poly(ADP-ribose) polymerase inhibitors (PARPi), chemotherapeutic agents (docetaxel, cabazitaxel), radiopharmaceuticals (radium 223,\\nRECOMMENDATIONS: Prior systemic therapy for castration-sensitive prostate cancer will determine subsequent therapy used for mCRPC.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40315400", "sentence_id": 2, "text": "RESULTS: Depending upon prior treatment received, androgen receptor pathway inhibitors (ARPIs: enzalutamide, abiraterone with prednisone), poly(ADP-ribose) polymerase inhibitors (PARPi), chemotherapeutic agents (docetaxel, cabazitaxel), radiopharmaceuticals (radium 223,\nRECOMMENDATIONS: Prior systemic therapy for castration-sensitive prostate cancer will determine subsequent therapy used for mCRPC."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40315400\", \"sentence_id\": 3, \"text\": \"Continue androgen-deprivation therapy for patients with mCRPC indefinitely.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40315400", "sentence_id": 3, "text": "Continue androgen-deprivation therapy for patients with mCRPC indefinitely."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40315400\", \"sentence_id\": 4, \"text\": \"Early adoption of somatic genetic testing and palliative care is recommended.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40315400", "sentence_id": 4, "text": "Early adoption of somatic genetic testing and palliative care is recommended."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40315400\", \"sentence_id\": 5, \"text\": \"Patients with mCRPC and bony metastases should receive a bone-protective agent.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40315400", "sentence_id": 5, "text": "Patients with mCRPC and bony metastases should receive a bone-protective agent."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40315400\", \"sentence_id\": 6, \"text\": \"The panel recommends the combination of ARPI with PARPi in patients with\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40315400", "sentence_id": 6, "text": "The panel recommends the combination of ARPI with PARPi in patients with"}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40179907\", \"sentence_id\": 0, \"text\": \"BACKGROUND: In the phase 3 TALAPRO-2 trial, talazoparib plus enzalutamide significantly improved radiographic progression-free survival compared with placebo plus enzalutamide in men with metastatic castration-resistant prostate cancer harbouring alterations in genes involved in homologous recombination repair (HRR).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40179907", "sentence_id": 0, "text": "BACKGROUND: In the phase 3 TALAPRO-2 trial, talazoparib plus enzalutamide significantly improved radiographic progression-free survival compared with placebo plus enzalutamide in men with metastatic castration-resistant prostate cancer harbouring alterations in genes involved in homologous recombination repair (HRR)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40179907\", \"sentence_id\": 1, \"text\": \"We aimed to assess patient-reported outcomes in patients with HRR-deficient metastatic castration-resistant prostate cancer in TALAPRO-2.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40179907", "sentence_id": 1, "text": "We aimed to assess patient-reported outcomes in patients with HRR-deficient metastatic castration-resistant prostate cancer in TALAPRO-2."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40179907\", \"sentence_id\": 2, \"text\": \"METHODS: TALAPRO-2 is a randomised, double-blind, placebo-controlled, phase 3 trial conducted at 223 hospitals, cancer centres, and medical centres in 26 countries worldwide.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40179907", "sentence_id": 2, "text": "METHODS: TALAPRO-2 is a randomised, double-blind, placebo-controlled, phase 3 trial conducted at 223 hospitals, cancer centres, and medical centres in 26 countries worldwide."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40179907\", \"sentence_id\": 3, \"text\": \"Eligible participants were male patients aged 18 years or older (\u226520 years in Japan) who were receiving ongoing androgen deprivation therapy, had asymptomatic or mildly symptomatic metastatic castration-resistant prostate cancer, an Eastern Cooperative Oncology Group performance status of 0 or 1, and had not received previous life-prolonging systemic therapy for castration-resistant prostate cancer or metastatic castration-resistant prostate cancer.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40179907", "sentence_id": 3, "text": "Eligible participants were male patients aged 18 years or older (\u226520 years in Japan) who were receiving ongoing androgen deprivation therapy, had asymptomatic or mildly symptomatic metastatic castration-resistant prostate cancer, an Eastern Cooperative Oncology Group performance status of 0 or 1, and had not received previous life-prolonging systemic therapy for castration-resistant prostate cancer or metastatic castration-resistant prostate cancer."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40179907\", \"sentence_id\": 4, \"text\": \"Patients with HRR gene alterations were randomly assigned (1:1) using a centralised interactive web response system and a permuted block size of 4 to oral talazoparib 0\u00b75 mg once daily or placebo, plus oral enzalutamide 160 mg once daily, stratified by previous second-generation androgen receptor pathway inhibitor (abiraterone or orteronel) or docetaxel (yes vs no) in the castration-sensitive setting.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40179907", "sentence_id": 4, "text": "Patients with HRR gene alterations were randomly assigned (1:1) using a centralised interactive web response system and a permuted block size of 4 to oral talazoparib 0\u00b75 mg once daily or placebo, plus oral enzalutamide 160 mg once daily, stratified by previous second-generation androgen receptor pathway inhibitor (abiraterone or orteronel) or docetaxel (yes vs no) in the castration-sensitive setting."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40179907\", \"sentence_id\": 5, \"text\": \"The sponsor, patients, and investigators were masked to allocation of talazoparib or placebo; enzalutamide was open-label.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40179907", "sentence_id": 5, "text": "The sponsor, patients, and investigators were masked to allocation of talazoparib or placebo; enzalutamide was open-label."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40179907\", \"sentence_id\": 6, \"text\": \"The primary endpoint was radiographic progression-free survival by blinded independent central review and has been reported previously.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40179907", "sentence_id": 6, "text": "The primary endpoint was radiographic progression-free survival by blinded independent central review and has been reported previously."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40179907\", \"sentence_id\": 7, \"text\": \"Patient-reported outcomes were assessed as secondary outcomes in the patient-reported outcomes population, which comprised patients from the intention-to-treat population with a baseline patient-reported outcome assessment and at least one post-baseline patient-reported outcome assessment.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40179907", "sentence_id": 7, "text": "Patient-reported outcomes were assessed as secondary outcomes in the patient-reported outcomes population, which comprised patients from the intention-to-treat population with a baseline patient-reported outcome assessment and at least one post-baseline patient-reported outcome assessment."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40179907\", \"sentence_id\": 8, \"text\": \"Patient-reported outcomes included time to definitive deterioration in global health status/quality of life (GHS/QoL) per European Organisation for Research and Treatment of Cancer (EORTC) Core Quality of Life Questionnaire (QLQ-C30) and prostate cancer-specific urinary symptoms per EORTC Quality of Life Questionnaire-Prostate (QLQ-PR25), and time to deterioration in pain symptoms per Brief Pain Inventory-Short Form (BPI-SF).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40179907", "sentence_id": 8, "text": "Patient-reported outcomes included time to definitive deterioration in global health status/quality of life (GHS/QoL) per European Organisation for Research and Treatment of Cancer (EORTC) Core Quality of Life Questionnaire (QLQ-C30) and prostate cancer-specific urinary symptoms per EORTC Quality of Life Questionnaire-Prostate (QLQ-PR25), and time to deterioration in pain symptoms per Brief Pain Inventory-Short Form (BPI-SF)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40179907\", \"sentence_id\": 9, \"text\": \"Mean change from baseline in GHS/QoL, overall cancer and prostate cancer-specific functioning and symptoms (per EORTC QLQ-C30 and QLQ-PR25), in pain symptoms per BPI-SF, and in general health status per EQ-5D-5L were also patient-reported secondary outcomes.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40179907", "sentence_id": 9, "text": "Mean change from baseline in GHS/QoL, overall cancer and prostate cancer-specific functioning and symptoms (per EORTC QLQ-C30 and QLQ-PR25), in pain symptoms per BPI-SF, and in general health status per EQ-5D-5L were also patient-reported secondary outcomes."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40179907\", \"sentence_id\": 10, \"text\": \"This study is registered with ClinicalTrials.gov, NCT03395197, and is ongoing.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40179907", "sentence_id": 10, "text": "This study is registered with ClinicalTrials.gov, NCT03395197, and is ongoing."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40179907\", \"sentence_id\": 11, \"text\": \"FINDINGS: Between Dec 18, 2018, and Jan 20, 2022, 399 patients with HRR-deficient metastatic castration-resistant prostate cancer were enrolled and randomly assigned, of whom 197 assigned to talazoparib plus enzalutamide and 197 assigned to placebo plus enzalutamide were included in the patient-reported outcome population.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40179907", "sentence_id": 11, "text": "FINDINGS: Between Dec 18, 2018, and Jan 20, 2022, 399 patients with HRR-deficient metastatic castration-resistant prostate cancer were enrolled and randomly assigned, of whom 197 assigned to talazoparib plus enzalutamide and 197 assigned to placebo plus enzalutamide were included in the patient-reported outcome population."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40179907\", \"sentence_id\": 12, \"text\": \"Median follow-up was 22\u00b72 months (IQR 13\u00b78-27\u00b77) in the talazoparib plus enzalutamide group and 20\u00b72 months (13\u00b75-26\u00b76) for the placebo plus enzalutamide group.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40179907", "sentence_id": 12, "text": "Median follow-up was 22\u00b72 months (IQR 13\u00b78-27\u00b77) in the talazoparib plus enzalutamide group and 20\u00b72 months (13\u00b75-26\u00b76) for the placebo plus enzalutamide group."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40179907\", \"sentence_id\": 13, \"text\": \"Median time to definitive deterioration of GHS/QoL was longer in the talazoparib plus enzalutamide group (27\u00b71 months [95% CI 21\u00b72-non-estimable]) than in the placebo plus enzalutamide group (19\u00b73 months [16\u00b76-23\u00b70]; hazard ratio [HR] 0\u00b769 [95% CI 0\u00b749-0\u00b797]; two-sided p=0\u00b7032).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40179907", "sentence_id": 13, "text": "Median time to definitive deterioration of GHS/QoL was longer in the talazoparib plus enzalutamide group (27\u00b71 months [95% CI 21\u00b72-non-estimable]) than in the placebo plus enzalutamide group (19\u00b73 months [16\u00b76-23\u00b70]; hazard ratio [HR] 0\u00b769 [95% CI 0\u00b749-0\u00b797]; two-sided p=0\u00b7032)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40179907\", \"sentence_id\": 14, \"text\": \"Median time to definitive deterioration in urinary symptoms was also longer in the talazoparib plus enzalutamide group (non-estimable [95% CI 32\u00b72-non-estimable]) than in the placebo plus enzalutamide group (30\u00b72 months [24\u00b76-non-estimable; HR 0\u00b756 [0\u00b734-0\u00b793]; two-sided p=0\u00b7022).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40179907", "sentence_id": 14, "text": "Median time to definitive deterioration in urinary symptoms was also longer in the talazoparib plus enzalutamide group (non-estimable [95% CI 32\u00b72-non-estimable]) than in the placebo plus enzalutamide group (30\u00b72 months [24\u00b76-non-estimable; HR 0\u00b756 [0\u00b734-0\u00b793]; two-sided p=0\u00b7022)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40179907\", \"sentence_id\": 15, \"text\": \"Median time to deterioration in pain symptoms was non-estimable for both treatment groups (HR 0\u00b758 [0\u00b733-1\u00b701]; two-sided p=0\u00b7051).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40179907", "sentence_id": 15, "text": "Median time to deterioration in pain symptoms was non-estimable for both treatment groups (HR 0\u00b758 [0\u00b733-1\u00b701]; two-sided p=0\u00b7051)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40179907\", \"sentence_id\": 16, \"text\": \"Changes from baseline in worst pain in the past 24 h (BPI-SF, question three) and in general health status (EQ-5D-5L) also favoured talazoparib plus enzalutamide versus placebo plus enzalutamide, although the differences were not clinically meaningful.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40179907", "sentence_id": 16, "text": "Changes from baseline in worst pain in the past 24 h (BPI-SF, question three) and in general health status (EQ-5D-5L) also favoured talazoparib plus enzalutamide versus placebo plus enzalutamide, although the differences were not clinically meaningful."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40179907\", \"sentence_id\": 17, \"text\": \"Between-group differences in mean changes from baseline in GHS/QoL, functioning, and symptoms per EORTC QLQ-C30 did not reach the clinically meaningful threshold of 10 or more points, although physical, emotional, and cognitive functioning and pain favoured talazoparib plus enzalutamide.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40179907", "sentence_id": 17, "text": "Between-group differences in mean changes from baseline in GHS/QoL, functioning, and symptoms per EORTC QLQ-C30 did not reach the clinically meaningful threshold of 10 or more points, although physical, emotional, and cognitive functioning and pain favoured talazoparib plus enzalutamide."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40179907\", \"sentence_id\": 18, \"text\": \"Similarly, differences in mean changes from baseline for urinary and bowel symptoms per EORTC QLQ-PR25 favoured talazoparib plus enzalutamide, but were not clinically meaningful.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40179907", "sentence_id": 18, "text": "Similarly, differences in mean changes from baseline for urinary and bowel symptoms per EORTC QLQ-PR25 favoured talazoparib plus enzalutamide, but were not clinically meaningful."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40179907\", \"sentence_id\": 19, \"text\": \"INTERPRETATION: The demonstrated delays in definitive deterioration in GHS/QoL, urinary symptoms, and other functioning and symptom scales with talazoparib plus enzalutamide compared with placebo plus enzalutamide in patients with HRR-deficient metastatic castration-resistant prostate cancer provide insight that might inform clinical decisions for these patients.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40179907", "sentence_id": 19, "text": "INTERPRETATION: The demonstrated delays in definitive deterioration in GHS/QoL, urinary symptoms, and other functioning and symptom scales with talazoparib plus enzalutamide compared with placebo plus enzalutamide in patients with HRR-deficient metastatic castration-resistant prostate cancer provide insight that might inform clinical decisions for these patients."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40179907\", \"sentence_id\": 20, \"text\": \"FUNDING: Pfizer.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40179907", "sentence_id": 20, "text": "FUNDING: Pfizer."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40179906\", \"sentence_id\": 0, \"text\": \"BACKGROUND: Patients with metastatic castration-resistant prostate cancer have poor prognoses, underscoring the need for novel therapeutic strategies.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40179906", "sentence_id": 0, "text": "BACKGROUND: Patients with metastatic castration-resistant prostate cancer have poor prognoses, underscoring the need for novel therapeutic strategies."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40179906\", \"sentence_id\": 1, \"text\": \"First-line talazoparib plus enzalutamide significantly improved radiographic progression-free survival compared with placebo plus enzalutamide in men with metastatic castration-resistant prostate cancer in the phase 3 TALAPRO-2 study.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40179906", "sentence_id": 1, "text": "First-line talazoparib plus enzalutamide significantly improved radiographic progression-free survival compared with placebo plus enzalutamide in men with metastatic castration-resistant prostate cancer in the phase 3 TALAPRO-2 study."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40179906\", \"sentence_id\": 2, \"text\": \"We aimed to evaluate patient-reported outcomes in the all-comers cohort of TALAPRO-2, which included patients with and without alterations in homologous recombination repair (HRR) genes.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40179906", "sentence_id": 2, "text": "We aimed to evaluate patient-reported outcomes in the all-comers cohort of TALAPRO-2, which included patients with and without alterations in homologous recombination repair (HRR) genes."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40179906\", \"sentence_id\": 3, \"text\": \"METHODS: TALAPRO-2 is a randomised, double-blind, placebo-controlled, phase 3 trial conducted at 223 hospitals, cancer centres, and medical centres in 26 countries worldwide.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40179906", "sentence_id": 3, "text": "METHODS: TALAPRO-2 is a randomised, double-blind, placebo-controlled, phase 3 trial conducted at 223 hospitals, cancer centres, and medical centres in 26 countries worldwide."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40179906\", \"sentence_id\": 4, \"text\": \"Eligible participants were male patients aged 18 years or older (\u226520 years in Japan) who were receiving ongoing androgen deprivation therapy, had asymptomatic or mildly symptomatic metastatic castration-resistant prostate cancer, Eastern Cooperative Oncology Group performance status of 0 or 1, and had not received previous life-prolonging systemic therapy for castration-resistant prostate cancer or metastatic castration-resistant prostate cancer.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40179906", "sentence_id": 4, "text": "Eligible participants were male patients aged 18 years or older (\u226520 years in Japan) who were receiving ongoing androgen deprivation therapy, had asymptomatic or mildly symptomatic metastatic castration-resistant prostate cancer, Eastern Cooperative Oncology Group performance status of 0 or 1, and had not received previous life-prolonging systemic therapy for castration-resistant prostate cancer or metastatic castration-resistant prostate cancer."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40179906\", \"sentence_id\": 5, \"text\": \"Patients were randomly assigned (1:1) using a centralised interactive web response system and a permuted block size of 4 to oral talazoparib 0\u00b75 mg once daily or placebo, plus oral enzalutamide 160 mg once daily.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40179906", "sentence_id": 5, "text": "Patients were randomly assigned (1:1) using a centralised interactive web response system and a permuted block size of 4 to oral talazoparib 0\u00b75 mg once daily or placebo, plus oral enzalutamide 160 mg once daily."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40179906\", \"sentence_id\": 6, \"text\": \"The funder, patients, and investigators were masked to allocation of talazoparib or placebo; enzalutamide was open-label.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40179906", "sentence_id": 6, "text": "The funder, patients, and investigators were masked to allocation of talazoparib or placebo; enzalutamide was open-label."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40179906\", \"sentence_id\": 7, \"text\": \"Stratification factors were HRR gene alteration status (deficient vs non-deficient or unknown) and previous treatment with docetaxel or abiraterone, or both (yes vs no) in the castration-sensitive setting.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40179906", "sentence_id": 7, "text": "Stratification factors were HRR gene alteration status (deficient vs non-deficient or unknown) and previous treatment with docetaxel or abiraterone, or both (yes vs no) in the castration-sensitive setting."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40179906\", \"sentence_id\": 8, \"text\": \"The primary endpoint was radiographic progression-free survival by blinded independent central review and has been reported previously.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40179906", "sentence_id": 8, "text": "The primary endpoint was radiographic progression-free survival by blinded independent central review and has been reported previously."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40179906\", \"sentence_id\": 9, \"text\": \"Patient-reported outcomes were assessed as secondary endpoints in the patient-reported outcomes population, which comprised patients from the intention-to-treat population with a baseline patient-reported outcome assessment followed by at least one post-baseline patient-reported outcome assessment.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40179906", "sentence_id": 9, "text": "Patient-reported outcomes were assessed as secondary endpoints in the patient-reported outcomes population, which comprised patients from the intention-to-treat population with a baseline patient-reported outcome assessment followed by at least one post-baseline patient-reported outcome assessment."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40179906\", \"sentence_id\": 10, \"text\": \"Patient-reported outcomes included mean change from baseline in patient-reported pain symptoms (per Brief Pain Inventory-Short Form [BPI-SF]); global health status/quality of life (GHS/QoL), overall cancer and prostate cancer-specific functioning and symptoms (per European Organisation for Research and Treatment of Cancer [EORTC] Core Quality of Life Questionnaire [QLQ-C30] and Quality of Life Questionnaire-Prostate [QLQ-PR25]); and general health status (per EQ-5D-5L).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40179906", "sentence_id": 10, "text": "Patient-reported outcomes included mean change from baseline in patient-reported pain symptoms (per Brief Pain Inventory-Short Form [BPI-SF]); global health status/quality of life (GHS/QoL), overall cancer and prostate cancer-specific functioning and symptoms (per European Organisation for Research and Treatment of Cancer [EORTC] Core Quality of Life Questionnaire [QLQ-C30] and Quality of Life Questionnaire-Prostate [QLQ-PR25]); and general health status (per EQ-5D-5L)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40179906\", \"sentence_id\": 11, \"text\": \"Time to deterioration in patient-reported pain symptoms (per BPI-SF), and time to definitive deterioration in patient-reported GHS/QoL (per EORTC QLQ-C30) and prostate cancer-specific urinary symptoms (per EORTC-QLQ-PR25) were the other secondary endpoints.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40179906", "sentence_id": 11, "text": "Time to deterioration in patient-reported pain symptoms (per BPI-SF), and time to definitive deterioration in patient-reported GHS/QoL (per EORTC QLQ-C30) and prostate cancer-specific urinary symptoms (per EORTC-QLQ-PR25) were the other secondary endpoints."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40179906\", \"sentence_id\": 12, \"text\": \"This study is registered with ClinicalTrials.gov, NCT03395197, and is ongoing.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40179906", "sentence_id": 12, "text": "This study is registered with ClinicalTrials.gov, NCT03395197, and is ongoing."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40179906\", \"sentence_id\": 13, \"text\": \"FINDINGS: Between Jan 7, 2019, and Sept 17, 2020, 805 patients were enrolled and randomly assigned to treatment irrespective of HRR gene alteration status.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40179906", "sentence_id": 13, "text": "FINDINGS: Between Jan 7, 2019, and Sept 17, 2020, 805 patients were enrolled and randomly assigned to treatment irrespective of HRR gene alteration status."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40179906\", \"sentence_id\": 14, \"text\": \"395 patients assigned to talazoparib plus enzalutamide and 398 assigned to placebo plus enzalutamide were included in the patient-reported outcome population.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40179906", "sentence_id": 14, "text": "395 patients assigned to talazoparib plus enzalutamide and 398 assigned to placebo plus enzalutamide were included in the patient-reported outcome population."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40179906\", \"sentence_id\": 15, \"text\": \"Median follow-up was 28\u00b70 months (IQR 23\u00b79-31\u00b77) for talazoparib plus enzalutamide and 26\u00b78 months (23\u00b74-30\u00b76) for placebo plus enzalutamide.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40179906", "sentence_id": 15, "text": "Median follow-up was 28\u00b70 months (IQR 23\u00b79-31\u00b77) for talazoparib plus enzalutamide and 26\u00b78 months (23\u00b74-30\u00b76) for placebo plus enzalutamide."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40179906\", \"sentence_id\": 16, \"text\": \"Time to definitive deterioration in GHS/QoL was longer with talazoparib plus enzalutamide versus placebo plus enzalutamide (median 30\u00b78 months [95% CI 27\u00b70-non-estimable] vs 25\u00b70 months [22\u00b79-30\u00b77]; hazard ratio [HR] 0\u00b778 [95% CI 0\u00b762-0\u00b799]; two-sided p=0\u00b7038).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40179906", "sentence_id": 16, "text": "Time to definitive deterioration in GHS/QoL was longer with talazoparib plus enzalutamide versus placebo plus enzalutamide (median 30\u00b78 months [95% CI 27\u00b70-non-estimable] vs 25\u00b70 months [22\u00b79-30\u00b77]; hazard ratio [HR] 0\u00b778 [95% CI 0\u00b762-0\u00b799]; two-sided p=0\u00b7038)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40179906\", \"sentence_id\": 17, \"text\": \"Median time to definitive deterioration in urinary symptoms was non-estimable (95% CI non-estimable-non-estimable) in the talazoparib plus enzalutamide group and was 35\u00b79 months (95% CI 32\u00b73-non-estimable) in the placebo plus enzalutamide group (HR 0\u00b776 [95% CI 0\u00b754-1\u00b706]; two-sided p=0\u00b711).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40179906", "sentence_id": 17, "text": "Median time to definitive deterioration in urinary symptoms was non-estimable (95% CI non-estimable-non-estimable) in the talazoparib plus enzalutamide group and was 35\u00b79 months (95% CI 32\u00b73-non-estimable) in the placebo plus enzalutamide group (HR 0\u00b776 [95% CI 0\u00b754-1\u00b706]; two-sided p=0\u00b711)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40179906\", \"sentence_id\": 18, \"text\": \"No clinically meaningful differences (\u226510 points) in mean changes from baseline were observed in GHS/QoL, symptom, and functional scales between the treatment groups.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40179906", "sentence_id": 18, "text": "No clinically meaningful differences (\u226510 points) in mean changes from baseline were observed in GHS/QoL, symptom, and functional scales between the treatment groups."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40179906\", \"sentence_id\": 19, \"text\": \"No differences were observed between the groups in time to deterioration of pain as measured by the BPI-SF (HR 0\u00b798 [95% CI 0\u00b769-1\u00b740]; two-sided p=0\u00b793), mean pain scores (estimated mean difference in value of worst pain in the past 24 h between treatment groups was -0\u00b71 [95% CI -0\u00b73 to 0\u00b71]; two-sided p=0\u00b727), or general health status as measured by the EQ-5D-5L (estimated mean difference 0\u00b70 [95% CI 0\u00b70-0\u00b70]; two-sided p=0\u00b737).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40179906", "sentence_id": 19, "text": "No differences were observed between the groups in time to deterioration of pain as measured by the BPI-SF (HR 0\u00b798 [95% CI 0\u00b769-1\u00b740]; two-sided p=0\u00b793), mean pain scores (estimated mean difference in value of worst pain in the past 24 h between treatment groups was -0\u00b71 [95% CI -0\u00b73 to 0\u00b71]; two-sided p=0\u00b727), or general health status as measured by the EQ-5D-5L (estimated mean difference 0\u00b70 [95% CI 0\u00b70-0\u00b70]; two-sided p=0\u00b737)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40179906\", \"sentence_id\": 20, \"text\": \"INTERPRETATION: Talazoparib plus enzalutamide prolonged time to definitive deterioration in GHS/QoL versus placebo plus enzalutamide.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40179906", "sentence_id": 20, "text": "INTERPRETATION: Talazoparib plus enzalutamide prolonged time to definitive deterioration in GHS/QoL versus placebo plus enzalutamide."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40179906\", \"sentence_id\": 21, \"text\": \"Together with clinical efficacy and safety data, these results inform the risk-benefit assessment of talazoparib plus enzalutamide in patients with metastatic castration-resistant prostate cancer in TALAPRO-2.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40179906", "sentence_id": 21, "text": "Together with clinical efficacy and safety data, these results inform the risk-benefit assessment of talazoparib plus enzalutamide in patients with metastatic castration-resistant prostate cancer in TALAPRO-2."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40179906\", \"sentence_id\": 22, \"text\": \"FUNDING: Pfizer.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40179906", "sentence_id": 22, "text": "FUNDING: Pfizer."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40089867\", \"sentence_id\": 0, \"text\": \"Synthetic lethality in homologous recombination (HR)-deficient cancers caused by Poly (ADP-ribose) polymerase inhibitors (PARPi) has been classically attributed to its role in DNA repair.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40089867", "sentence_id": 0, "text": "Synthetic lethality in homologous recombination (HR)-deficient cancers caused by Poly (ADP-ribose) polymerase inhibitors (PARPi) has been classically attributed to its role in DNA repair."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40089867\", \"sentence_id\": 1, \"text\": \"The mode of action of PARPi and resistance thereof are now believed to be predominantly replication associated.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40089867", "sentence_id": 1, "text": "The mode of action of PARPi and resistance thereof are now believed to be predominantly replication associated."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40089867\", \"sentence_id\": 2, \"text\": \"Therefore, effective combinatorial approaches of targeting replication fork processing along with HR-downregulation to target HR-proficient and possibly PARPi-resistant tumors are warranted.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40089867", "sentence_id": 2, "text": "Therefore, effective combinatorial approaches of targeting replication fork processing along with HR-downregulation to target HR-proficient and possibly PARPi-resistant tumors are warranted."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40089867\", \"sentence_id\": 3, \"text\": \"Stilbenes are a privileged class of molecules, which include\u00a0resveratrol, pterostilbene, piceatannol,\u00a0etc,\u00a0that modulate both\u00a0replication processes\u00a0and RAD51-expression.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40089867", "sentence_id": 3, "text": "Stilbenes are a privileged class of molecules, which include\u00a0resveratrol, pterostilbene, piceatannol,\u00a0etc,\u00a0that modulate both\u00a0replication processes\u00a0and RAD51-expression."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40089867\", \"sentence_id\": 4, \"text\": \"In this investigation, by screening a\u00a0small\u00a0library of stilbenes, including in-house synthesized molecules, trans-4,4'-dihydroxystilbene (DHS) was discovered as a potent natural agent, which downregulates RAD51 expression and HR repair (GFP-reporter assay).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40089867", "sentence_id": 4, "text": "In this investigation, by screening a\u00a0small\u00a0library of stilbenes, including in-house synthesized molecules, trans-4,4'-dihydroxystilbene (DHS) was discovered as a potent natural agent, which downregulates RAD51 expression and HR repair (GFP-reporter assay)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40089867\", \"sentence_id\": 5, \"text\": \"DHS induces extensive synergistic cell death in ovarian cancers when combined with talazoparib (PARPi).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40089867", "sentence_id": 5, "text": "DHS induces extensive synergistic cell death in ovarian cancers when combined with talazoparib (PARPi)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40089867\", \"sentence_id\": 6, \"text\": \"Mechanistically, DHS elicits replication-stress through severely impeding replication fork progress, speed, and inducing fork-asymmetry.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40089867", "sentence_id": 6, "text": "Mechanistically, DHS elicits replication-stress through severely impeding replication fork progress, speed, and inducing fork-asymmetry."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40089867\", \"sentence_id\": 7, \"text\": \"This leads to robust induction of single stranded DNA (ssDNA) gaps and poly-ADP-ribosylation (PARylation) in S-phase cells, signifying issues related to lagging\u00a0(Okazaki)\u00a0strand synthesis.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40089867", "sentence_id": 7, "text": "This leads to robust induction of single stranded DNA (ssDNA) gaps and poly-ADP-ribosylation (PARylation) in S-phase cells, signifying issues related to lagging\u00a0(Okazaki)\u00a0strand synthesis."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40089867\", \"sentence_id\": 8, \"text\": \"PARPi, which abrogates PARylation, potentiates DHS induced ssDNA gaps, and their conversion into lethal double strand breaks through MRE11 action.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40089867", "sentence_id": 8, "text": "PARPi, which abrogates PARylation, potentiates DHS induced ssDNA gaps, and their conversion into lethal double strand breaks through MRE11 action."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40089867\", \"sentence_id\": 9, \"text\": \"Furthermore, the combination is highly effective in mitigating ovarian tumor xenograft growth in SCID mice and exhibited a good therapeutic-index with no/minimal tissue-toxicity.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40089867", "sentence_id": 9, "text": "Furthermore, the combination is highly effective in mitigating ovarian tumor xenograft growth in SCID mice and exhibited a good therapeutic-index with no/minimal tissue-toxicity."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40082588\", \"sentence_id\": 0, \"text\": \"Trophoblast cell surface antigen 2 (TROP2), a transmembrane glycoprotein highly expressed in a variety of epithelial cancers, has been considered as a primary therapeutic target for the development of antibody-drug conjugates (ADCs).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40082588", "sentence_id": 0, "text": "Trophoblast cell surface antigen 2 (TROP2), a transmembrane glycoprotein highly expressed in a variety of epithelial cancers, has been considered as a primary therapeutic target for the development of antibody-drug conjugates (ADCs)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40082588\", \"sentence_id\": 1, \"text\": \"OBI-992, an investigational TROP2-targeted ADC, is composed of a novel TROP2 antibody (R4702) conjugated to the topoisomerase I (TOP1) inhibitor exatecan through a hydrophilic enzyme-cleavable linker.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40082588", "sentence_id": 1, "text": "OBI-992, an investigational TROP2-targeted ADC, is composed of a novel TROP2 antibody (R4702) conjugated to the topoisomerase I (TOP1) inhibitor exatecan through a hydrophilic enzyme-cleavable linker."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40082588\", \"sentence_id\": 2, \"text\": \"This study aimed to characterize R4702 and OBI-992 in vitro.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40082588", "sentence_id": 2, "text": "This study aimed to characterize R4702 and OBI-992 in vitro."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40082588\", \"sentence_id\": 3, \"text\": \"TROP2-targeted antibodies sacituzumab and datopotamab were employed as the comparators for R4702.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40082588", "sentence_id": 3, "text": "TROP2-targeted antibodies sacituzumab and datopotamab were employed as the comparators for R4702."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40082588\", \"sentence_id\": 4, \"text\": \"ADCs sacituzumab govitecan (SG) and datopotamab deruxtecan (Dato-DXd) were used as benchmarks for OBI-992.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40082588", "sentence_id": 4, "text": "ADCs sacituzumab govitecan (SG) and datopotamab deruxtecan (Dato-DXd) were used as benchmarks for OBI-992."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40082588\", \"sentence_id\": 5, \"text\": \"Results revealed that R4702 binds to an epitope that is distinct from sacituzumab and datopotamab.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40082588", "sentence_id": 5, "text": "Results revealed that R4702 binds to an epitope that is distinct from sacituzumab and datopotamab."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40082588\", \"sentence_id\": 6, \"text\": \"The cytotoxicity of the OBI-992, SG, and Dato-DXd against different cancer cells is comparable despite they have different internalization profile.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40082588", "sentence_id": 6, "text": "The cytotoxicity of the OBI-992, SG, and Dato-DXd against different cancer cells is comparable despite they have different internalization profile."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40082588\", \"sentence_id\": 7, \"text\": \"Upregulation of breast cancer resistance protein (BCRP) was observed in SG-resistant and Dato-DXd-resistant cells, but not in OBI-992-resistant cells.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40082588", "sentence_id": 7, "text": "Upregulation of breast cancer resistance protein (BCRP) was observed in SG-resistant and Dato-DXd-resistant cells, but not in OBI-992-resistant cells."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40082588\", \"sentence_id\": 8, \"text\": \"In addition, significant downregulation of TROP2 expression was detected with Dato-DXd-resistant cells and only slightly downregulation with SG- and OBI-992-resistant cells was observed.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40082588", "sentence_id": 8, "text": "In addition, significant downregulation of TROP2 expression was detected with Dato-DXd-resistant cells and only slightly downregulation with SG- and OBI-992-resistant cells was observed."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40082588\", \"sentence_id\": 9, \"text\": \"Moreover, substantial enhancement of cytotoxicity and DNA damage was found in the combination of OBI-992 with a poly (ADP-ribose) polymerase (PARP) inhibitor (talazoparib).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40082588", "sentence_id": 9, "text": "Moreover, substantial enhancement of cytotoxicity and DNA damage was found in the combination of OBI-992 with a poly (ADP-ribose) polymerase (PARP) inhibitor (talazoparib)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40082588\", \"sentence_id\": 10, \"text\": \"Taken together, the findings in this study support further clinical development of OBI-992.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40082588", "sentence_id": 10, "text": "Taken together, the findings in this study support further clinical development of OBI-992."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40054125\", \"sentence_id\": 0, \"text\": \"Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40054125", "sentence_id": 0, "text": "Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40054125\", \"sentence_id\": 1, \"text\": \"The only targeted therapeutic approach that has emerged for early TNBC patients with BRCA-mutations (BRCA\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40054125", "sentence_id": 1, "text": "The only targeted therapeutic approach that has emerged for early TNBC patients with BRCA-mutations (BRCA"}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40051364\", \"sentence_id\": 0, \"text\": \"Among the Poly(ADP-ribose) Polymerase (PARP) family in mammals, PARP1 is the first identified and well-studied member that plays a critical role in DNA damage repair and has been proven to be an effective target for cancer therapy.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40051364", "sentence_id": 0, "text": "Among the Poly(ADP-ribose) Polymerase (PARP) family in mammals, PARP1 is the first identified and well-studied member that plays a critical role in DNA damage repair and has been proven to be an effective target for cancer therapy."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40051364\", \"sentence_id\": 1, \"text\": \"Here, we have reviewed not only the role of PARP1 in different DNA damage repair pathways, but also the working mech-anisms of several PARP inhibitors (PARPi), inhibiting Poly-ADP-ribosylation (PARylation) processing and PAR chains production to trap PARP1 on impaired DNA and inducing Tran-scription-replication Conflicts (TRCs) by inhibiting the PARP1 activity.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40051364", "sentence_id": 1, "text": "Here, we have reviewed not only the role of PARP1 in different DNA damage repair pathways, but also the working mech-anisms of several PARP inhibitors (PARPi), inhibiting Poly-ADP-ribosylation (PARylation) processing and PAR chains production to trap PARP1 on impaired DNA and inducing Tran-scription-replication Conflicts (TRCs) by inhibiting the PARP1 activity."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40051364\", \"sentence_id\": 2, \"text\": \"This review has sys-tematically summarized the latest clinical application of six authorized PARPi, including olaparib, rucaparib, niraparib, talazoparib, fuzuloparib and pamiparib, in monotherapy and combination therapies with chemotherapy, radiotherapy, and immunotherapy, in different kinds of cancer.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40051364", "sentence_id": 2, "text": "This review has sys-tematically summarized the latest clinical application of six authorized PARPi, including olaparib, rucaparib, niraparib, talazoparib, fuzuloparib and pamiparib, in monotherapy and combination therapies with chemotherapy, radiotherapy, and immunotherapy, in different kinds of cancer."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40051364\", \"sentence_id\": 3, \"text\": \"Furthermore, probable challenges in PARPi application and drug resistance mechanisms have also been discussed.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40051364", "sentence_id": 3, "text": "Furthermore, probable challenges in PARPi application and drug resistance mechanisms have also been discussed."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40051364\", \"sentence_id\": 4, \"text\": \"Despite these challenges, further development of new PARP1 inhibitors appears promising as a valuable approach to cancer treatment.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40051364", "sentence_id": 4, "text": "Despite these challenges, further development of new PARP1 inhibitors appears promising as a valuable approach to cancer treatment."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40045559\", \"sentence_id\": 0, \"text\": \"AIMS: The absence of direct comparisons between talazoparib plus enzalutamide (TALA+ENZA) and current standard of care hinders evaluating their relative efficacy for first-line (1\u2009L) metastatic castration resistant prostate cancer (mCRPC).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40045559", "sentence_id": 0, "text": "AIMS: The absence of direct comparisons between talazoparib plus enzalutamide (TALA+ENZA) and current standard of care hinders evaluating their relative efficacy for first-line (1\u2009L) metastatic castration resistant prostate cancer (mCRPC)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40045559\", \"sentence_id\": 1, \"text\": \"This study aimed to compare TALA+ENZA (TALAPRO-2) to abiraterone acetate plus prednisone (AAP) (COU-AA-302) and docetaxel (TAX 327) using a matching-adjusted indirect treatment comparison (MAIC).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40045559", "sentence_id": 1, "text": "This study aimed to compare TALA+ENZA (TALAPRO-2) to abiraterone acetate plus prednisone (AAP) (COU-AA-302) and docetaxel (TAX 327) using a matching-adjusted indirect treatment comparison (MAIC)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40045559\", \"sentence_id\": 2, \"text\": \"METHODS: A systematic literature review using the Ovid\u00ae interface was performed to identify relevant evidence.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40045559", "sentence_id": 2, "text": "METHODS: A systematic literature review using the Ovid\u00ae interface was performed to identify relevant evidence."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40045559\", \"sentence_id\": 3, \"text\": \"Patient-level data from TALAPRO-2 and published data from COU-AA-302 and TAX 327 were used to match populations on clinically relevant confounders.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40045559", "sentence_id": 3, "text": "Patient-level data from TALAPRO-2 and published data from COU-AA-302 and TAX 327 were used to match populations on clinically relevant confounders."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40045559\", \"sentence_id\": 4, \"text\": \"The MAICs were conducted for radiographic progression-free survival (rPFS), overall survival (OS), objective response rate (ORR), along with additional efficacy outcomes.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40045559", "sentence_id": 4, "text": "The MAICs were conducted for radiographic progression-free survival (rPFS), overall survival (OS), objective response rate (ORR), along with additional efficacy outcomes."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40045559\", \"sentence_id\": 5, \"text\": \"RESULTS: In all-comers, TALA+ENZA statistically significantly prolonged rPFS (HR: 0.256; 95% confidence interval [CI]: 0.183, 0.359;\\nCONCLUSIONS: These results suggest TALA+ENZA improves clinical outcomes relative to AAP and docetaxel in the 1\u2009L mCRPC all-comers population.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40045559", "sentence_id": 5, "text": "RESULTS: In all-comers, TALA+ENZA statistically significantly prolonged rPFS (HR: 0.256; 95% confidence interval [CI]: 0.183, 0.359;\nCONCLUSIONS: These results suggest TALA+ENZA improves clinical outcomes relative to AAP and docetaxel in the 1\u2009L mCRPC all-comers population."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39882554\", \"sentence_id\": 0, \"text\": \"BACKGROUND AND OBJECTIVE: PARP inhibitor (PARPi) treatment is an effective option for patients with metastatic castration-resistant prostate cancer (mCRPC).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39882554", "sentence_id": 0, "text": "BACKGROUND AND OBJECTIVE: PARP inhibitor (PARPi) treatment is an effective option for patients with metastatic castration-resistant prostate cancer (mCRPC)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39882554\", \"sentence_id\": 1, \"text\": \"There are few data on the cardiovascular and thromboembolic safety of these agents in mCRPC, as cardiovascular and thromboembolic adverse events (AEs) are uncommon.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39882554", "sentence_id": 1, "text": "There are few data on the cardiovascular and thromboembolic safety of these agents in mCRPC, as cardiovascular and thromboembolic adverse events (AEs) are uncommon."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39882554\", \"sentence_id\": 2, \"text\": \"Our aim was to analyze the incidence and risk of major adverse cardiovascular events (MACEs), thromboembolic events, and hypertension with PARPi therapy in mCRPC.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39882554", "sentence_id": 2, "text": "Our aim was to analyze the incidence and risk of major adverse cardiovascular events (MACEs), thromboembolic events, and hypertension with PARPi therapy in mCRPC."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39882554\", \"sentence_id\": 3, \"text\": \"METHODS: We conducted a systematic review and meta-analysis in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39882554", "sentence_id": 3, "text": "METHODS: We conducted a systematic review and meta-analysis in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39882554\", \"sentence_id\": 4, \"text\": \"We systematically searched the PubMed, EMBASE, and Cochrane databases and the American Society of Clinical Oncology and European Society of Medical Oncology meeting abstracts for clinical trials on PARPi use in mCRPC up to March 31, 2024.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39882554", "sentence_id": 4, "text": "We systematically searched the PubMed, EMBASE, and Cochrane databases and the American Society of Clinical Oncology and European Society of Medical Oncology meeting abstracts for clinical trials on PARPi use in mCRPC up to March 31, 2024."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39882554\", \"sentence_id\": 5, \"text\": \"We analyzed the pooled incidence of all-grade and high-grade MACEs, thromboembolic events, and hypertension, and calculated risk ratios (RRs) for PARPi versus non-PARPi treatment.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39882554", "sentence_id": 5, "text": "We analyzed the pooled incidence of all-grade and high-grade MACEs, thromboembolic events, and hypertension, and calculated risk ratios (RRs) for PARPi versus non-PARPi treatment."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39882554\", \"sentence_id\": 6, \"text\": \"KEY FINDINGS AND LIMITATIONS: We included 11 phase 2 or 3 trials in our meta-analysis.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39882554", "sentence_id": 6, "text": "KEY FINDINGS AND LIMITATIONS: We included 11 phase 2 or 3 trials in our meta-analysis."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39882554\", \"sentence_id\": 7, \"text\": \"Hypertension was the most common AE for both any-grade (17.2%) and high-grade (9.3%) events.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39882554", "sentence_id": 7, "text": "Hypertension was the most common AE for both any-grade (17.2%) and high-grade (9.3%) events."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39882554\", \"sentence_id\": 8, \"text\": \"In comparison to other treatments, PARPi was associated with significantly higher risk of high-grade MACEs (RR 2.03;\\nCONCLUSIONS AND CLINICAL IMPLICATIONS: There is higher risk of high-grade cardiovascular and thromboembolic toxicity with PARPi use in comparison to other treatments in mCRPC, although these toxicities are rare.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39882554", "sentence_id": 8, "text": "In comparison to other treatments, PARPi was associated with significantly higher risk of high-grade MACEs (RR 2.03;\nCONCLUSIONS AND CLINICAL IMPLICATIONS: There is higher risk of high-grade cardiovascular and thromboembolic toxicity with PARPi use in comparison to other treatments in mCRPC, although these toxicities are rare."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39882554\", \"sentence_id\": 9, \"text\": \"Clinicians should be aware of this risk, especially in a population that often has comorbidities and concomitant treatments, for correct monitoring and management of these AEs.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39882554", "sentence_id": 9, "text": "Clinicians should be aware of this risk, especially in a population that often has comorbidities and concomitant treatments, for correct monitoring and management of these AEs."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39882554\", \"sentence_id\": 10, \"text\": \"PATIENT SUMMARY: Drugs called PARP inhibitors are very effective in the treatment of metastatic prostate cancer that does not respond to hormone treatment.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39882554", "sentence_id": 10, "text": "PATIENT SUMMARY: Drugs called PARP inhibitors are very effective in the treatment of metastatic prostate cancer that does not respond to hormone treatment."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39882554\", \"sentence_id\": 11, \"text\": \"However, their use is associated with some cardiovascular adverse events, although these are rare.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39882554", "sentence_id": 11, "text": "However, their use is associated with some cardiovascular adverse events, although these are rare."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39882554\", \"sentence_id\": 12, \"text\": \"Our study shows that these events seem to be more frequent with PARP inhibitors than with other treatments, especially for severe grades.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39882554", "sentence_id": 12, "text": "Our study shows that these events seem to be more frequent with PARP inhibitors than with other treatments, especially for severe grades."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39882554\", \"sentence_id\": 13, \"text\": \"Doctors and patients should be aware of this risk to help in preventing, recognizing, and managing the occurrence of these rare complications.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39882554", "sentence_id": 13, "text": "Doctors and patients should be aware of this risk to help in preventing, recognizing, and managing the occurrence of these rare complications."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39796671\", \"sentence_id\": 0, \"text\": \"BACKGROUND/OBJECTIVES: Through phase III clinical trials, PARP inhibitors have demonstrated outcome improvements in mCRPC patients with alterations in BRCA1/2 genes who have progressed on a second-generation androgen receptor pathway inhibitor (ARPI).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39796671", "sentence_id": 0, "text": "BACKGROUND/OBJECTIVES: Through phase III clinical trials, PARP inhibitors have demonstrated outcome improvements in mCRPC patients with alterations in BRCA1/2 genes who have progressed on a second-generation androgen receptor pathway inhibitor (ARPI)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39796671\", \"sentence_id\": 1, \"text\": \"While improving outcomes, PARP inhibitors contribute to the ever-growing economic burden of PCa.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39796671", "sentence_id": 1, "text": "While improving outcomes, PARP inhibitors contribute to the ever-growing economic burden of PCa."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39796671\", \"sentence_id\": 2, \"text\": \"The objective of this project is to evaluate the cost-effectiveness of PARP inhibitors (olaparib, rucaparib, or talazoparib) versus the SOC (docetaxel or androgen receptor pathway inhibitors (ARPI)) for previously progressed mCRPC patients with BRCA1/2 mutations from the Canadian healthcare system perspective.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39796671", "sentence_id": 2, "text": "The objective of this project is to evaluate the cost-effectiveness of PARP inhibitors (olaparib, rucaparib, or talazoparib) versus the SOC (docetaxel or androgen receptor pathway inhibitors (ARPI)) for previously progressed mCRPC patients with BRCA1/2 mutations from the Canadian healthcare system perspective."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39796671\", \"sentence_id\": 3, \"text\": \"METHODS: Partitioned survival models were created to represent mCRPC disease after progression until death.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39796671", "sentence_id": 3, "text": "METHODS: Partitioned survival models were created to represent mCRPC disease after progression until death."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39796671\", \"sentence_id\": 4, \"text\": \"Survival inputs for BRCA1/2-mutated patients were extracted from the PROfound, TRITON3, and TALAPRO-1 clinical trials, while Canadian-specific costs are presented in 2023 dollars.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39796671", "sentence_id": 4, "text": "Survival inputs for BRCA1/2-mutated patients were extracted from the PROfound, TRITON3, and TALAPRO-1 clinical trials, while Canadian-specific costs are presented in 2023 dollars."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39796671\", \"sentence_id\": 5, \"text\": \"Upon progression, patients were treated with chemotherapy.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39796671", "sentence_id": 5, "text": "Upon progression, patients were treated with chemotherapy."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39796671\", \"sentence_id\": 6, \"text\": \"The considered time horizon was 5 years and outcomes were discounted at 1.5% per year.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39796671", "sentence_id": 6, "text": "The considered time horizon was 5 years and outcomes were discounted at 1.5% per year."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39796671\", \"sentence_id\": 7, \"text\": \"RESULTS: PARP inhibitors provide an additional survival of 0.19 quality-adjusted life years (QALY) when compared to the current standard of care, with additional costs of CAD 101,679 resulting in an incremental cost-utility ratio (ICUR) of CAD 565,383/QALY.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39796671", "sentence_id": 7, "text": "RESULTS: PARP inhibitors provide an additional survival of 0.19 quality-adjusted life years (QALY) when compared to the current standard of care, with additional costs of CAD 101,679 resulting in an incremental cost-utility ratio (ICUR) of CAD 565,383/QALY."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39796671\", \"sentence_id\": 8, \"text\": \"The results were most sensitive to PARP inhibitors' acquisition costs and health-state utilities.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39796671", "sentence_id": 8, "text": "The results were most sensitive to PARP inhibitors' acquisition costs and health-state utilities."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39796671\", \"sentence_id\": 9, \"text\": \"PARP inhibitors required price reductions of up to 83% to meet the CAD 50,000/QALY willingness-to-pay threshold (WTP).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39796671", "sentence_id": 9, "text": "PARP inhibitors required price reductions of up to 83% to meet the CAD 50,000/QALY willingness-to-pay threshold (WTP)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39796671\", \"sentence_id\": 10, \"text\": \"CONCLUSIONS: While providing survival benefits to previously progressed mCRPC patients presenting deleterious BRCA1/2 gene mutations, PARP inhibitors are not cost-effective and require major price reductions to reach local WTP thresholds.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39796671", "sentence_id": 10, "text": "CONCLUSIONS: While providing survival benefits to previously progressed mCRPC patients presenting deleterious BRCA1/2 gene mutations, PARP inhibitors are not cost-effective and require major price reductions to reach local WTP thresholds."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39796639\", \"sentence_id\": 0, \"text\": \"BACKGROUND: Identifying patients with g\\nCLINICAL DESCRIPTION: Data supports the use of adjuvant olaparib in patients with g\\nCONCLUSION: Identifying breast, ovarian, pancreatic and prostate cancer patients with g\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39796639", "sentence_id": 0, "text": "BACKGROUND: Identifying patients with g\nCLINICAL DESCRIPTION: Data supports the use of adjuvant olaparib in patients with g\nCONCLUSION: Identifying breast, ovarian, pancreatic and prostate cancer patients with g"}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39779573\", \"sentence_id\": 0, \"text\": \"Among the Poly(ADP-ribose) Polymerase (PARP) family in mammals, PARP1 is the first identified and well-studied member that plays a critical role in DNA damage repair and has been proven to be an effective target for cancer therapy.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39779573", "sentence_id": 0, "text": "Among the Poly(ADP-ribose) Polymerase (PARP) family in mammals, PARP1 is the first identified and well-studied member that plays a critical role in DNA damage repair and has been proven to be an effective target for cancer therapy."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39779573\", \"sentence_id\": 1, \"text\": \"Here, we have reviewed not only the role of PARP1 in different DNA damage repair pathways, but also the working mechanisms of several PARP inhibitors (PARPi), inhibiting Poly-ADP-ribosylation (PARylation) processing and PAR chains production to trap PARP1 on impaired DNA and inducing Transcription- replication Conflicts (TRCs) by inhibiting the PARP1 activity.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39779573", "sentence_id": 1, "text": "Here, we have reviewed not only the role of PARP1 in different DNA damage repair pathways, but also the working mechanisms of several PARP inhibitors (PARPi), inhibiting Poly-ADP-ribosylation (PARylation) processing and PAR chains production to trap PARP1 on impaired DNA and inducing Transcription- replication Conflicts (TRCs) by inhibiting the PARP1 activity."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39779573\", \"sentence_id\": 2, \"text\": \"This review has systematically summarized the latest clinical application of six authorized PARPi, including olaparib, rucaparib, niraparib, talazoparib, fuzuloparib and pamiparib, in monotherapy and combination therapies with chemotherapy, radiotherapy, and immunotherapy, in different kinds of cancer.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39779573", "sentence_id": 2, "text": "This review has systematically summarized the latest clinical application of six authorized PARPi, including olaparib, rucaparib, niraparib, talazoparib, fuzuloparib and pamiparib, in monotherapy and combination therapies with chemotherapy, radiotherapy, and immunotherapy, in different kinds of cancer."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39779573\", \"sentence_id\": 3, \"text\": \"Furthermore, probable challenges in PARPi application and drug resistance mechanisms have also been discussed.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39779573", "sentence_id": 3, "text": "Furthermore, probable challenges in PARPi application and drug resistance mechanisms have also been discussed."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39779573\", \"sentence_id\": 4, \"text\": \"Despite these challenges, further development of new PARP1 inhibitors appears promising as a valuable approach to cancer treatment.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39779573", "sentence_id": 4, "text": "Despite these challenges, further development of new PARP1 inhibitors appears promising as a valuable approach to cancer treatment."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39761644\", \"sentence_id\": 0, \"text\": \"Breast and prostate cancer are among the most commonly diagnosed cancers worldwide.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39761644", "sentence_id": 0, "text": "Breast and prostate cancer are among the most commonly diagnosed cancers worldwide."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39761644\", \"sentence_id\": 1, \"text\": \"Recent advances in tumor sequencing and gene studies have led to a paradigm shift from treatment centered on the type of tumor to therapy more focused on specific immune phenotype markers and molecular alterations.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39761644", "sentence_id": 1, "text": "Recent advances in tumor sequencing and gene studies have led to a paradigm shift from treatment centered on the type of tumor to therapy more focused on specific immune phenotype markers and molecular alterations."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39761644\", \"sentence_id\": 2, \"text\": \"In this review, we discuss the utility and function of talazoparib concerning prostate cancer treatment and summarize recent and planned clinical trials on talazoparib.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39761644", "sentence_id": 2, "text": "In this review, we discuss the utility and function of talazoparib concerning prostate cancer treatment and summarize recent and planned clinical trials on talazoparib."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39761644\", \"sentence_id\": 3, \"text\": \"We searched medical databases for articles relating to the use of talazoparib in prostate cancer from inception.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39761644", "sentence_id": 3, "text": "We searched medical databases for articles relating to the use of talazoparib in prostate cancer from inception."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39761644\", \"sentence_id\": 4, \"text\": \"Poly ADP ribose polymerase (PARP) is a family of 17 necessary DNA repair enzymes responsible for base excision repair, single-strand break repair, and double-strand break repair.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39761644", "sentence_id": 4, "text": "Poly ADP ribose polymerase (PARP) is a family of 17 necessary DNA repair enzymes responsible for base excision repair, single-strand break repair, and double-strand break repair."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39761644\", \"sentence_id\": 5, \"text\": \"PARP inhibitors are a class of oral targeted therapies that compete for the NAD + binding site on PARP molecules.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39761644", "sentence_id": 5, "text": "PARP inhibitors are a class of oral targeted therapies that compete for the NAD + binding site on PARP molecules."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39761644\", \"sentence_id\": 6, \"text\": \"Talazoparib, a potent PARP inhibitor, has emerged as a significant therapeutic option in the treatment of metastatic castration-resistant prostate cancer (mCRPC), particularly for patients with specific genetic alterations.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39761644", "sentence_id": 6, "text": "Talazoparib, a potent PARP inhibitor, has emerged as a significant therapeutic option in the treatment of metastatic castration-resistant prostate cancer (mCRPC), particularly for patients with specific genetic alterations."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39761644\", \"sentence_id\": 7, \"text\": \"Its role as a PARP inhibitor makes it a targeted therapy, focusing on cancer cells with DNA repair deficiencies.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39761644", "sentence_id": 7, "text": "Its role as a PARP inhibitor makes it a targeted therapy, focusing on cancer cells with DNA repair deficiencies."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39761644\", \"sentence_id\": 8, \"text\": \"Talazoparib's role as a biomarker-directed therapy in advanced prostate cancer has been increasingly recognized.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39761644", "sentence_id": 8, "text": "Talazoparib's role as a biomarker-directed therapy in advanced prostate cancer has been increasingly recognized."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39761644\", \"sentence_id\": 9, \"text\": \"The TALAPRO-1 demonstrated durable antitumor activity in mCRPC patients.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39761644", "sentence_id": 9, "text": "The TALAPRO-1 demonstrated durable antitumor activity in mCRPC patients."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39761644\", \"sentence_id\": 10, \"text\": \"TALAPRO-2 is a notable clinical trial, specifically examining the effectiveness of Talazoparib when used in combination therapies.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39761644", "sentence_id": 10, "text": "TALAPRO-2 is a notable clinical trial, specifically examining the effectiveness of Talazoparib when used in combination therapies."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39761644\", \"sentence_id\": 11, \"text\": \"Current investigations demonstrate a significant improvement in survival outcomes for the patients of mCRPC, making Talazoparib a promising intervention.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39761644", "sentence_id": 11, "text": "Current investigations demonstrate a significant improvement in survival outcomes for the patients of mCRPC, making Talazoparib a promising intervention."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39737542\", \"sentence_id\": 0, \"text\": \"BACKGROUND: In TALAPRO-2, the poly(ADP-ribose) polymerase inhibitor talazoparib plus the androgen receptor-signaling inhibitor enzalutamide improved radiographic progression-free survival (rPFS) versus placebo plus enzalutamide (hazard ratio [HR]\u2009=\u20090.63; 95% CI, 0.51-0.78) in molecularly unselected patients with metastatic castration-resistant prostate cancer (mCRPC).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39737542", "sentence_id": 0, "text": "BACKGROUND: In TALAPRO-2, the poly(ADP-ribose) polymerase inhibitor talazoparib plus the androgen receptor-signaling inhibitor enzalutamide improved radiographic progression-free survival (rPFS) versus placebo plus enzalutamide (hazard ratio [HR]\u2009=\u20090.63; 95% CI, 0.51-0.78) in molecularly unselected patients with metastatic castration-resistant prostate cancer (mCRPC)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39737542\", \"sentence_id\": 1, \"text\": \"We report an exploratory analysis of efficacy, safety, and pharmacokinetics in Japanese patients enrolled in the TALAPRO-2 study.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39737542", "sentence_id": 1, "text": "We report an exploratory analysis of efficacy, safety, and pharmacokinetics in Japanese patients enrolled in the TALAPRO-2 study."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39737542\", \"sentence_id\": 2, \"text\": \"METHODS: The ongoing, multinational, randomized, double-blind, phase 3 TALAPRO-2 study enrolled patients with mCRPC receiving ongoing androgen deprivation therapy.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39737542", "sentence_id": 2, "text": "METHODS: The ongoing, multinational, randomized, double-blind, phase 3 TALAPRO-2 study enrolled patients with mCRPC receiving ongoing androgen deprivation therapy."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39737542\", \"sentence_id\": 3, \"text\": \"Patients were prospectively assessed for homologous recombination repair (HRR) gene alterations and randomized 1:1 to receive talazoparib or placebo plus enzalutamide once daily.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39737542", "sentence_id": 3, "text": "Patients were prospectively assessed for homologous recombination repair (HRR) gene alterations and randomized 1:1 to receive talazoparib or placebo plus enzalutamide once daily."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39737542\", \"sentence_id\": 4, \"text\": \"The primary endpoint was rPFS by blinded independent central review (BICR).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39737542", "sentence_id": 4, "text": "The primary endpoint was rPFS by blinded independent central review (BICR)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39737542\", \"sentence_id\": 5, \"text\": \"Secondary endpoints included overall survival, objective response, safety, and pharmacokinetics.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39737542", "sentence_id": 5, "text": "Secondary endpoints included overall survival, objective response, safety, and pharmacokinetics."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39737542\", \"sentence_id\": 6, \"text\": \"RESULTS: For the 116 Japanese all-comers patients enrolled in TALAPRO-2, the HR for rPFS was 0.89 (95% CI, 0.45-1.75) for the talazoparib versus placebo arm; among those with HRR-deficient disease, the HR was 0.58 (95% CI, 0.16-2.20).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39737542", "sentence_id": 6, "text": "RESULTS: For the 116 Japanese all-comers patients enrolled in TALAPRO-2, the HR for rPFS was 0.89 (95% CI, 0.45-1.75) for the talazoparib versus placebo arm; among those with HRR-deficient disease, the HR was 0.58 (95% CI, 0.16-2.20)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39737542\", \"sentence_id\": 7, \"text\": \"Among patients with BRCA1/2 gene alterations in the HRR-deficient population (n\u2009=\u200910), the HR for rPFS was <\u20090.01 (95% CI, <\u20090.01-not reached) for the talazoparib versus placebo arm.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39737542", "sentence_id": 7, "text": "Among patients with BRCA1/2 gene alterations in the HRR-deficient population (n\u2009=\u200910), the HR for rPFS was <\u20090.01 (95% CI, <\u20090.01-not reached) for the talazoparib versus placebo arm."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39737542\", \"sentence_id\": 8, \"text\": \"In the all-comers population, the objective response rate by BICR was 55% (all complete responses) in the talazoparib arm versus 36% in the placebo arm.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39737542", "sentence_id": 8, "text": "In the all-comers population, the objective response rate by BICR was 55% (all complete responses) in the talazoparib arm versus 36% in the placebo arm."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39737542\", \"sentence_id\": 9, \"text\": \"The safety profile of talazoparib plus enzalutamide was similar between Japanese patients and the overall all-comers population; no new safety signals were identified.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39737542", "sentence_id": 9, "text": "The safety profile of talazoparib plus enzalutamide was similar between Japanese patients and the overall all-comers population; no new safety signals were identified."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39737542\", \"sentence_id\": 10, \"text\": \"Anemia was the most common grade 3/4 treatment-emergent adverse event (55%) and cause of talazoparib discontinuation (12%).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39737542", "sentence_id": 10, "text": "Anemia was the most common grade 3/4 treatment-emergent adverse event (55%) and cause of talazoparib discontinuation (12%)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39737542\", \"sentence_id\": 11, \"text\": \"Talazoparib C\\nCONCLUSIONS: In this exploratory analysis, efficacy outcomes with talazoparib plus enzalutamide in Japanese patients in TALAPRO-2 were consistent with those in the overall all-comers population.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39737542", "sentence_id": 11, "text": "Talazoparib C\nCONCLUSIONS: In this exploratory analysis, efficacy outcomes with talazoparib plus enzalutamide in Japanese patients in TALAPRO-2 were consistent with those in the overall all-comers population."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39737542\", \"sentence_id\": 12, \"text\": \"The safety profile and pharmacokinetics of the combination were similar between Japanese patients and the overall all-comers population.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39737542", "sentence_id": 12, "text": "The safety profile and pharmacokinetics of the combination were similar between Japanese patients and the overall all-comers population."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39737542\", \"sentence_id\": 13, \"text\": \"TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03395197.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39737542", "sentence_id": 13, "text": "TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03395197."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39716888\", \"sentence_id\": 0, \"text\": \"INTRODUCTION: Prostate cancer (PCa) is the second most common cancer diagnosis among men worldwide, with poor prognosis in its advanced stage.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39716888", "sentence_id": 0, "text": "INTRODUCTION: Prostate cancer (PCa) is the second most common cancer diagnosis among men worldwide, with poor prognosis in its advanced stage."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39716888\", \"sentence_id\": 1, \"text\": \"Treatment strategies have evolved, including the use of androgen receptor pathway inhibitors (ARPIs) and poly (ADP-ribose) polymerase inhibitors (PARPis).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39716888", "sentence_id": 1, "text": "Treatment strategies have evolved, including the use of androgen receptor pathway inhibitors (ARPIs) and poly (ADP-ribose) polymerase inhibitors (PARPis)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39716888\", \"sentence_id\": 2, \"text\": \"AREAS COVERED: This review evaluates the clinical efficacy, safety, and future potential of combining talazoparib, a potent PARPi, with enzalutamide, a strong androgen receptor (AR) antagonist.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39716888", "sentence_id": 2, "text": "AREAS COVERED: This review evaluates the clinical efficacy, safety, and future potential of combining talazoparib, a potent PARPi, with enzalutamide, a strong androgen receptor (AR) antagonist."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39716888\", \"sentence_id\": 3, \"text\": \"The combination of these two drugs was evaluated by the TALAPRO-2 trial, demonstrating significant improvement in radiographic progression-free survival (rPFS) in metastatic castration-resistant prostate cancer (mCRPC) patients, particularly those with Homologous Recombination Repair (HRR) gene mutations such as BRCA1/2.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39716888", "sentence_id": 3, "text": "The combination of these two drugs was evaluated by the TALAPRO-2 trial, demonstrating significant improvement in radiographic progression-free survival (rPFS) in metastatic castration-resistant prostate cancer (mCRPC) patients, particularly those with Homologous Recombination Repair (HRR) gene mutations such as BRCA1/2."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39716888\", \"sentence_id\": 4, \"text\": \"EXPERT OPINION: Emerging biomarkers like TMPRSS2-ERG and RB1 gene mutations have been recently reported as potential predictors of clinical outcome in the TALAPRO-2 all-comers population.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39716888", "sentence_id": 4, "text": "EXPERT OPINION: Emerging biomarkers like TMPRSS2-ERG and RB1 gene mutations have been recently reported as potential predictors of clinical outcome in the TALAPRO-2 all-comers population."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39716888\", \"sentence_id\": 5, \"text\": \"Genomic markers for homologous recombination deficiency (HRD) are other potential drivers of response to PARPi/ARPI combination.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39716888", "sentence_id": 5, "text": "Genomic markers for homologous recombination deficiency (HRD) are other potential drivers of response to PARPi/ARPI combination."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39716888\", \"sentence_id\": 6, \"text\": \"Further investigation is needed to refine treatment strategies, including targeting non-HRR mutations, and to expand the role of this combination therapy in earlier stages of prostate cancer.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39716888", "sentence_id": 6, "text": "Further investigation is needed to refine treatment strategies, including targeting non-HRR mutations, and to expand the role of this combination therapy in earlier stages of prostate cancer."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39645562\", \"sentence_id\": 0, \"text\": \"BACKGROUND: Without head-to-head trials between talazoparib+enzalutamide (TALA\u2009+\u2009ENZA), olaparib+abiraterone acetate (OLAP\u2009+\u2009AAP), and niraparib plus AAP (NIRA\u2009+\u2009AAP) the ability to evaluate their relative efficacy as first-line (1\u2009L) treatment in metastatic castration-resistant prostate cancer (mCRPC) is limited.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39645562", "sentence_id": 0, "text": "BACKGROUND: Without head-to-head trials between talazoparib+enzalutamide (TALA\u2009+\u2009ENZA), olaparib+abiraterone acetate (OLAP\u2009+\u2009AAP), and niraparib plus AAP (NIRA\u2009+\u2009AAP) the ability to evaluate their relative efficacy as first-line (1\u2009L) treatment in metastatic castration-resistant prostate cancer (mCRPC) is limited."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39645562\", \"sentence_id\": 1, \"text\": \"The objective of this study was to assess the relative efficacy between TALA\u2009+\u2009ENZA (TALAPRO-2) versus OLAP\u2009+\u2009AAP (PROpel) and NIRA\u2009+\u2009AAP (MAGNITUDE) in 1\u2009L mCRPC via a matching-adjusted indirect treatment comparison (MAIC).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39645562", "sentence_id": 1, "text": "The objective of this study was to assess the relative efficacy between TALA\u2009+\u2009ENZA (TALAPRO-2) versus OLAP\u2009+\u2009AAP (PROpel) and NIRA\u2009+\u2009AAP (MAGNITUDE) in 1\u2009L mCRPC via a matching-adjusted indirect treatment comparison (MAIC)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39645562\", \"sentence_id\": 2, \"text\": \"METHODS: Patient-level data from TALAPRO-2 and published data from PROpel and MAGNITUDE were used.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39645562", "sentence_id": 2, "text": "METHODS: Patient-level data from TALAPRO-2 and published data from PROpel and MAGNITUDE were used."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39645562\", \"sentence_id\": 3, \"text\": \"TALAPRO-2 data were reweighted to satisfy the eligibility criteria for PROpel and MAGNITUDE.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39645562", "sentence_id": 3, "text": "TALAPRO-2 data were reweighted to satisfy the eligibility criteria for PROpel and MAGNITUDE."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39645562\", \"sentence_id\": 4, \"text\": \"Talazoparib (0.5\u2009mg/day) plus enzalutamide (160\u2009mg/day) was compared to olaparib (300\u2009mg twice daily) plus abiraterone acetate (1000\u2009mg/day) and niraparib (200\u2009mg/day) plus abiraterone acetate (1000\u2009mg/day).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39645562", "sentence_id": 4, "text": "Talazoparib (0.5\u2009mg/day) plus enzalutamide (160\u2009mg/day) was compared to olaparib (300\u2009mg twice daily) plus abiraterone acetate (1000\u2009mg/day) and niraparib (200\u2009mg/day) plus abiraterone acetate (1000\u2009mg/day)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39645562\", \"sentence_id\": 5, \"text\": \"Hazard ratios (HRs) were calculated for radiographic progression-free survival (rPFS) and overall survival (OS), and odds ratios (ORs) for prostate-specific antigen (PSA) response and objective response rate (ORR).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39645562", "sentence_id": 5, "text": "Hazard ratios (HRs) were calculated for radiographic progression-free survival (rPFS) and overall survival (OS), and odds ratios (ORs) for prostate-specific antigen (PSA) response and objective response rate (ORR)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39645562\", \"sentence_id\": 6, \"text\": \"Additional efficacy outcomes were assessed.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39645562", "sentence_id": 6, "text": "Additional efficacy outcomes were assessed."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39645562\", \"sentence_id\": 7, \"text\": \"RESULTS: In all-comers, TALA\u2009+\u2009ENZA was statistically superior to OLAP\u2009+\u2009AAP for rPFS (HR: 0.727; 95% confidence interval [CI]: 0.565, 0.935) and PSA response (OR: 1.663; 1.101, 2.510), and numerically favored for OS (HR: 0.847; 0.667, 1.076) and ORR (OR: 1.109; 0.646, 1.903).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39645562", "sentence_id": 7, "text": "RESULTS: In all-comers, TALA\u2009+\u2009ENZA was statistically superior to OLAP\u2009+\u2009AAP for rPFS (HR: 0.727; 95% confidence interval [CI]: 0.565, 0.935) and PSA response (OR: 1.663; 1.101, 2.510), and numerically favored for OS (HR: 0.847; 0.667, 1.076) and ORR (OR: 1.109; 0.646, 1.903)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39645562\", \"sentence_id\": 8, \"text\": \"In patients with homologous recombination repair mutations (HRRm), relative to NIRA\u2009+\u2009AAP, TALA\u2009+\u2009ENZA was statistically superior for rPFS (HR: 0.460; 0.280, 0.754), and numerically favored for OS (HR: 0.601; 0.347, 1.041) and ORR (OR: 1.524; 0.579, 4.016).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39645562", "sentence_id": 8, "text": "In patients with homologous recombination repair mutations (HRRm), relative to NIRA\u2009+\u2009AAP, TALA\u2009+\u2009ENZA was statistically superior for rPFS (HR: 0.460; 0.280, 0.754), and numerically favored for OS (HR: 0.601; 0.347, 1.041) and ORR (OR: 1.524; 0.579, 4.016)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39645562\", \"sentence_id\": 9, \"text\": \"CONCLUSIONS: Results suggest that TALA\u2009+\u2009ENZA may provide improvements in clinical outcomes relative to OLAP\u2009+\u2009AAP and NIRA\u2009+\u2009AAP in 1\u2009L mCRPC; however, inherent limitations associated with the complexity of the analyses must be considered.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39645562", "sentence_id": 9, "text": "CONCLUSIONS: Results suggest that TALA\u2009+\u2009ENZA may provide improvements in clinical outcomes relative to OLAP\u2009+\u2009AAP and NIRA\u2009+\u2009AAP in 1\u2009L mCRPC; however, inherent limitations associated with the complexity of the analyses must be considered."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39638687\", \"sentence_id\": 0, \"text\": \"BACKGROUND AND OBJECTIVE: Advanced prostate cancer (PCa) is enriched for alterations in DNA damage repair genes; poly (ADP-ribose) polymerase (PARP) inhibitors (PARPi) are a class of drugs that have demonstrated effectiveness in PCa, particularly in tumors with alterations in BRCA1/2 and other homologous recombination repair (HRR) genes, acting through a synthetic lethal mechanism.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39638687", "sentence_id": 0, "text": "BACKGROUND AND OBJECTIVE: Advanced prostate cancer (PCa) is enriched for alterations in DNA damage repair genes; poly (ADP-ribose) polymerase (PARP) inhibitors (PARPi) are a class of drugs that have demonstrated effectiveness in PCa, particularly in tumors with alterations in BRCA1/2 and other homologous recombination repair (HRR) genes, acting through a synthetic lethal mechanism."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39638687\", \"sentence_id\": 1, \"text\": \"To prevent or delay drug resistance, and to expand the patient population that can benefit from this class of drug, combination treatment strategies have been developed in preclinical and clinical studies.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39638687", "sentence_id": 1, "text": "To prevent or delay drug resistance, and to expand the patient population that can benefit from this class of drug, combination treatment strategies have been developed in preclinical and clinical studies."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39638687\", \"sentence_id\": 2, \"text\": \"METHODS: This review examines the latest developments in clinical trials testing PARPi for advanced PCa and their emerging role in earlier disease settings.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39638687", "sentence_id": 2, "text": "METHODS: This review examines the latest developments in clinical trials testing PARPi for advanced PCa and their emerging role in earlier disease settings."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39638687\", \"sentence_id\": 3, \"text\": \"Furthermore, it discusses the critical role of careful patient selection and identification of additional biomarkers to enhance treatment efficacy.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39638687", "sentence_id": 3, "text": "Furthermore, it discusses the critical role of careful patient selection and identification of additional biomarkers to enhance treatment efficacy."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39638687\", \"sentence_id\": 4, \"text\": \"KEY FINDINGS AND LIMITATIONS: Two PARPi (olaparib and rucaparib) have been approved as monotherapy in metastatic castration-resistant PCa, thereby establishing the first biomarker-guided drug indications in PCa.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39638687", "sentence_id": 4, "text": "KEY FINDINGS AND LIMITATIONS: Two PARPi (olaparib and rucaparib) have been approved as monotherapy in metastatic castration-resistant PCa, thereby establishing the first biomarker-guided drug indications in PCa."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39638687\", \"sentence_id\": 5, \"text\": \"Several combinations of PARPi with androgen receptor pathway inhibitors have now also been approved.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39638687", "sentence_id": 5, "text": "Several combinations of PARPi with androgen receptor pathway inhibitors have now also been approved."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39638687\", \"sentence_id\": 6, \"text\": \"Anemia and fatigue are the main adverse events associated with this drug class in clinical trials; gastrointestinal toxicities are common but usually manageble.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39638687", "sentence_id": 6, "text": "Anemia and fatigue are the main adverse events associated with this drug class in clinical trials; gastrointestinal toxicities are common but usually manageble."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39638687\", \"sentence_id\": 7, \"text\": \"CONCLUSIONS AND CLINICAL IMPLICATIONS: PARPi are active against PCa with HRR mutations, especially in those with germline or somatic\u00a0BRCA1/2\u00a0mutations.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39638687", "sentence_id": 7, "text": "CONCLUSIONS AND CLINICAL IMPLICATIONS: PARPi are active against PCa with HRR mutations, especially in those with germline or somatic\u00a0BRCA1/2\u00a0mutations."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39638687\", \"sentence_id\": 8, \"text\": \"There is still a need to further optimize patient stratification strategies, particularly for combination approaches.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39638687", "sentence_id": 8, "text": "There is still a need to further optimize patient stratification strategies, particularly for combination approaches."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39638687\", \"sentence_id\": 9, \"text\": \"Future research should focus on refining predictive biomarkers, improving treatment delivery strategies, and exploring the potential benefits of PARPi in earlier stages of the disease.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39638687", "sentence_id": 9, "text": "Future research should focus on refining predictive biomarkers, improving treatment delivery strategies, and exploring the potential benefits of PARPi in earlier stages of the disease."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39638687\", \"sentence_id\": 10, \"text\": \"PATIENT SUMMARY: Here, we summarize the results from clinical trials testing different poly (ADP-ribose) polymerase inhibitors (PARPi), a novel targeted drug class, in prostate cancer.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39638687", "sentence_id": 10, "text": "PATIENT SUMMARY: Here, we summarize the results from clinical trials testing different poly (ADP-ribose) polymerase inhibitors (PARPi), a novel targeted drug class, in prostate cancer."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39638687\", \"sentence_id\": 11, \"text\": \"Overall, the data from these trials confirm the efficacy of this drug class in those metastatic prostate cancers that show specific gene alterations, such as mutations in the BRCA1/2 genes.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39638687", "sentence_id": 11, "text": "Overall, the data from these trials confirm the efficacy of this drug class in those metastatic prostate cancers that show specific gene alterations, such as mutations in the BRCA1/2 genes."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39638687\", \"sentence_id\": 12, \"text\": \"Several studies combining PARPi with other standard drugs for prostate cancer suggest that there may be efficacy in larger patient populations, but some of these data still need validation in longer follow-up analyses.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39638687", "sentence_id": 12, "text": "Several studies combining PARPi with other standard drugs for prostate cancer suggest that there may be efficacy in larger patient populations, but some of these data still need validation in longer follow-up analyses."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39631207\", \"sentence_id\": 0, \"text\": \"MYC amplification is disproportionally elevated in triple-negative breast cancer (TNBC) compared to other subtypes of breast cancer.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39631207", "sentence_id": 0, "text": "MYC amplification is disproportionally elevated in triple-negative breast cancer (TNBC) compared to other subtypes of breast cancer."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39631207\", \"sentence_id\": 1, \"text\": \"Indeed, MYC has long been considered an undruggable oncogene using conventional drug design strategies or small molecules.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39631207", "sentence_id": 1, "text": "Indeed, MYC has long been considered an undruggable oncogene using conventional drug design strategies or small molecules."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39631207\", \"sentence_id\": 2, \"text\": \"We hypothesized that targeting MYC using asymmetric siRNA (asiRNA) alone or in combination with chemotherapeutic agents or indirectly via BRD4 and RRM2, may curb its oncogenic behavior.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39631207", "sentence_id": 2, "text": "We hypothesized that targeting MYC using asymmetric siRNA (asiRNA) alone or in combination with chemotherapeutic agents or indirectly via BRD4 and RRM2, may curb its oncogenic behavior."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39631207\", \"sentence_id\": 3, \"text\": \"We developed paclitaxel-, doxorubicin-, and cisplatin-resistant MDA-MB-231 cells to study MYC's role in upregulating DNA repair genes during drug resistance development.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39631207", "sentence_id": 3, "text": "We developed paclitaxel-, doxorubicin-, and cisplatin-resistant MDA-MB-231 cells to study MYC's role in upregulating DNA repair genes during drug resistance development."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39631207\", \"sentence_id\": 4, \"text\": \"Our results showed that the knockdown of either MYC or RRM2 downregulated both RAD51 and PARP1 but increased \u03b3H2AX.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39631207", "sentence_id": 4, "text": "Our results showed that the knockdown of either MYC or RRM2 downregulated both RAD51 and PARP1 but increased \u03b3H2AX."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39631207\", \"sentence_id\": 5, \"text\": \"The cytotoxic effect of RRM2 knockdown was significantly (p < 0.05) higher than that of direct MYC knockdown.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39631207", "sentence_id": 5, "text": "The cytotoxic effect of RRM2 knockdown was significantly (p < 0.05) higher than that of direct MYC knockdown."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39631207\", \"sentence_id\": 6, \"text\": \"The knockdown of BRD4 was more effective than the direct knockdown of MYC in downregulating MYC protein.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39631207", "sentence_id": 6, "text": "The knockdown of BRD4 was more effective than the direct knockdown of MYC in downregulating MYC protein."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39631207\", \"sentence_id\": 7, \"text\": \"The combined use of asiRNA-VP (Vinylphosphonate) with dacomitinib or talazoparib was synthetic lethal in TNBC cell lines.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39631207", "sentence_id": 7, "text": "The combined use of asiRNA-VP (Vinylphosphonate) with dacomitinib or talazoparib was synthetic lethal in TNBC cell lines."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39631207\", \"sentence_id\": 8, \"text\": \"Compared to chemotherapy-sensitive cells, resistant cells showed overexpression of MYC, RRM2, RAD51, and PARP1 proteins upon chemotherapy treatment, but downregulated in cells treated with asiRNA-VP combination.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39631207", "sentence_id": 8, "text": "Compared to chemotherapy-sensitive cells, resistant cells showed overexpression of MYC, RRM2, RAD51, and PARP1 proteins upon chemotherapy treatment, but downregulated in cells treated with asiRNA-VP combination."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39631207\", \"sentence_id\": 9, \"text\": \"We confirmed that MYC knockdown upregulated cFLIP, BCL2, STAT1, pSTAT1, STAT2, and cleaved saspase-3 in both TNBC and non-small cell lung cancer (NSCLC) cell lines.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39631207", "sentence_id": 9, "text": "We confirmed that MYC knockdown upregulated cFLIP, BCL2, STAT1, pSTAT1, STAT2, and cleaved saspase-3 in both TNBC and non-small cell lung cancer (NSCLC) cell lines."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39631207\", \"sentence_id\": 10, \"text\": \"Finally, we recommend a combination treatment approach that synergizes with MYC inhibition rather than monotherapy or indirect targeting via upstream regulators such as the BRD4 and RRM2 genes or selective modulation at the protein level to suppress anti-apoptotic genes (cFLIP and BCL2) at the same time.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39631207", "sentence_id": 10, "text": "Finally, we recommend a combination treatment approach that synergizes with MYC inhibition rather than monotherapy or indirect targeting via upstream regulators such as the BRD4 and RRM2 genes or selective modulation at the protein level to suppress anti-apoptotic genes (cFLIP and BCL2) at the same time."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39594596\", \"sentence_id\": 0, \"text\": \"Poly (ADP-ribose) polymerase inhibitors (PARPis) show cytotoxicity in homologous recombination deficiency (HRD) seen in\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39594596", "sentence_id": 0, "text": "Poly (ADP-ribose) polymerase inhibitors (PARPis) show cytotoxicity in homologous recombination deficiency (HRD) seen in"}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39486165\", \"sentence_id\": 0, \"text\": \"BACKGROUND: This detailed analysis further characterizes the safety profile of talazoparib plus enzalutamide in the ongoing randomized, phase III TALAPRO-2 study in patients with metastatic castration-resistant prostate cancer (mCRPC).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39486165", "sentence_id": 0, "text": "BACKGROUND: This detailed analysis further characterizes the safety profile of talazoparib plus enzalutamide in the ongoing randomized, phase III TALAPRO-2 study in patients with metastatic castration-resistant prostate cancer (mCRPC)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39486165\", \"sentence_id\": 1, \"text\": \"In both the all-comers and homologous recombination repair (HRR)-deficient populations, talazoparib plus enzalutamide significantly improved radiographic progression-free survival compared with placebo plus enzalutamide.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39486165", "sentence_id": 1, "text": "In both the all-comers and homologous recombination repair (HRR)-deficient populations, talazoparib plus enzalutamide significantly improved radiographic progression-free survival compared with placebo plus enzalutamide."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39486165\", \"sentence_id\": 2, \"text\": \"METHODS: The talazoparib plus enzalutamide safety populations in TALAPRO-2 included 398 patients from cohort 1 (all-comers, unselected for HRR gene alterations) and 198 patients from the combined HRR-deficient population (patients from the all-comers population with HRR gene alterations plus subsequently enrolled patients with HRR gene alterations; cohort 2).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39486165", "sentence_id": 2, "text": "METHODS: The talazoparib plus enzalutamide safety populations in TALAPRO-2 included 398 patients from cohort 1 (all-comers, unselected for HRR gene alterations) and 198 patients from the combined HRR-deficient population (patients from the all-comers population with HRR gene alterations plus subsequently enrolled patients with HRR gene alterations; cohort 2)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39486165\", \"sentence_id\": 3, \"text\": \"Patients received talazoparib 0.5\u00a0mg (0.35\u00a0mg, moderate renal impairment) and enzalutamide 160\u00a0mg once daily.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39486165", "sentence_id": 3, "text": "Patients received talazoparib 0.5\u00a0mg (0.35\u00a0mg, moderate renal impairment) and enzalutamide 160\u00a0mg once daily."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39486165\", \"sentence_id\": 4, \"text\": \"Safety analyses evaluated common treatment-emergent adverse events (TEAE), their type, severity, timing, seriousness, and relationship to study treatment.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39486165", "sentence_id": 4, "text": "Safety analyses evaluated common treatment-emergent adverse events (TEAE), their type, severity, timing, seriousness, and relationship to study treatment."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39486165\", \"sentence_id\": 5, \"text\": \"RESULTS: In the all-comers (n\u00a0=\u00a0398) and HRR-deficient populations (n\u00a0=\u00a0198), all-cause grade 3/4 (G3/4) TEAEs with talazoparib plus enzalutamide were reported in 71.9\u00a0% and 66.2\u00a0% of patients, respectively.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39486165", "sentence_id": 5, "text": "RESULTS: In the all-comers (n\u00a0=\u00a0398) and HRR-deficient populations (n\u00a0=\u00a0198), all-cause grade 3/4 (G3/4) TEAEs with talazoparib plus enzalutamide were reported in 71.9\u00a0% and 66.2\u00a0% of patients, respectively."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39486165\", \"sentence_id\": 6, \"text\": \"Most common G3/4 hematologic TEAEs were anemia (46.7\u00a0% and 40.9\u00a0%, respectively), neutropenia (18.3\u00a0% and 18.7\u00a0%), and thrombocytopenia (7.3\u00a0% and 7.1\u00a0%).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39486165", "sentence_id": 6, "text": "Most common G3/4 hematologic TEAEs were anemia (46.7\u00a0% and 40.9\u00a0%, respectively), neutropenia (18.3\u00a0% and 18.7\u00a0%), and thrombocytopenia (7.3\u00a0% and 7.1\u00a0%)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39486165\", \"sentence_id\": 7, \"text\": \"Median time to event was 3.3 and 3.3 months for G3/4 anemia, 2.3 and 2.3 months for G3/4 neutropenia, and 2.3 and 1.5 months for G3/4 thrombocytopenia.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39486165", "sentence_id": 7, "text": "Median time to event was 3.3 and 3.3 months for G3/4 anemia, 2.3 and 2.3 months for G3/4 neutropenia, and 2.3 and 1.5 months for G3/4 thrombocytopenia."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39486165\", \"sentence_id\": 8, \"text\": \"Maximum hemoglobin reduction occurred after 13 and 15 weeks of treatment.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39486165", "sentence_id": 8, "text": "Maximum hemoglobin reduction occurred after 13 and 15 weeks of treatment."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39486165\", \"sentence_id\": 9, \"text\": \"18.8\u00a0% and 10.1\u00a0% of patients discontinued talazoparib.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39486165", "sentence_id": 9, "text": "18.8\u00a0% and 10.1\u00a0% of patients discontinued talazoparib."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39486165\", \"sentence_id\": 10, \"text\": \"TEAEs were managed with dose interruption (62.1\u00a0% and 57.6\u00a0%), reduction (52.8\u00a0% and 52.0\u00a0%), hematologic supportive care (13.1\u00a0% and 10.6\u00a0%), and packed red blood cell transfusions (39.2\u00a0% and 35.9\u00a0%).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39486165", "sentence_id": 10, "text": "TEAEs were managed with dose interruption (62.1\u00a0% and 57.6\u00a0%), reduction (52.8\u00a0% and 52.0\u00a0%), hematologic supportive care (13.1\u00a0% and 10.6\u00a0%), and packed red blood cell transfusions (39.2\u00a0% and 35.9\u00a0%)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39486165\", \"sentence_id\": 11, \"text\": \"CONCLUSION: Talazoparib plus enzalutamide had a generally manageable safety profile in patients with mCRPC within the all-comers and the HRR-deficient populations.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39486165", "sentence_id": 11, "text": "CONCLUSION: Talazoparib plus enzalutamide had a generally manageable safety profile in patients with mCRPC within the all-comers and the HRR-deficient populations."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39486165\", \"sentence_id\": 12, \"text\": \"GOV IDENTIFIER: NCT03395197.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39486165", "sentence_id": 12, "text": "GOV IDENTIFIER: NCT03395197."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39451095\", \"sentence_id\": 0, \"text\": \"WHAT IS THIS SUMMARY ABOUT?: This summary is about the ongoing research study called TALAPRO-3.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39451095", "sentence_id": 0, "text": "WHAT IS THIS SUMMARY ABOUT?: This summary is about the ongoing research study called TALAPRO-3."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39451095\", \"sentence_id\": 1, \"text\": \"This study is testing the use of two medicines called talazoparib and enzalutamide.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39451095", "sentence_id": 1, "text": "This study is testing the use of two medicines called talazoparib and enzalutamide."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39451095\", \"sentence_id\": 2, \"text\": \"The two medicines are being used together as a treatment for patients with a type of cancer called metastatic castration-sensitive prostate cancer and changes in specific DNA repair genes within their tumors.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39451095", "sentence_id": 2, "text": "The two medicines are being used together as a treatment for patients with a type of cancer called metastatic castration-sensitive prostate cancer and changes in specific DNA repair genes within their tumors."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39451095\", \"sentence_id\": 3, \"text\": \"The study began in May 2021, and includes 599 patients from 27 countries.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39451095", "sentence_id": 3, "text": "The study began in May 2021, and includes 599 patients from 27 countries."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39451095\", \"sentence_id\": 4, \"text\": \"WHAT IS METASTATIC CASTRATION-SENSITIVE PROSTATE CANCER?: Metastatic castration-sensitive prostate cancer is known as mCSPC for short.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39451095", "sentence_id": 4, "text": "WHAT IS METASTATIC CASTRATION-SENSITIVE PROSTATE CANCER?: Metastatic castration-sensitive prostate cancer is known as mCSPC for short."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39451095\", \"sentence_id\": 5, \"text\": \"It is cancer that has started in the prostate and spread to other body parts.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39451095", "sentence_id": 5, "text": "It is cancer that has started in the prostate and spread to other body parts."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39451095\", \"sentence_id\": 6, \"text\": \"The prostate is a gland below the bladder and helps make semen (the liquid that contains sperm).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39451095", "sentence_id": 6, "text": "The prostate is a gland below the bladder and helps make semen (the liquid that contains sperm)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39451095\", \"sentence_id\": 7, \"text\": \"Castration-sensitive means that the cancer responds to treatments that lower testosterone in the blood.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39451095", "sentence_id": 7, "text": "Castration-sensitive means that the cancer responds to treatments that lower testosterone in the blood."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39451095\", \"sentence_id\": 8, \"text\": \"WHICH MEDICINES ARE BEING TESTED?: In this study, some patients will take talazoparib plus enzalutamide while others will take a placebo plus enzalutamide.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39451095", "sentence_id": 8, "text": "WHICH MEDICINES ARE BEING TESTED?: In this study, some patients will take talazoparib plus enzalutamide while others will take a placebo plus enzalutamide."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39451095\", \"sentence_id\": 9, \"text\": \"Talazoparib and enzalutamide are two different cancer medicines.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39451095", "sentence_id": 9, "text": "Talazoparib and enzalutamide are two different cancer medicines."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39451095\", \"sentence_id\": 10, \"text\": \"Talazoparib is not currently used to treat patients with mCSPC.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39451095", "sentence_id": 10, "text": "Talazoparib is not currently used to treat patients with mCSPC."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39451095\", \"sentence_id\": 11, \"text\": \"Enzalutamide is used to treat patients with prostate cancer.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39451095", "sentence_id": 11, "text": "Enzalutamide is used to treat patients with prostate cancer."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39451095\", \"sentence_id\": 12, \"text\": \"Talazoparib plus enzalutamide is being compared with a placebo plus enzalutamide to see if patients live longer without their cancer getting worse, or them dying, when taking talazoparib plus enzalutamide or when taking a placebo plus enzalutamide.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39451095", "sentence_id": 12, "text": "Talazoparib plus enzalutamide is being compared with a placebo plus enzalutamide to see if patients live longer without their cancer getting worse, or them dying, when taking talazoparib plus enzalutamide or when taking a placebo plus enzalutamide."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39451095\", \"sentence_id\": 13, \"text\": \"WHAT ARE THE AIMS OF THE TALAPRO-3 STUDY?: This study aims to find out if treatment with talazoparib plus enzalutamide increases the length of time the patients in the study live without their cancer getting worse, or them dying, compared with treatment with a placebo plus enzalutamide.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39451095", "sentence_id": 13, "text": "WHAT ARE THE AIMS OF THE TALAPRO-3 STUDY?: This study aims to find out if treatment with talazoparib plus enzalutamide increases the length of time the patients in the study live without their cancer getting worse, or them dying, compared with treatment with a placebo plus enzalutamide."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39451095\", \"sentence_id\": 14, \"text\": \"The study will also measure how long the patients in the study live, the number and types of side effects they have, their general health and quality of life, and whether there are changes in how patients report their pain.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39451095", "sentence_id": 14, "text": "The study will also measure how long the patients in the study live, the number and types of side effects they have, their general health and quality of life, and whether there are changes in how patients report their pain."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39427229\", \"sentence_id\": 0, \"text\": \"BACKGROUND: Talazoparib plus enzalutamide (TALA\u2005+\u2005ENZA) has demonstrated antitumor activity in the phase 3 clinical trial (TALAPRO-2; NCT03395197) as first-line (1L) therapy in men with asymptomatic or mildly symptomatic metastatic castration-resistant prostate cancer (mCRPC).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39427229", "sentence_id": 0, "text": "BACKGROUND: Talazoparib plus enzalutamide (TALA\u2005+\u2005ENZA) has demonstrated antitumor activity in the phase 3 clinical trial (TALAPRO-2; NCT03395197) as first-line (1L) therapy in men with asymptomatic or mildly symptomatic metastatic castration-resistant prostate cancer (mCRPC)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39427229\", \"sentence_id\": 1, \"text\": \"Although many active interventions are available, randomized controlled trials (RCTs) involving talazoparib have only been conducted to assess its efficacy and safety compared to enzalutamide.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39427229", "sentence_id": 1, "text": "Although many active interventions are available, randomized controlled trials (RCTs) involving talazoparib have only been conducted to assess its efficacy and safety compared to enzalutamide."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39427229\", \"sentence_id\": 2, \"text\": \"To estimate comparisons between all relevant interventions, indirect comparisons are needed.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39427229", "sentence_id": 2, "text": "To estimate comparisons between all relevant interventions, indirect comparisons are needed."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39427229\", \"sentence_id\": 3, \"text\": \"OBJECTIVE: To estimate the comparative efficacy and safety of TALA\u2005+\u2005ENZA in 1L patients with mCRPC by conducting a systematic literature review and network meta-analyses (NMAs).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39427229", "sentence_id": 3, "text": "OBJECTIVE: To estimate the comparative efficacy and safety of TALA\u2005+\u2005ENZA in 1L patients with mCRPC by conducting a systematic literature review and network meta-analyses (NMAs)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39427229\", \"sentence_id\": 4, \"text\": \"METHODS: Databases were searched using Ovid, along with several gray literature sources to identify RCTs evaluating treatments in 1L mCRPC (PROSPERO registration: CRD42021283512).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39427229", "sentence_id": 4, "text": "METHODS: Databases were searched using Ovid, along with several gray literature sources to identify RCTs evaluating treatments in 1L mCRPC (PROSPERO registration: CRD42021283512)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39427229\", \"sentence_id\": 5, \"text\": \"Feasibility assessment evaluated trial suitability for NMA inclusion and Bayesian or frequentist NMAs were conducted for evaluable efficacy and safety outcomes, respectively.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39427229", "sentence_id": 5, "text": "Feasibility assessment evaluated trial suitability for NMA inclusion and Bayesian or frequentist NMAs were conducted for evaluable efficacy and safety outcomes, respectively."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39427229\", \"sentence_id\": 6, \"text\": \"RESULTS: Thirty-three RCTs met the eligibility criteria and were feasible for NMAs.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39427229", "sentence_id": 6, "text": "RESULTS: Thirty-three RCTs met the eligibility criteria and were feasible for NMAs."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39427229\", \"sentence_id\": 7, \"text\": \"Across multiple efficacy outcomes assessed, except for overall survival (OS), TALA\u2005+\u2005ENZA was ranked the most efficacious treatment.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39427229", "sentence_id": 7, "text": "Across multiple efficacy outcomes assessed, except for overall survival (OS), TALA\u2005+\u2005ENZA was ranked the most efficacious treatment."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39427229\", \"sentence_id\": 8, \"text\": \"For OS, TALA\u2005+\u2005ENZA showed the second-highest probability of being the most effective treatment; second to docetaxel 50\u00a0mg plus prednisolone 10\u00a0mg.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39427229", "sentence_id": 8, "text": "For OS, TALA\u2005+\u2005ENZA showed the second-highest probability of being the most effective treatment; second to docetaxel 50\u00a0mg plus prednisolone 10\u00a0mg."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39427229\", \"sentence_id\": 9, \"text\": \"With respect to safety outcomes, TALA\u2005+\u2005ENZA, in general, showed increased rates of hematological adverse events.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39427229", "sentence_id": 9, "text": "With respect to safety outcomes, TALA\u2005+\u2005ENZA, in general, showed increased rates of hematological adverse events."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39427229\", \"sentence_id\": 10, \"text\": \"CONCLUSIONS: TALA\u2005+\u2005ENZA showed favorable results across multiple efficacy endpoints, but not across hematological toxicities compared with other 1L treatments in asymptomatic or mildly symptomatic mCRPC in the all-comers patient population.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39427229", "sentence_id": 10, "text": "CONCLUSIONS: TALA\u2005+\u2005ENZA showed favorable results across multiple efficacy endpoints, but not across hematological toxicities compared with other 1L treatments in asymptomatic or mildly symptomatic mCRPC in the all-comers patient population."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39368455\", \"sentence_id\": 0, \"text\": \"BACKGROUND: Loss of heterozygosity (LOH) diminishes genetic diversity within cancer genomes.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39368455", "sentence_id": 0, "text": "BACKGROUND: Loss of heterozygosity (LOH) diminishes genetic diversity within cancer genomes."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39368455\", \"sentence_id\": 1, \"text\": \"A tumour arising in an individual heterozygous for a functional and a loss-of-function (LoF) allele of a gene occasionally retain only the LoF allele.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39368455", "sentence_id": 1, "text": "A tumour arising in an individual heterozygous for a functional and a loss-of-function (LoF) allele of a gene occasionally retain only the LoF allele."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39368455\", \"sentence_id\": 2, \"text\": \"This can result in deficiency of specific protein activities in cancer cells, creating unique differences between tumour cells and normal cells of the individual.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39368455", "sentence_id": 2, "text": "This can result in deficiency of specific protein activities in cancer cells, creating unique differences between tumour cells and normal cells of the individual."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39368455\", \"sentence_id\": 3, \"text\": \"Such differences may constitute vulnerabilities that can be exploited through allele-specific therapies.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39368455", "sentence_id": 3, "text": "Such differences may constitute vulnerabilities that can be exploited through allele-specific therapies."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39368455\", \"sentence_id\": 4, \"text\": \"METHODS: To discover frequently lost genes with prevalent LoF alleles, we mined the 1000 Genomes dataset for SNVs causing protein truncation through base substitution, indels or splice site disruptions, resulting in 60 LoF variants in 60 genes.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39368455", "sentence_id": 4, "text": "METHODS: To discover frequently lost genes with prevalent LoF alleles, we mined the 1000 Genomes dataset for SNVs causing protein truncation through base substitution, indels or splice site disruptions, resulting in 60 LoF variants in 60 genes."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39368455\", \"sentence_id\": 5, \"text\": \"From these, the variant rs3892097 in the liver enzyme CYP2D6 was selected because it is located within a genomic region that frequently undergoes LOH in several tumor types including hepatocellular cancers.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39368455", "sentence_id": 5, "text": "From these, the variant rs3892097 in the liver enzyme CYP2D6 was selected because it is located within a genomic region that frequently undergoes LOH in several tumor types including hepatocellular cancers."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39368455\", \"sentence_id\": 6, \"text\": \"To evaluate the relationship between CYP2D6 activity and the toxicities of anticancer agents, we screened 525 compounds currently in clinical use or undergoing clinical trials using cell model systems with or without CYP2D6 activity.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39368455", "sentence_id": 6, "text": "To evaluate the relationship between CYP2D6 activity and the toxicities of anticancer agents, we screened 525 compounds currently in clinical use or undergoing clinical trials using cell model systems with or without CYP2D6 activity."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39368455\", \"sentence_id\": 7, \"text\": \"FINDINGS: We identified 12 compounds, AZD-3463, CYC-116, etoposide, everolimus, GDC-0349, lenvatinib, MK-8776, PHA-680632, talazoparib, tyrphostin 9, VX-702, and WZ-3146, using an engineered HEK293T cell model.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39368455", "sentence_id": 7, "text": "FINDINGS: We identified 12 compounds, AZD-3463, CYC-116, etoposide, everolimus, GDC-0349, lenvatinib, MK-8776, PHA-680632, talazoparib, tyrphostin 9, VX-702, and WZ-3146, using an engineered HEK293T cell model."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39368455\", \"sentence_id\": 8, \"text\": \"Of these, talazoparib and MK-8776 demonstrated consistently heightened cytotoxic effects against cells with compromised CYP2D6 activity in engineered hepatocellular cancer cell models.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39368455", "sentence_id": 8, "text": "Of these, talazoparib and MK-8776 demonstrated consistently heightened cytotoxic effects against cells with compromised CYP2D6 activity in engineered hepatocellular cancer cell models."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39368455\", \"sentence_id\": 9, \"text\": \"Moreover, talazoparib displayed CYP2D6 genotype dependent effects on primary hepatocellular carcinoma organoids.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39368455", "sentence_id": 9, "text": "Moreover, talazoparib displayed CYP2D6 genotype dependent effects on primary hepatocellular carcinoma organoids."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39368455\", \"sentence_id\": 10, \"text\": \"INTERPRETATION: Exploiting the loss of drug-metabolizing enzyme gene activity in tumor cells following loss of heterozygosity could present a promising therapeutic strategy for targeted cancer treatment.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39368455", "sentence_id": 10, "text": "INTERPRETATION: Exploiting the loss of drug-metabolizing enzyme gene activity in tumor cells following loss of heterozygosity could present a promising therapeutic strategy for targeted cancer treatment."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39368455\", \"sentence_id\": 11, \"text\": \"FUNDING: This work was funded by Barncancerfonden (T.S, PR2022-0099 and PR2020-0171, X.Z, TJ2021-0111), Cancerfonden (T.S, 211719Pj and D.G, 222449Pj), Vetenskapsr\u00e5det (T.S, 2020-02371 and D.G, 2020-04707), and the Erling Persson Foundation (T.S, 2020-0037 and T.S, 2023-0113).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39368455", "sentence_id": 11, "text": "FUNDING: This work was funded by Barncancerfonden (T.S, PR2022-0099 and PR2020-0171, X.Z, TJ2021-0111), Cancerfonden (T.S, 211719Pj and D.G, 222449Pj), Vetenskapsr\u00e5det (T.S, 2020-02371 and D.G, 2020-04707), and the Erling Persson Foundation (T.S, 2020-0037 and T.S, 2023-0113)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39353240\", \"sentence_id\": 0, \"text\": \"Latest developments in cancer treatment have shed a light on the crucial role of PARP inhibitors that enhance the treatment effectiveness by modifying abnormal repair pathways.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39353240", "sentence_id": 0, "text": "Latest developments in cancer treatment have shed a light on the crucial role of PARP inhibitors that enhance the treatment effectiveness by modifying abnormal repair pathways."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39353240\", \"sentence_id\": 1, \"text\": \"PARP inhibitors, such as Olaparib, Rucaparib, Niraparib, and Talazoparib have been approved in a number of cancers including BRCA 1/BRCA2 associated malignancies although there are many difficulties as therapeutical resistance.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39353240", "sentence_id": 1, "text": "PARP inhibitors, such as Olaparib, Rucaparib, Niraparib, and Talazoparib have been approved in a number of cancers including BRCA 1/BRCA2 associated malignancies although there are many difficulties as therapeutical resistance."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39353240\", \"sentence_id\": 2, \"text\": \"Besides the conventional synthetic drugs, natural compounds such as flavones and flavonoids have been found to be PARP inhibitors but only in preclinical studies.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39353240", "sentence_id": 2, "text": "Besides the conventional synthetic drugs, natural compounds such as flavones and flavonoids have been found to be PARP inhibitors but only in preclinical studies."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39353240\", \"sentence_id\": 3, \"text\": \"Isoxazole is very important class of potential candidates for medicinal chemistry with anti-cancer and other pharmacological activities.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39353240", "sentence_id": 3, "text": "Isoxazole is very important class of potential candidates for medicinal chemistry with anti-cancer and other pharmacological activities."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39353240\", \"sentence_id\": 4, \"text\": \"At present, there are no approved PARP inhibitors of isoxazole origin but their ability to hit many pathways inside the cancer cells points out on its importance for future treatments design.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39353240", "sentence_id": 4, "text": "At present, there are no approved PARP inhibitors of isoxazole origin but their ability to hit many pathways inside the cancer cells points out on its importance for future treatments design."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39353240\", \"sentence_id\": 5, \"text\": \"In drug development, isoxazoles are helpful because of the molecular design flexibility that may be enhanced using various synthetic approaches.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39353240", "sentence_id": 5, "text": "In drug development, isoxazoles are helpful because of the molecular design flexibility that may be enhanced using various synthetic approaches."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39353240\", \"sentence_id\": 6, \"text\": \"This review highlights the molecular mechanisms of PARP inhibition, importance of isoxazole compounds and present advances in their synthetic strategies that demonstrate promise for these agents as new anticancer drugs.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39353240", "sentence_id": 6, "text": "This review highlights the molecular mechanisms of PARP inhibition, importance of isoxazole compounds and present advances in their synthetic strategies that demonstrate promise for these agents as new anticancer drugs."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39353240\", \"sentence_id\": 7, \"text\": \"It emphasizes that isoxazole-based PARP inhibitors compounds could be novel anti-cancer drugs.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39353240", "sentence_id": 7, "text": "It emphasizes that isoxazole-based PARP inhibitors compounds could be novel anti-cancer drugs."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39353240\", \"sentence_id\": 8, \"text\": \"Through this review, we hope to grow a curiosity in additional explorations of isoxazole-based PARP inhibitors and their applications in the trends of novel insights towards precision cancer therapy.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39353240", "sentence_id": 8, "text": "Through this review, we hope to grow a curiosity in additional explorations of isoxazole-based PARP inhibitors and their applications in the trends of novel insights towards precision cancer therapy."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39324718\", \"sentence_id\": 0, \"text\": \"BACKGROUND: About one-quarter of patients with advanced prostate cancer have alterations in homologous recombination repair (HRR) genes.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39324718", "sentence_id": 0, "text": "BACKGROUND: About one-quarter of patients with advanced prostate cancer have alterations in homologous recombination repair (HRR) genes."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39324718\", \"sentence_id\": 1, \"text\": \"In a global phase 3 study, talazoparib plus enzalutamide significantly improved progression-free survival in patients with HRR-deficient metastatic castration-resistant prostate cancer (mCRPC).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39324718", "sentence_id": 1, "text": "In a global phase 3 study, talazoparib plus enzalutamide significantly improved progression-free survival in patients with HRR-deficient metastatic castration-resistant prostate cancer (mCRPC)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39324718\", \"sentence_id\": 2, \"text\": \"OBJECTIVES: This article reviews the role of oncology nurses and advanced practice providers (APPs) in administering talazoparib plus enzalutamide in patients with mCRPC.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39324718", "sentence_id": 2, "text": "OBJECTIVES: This article reviews the role of oncology nurses and advanced practice providers (APPs) in administering talazoparib plus enzalutamide in patients with mCRPC."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39324718\", \"sentence_id\": 3, \"text\": \"METHODS: This review and hypothetical case study illustrate the role of oncology nurses and APPs in the administration of talazoparib plus enzalutamide and the management of adverse events to ensure safe and effective use in clinical practice.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39324718", "sentence_id": 3, "text": "METHODS: This review and hypothetical case study illustrate the role of oncology nurses and APPs in the administration of talazoparib plus enzalutamide and the management of adverse events to ensure safe and effective use in clinical practice."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39324718\", \"sentence_id\": 4, \"text\": \"FINDINGS: Oncology nurses and APPs play an important role in the dosing and administration of talazoparib plus enzalutamide and can recognize and manage adverse events in patients with HRR-deficient mCRPC.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39324718", "sentence_id": 4, "text": "FINDINGS: Oncology nurses and APPs play an important role in the dosing and administration of talazoparib plus enzalutamide and can recognize and manage adverse events in patients with HRR-deficient mCRPC."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39318358\", \"sentence_id\": 0, \"text\": \"Poly (ADP-ribose) polymerases (PARP) inhibitors (PARPi) are the first-approved anticancer drug designed to exploit synthetic lethality.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39318358", "sentence_id": 0, "text": "Poly (ADP-ribose) polymerases (PARP) inhibitors (PARPi) are the first-approved anticancer drug designed to exploit synthetic lethality."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39318358\", \"sentence_id\": 1, \"text\": \"PARPi selectively kill cancer cells with homologous recombination repair deficiency (HRD), as a result, PARPi are widely employed to treated\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39318358", "sentence_id": 1, "text": "PARPi selectively kill cancer cells with homologous recombination repair deficiency (HRD), as a result, PARPi are widely employed to treated"}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39308935\", \"sentence_id\": 0, \"text\": \"Metastatic castrate-resistant prostate cancer (mCRPC) is associated with poor prognosis.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39308935", "sentence_id": 0, "text": "Metastatic castrate-resistant prostate cancer (mCRPC) is associated with poor prognosis."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39308935\", \"sentence_id\": 1, \"text\": \"DNA damage response (DDR) genes are commonly altered in mCRPC rendering them as promising therapeutic targets.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39308935", "sentence_id": 1, "text": "DNA damage response (DDR) genes are commonly altered in mCRPC rendering them as promising therapeutic targets."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39308935\", \"sentence_id\": 2, \"text\": \"Poly (ADP ribose) polymerase inhibitors (PARPi) demonstrated antitumor activity in mCRPC patients with DDR gene mutations through synthetic lethality.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39308935", "sentence_id": 2, "text": "Poly (ADP ribose) polymerase inhibitors (PARPi) demonstrated antitumor activity in mCRPC patients with DDR gene mutations through synthetic lethality."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39308935\", \"sentence_id\": 3, \"text\": \"Multiple clinical trials with PARPi monotherapy exhibited encouraging clinical outcomes in selected patients with mCRPC.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39308935", "sentence_id": 3, "text": "Multiple clinical trials with PARPi monotherapy exhibited encouraging clinical outcomes in selected patients with mCRPC."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39308935\", \"sentence_id\": 4, \"text\": \"More recently, three Phase III randomized clinical trials (RCTs) combining PARPi with androgen receptor signaling inhibitors (ARSIs) demonstrated improved antitumor activity compared to ARSI monotherapy in mCRPC patients as the first-line therapy.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39308935", "sentence_id": 4, "text": "More recently, three Phase III randomized clinical trials (RCTs) combining PARPi with androgen receptor signaling inhibitors (ARSIs) demonstrated improved antitumor activity compared to ARSI monotherapy in mCRPC patients as the first-line therapy."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39308935\", \"sentence_id\": 5, \"text\": \"Clinical benefit was more pronounced in patients harboring DDR alterations, specifically\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39308935", "sentence_id": 5, "text": "Clinical benefit was more pronounced in patients harboring DDR alterations, specifically"}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39238347\", \"sentence_id\": 0, \"text\": \"BACKGROUND: Prostate cancer (PCa) is the most common cancer and the second leading cause of cancer-related death in men.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39238347", "sentence_id": 0, "text": "BACKGROUND: Prostate cancer (PCa) is the most common cancer and the second leading cause of cancer-related death in men."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39238347\", \"sentence_id\": 1, \"text\": \"Previous studies have shown that the poly (adenosine diphosphate-ribose) polymerase (PARP) inhibitors (PARPis) improve the treatment response of patients with metastatic castration-resistant PCa (mCRPC).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39238347", "sentence_id": 1, "text": "Previous studies have shown that the poly (adenosine diphosphate-ribose) polymerase (PARP) inhibitors (PARPis) improve the treatment response of patients with metastatic castration-resistant PCa (mCRPC)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39238347\", \"sentence_id\": 2, \"text\": \"However, the efficacy and safety of various PARPis in mCRPC patients remain unclear, presenting a significant challenge for clinicians when making treatment decisions.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39238347", "sentence_id": 2, "text": "However, the efficacy and safety of various PARPis in mCRPC patients remain unclear, presenting a significant challenge for clinicians when making treatment decisions."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39238347\", \"sentence_id\": 3, \"text\": \"To address this, this study conducted two indirect comparisons to evaluate the efficacy and safety of four PARPis (olaparib, niraparib, rucaparib, and talazoparib) in patients with mCRPC.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39238347", "sentence_id": 3, "text": "To address this, this study conducted two indirect comparisons to evaluate the efficacy and safety of four PARPis (olaparib, niraparib, rucaparib, and talazoparib) in patients with mCRPC."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39238347\", \"sentence_id\": 4, \"text\": \"METHODS: A systematic review and network meta-analysis (NMA) using Bayesian statistics was conducted.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39238347", "sentence_id": 4, "text": "METHODS: A systematic review and network meta-analysis (NMA) using Bayesian statistics was conducted."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39238347\", \"sentence_id\": 5, \"text\": \"A comprehensive literature search was performed of the PubMed, Web of Science, Cochrane Library, Embase, and China National Knowledge Infrastructure (CNKI) databases to identify relevant studies from the inception to November 8, 2023, using search terms such as \\\"PARP inhibitor\\\", \\\"olaparib\\\", \\\"rucaparib\\\", \\\"niraparib\\\", \\\"talazoparib\\\", and \\\"mCRPC\\\".\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39238347", "sentence_id": 5, "text": "A comprehensive literature search was performed of the PubMed, Web of Science, Cochrane Library, Embase, and China National Knowledge Infrastructure (CNKI) databases to identify relevant studies from the inception to November 8, 2023, using search terms such as \"PARP inhibitor\", \"olaparib\", \"rucaparib\", \"niraparib\", \"talazoparib\", and \"mCRPC\"."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39238347\", \"sentence_id\": 6, \"text\": \"Phase 2/3 randomized controlled trials (RCTs) related to PARPi therapy and novel hormonal therapy in patients with mCRPC were included in the analysis.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39238347", "sentence_id": 6, "text": "Phase 2/3 randomized controlled trials (RCTs) related to PARPi therapy and novel hormonal therapy in patients with mCRPC were included in the analysis."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39238347\", \"sentence_id\": 7, \"text\": \"The targeted outcomes included radiographic progression-free survival (rPFS), overall survival (OS), adverse events (AEs), and grade \u22653 AEs.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39238347", "sentence_id": 7, "text": "The targeted outcomes included radiographic progression-free survival (rPFS), overall survival (OS), adverse events (AEs), and grade \u22653 AEs."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39238347\", \"sentence_id\": 8, \"text\": \"Four reviewers screened the titles and abstracts independently to assess the eligibility of each article.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39238347", "sentence_id": 8, "text": "Four reviewers screened the titles and abstracts independently to assess the eligibility of each article."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39238347\", \"sentence_id\": 9, \"text\": \"Two researchers independently extracted data from the included studies.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39238347", "sentence_id": 9, "text": "Two researchers independently extracted data from the included studies."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39238347\", \"sentence_id\": 10, \"text\": \"The risk of bias and quality of the studies were assessed using the Risk-of-Bias 2 tool.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39238347", "sentence_id": 10, "text": "The risk of bias and quality of the studies were assessed using the Risk-of-Bias 2 tool."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39238347\", \"sentence_id\": 11, \"text\": \"RESULTS: Six high-quality phase 2/3 clinical trials, comprising 3,205 individuals, were selected for the systematic review and NMAs.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39238347", "sentence_id": 11, "text": "RESULTS: Six high-quality phase 2/3 clinical trials, comprising 3,205 individuals, were selected for the systematic review and NMAs."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39238347\", \"sentence_id\": 12, \"text\": \"Two NMAs were conducted due to the different designs of the six clinical trials.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39238347", "sentence_id": 12, "text": "Two NMAs were conducted due to the different designs of the six clinical trials."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39238347\", \"sentence_id\": 13, \"text\": \"The indirect comparison with a random-effects model of olaparib, niraparib, and talazoparib showed that olaparib significantly improved rPFS with a hazard ratio (HR) of 0.67 [95% confidence interval (CI): 0.46-0.96]; however, no such significant difference was observed in relation to olaparib and rucaparib.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39238347", "sentence_id": 13, "text": "The indirect comparison with a random-effects model of olaparib, niraparib, and talazoparib showed that olaparib significantly improved rPFS with a hazard ratio (HR) of 0.67 [95% confidence interval (CI): 0.46-0.96]; however, no such significant difference was observed in relation to olaparib and rucaparib."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39238347\", \"sentence_id\": 14, \"text\": \"In terms of OS, no significant difference was observed among olaparib, niraparib, and talazoparib.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39238347", "sentence_id": 14, "text": "In terms of OS, no significant difference was observed among olaparib, niraparib, and talazoparib."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39238347\", \"sentence_id\": 15, \"text\": \"In relation to the AEs, the PARPi interventions using olaparib, niraparib, and talazoparib increased the rates of grade \u22653 AEs with odds ratios (ORs) of 2.0 (95% CI: 0.89-5.3), 3.0 (95% CI: 1.3-7.4), and 3.7 (95% CI: 1.1-12.0), respectively.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39238347", "sentence_id": 15, "text": "In relation to the AEs, the PARPi interventions using olaparib, niraparib, and talazoparib increased the rates of grade \u22653 AEs with odds ratios (ORs) of 2.0 (95% CI: 0.89-5.3), 3.0 (95% CI: 1.3-7.4), and 3.7 (95% CI: 1.1-12.0), respectively."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39238347\", \"sentence_id\": 16, \"text\": \"In the rank probability analysis, according to the surface under the cumulative ranking (SUCRA), olaparib ranked first, followed by niraparib, and talazoparib.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39238347", "sentence_id": 16, "text": "In the rank probability analysis, according to the surface under the cumulative ranking (SUCRA), olaparib ranked first, followed by niraparib, and talazoparib."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39238347\", \"sentence_id\": 17, \"text\": \"Most of the included studies were assessed to be at low risk of bias.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39238347", "sentence_id": 17, "text": "Most of the included studies were assessed to be at low risk of bias."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39238347\", \"sentence_id\": 18, \"text\": \"CONCLUSIONS: Olaparib significantly improved rPFS among olaparib, niraparib, and talazoparib.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39238347", "sentence_id": 18, "text": "CONCLUSIONS: Olaparib significantly improved rPFS among olaparib, niraparib, and talazoparib."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39238347\", \"sentence_id\": 19, \"text\": \"Talazoparib exhibited the highest SUCRA value.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39238347", "sentence_id": 19, "text": "Talazoparib exhibited the highest SUCRA value."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39238347\", \"sentence_id\": 20, \"text\": \"Regarding safety, olaparib and rucaparib did not significantly increase the incidence of grade \u22653 AEs.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39238347", "sentence_id": 20, "text": "Regarding safety, olaparib and rucaparib did not significantly increase the incidence of grade \u22653 AEs."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39238347\", \"sentence_id\": 21, \"text\": \"When making personalized treatment decisions, clinicians should consider individual patient characteristics, treatment efficacy, and potential AEs.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39238347", "sentence_id": 21, "text": "When making personalized treatment decisions, clinicians should consider individual patient characteristics, treatment efficacy, and potential AEs."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39210559\", \"sentence_id\": 0, \"text\": \"INTRODUCTION: Around 25% of patients with advanced prostate cancer harbor alterations in the homologous recombination/DNA damage repair (HRR) pathway.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39210559", "sentence_id": 0, "text": "INTRODUCTION: Around 25% of patients with advanced prostate cancer harbor alterations in the homologous recombination/DNA damage repair (HRR) pathway."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39210559\", \"sentence_id\": 1, \"text\": \"Inhibiting poly (ADP-ribose) polymerase (PARP) in these patients leads to synthetic lethality, making PARP inhibitors (PARPi), including talazoparib, a promising treatment for metastatic castration-resistant prostate cancer (mCRPC) and potentially for metastatic hormone-sensitive prostate cancer (mHSPC).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39210559", "sentence_id": 1, "text": "Inhibiting poly (ADP-ribose) polymerase (PARP) in these patients leads to synthetic lethality, making PARP inhibitors (PARPi), including talazoparib, a promising treatment for metastatic castration-resistant prostate cancer (mCRPC) and potentially for metastatic hormone-sensitive prostate cancer (mHSPC)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39210559\", \"sentence_id\": 2, \"text\": \"AREAS COVERED: This article examines the mechanism of action, chemical properties, pharmacokinetics, pharmacodynamics, and clinical safety and efficacy data of different PARPis, including talazoparib in prostate cancer.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39210559", "sentence_id": 2, "text": "AREAS COVERED: This article examines the mechanism of action, chemical properties, pharmacokinetics, pharmacodynamics, and clinical safety and efficacy data of different PARPis, including talazoparib in prostate cancer."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39210559\", \"sentence_id\": 3, \"text\": \"It reviews the TALAPRO-1 and TALAPRO-2 clinical trials and the ongoing TALAPRO-3 trial.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39210559", "sentence_id": 3, "text": "It reviews the TALAPRO-1 and TALAPRO-2 clinical trials and the ongoing TALAPRO-3 trial."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39210559\", \"sentence_id\": 4, \"text\": \"EXPERT OPINION: Despite recent therapeutic advancements, mCRPC remains a lethal disease.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39210559", "sentence_id": 4, "text": "EXPERT OPINION: Despite recent therapeutic advancements, mCRPC remains a lethal disease."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39210559\", \"sentence_id\": 5, \"text\": \"Androgen receptor pathway inhibitors (ARPIs) are approved for patients with mCRPC and mHSPC, yet most patients first receive these agents in the castration-resistant setting.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39210559", "sentence_id": 5, "text": "Androgen receptor pathway inhibitors (ARPIs) are approved for patients with mCRPC and mHSPC, yet most patients first receive these agents in the castration-resistant setting."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39210559\", \"sentence_id\": 6, \"text\": \"Real-world data indicate that around half of patients with mCRPC do not receive subsequent lines of therapy, underscoring the efficacy of upfront combination therapies.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39210559", "sentence_id": 6, "text": "Real-world data indicate that around half of patients with mCRPC do not receive subsequent lines of therapy, underscoring the efficacy of upfront combination therapies."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39210559\", \"sentence_id\": 7, \"text\": \"The combinations of ARPI plus PARPi are indicated for patients with mCRPC harboring HRR mutations, though identifying these patients is challenging due to limited genomic testing.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39210559", "sentence_id": 7, "text": "The combinations of ARPI plus PARPi are indicated for patients with mCRPC harboring HRR mutations, though identifying these patients is challenging due to limited genomic testing."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"39210559\", \"sentence_id\": 8, \"text\": \"Further research and improved access to genomic testing are essential to optimize treatment strategies.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "39210559", "sentence_id": 8, "text": "Further research and improved access to genomic testing are essential to optimize treatment strategies."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38995237\", \"sentence_id\": 0, \"text\": \"WHAT IS THIS SUMMARY ABOUT?: This summary describes the results from the TALAPRO-2 research study (also known as a clinical trial).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38995237", "sentence_id": 0, "text": "WHAT IS THIS SUMMARY ABOUT?: This summary describes the results from the TALAPRO-2 research study (also known as a clinical trial)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38995237\", \"sentence_id\": 1, \"text\": \"The TALAPRO-2 study tested the combination of two medicines called talazoparib plus enzalutamide.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38995237", "sentence_id": 1, "text": "The TALAPRO-2 study tested the combination of two medicines called talazoparib plus enzalutamide."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38995237\", \"sentence_id\": 2, \"text\": \"This combination of medicines was used as the first treatment for adult patients with metastatic castration-resistant prostate cancer.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38995237", "sentence_id": 2, "text": "This combination of medicines was used as the first treatment for adult patients with metastatic castration-resistant prostate cancer."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38995237\", \"sentence_id\": 3, \"text\": \"The combination of talazoparib plus enzalutamide was compared with a placebo plus enzalutamide.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38995237", "sentence_id": 3, "text": "The combination of talazoparib plus enzalutamide was compared with a placebo plus enzalutamide."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38995237\", \"sentence_id\": 4, \"text\": \"WHAT IS METASTATIC CASTRATION-RESISTANT PROSTATE CANCER?: Metastatic castration-resistant prostate cancer is a type of cancer that starts in the prostate and has spread to other parts of the body.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38995237", "sentence_id": 4, "text": "WHAT IS METASTATIC CASTRATION-RESISTANT PROSTATE CANCER?: Metastatic castration-resistant prostate cancer is a type of cancer that starts in the prostate and has spread to other parts of the body."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38995237\", \"sentence_id\": 5, \"text\": \"Castration-resistant means that the cancer continues to grow even when testosterone levels in the blood are reduced to very low levels.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38995237", "sentence_id": 5, "text": "Castration-resistant means that the cancer continues to grow even when testosterone levels in the blood are reduced to very low levels."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38995237\", \"sentence_id\": 6, \"text\": \"Taking medicines to lower testosterone levels in the blood is a standard treatment for men with advanced prostate cancer.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38995237", "sentence_id": 6, "text": "Taking medicines to lower testosterone levels in the blood is a standard treatment for men with advanced prostate cancer."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38995237\", \"sentence_id\": 7, \"text\": \"WHAT ARE THE AIMS OF THE TALAPRO-2 TRIAL?: TALAPRO-2 looked at if combining talazoparib plus enzalutamide would increase the length of time patients lived before their cancer got worse or they died compared with a placebo plus enzalutamide.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38995237", "sentence_id": 7, "text": "WHAT ARE THE AIMS OF THE TALAPRO-2 TRIAL?: TALAPRO-2 looked at if combining talazoparib plus enzalutamide would increase the length of time patients lived before their cancer got worse or they died compared with a placebo plus enzalutamide."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38995237\", \"sentence_id\": 8, \"text\": \"Researchers looked at how treatment affected the size and number of tumors and the length of time before patients needed to change to a new cancer medicine.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38995237", "sentence_id": 8, "text": "Researchers looked at how treatment affected the size and number of tumors and the length of time before patients needed to change to a new cancer medicine."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38995237\", \"sentence_id\": 9, \"text\": \"Researchers also looked at any side effects patients had during the study.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38995237", "sentence_id": 9, "text": "Researchers also looked at any side effects patients had during the study."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38995237\", \"sentence_id\": 10, \"text\": \"WHAT ARE THE KEY TAKEAWAYS?: A total of 805 patients with metastatic castration-resistant prostate cancer took part in the study.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38995237", "sentence_id": 10, "text": "WHAT ARE THE KEY TAKEAWAYS?: A total of 805 patients with metastatic castration-resistant prostate cancer took part in the study."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38995237\", \"sentence_id\": 11, \"text\": \"Compared with patients who took a placebo plus enzalutamide, the group of patients who took talazoparib plus enzalutamide had a 37% reduced risk of their cancer getting worse or dying.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38995237", "sentence_id": 11, "text": "Compared with patients who took a placebo plus enzalutamide, the group of patients who took talazoparib plus enzalutamide had a 37% reduced risk of their cancer getting worse or dying."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38995237\", \"sentence_id\": 12, \"text\": \"Some patients had tumors that at the start of the study could be measured with scans.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38995237", "sentence_id": 12, "text": "Some patients had tumors that at the start of the study could be measured with scans."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38995237\", \"sentence_id\": 13, \"text\": \"Sixty-two percent of patients who took talazoparib plus enzalutamide had their tumors decrease or shrink to the point that they could no longer be seen on scans versus 44% of patients who took a placebo plus enzalutamide.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38995237", "sentence_id": 13, "text": "Sixty-two percent of patients who took talazoparib plus enzalutamide had their tumors decrease or shrink to the point that they could no longer be seen on scans versus 44% of patients who took a placebo plus enzalutamide."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38995237\", \"sentence_id\": 14, \"text\": \"Patients who took talazoparib plus enzalutamide were more likely to have a longer time before they needed to change to a new cancer medicine.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38995237", "sentence_id": 14, "text": "Patients who took talazoparib plus enzalutamide were more likely to have a longer time before they needed to change to a new cancer medicine."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38995237\", \"sentence_id\": 15, \"text\": \"The most common side effects of talazoparib plus enzalutamide were low levels of red blood cells (66% of patients) and neutrophils (36% of patients), and excessive tiredness or exhaustion (34% of patients).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38995237", "sentence_id": 15, "text": "The most common side effects of talazoparib plus enzalutamide were low levels of red blood cells (66% of patients) and neutrophils (36% of patients), and excessive tiredness or exhaustion (34% of patients)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38991256\", \"sentence_id\": 0, \"text\": \"Surrogate endpoints are becoming increasingly important in health technology assessment, where decisions are based on complex cost-effectiveness models (CEMs) that require numerous input parameters.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38991256", "sentence_id": 0, "text": "Surrogate endpoints are becoming increasingly important in health technology assessment, where decisions are based on complex cost-effectiveness models (CEMs) that require numerous input parameters."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38991256\", \"sentence_id\": 1, \"text\": \"Daniels and Hughes Surrogate Model was used to predict missing effect estimates in randomized controlled trials (RCTs) evaluating first-line treatments in metastatic castration-resistant prostate cancer (mCRPC) patients.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38991256", "sentence_id": 1, "text": "Daniels and Hughes Surrogate Model was used to predict missing effect estimates in randomized controlled trials (RCTs) evaluating first-line treatments in metastatic castration-resistant prostate cancer (mCRPC) patients."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38991256\", \"sentence_id\": 2, \"text\": \"Network meta-analyses (NMAs) were conducted to assess the comparative efficacy of these treatments.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38991256", "sentence_id": 2, "text": "Network meta-analyses (NMAs) were conducted to assess the comparative efficacy of these treatments."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38991256\", \"sentence_id\": 3, \"text\": \"Databases were searched (inception to October 2022) using Ovid\u00ae.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38991256", "sentence_id": 3, "text": "Databases were searched (inception to October 2022) using Ovid\u00ae."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38991256\", \"sentence_id\": 4, \"text\": \"Several grey literature searches were also conducted (PROSPERO: CRD42021283512).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38991256", "sentence_id": 4, "text": "Several grey literature searches were also conducted (PROSPERO: CRD42021283512)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38991256\", \"sentence_id\": 5, \"text\": \"Available trial data for radiographic progression-free survival (rPFS) and overall survival (OS) were used to predict the unreported effect of rPFS or OS for relevant comparator treatments.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38991256", "sentence_id": 5, "text": "Available trial data for radiographic progression-free survival (rPFS) and overall survival (OS) were used to predict the unreported effect of rPFS or OS for relevant comparator treatments."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38991256\", \"sentence_id\": 6, \"text\": \"Bayesian NMAs were conducted using observed and predicted treatment effects.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38991256", "sentence_id": 6, "text": "Bayesian NMAs were conducted using observed and predicted treatment effects."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38991256\", \"sentence_id\": 7, \"text\": \"Effect estimates and 95% credible intervals were calculated for each comparison.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38991256", "sentence_id": 7, "text": "Effect estimates and 95% credible intervals were calculated for each comparison."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38991256\", \"sentence_id\": 8, \"text\": \"Mean ranks and the probability of being best (p-best) were obtained.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38991256", "sentence_id": 8, "text": "Mean ranks and the probability of being best (p-best) were obtained."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38991256\", \"sentence_id\": 9, \"text\": \"Twenty-five RCTs met the eligibility criteria and of these, 8 reported jointly rPFS and OS; while rPFS was predicted for 12 RCTs and 10 comparators, and OS was predicted for 5 RCTs and 6 comparators.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38991256", "sentence_id": 9, "text": "Twenty-five RCTs met the eligibility criteria and of these, 8 reported jointly rPFS and OS; while rPFS was predicted for 12 RCTs and 10 comparators, and OS was predicted for 5 RCTs and 6 comparators."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38991256\", \"sentence_id\": 10, \"text\": \"A nonstandard dose of docetaxel (docetaxel 50 mg/m\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38991256", "sentence_id": 10, "text": "A nonstandard dose of docetaxel (docetaxel 50 mg/m"}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38958846\", \"sentence_id\": 0, \"text\": \"INTRODUCTION: Poly(ADP-ribose) polymerase inhibitors (PARPi) are a novel option to treat patients with metastatic castration-resistant prostate cancer (mCRPC).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38958846", "sentence_id": 0, "text": "INTRODUCTION: Poly(ADP-ribose) polymerase inhibitors (PARPi) are a novel option to treat patients with metastatic castration-resistant prostate cancer (mCRPC)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38958846\", \"sentence_id\": 1, \"text\": \"Niraparib plus\u00a0abiraterone acetate and prednisone (AAP) is indicated for BRCA1/2 mutation-positive mCRPC.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38958846", "sentence_id": 1, "text": "Niraparib plus\u00a0abiraterone acetate and prednisone (AAP) is indicated for BRCA1/2 mutation-positive mCRPC."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38958846\", \"sentence_id\": 2, \"text\": \"Niraparib plus AAP demonstrated safety and efficacy in the phase 3 MAGNITUDE trial (NCT03748641).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38958846", "sentence_id": 2, "text": "Niraparib plus AAP demonstrated safety and efficacy in the phase 3 MAGNITUDE trial (NCT03748641)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38958846\", \"sentence_id\": 3, \"text\": \"In the absence of head-to-head studies comparing PARPi regimens, the feasibility of conducting indirect treatment comparisons (ITC) to inform decisions for patients with first-line BRCA1/2 mutation-positive mCRPC has been explored.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38958846", "sentence_id": 3, "text": "In the absence of head-to-head studies comparing PARPi regimens, the feasibility of conducting indirect treatment comparisons (ITC) to inform decisions for patients with first-line BRCA1/2 mutation-positive mCRPC has been explored."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38958846\", \"sentence_id\": 4, \"text\": \"METHODS: A systematic literature review was conducted to identify evidence from randomized controlled trials on relevant comparators to inform the feasibility of conducting ITCs via network meta-analysis (NMA) or population-adjusted indirect comparisons (PAIC).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38958846", "sentence_id": 4, "text": "METHODS: A systematic literature review was conducted to identify evidence from randomized controlled trials on relevant comparators to inform the feasibility of conducting ITCs via network meta-analysis (NMA) or population-adjusted indirect comparisons (PAIC)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38958846\", \"sentence_id\": 5, \"text\": \"Feasibility was assessed based on network connectivity, data availability in the BRCA1/2 mutation-positive population, and degree of within- and between-study heterogeneity or bias.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38958846", "sentence_id": 5, "text": "Feasibility was assessed based on network connectivity, data availability in the BRCA1/2 mutation-positive population, and degree of within- and between-study heterogeneity or bias."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38958846\", \"sentence_id\": 6, \"text\": \"RESULTS: NMAs between niraparib plus AAP and other PARPi regimens (olaparib monotherapy, olaparib plus AAP, and talazoparib plus enzalutamide) were inappropriate due to the disconnected network, differences in trial populations related to effect modifiers, or imbalances within BRCA1/2 mutation-positive subgroups.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38958846", "sentence_id": 6, "text": "RESULTS: NMAs between niraparib plus AAP and other PARPi regimens (olaparib monotherapy, olaparib plus AAP, and talazoparib plus enzalutamide) were inappropriate due to the disconnected network, differences in trial populations related to effect modifiers, or imbalances within BRCA1/2 mutation-positive subgroups."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38958846\", \"sentence_id\": 7, \"text\": \"The latter issue, coupled with the lack of a common comparator (except for olaparib plus AAP), also rendered anchored PAICs infeasible.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38958846", "sentence_id": 7, "text": "The latter issue, coupled with the lack of a common comparator (except for olaparib plus AAP), also rendered anchored PAICs infeasible."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38958846\", \"sentence_id\": 8, \"text\": \"Unanchored PAICs were either inappropriate due to lack of population overlap (vs.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38958846", "sentence_id": 8, "text": "Unanchored PAICs were either inappropriate due to lack of population overlap (vs."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38958846\", \"sentence_id\": 9, \"text\": \"olaparib monotherapy) or were restricted by unmeasured confounders and small sample size (vs.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38958846", "sentence_id": 9, "text": "olaparib monotherapy) or were restricted by unmeasured confounders and small sample size (vs."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38958846\", \"sentence_id\": 10, \"text\": \"olaparib plus AAP).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38958846", "sentence_id": 10, "text": "olaparib plus AAP)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38958846\", \"sentence_id\": 11, \"text\": \"PAIC versus talazoparib plus enzalutamide was not possible due to lack of published arm-level baseline characteristics and sufficient efficacy outcome data in the relevant population.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38958846", "sentence_id": 11, "text": "PAIC versus talazoparib plus enzalutamide was not possible due to lack of published arm-level baseline characteristics and sufficient efficacy outcome data in the relevant population."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38958846\", \"sentence_id\": 12, \"text\": \"CONCLUSION: The current randomized controlled trial evidence network does not permit robust comparisons between niraparib plus AAP and other PARPi regimens for patients with 1L BRCA-positive mCRPC.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38958846", "sentence_id": 12, "text": "CONCLUSION: The current randomized controlled trial evidence network does not permit robust comparisons between niraparib plus AAP and other PARPi regimens for patients with 1L BRCA-positive mCRPC."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38958846\", \"sentence_id\": 13, \"text\": \"Decision-makers should scrutinize any ITC results in light of their limitations.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38958846", "sentence_id": 13, "text": "Decision-makers should scrutinize any ITC results in light of their limitations."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38958846\", \"sentence_id\": 14, \"text\": \"Real-world evidence combined with clinical experience should inform treatment recommendations in this indication.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38958846", "sentence_id": 14, "text": "Real-world evidence combined with clinical experience should inform treatment recommendations in this indication."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38893160\", \"sentence_id\": 0, \"text\": \"Malignant rhabdoid tumors (MRTs) are among the most aggressive and treatment-resistant malignancies affecting infants, originating in the kidney, brain, liver, and soft tissues.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38893160", "sentence_id": 0, "text": "Malignant rhabdoid tumors (MRTs) are among the most aggressive and treatment-resistant malignancies affecting infants, originating in the kidney, brain, liver, and soft tissues."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38893160\", \"sentence_id\": 1, \"text\": \"The 5-year event-free survival rate for these cancers is a mere 20%.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38893160", "sentence_id": 1, "text": "The 5-year event-free survival rate for these cancers is a mere 20%."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38893160\", \"sentence_id\": 2, \"text\": \"In nearly all cases of MRT, the\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38893160", "sentence_id": 2, "text": "In nearly all cases of MRT, the"}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38889771\", \"sentence_id\": 0, \"text\": \"Traditional medication and alternative therapies have long been used to treat breast cancer.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38889771", "sentence_id": 0, "text": "Traditional medication and alternative therapies have long been used to treat breast cancer."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38889771\", \"sentence_id\": 1, \"text\": \"One of the main problems with current treatments is that there is an increase in drug resistance in the cancer cells owing to genetic differences such as mutational changes, epigenetic changes and miRNA (microRNA) alterations such as miR-1246, miR-298, miR-27b and miR-33a, along with epigenetic modifications, such as Histone3 acetylation and CCCTC-Binding Factor (CTCF) hypermethylation for drug resistance in breast cancer cell lines.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38889771", "sentence_id": 1, "text": "One of the main problems with current treatments is that there is an increase in drug resistance in the cancer cells owing to genetic differences such as mutational changes, epigenetic changes and miRNA (microRNA) alterations such as miR-1246, miR-298, miR-27b and miR-33a, along with epigenetic modifications, such as Histone3 acetylation and CCCTC-Binding Factor (CTCF) hypermethylation for drug resistance in breast cancer cell lines."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38889771\", \"sentence_id\": 2, \"text\": \"Certain forms of conventional drug resistance have been linked to genetic changes in genes such as\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38889771", "sentence_id": 2, "text": "Certain forms of conventional drug resistance have been linked to genetic changes in genes such as"}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38885819\", \"sentence_id\": 0, \"text\": \"BACKGROUND: Cancer stem cells (CSCs) play a significant role in the recurrence and drug resistance of esophageal carcinoma (ESCA).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38885819", "sentence_id": 0, "text": "BACKGROUND: Cancer stem cells (CSCs) play a significant role in the recurrence and drug resistance of esophageal carcinoma (ESCA)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38885819\", \"sentence_id\": 1, \"text\": \"Ferroptosis is a promising anticancer therapeutic strategy that effectively targets CSCs exhibiting high tumorigenicity and treatment resistance.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38885819", "sentence_id": 1, "text": "Ferroptosis is a promising anticancer therapeutic strategy that effectively targets CSCs exhibiting high tumorigenicity and treatment resistance."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38885819\", \"sentence_id\": 2, \"text\": \"However, there is a lack of research on the combined role of ferroptosis-related genes (FRGs) and stemness signature in the prognosis of ESCA.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38885819", "sentence_id": 2, "text": "However, there is a lack of research on the combined role of ferroptosis-related genes (FRGs) and stemness signature in the prognosis of ESCA."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38885819\", \"sentence_id\": 3, \"text\": \"METHODS: The cellular compositions were characterized using single-cell RNA sequencing (scRNA-seq) data from 18 untreated ESCA samples.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38885819", "sentence_id": 3, "text": "METHODS: The cellular compositions were characterized using single-cell RNA sequencing (scRNA-seq) data from 18 untreated ESCA samples."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38885819\", \"sentence_id\": 4, \"text\": \"50 ferroptosis-related stemness genes (FRSGs) were identified by integrating FRGs with stemness-related genes (SRGs), and then the cells were grouped by AUCell analysis.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38885819", "sentence_id": 4, "text": "50 ferroptosis-related stemness genes (FRSGs) were identified by integrating FRGs with stemness-related genes (SRGs), and then the cells were grouped by AUCell analysis."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38885819\", \"sentence_id\": 5, \"text\": \"Next, functional enrichment, intercellular communication, and trajectory analyses were performed to characterize the different groups of cells.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38885819", "sentence_id": 5, "text": "Next, functional enrichment, intercellular communication, and trajectory analyses were performed to characterize the different groups of cells."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38885819\", \"sentence_id\": 6, \"text\": \"Subsequently, the stem-ferr-index was calculated using machine learning algorithms based on the expression profiles of the identified risk genes.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38885819", "sentence_id": 6, "text": "Subsequently, the stem-ferr-index was calculated using machine learning algorithms based on the expression profiles of the identified risk genes."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38885819\", \"sentence_id\": 7, \"text\": \"Additionally, therapeutic drugs were predicted by analyzing the GDSC2 database.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38885819", "sentence_id": 7, "text": "Additionally, therapeutic drugs were predicted by analyzing the GDSC2 database."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38885819\", \"sentence_id\": 8, \"text\": \"Finally, the expression and functional roles of the identified marker genes were validated through in vitro experiments.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38885819", "sentence_id": 8, "text": "Finally, the expression and functional roles of the identified marker genes were validated through in vitro experiments."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38885819\", \"sentence_id\": 9, \"text\": \"RESULTS: The analysis of scRNA-seq data demonstrates the diversity and cellular heterogeneity of ESCA.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38885819", "sentence_id": 9, "text": "RESULTS: The analysis of scRNA-seq data demonstrates the diversity and cellular heterogeneity of ESCA."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38885819\", \"sentence_id\": 10, \"text\": \"Then, we identified 50 FRSGs and classified cells into high or low ferroptosis score stemness cells accordingly.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38885819", "sentence_id": 10, "text": "Then, we identified 50 FRSGs and classified cells into high or low ferroptosis score stemness cells accordingly."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38885819\", \"sentence_id\": 11, \"text\": \"Functional enrichment analysis conducted on the differentially up-regulated genes between these groups revealed predominant enrichment in pathways associated with intercellular communication and cell differentiation.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38885819", "sentence_id": 11, "text": "Functional enrichment analysis conducted on the differentially up-regulated genes between these groups revealed predominant enrichment in pathways associated with intercellular communication and cell differentiation."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38885819\", \"sentence_id\": 12, \"text\": \"Subsequently, we identified 9 risk genes and developed a prognostic signature, termed stem_ferr_index, based on these identified risk genes.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38885819", "sentence_id": 12, "text": "Subsequently, we identified 9 risk genes and developed a prognostic signature, termed stem_ferr_index, based on these identified risk genes."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38885819\", \"sentence_id\": 13, \"text\": \"We found that the stem-ferr-index was correlated with the clinical characteristics of patients, and patients with high stem-ferr-index had poor prognosis.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38885819", "sentence_id": 13, "text": "We found that the stem-ferr-index was correlated with the clinical characteristics of patients, and patients with high stem-ferr-index had poor prognosis."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38885819\", \"sentence_id\": 14, \"text\": \"Furthermore, we identified four drugs (Navitoclax, Foretinib, Axitinib, and Talazoparib) with potential efficacy targeting patients with a high stem_ferr_index.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38885819", "sentence_id": 14, "text": "Furthermore, we identified four drugs (Navitoclax, Foretinib, Axitinib, and Talazoparib) with potential efficacy targeting patients with a high stem_ferr_index."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38885819\", \"sentence_id\": 15, \"text\": \"Additionally, we delineated two marker genes (STMN1 and SLC2A1).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38885819", "sentence_id": 15, "text": "Additionally, we delineated two marker genes (STMN1 and SLC2A1)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38885819\", \"sentence_id\": 16, \"text\": \"Particularly noteworthy, SLC2A1 exhibited elevated expression levels in ESCA tissues and cells.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38885819", "sentence_id": 16, "text": "Particularly noteworthy, SLC2A1 exhibited elevated expression levels in ESCA tissues and cells."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38885819\", \"sentence_id\": 17, \"text\": \"We provided evidence suggesting that SLC2A1 could influence the migration, invasion, and stemness of ESCA cells, and it was associated with sensitivity to Foretinib.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38885819", "sentence_id": 17, "text": "We provided evidence suggesting that SLC2A1 could influence the migration, invasion, and stemness of ESCA cells, and it was associated with sensitivity to Foretinib."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38885819\", \"sentence_id\": 18, \"text\": \"CONCLUSION: This study constructed a novel ferroptosis-related stemness signature, identified two marker genes for ESCA, and provided valuable insights for developing more effective therapeutic targets targeting ESCA CSCs in the future.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38885819", "sentence_id": 18, "text": "CONCLUSION: This study constructed a novel ferroptosis-related stemness signature, identified two marker genes for ESCA, and provided valuable insights for developing more effective therapeutic targets targeting ESCA CSCs in the future."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38750344\", \"sentence_id\": 0, \"text\": \"OBJECTIVES: No head-to-head trials had been performed to estimate the relative effectiveness of poly ADP-ribose polymerase inhibitor (PARPi) and androgen receptor signaling inhibitor (ARSi) in the first-line treatment for metastatic castration-resistant prostate cancer (mCRPC).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38750344", "sentence_id": 0, "text": "OBJECTIVES: No head-to-head trials had been performed to estimate the relative effectiveness of poly ADP-ribose polymerase inhibitor (PARPi) and androgen receptor signaling inhibitor (ARSi) in the first-line treatment for metastatic castration-resistant prostate cancer (mCRPC)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38750344\", \"sentence_id\": 1, \"text\": \"We aimed to perform a systematic review and network meta-analysis to evaluate the comparative effectiveness of various systemic treatment agents for patients with mCRPC.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38750344", "sentence_id": 1, "text": "We aimed to perform a systematic review and network meta-analysis to evaluate the comparative effectiveness of various systemic treatment agents for patients with mCRPC."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38750344\", \"sentence_id\": 2, \"text\": \"METHODS: A comprehensive literature search was conducted for abstracts and full-text articles from the database's inception through April 27, 2023.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38750344", "sentence_id": 2, "text": "METHODS: A comprehensive literature search was conducted for abstracts and full-text articles from the database's inception through April 27, 2023."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38750344\", \"sentence_id\": 3, \"text\": \"The study concentrated on assessing radiographic progression-free survival (rPFS) for both overall and homologous recombination repair mutation (HRRm) population, with overall survival (OS) as the secondary measure.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38750344", "sentence_id": 3, "text": "The study concentrated on assessing radiographic progression-free survival (rPFS) for both overall and homologous recombination repair mutation (HRRm) population, with overall survival (OS) as the secondary measure."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38750344\", \"sentence_id\": 4, \"text\": \"Under the Bayesian framework, the overall effect was pooled using the fixed-effects model in base case analysis.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38750344", "sentence_id": 4, "text": "Under the Bayesian framework, the overall effect was pooled using the fixed-effects model in base case analysis."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38750344\", \"sentence_id\": 5, \"text\": \"Scenario analysis using restricted mean survival time (RMST) methods was performed to test the robustness of the results.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38750344", "sentence_id": 5, "text": "Scenario analysis using restricted mean survival time (RMST) methods was performed to test the robustness of the results."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38750344\", \"sentence_id\": 6, \"text\": \"RESULTS: Nine studies with 6,830 patients and 8 unique treatment options were included.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38750344", "sentence_id": 6, "text": "RESULTS: Nine studies with 6,830 patients and 8 unique treatment options were included."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38750344\", \"sentence_id\": 7, \"text\": \"Network meta-analysis demonstrated that talazoparib in combination with enzalutamide (TALA\u2009+\u2009ENZA; overall population, hazard ratio [HR], 0.20; 95% credible interval [CrI]: 0.16-0.26; RMST, 3.51; 95% confidence interval [CI] 2.46-4.60; HRRm population, HR, 0.15; 95% CrI: 0.09-0.23; RMST, 4.14; 95% CI 2.84-5.39) was superior to other treatments in the first-line setting in terms of rPFS.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38750344", "sentence_id": 7, "text": "Network meta-analysis demonstrated that talazoparib in combination with enzalutamide (TALA\u2009+\u2009ENZA; overall population, hazard ratio [HR], 0.20; 95% credible interval [CrI]: 0.16-0.26; RMST, 3.51; 95% confidence interval [CI] 2.46-4.60; HRRm population, HR, 0.15; 95% CrI: 0.09-0.23; RMST, 4.14; 95% CI 2.84-5.39) was superior to other treatments in the first-line setting in terms of rPFS."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38750344\", \"sentence_id\": 8, \"text\": \"The results of Bayesian framework and RMST models showed consistent efficacy ranks.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38750344", "sentence_id": 8, "text": "The results of Bayesian framework and RMST models showed consistent efficacy ranks."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38750344\", \"sentence_id\": 9, \"text\": \"When extrapolated to overall survival benefit, within the Bayesian framework, olaparib plus abiraterone acetate and prednisone (OLAP\u2009+\u2009AAP) achieved the highest OS benefit for the overall population, which was not statistically significant when compared to TALA\u2009+\u2009ENZA.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38750344", "sentence_id": 9, "text": "When extrapolated to overall survival benefit, within the Bayesian framework, olaparib plus abiraterone acetate and prednisone (OLAP\u2009+\u2009AAP) achieved the highest OS benefit for the overall population, which was not statistically significant when compared to TALA\u2009+\u2009ENZA."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38750344\", \"sentence_id\": 10, \"text\": \"However, TALA\u2009+\u2009ENZA achieved the highest OS benefit at 3\u00a0years by applying RMST.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38750344", "sentence_id": 10, "text": "However, TALA\u2009+\u2009ENZA achieved the highest OS benefit at 3\u00a0years by applying RMST."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38750344\", \"sentence_id\": 11, \"text\": \"CONCLUSIONS: We suggest that talazoparib in combination with enzalutamide is probably a preferred treatment agent for the overall population and HRRm patients with mCRPC.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38750344", "sentence_id": 11, "text": "CONCLUSIONS: We suggest that talazoparib in combination with enzalutamide is probably a preferred treatment agent for the overall population and HRRm patients with mCRPC."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38750344\", \"sentence_id\": 12, \"text\": \"Given the limitations of network framework and the modeling assumptions undertaken to finalize the analyses, results should be cautiously interpreted.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38750344", "sentence_id": 12, "text": "Given the limitations of network framework and the modeling assumptions undertaken to finalize the analyses, results should be cautiously interpreted."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38693852\", \"sentence_id\": 0, \"text\": \"Urothelial carcinoma (UC) urgently requires new therapeutic options.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38693852", "sentence_id": 0, "text": "Urothelial carcinoma (UC) urgently requires new therapeutic options."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38693852\", \"sentence_id\": 1, \"text\": \"Histone deacetylases (HDAC) are frequently dysregulated in UC and constitute interesting targets for the development of alternative therapy options.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38693852", "sentence_id": 1, "text": "Histone deacetylases (HDAC) are frequently dysregulated in UC and constitute interesting targets for the development of alternative therapy options."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38693852\", \"sentence_id\": 2, \"text\": \"Thus, we investigated the effect of the second generation HDAC inhibitor (HDACi) quisinostat in five UC cell lines (UCC) and two normal control cell lines in comparison to romidepsin, a well characterized HDACi which was previously shown to induce cell death and cell cycle arrest.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38693852", "sentence_id": 2, "text": "Thus, we investigated the effect of the second generation HDAC inhibitor (HDACi) quisinostat in five UC cell lines (UCC) and two normal control cell lines in comparison to romidepsin, a well characterized HDACi which was previously shown to induce cell death and cell cycle arrest."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38693852\", \"sentence_id\": 3, \"text\": \"In UCC, quisinostat led to cell cycle alterations, cell death induction and DNA damage, but was well tolerated by normal cells.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38693852", "sentence_id": 3, "text": "In UCC, quisinostat led to cell cycle alterations, cell death induction and DNA damage, but was well tolerated by normal cells."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38693852\", \"sentence_id\": 4, \"text\": \"Combinations of quisinostat with cisplatin or the PARP inhibitor talazoparib led to decrease in cell viability and significant synergistic effect in five UCCs and platinum-resistant sublines allowing dose reduction.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38693852", "sentence_id": 4, "text": "Combinations of quisinostat with cisplatin or the PARP inhibitor talazoparib led to decrease in cell viability and significant synergistic effect in five UCCs and platinum-resistant sublines allowing dose reduction."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38693852\", \"sentence_id\": 5, \"text\": \"Further analyses in UM-UC-3 and J82 at low dose ratio revealed that the mechanisms included cell cycle disturbance, apoptosis induction and DNA damage.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38693852", "sentence_id": 5, "text": "Further analyses in UM-UC-3 and J82 at low dose ratio revealed that the mechanisms included cell cycle disturbance, apoptosis induction and DNA damage."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38693852\", \"sentence_id\": 6, \"text\": \"These combinations appeared to be well tolerated in normal cells.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38693852", "sentence_id": 6, "text": "These combinations appeared to be well tolerated in normal cells."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38693852\", \"sentence_id\": 7, \"text\": \"In conclusion, our results suggest new promising combination regimes for treatment of UC, also in the cisplatin-resistant setting.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38693852", "sentence_id": 7, "text": "In conclusion, our results suggest new promising combination regimes for treatment of UC, also in the cisplatin-resistant setting."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38645014\", \"sentence_id\": 0, \"text\": \"We analyzed genomic data derived from the prostate cancer of African and European American men in order to identify differences that may contribute to racial disparity of outcome and that could also define novel therapeutic strategies.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38645014", "sentence_id": 0, "text": "We analyzed genomic data derived from the prostate cancer of African and European American men in order to identify differences that may contribute to racial disparity of outcome and that could also define novel therapeutic strategies."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38645014\", \"sentence_id\": 1, \"text\": \"In addition to analyzing patient derived next generation sequencing data, we performed FISH based confirmatory studies of Chromodomain helicase DNA-binding protein 1 (\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38645014", "sentence_id": 1, "text": "In addition to analyzing patient derived next generation sequencing data, we performed FISH based confirmatory studies of Chromodomain helicase DNA-binding protein 1 ("}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38625917\", \"sentence_id\": 0, \"text\": \"PARP inhibitors have been developed as anti-cancer agents based on synthetic lethality in homologous recombination deficient cancer cells.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38625917", "sentence_id": 0, "text": "PARP inhibitors have been developed as anti-cancer agents based on synthetic lethality in homologous recombination deficient cancer cells."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38625917\", \"sentence_id\": 1, \"text\": \"However, resistance to PARP inhibitors such as olaparib remains a problem in clinical use, and the mechanisms of resistance are not fully understood.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38625917", "sentence_id": 1, "text": "However, resistance to PARP inhibitors such as olaparib remains a problem in clinical use, and the mechanisms of resistance are not fully understood."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38625917\", \"sentence_id\": 2, \"text\": \"To investigate mechanisms of PARP inhibitor resistance, we established a BRCA1 knockout clone derived from the pancreatic cancer MIA PaCa-2 cells, which we termed C1 cells, and subsequently isolated an olaparib-resistant C1/OLA cells.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38625917", "sentence_id": 2, "text": "To investigate mechanisms of PARP inhibitor resistance, we established a BRCA1 knockout clone derived from the pancreatic cancer MIA PaCa-2 cells, which we termed C1 cells, and subsequently isolated an olaparib-resistant C1/OLA cells."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38625917\", \"sentence_id\": 3, \"text\": \"We then performed RNA-sequencing and pathway analysis on olaparib-treated C1 and C1/OLA cells.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38625917", "sentence_id": 3, "text": "We then performed RNA-sequencing and pathway analysis on olaparib-treated C1 and C1/OLA cells."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38625917\", \"sentence_id\": 4, \"text\": \"Our results revealed activation of cell signaling pathway related to NAD+ metabolism in the olaparib-resistant C1/OLA cells, with increased expression of genes encoding the NAD+ biosynthetic enzymes NAMPT and NMNAT2.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38625917", "sentence_id": 4, "text": "Our results revealed activation of cell signaling pathway related to NAD+ metabolism in the olaparib-resistant C1/OLA cells, with increased expression of genes encoding the NAD+ biosynthetic enzymes NAMPT and NMNAT2."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38625917\", \"sentence_id\": 5, \"text\": \"Moreover, intracellular NAD+ levels were significantly higher in C1/OLA cells than in the non-olaparib-resistant C1 cells.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38625917", "sentence_id": 5, "text": "Moreover, intracellular NAD+ levels were significantly higher in C1/OLA cells than in the non-olaparib-resistant C1 cells."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38625917\", \"sentence_id\": 6, \"text\": \"Upregulation of intracellular NAD+ levels by the addition of nicotinamide also induced resistance to olaparib and talazoparib in C1 cells.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38625917", "sentence_id": 6, "text": "Upregulation of intracellular NAD+ levels by the addition of nicotinamide also induced resistance to olaparib and talazoparib in C1 cells."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38625917\", \"sentence_id\": 7, \"text\": \"Taken together, our findings suggest that upregulation of intracellular NAD+ is one of the factors underlying the acquisition of PARP inhibitor resistance.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38625917", "sentence_id": 7, "text": "Taken together, our findings suggest that upregulation of intracellular NAD+ is one of the factors underlying the acquisition of PARP inhibitor resistance."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38613872\", \"sentence_id\": 0, \"text\": \"INTRODUCTION: Metastatic castration-resistant prostate cancer (mCRPC) remains incurable and develops from biochemically recurrent PC treated with androgen deprivation therapy (ADT) following definitive therapy for localized PC, or from metastatic castration-sensitive PC (mCSPC).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38613872", "sentence_id": 0, "text": "INTRODUCTION: Metastatic castration-resistant prostate cancer (mCRPC) remains incurable and develops from biochemically recurrent PC treated with androgen deprivation therapy (ADT) following definitive therapy for localized PC, or from metastatic castration-sensitive PC (mCSPC)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38613872\", \"sentence_id\": 1, \"text\": \"In the mCSPC setting, treatment intensification of ADT plus androgen receptor (AR)-signaling inhibitors (ARSIs), with or without chemotherapy, improves outcomes vs ADT alone.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38613872", "sentence_id": 1, "text": "In the mCSPC setting, treatment intensification of ADT plus androgen receptor (AR)-signaling inhibitors (ARSIs), with or without chemotherapy, improves outcomes vs ADT alone."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38613872\", \"sentence_id\": 2, \"text\": \"Despite multiple phase 3 trials demonstrating a survival benefit of treatment intensification in PC, there remains high use of ADT monotherapy in real-world clinical practice.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38613872", "sentence_id": 2, "text": "Despite multiple phase 3 trials demonstrating a survival benefit of treatment intensification in PC, there remains high use of ADT monotherapy in real-world clinical practice."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38613872\", \"sentence_id\": 3, \"text\": \"Prior studies indicate that co-inhibition of AR and poly(ADP-ribose) polymerase (PARP) may result in enhanced benefit in treating tumors regardless of alterations in DNA damage response genes involved either directly or indirectly in homologous recombination repair (HRR).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38613872", "sentence_id": 3, "text": "Prior studies indicate that co-inhibition of AR and poly(ADP-ribose) polymerase (PARP) may result in enhanced benefit in treating tumors regardless of alterations in DNA damage response genes involved either directly or indirectly in homologous recombination repair (HRR)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38613872\", \"sentence_id\": 4, \"text\": \"Three recent phase 3 studies evaluated the combination of a PARP inhibitor (PARPi) with an ARSI as first-line treatment for mCRPC: TALAPRO-2, talazoparib plus enzalutamide; PROpel, olaparib plus abiraterone acetate and prednisone (AAP); and MAGNITUDE, niraparib plus AAP.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38613872", "sentence_id": 4, "text": "Three recent phase 3 studies evaluated the combination of a PARP inhibitor (PARPi) with an ARSI as first-line treatment for mCRPC: TALAPRO-2, talazoparib plus enzalutamide; PROpel, olaparib plus abiraterone acetate and prednisone (AAP); and MAGNITUDE, niraparib plus AAP."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38613872\", \"sentence_id\": 5, \"text\": \"Results from these studies have led to the recent approval in the United States of talazoparib plus enzalutamide for the treatment of mCRPC with any HRR alteration, and of both olaparib and niraparib indicated in combination with AAP for the treatment of mCRPC with BRCA alterations.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38613872", "sentence_id": 5, "text": "Results from these studies have led to the recent approval in the United States of talazoparib plus enzalutamide for the treatment of mCRPC with any HRR alteration, and of both olaparib and niraparib indicated in combination with AAP for the treatment of mCRPC with BRCA alterations."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38613872\", \"sentence_id\": 6, \"text\": \"SUMMARY: Here, we review the newly approved PARPi plus ARSI treatments within the context of the mCRPC treatment landscape, provide an overview of practical considerations for the combinations in clinical practice, highlight the importance of HRR testing, and discuss the benefits of treatment intensification for patients with mCRPC.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38613872", "sentence_id": 6, "text": "SUMMARY: Here, we review the newly approved PARPi plus ARSI treatments within the context of the mCRPC treatment landscape, provide an overview of practical considerations for the combinations in clinical practice, highlight the importance of HRR testing, and discuss the benefits of treatment intensification for patients with mCRPC."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38452327\", \"sentence_id\": 0, \"text\": \"PURPOSE: The US Food and Drug Administration (FDA) approved talazoparib with enzalutamide for first-line treatment of patients with homologous recombination repair (HRR) gene-mutated metastatic castration-resistant prostate cancer (mCRPC).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38452327", "sentence_id": 0, "text": "PURPOSE: The US Food and Drug Administration (FDA) approved talazoparib with enzalutamide for first-line treatment of patients with homologous recombination repair (HRR) gene-mutated metastatic castration-resistant prostate cancer (mCRPC)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38452327\", \"sentence_id\": 1, \"text\": \"PATIENTS AND METHODS: The approval was based on the HRR gene-mutated (HRRm) population of TALAPRO-2, a randomized, double-blind trial that randomly assigned 1,035 patients with mCRPC to receive enzalutamide with either talazoparib or placebo.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38452327", "sentence_id": 1, "text": "PATIENTS AND METHODS: The approval was based on the HRR gene-mutated (HRRm) population of TALAPRO-2, a randomized, double-blind trial that randomly assigned 1,035 patients with mCRPC to receive enzalutamide with either talazoparib or placebo."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38452327\", \"sentence_id\": 2, \"text\": \"Two cohorts enrolled sequentially: an all-comer population (Cohort 1), followed by an HRRm-only population (Cohort 2).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38452327", "sentence_id": 2, "text": "Two cohorts enrolled sequentially: an all-comer population (Cohort 1), followed by an HRRm-only population (Cohort 2)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38452327\", \"sentence_id\": 3, \"text\": \"The independent primary end points were radiographic progression-free survival (rPFS) per blinded independent central review (BICR) in Cohort 1 (all-comers) and in the combined HRRm population (all HRRm patients from Cohorts 1 and 2).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38452327", "sentence_id": 3, "text": "The independent primary end points were radiographic progression-free survival (rPFS) per blinded independent central review (BICR) in Cohort 1 (all-comers) and in the combined HRRm population (all HRRm patients from Cohorts 1 and 2)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38452327\", \"sentence_id\": 4, \"text\": \"Overall survival (OS) was a key secondary end point.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38452327", "sentence_id": 4, "text": "Overall survival (OS) was a key secondary end point."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38452327\", \"sentence_id\": 5, \"text\": \"RESULTS: A statistically significant improvement in rPFS by BICR was demonstrated in both the all-comers cohort and the combined HRRm population, with hazard ratio (HR) of 0.63 (95% CI, 0.51 to 0.78;\\nCONCLUSION: Despite a statistically significant rPFS improvement in the all-comer cohort, FDA did not consider the magnitude of rPFS clinically meaningful in the context of the broad indication, combination treatment, and safety profile.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38452327", "sentence_id": 5, "text": "RESULTS: A statistically significant improvement in rPFS by BICR was demonstrated in both the all-comers cohort and the combined HRRm population, with hazard ratio (HR) of 0.63 (95% CI, 0.51 to 0.78;\nCONCLUSION: Despite a statistically significant rPFS improvement in the all-comer cohort, FDA did not consider the magnitude of rPFS clinically meaningful in the context of the broad indication, combination treatment, and safety profile."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38452327\", \"sentence_id\": 6, \"text\": \"Approval was therefore limited to patients with HRRm mCRPC, for whom there was a statistically significant and clinically meaningful improvement in rPFS and favorable OS results.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38452327", "sentence_id": 6, "text": "Approval was therefore limited to patients with HRRm mCRPC, for whom there was a statistically significant and clinically meaningful improvement in rPFS and favorable OS results."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38452327\", \"sentence_id\": 7, \"text\": \"This represents the first approval for the first-line treatment of patients with HRRm mCRPC.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38452327", "sentence_id": 7, "text": "This represents the first approval for the first-line treatment of patients with HRRm mCRPC."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38398706\", \"sentence_id\": 0, \"text\": \"The treatment landscape of metastatic prostate cancer (mPCa) is rapidly evolving with the recent approvals of poly-ADP ribose polymerase inhibitors (PARPis) as monotherapy or as part of combination therapy with androgen receptor pathway inhibitors in patients with metastatic castration-resistant prostate cancer (mCRPC).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38398706", "sentence_id": 0, "text": "The treatment landscape of metastatic prostate cancer (mPCa) is rapidly evolving with the recent approvals of poly-ADP ribose polymerase inhibitors (PARPis) as monotherapy or as part of combination therapy with androgen receptor pathway inhibitors in patients with metastatic castration-resistant prostate cancer (mCRPC)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38398706\", \"sentence_id\": 1, \"text\": \"Already part of the therapeutic armamentarium in different types of advanced cancers, these molecules have shaped a new era in mPCa by targeting genomic pathways altered in these patients, leading to promising responses.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38398706", "sentence_id": 1, "text": "Already part of the therapeutic armamentarium in different types of advanced cancers, these molecules have shaped a new era in mPCa by targeting genomic pathways altered in these patients, leading to promising responses."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38398706\", \"sentence_id\": 2, \"text\": \"These agents act by inhibiting poly-ADP ribose polymerase (PARP) enzymes involved in repairing single-strand breaks in the DNA.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38398706", "sentence_id": 2, "text": "These agents act by inhibiting poly-ADP ribose polymerase (PARP) enzymes involved in repairing single-strand breaks in the DNA."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38398706\", \"sentence_id\": 3, \"text\": \"Based on the PROfound and TRITON3 trials, olaparib and rucaparib were respectively approved as monotherapy in pretreated patients with mCRPC and alterations in prespecified genes.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38398706", "sentence_id": 3, "text": "Based on the PROfound and TRITON3 trials, olaparib and rucaparib were respectively approved as monotherapy in pretreated patients with mCRPC and alterations in prespecified genes."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38398706\", \"sentence_id\": 4, \"text\": \"The combinations of olaparib with abiraterone (PROpel) and niraparib with abiraterone (MAGNITUDE) were approved as first-line options in patients with mCRPC and alterations in\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38398706", "sentence_id": 4, "text": "The combinations of olaparib with abiraterone (PROpel) and niraparib with abiraterone (MAGNITUDE) were approved as first-line options in patients with mCRPC and alterations in"}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38340425\", \"sentence_id\": 0, \"text\": \"AIMS: The overexpression of ABC transporters on cancer cell membranes is one of the most common causes of multidrug resistance (MDR).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38340425", "sentence_id": 0, "text": "AIMS: The overexpression of ABC transporters on cancer cell membranes is one of the most common causes of multidrug resistance (MDR)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38340425\", \"sentence_id\": 1, \"text\": \"This study investigates the impact of ABCC1 and ABCG2 on the resistance to talazoparib (BMN-673), a potent poly (ADP-ribose) polymerase (PARP) inhibitor, in ovarian cancer treatment.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38340425", "sentence_id": 1, "text": "This study investigates the impact of ABCC1 and ABCG2 on the resistance to talazoparib (BMN-673), a potent poly (ADP-ribose) polymerase (PARP) inhibitor, in ovarian cancer treatment."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38340425\", \"sentence_id\": 2, \"text\": \"METHODS: The cell viability test was used to indicate the effect of talazoparib in different cell lines.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38340425", "sentence_id": 2, "text": "METHODS: The cell viability test was used to indicate the effect of talazoparib in different cell lines."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38340425\", \"sentence_id\": 3, \"text\": \"Computational molecular docking analysis was conducted to simulate the interaction between talazoparib and ABCC1 or ABCG2.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38340425", "sentence_id": 3, "text": "Computational molecular docking analysis was conducted to simulate the interaction between talazoparib and ABCC1 or ABCG2."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38340425\", \"sentence_id\": 4, \"text\": \"The mechanism of talazoparib resistance was investigated by constructing talazoparib-resistant subline A2780/T4 from A2780 through drug selection with gradually increasing talazoparib concentration.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38340425", "sentence_id": 4, "text": "The mechanism of talazoparib resistance was investigated by constructing talazoparib-resistant subline A2780/T4 from A2780 through drug selection with gradually increasing talazoparib concentration."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38340425\", \"sentence_id\": 5, \"text\": \"RESULTS: Talazoparib cytotoxicity decreased in drug-selected or gene-transfected cell lines overexpressing ABCC1 or ABCG2 but can be restored by ABCC1 or ABCG2 inhibitors.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38340425", "sentence_id": 5, "text": "RESULTS: Talazoparib cytotoxicity decreased in drug-selected or gene-transfected cell lines overexpressing ABCC1 or ABCG2 but can be restored by ABCC1 or ABCG2 inhibitors."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38340425\", \"sentence_id\": 6, \"text\": \"Talazoparib competitively inhibited substrate drug efflux activity of ABCC1 or ABCG2.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38340425", "sentence_id": 6, "text": "Talazoparib competitively inhibited substrate drug efflux activity of ABCC1 or ABCG2."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38340425\", \"sentence_id\": 7, \"text\": \"Upregulated ABCC1 and ABCG2 protein expression on the plasma membrane of A2780/T4 cells enhances resistance to other substrate drugs, which could be overcome by the knockout of either gene.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38340425", "sentence_id": 7, "text": "Upregulated ABCC1 and ABCG2 protein expression on the plasma membrane of A2780/T4 cells enhances resistance to other substrate drugs, which could be overcome by the knockout of either gene."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38340425\", \"sentence_id\": 8, \"text\": \"In vivo experiments confirmed the retention of drug-resistant characteristics in tumor xenograft mouse models.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38340425", "sentence_id": 8, "text": "In vivo experiments confirmed the retention of drug-resistant characteristics in tumor xenograft mouse models."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38340425\", \"sentence_id\": 9, \"text\": \"CONCLUSIONS: The therapeutic efficacy of talazoparib in cancer may be compromised by its susceptibility to MDR, which is attributed to its interactions with the ABCC1 or ABCG2 transporters.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38340425", "sentence_id": 9, "text": "CONCLUSIONS: The therapeutic efficacy of talazoparib in cancer may be compromised by its susceptibility to MDR, which is attributed to its interactions with the ABCC1 or ABCG2 transporters."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38340425\", \"sentence_id\": 10, \"text\": \"The overexpression of these transporters can potentially diminish the therapeutic impact of talazoparib in cancer treatment.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38340425", "sentence_id": 10, "text": "The overexpression of these transporters can potentially diminish the therapeutic impact of talazoparib in cancer treatment."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38321470\", \"sentence_id\": 0, \"text\": \"BACKGROUND: Within the last decade, poly(ADP-ribose) polymerase inhibitors (PARPi) have emerged in the clinic as an effective treatment for numerous malignancies.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38321470", "sentence_id": 0, "text": "BACKGROUND: Within the last decade, poly(ADP-ribose) polymerase inhibitors (PARPi) have emerged in the clinic as an effective treatment for numerous malignancies."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38321470\", \"sentence_id\": 1, \"text\": \"Preclinical data have demonstrated powerful combination effects of PARPi paired with photodynamic therapy (PDT), which involves light-activation of specialized dyes (photosensitizers) to stimulate cancer cell death through reactive oxygen species generation.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38321470", "sentence_id": 1, "text": "Preclinical data have demonstrated powerful combination effects of PARPi paired with photodynamic therapy (PDT), which involves light-activation of specialized dyes (photosensitizers) to stimulate cancer cell death through reactive oxygen species generation."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38321470\", \"sentence_id\": 2, \"text\": \"RESULTS: In this report, the most potent clinical PARP inhibitor, talazoparib, is loaded into the core of a polymeric nanoparticle (NP-Tal), which is interfaced with antibody-photosensitizer conjugates (photoimmunoconjugates, PICs) to form PIC-NP-Tal.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38321470", "sentence_id": 2, "text": "RESULTS: In this report, the most potent clinical PARP inhibitor, talazoparib, is loaded into the core of a polymeric nanoparticle (NP-Tal), which is interfaced with antibody-photosensitizer conjugates (photoimmunoconjugates, PICs) to form PIC-NP-Tal."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38321470\", \"sentence_id\": 3, \"text\": \"In parallel, a new 3D fluorescent coculture model is developed using the parental OVCAR-8-DsRed2 and the chemo-resistant subline, NCI/ADR-RES-EGFP.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38321470", "sentence_id": 3, "text": "In parallel, a new 3D fluorescent coculture model is developed using the parental OVCAR-8-DsRed2 and the chemo-resistant subline, NCI/ADR-RES-EGFP."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38321470\", \"sentence_id\": 4, \"text\": \"This model enables quantification of trends in the evolutionary dynamics of acquired chemoresistance in response to various treatment regimes.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38321470", "sentence_id": 4, "text": "This model enables quantification of trends in the evolutionary dynamics of acquired chemoresistance in response to various treatment regimes."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38321470\", \"sentence_id\": 5, \"text\": \"Results reveal that at a low dosage (0.01\u00a0\u03bcM), NP-Tal kills the parental cells while sparing the chemo-resistant subline, thereby driving chemoresistance.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38321470", "sentence_id": 5, "text": "Results reveal that at a low dosage (0.01\u00a0\u03bcM), NP-Tal kills the parental cells while sparing the chemo-resistant subline, thereby driving chemoresistance."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38321470\", \"sentence_id\": 6, \"text\": \"Next, PIC-NP-Tal and relevant controls are evaluated in the 3D coculture model at multiple irradiation doses to characterize effects on total spheroid ablation and relative changes in parental and subline cell population dynamics.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38321470", "sentence_id": 6, "text": "Next, PIC-NP-Tal and relevant controls are evaluated in the 3D coculture model at multiple irradiation doses to characterize effects on total spheroid ablation and relative changes in parental and subline cell population dynamics."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38321470\", \"sentence_id\": 7, \"text\": \"Total spheroid ablation data shows potent combination effects when PIC and NP-Tal are co-administered, but decreased efficacy with the conjugated formulation (PIC-NP-Tal).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38321470", "sentence_id": 7, "text": "Total spheroid ablation data shows potent combination effects when PIC and NP-Tal are co-administered, but decreased efficacy with the conjugated formulation (PIC-NP-Tal)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38321470\", \"sentence_id\": 8, \"text\": \"Analysis of cell population dynamics reveals that PIC, BPD\u2009+\u2009NP-Tal, PIC\u2009+\u2009NP-Tal, and PIC-NP-Tal demonstrate selection pressures towards chemoresistance.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38321470", "sentence_id": 8, "text": "Analysis of cell population dynamics reveals that PIC, BPD\u2009+\u2009NP-Tal, PIC\u2009+\u2009NP-Tal, and PIC-NP-Tal demonstrate selection pressures towards chemoresistance."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38321470\", \"sentence_id\": 9, \"text\": \"CONCLUSIONS: This study provides key insights into manufacturing parameters for PARPi-loaded nanoparticles, as well as the potential role of PDT-based combination therapies in the context of acquired drug resistance.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38321470", "sentence_id": 9, "text": "CONCLUSIONS: This study provides key insights into manufacturing parameters for PARPi-loaded nanoparticles, as well as the potential role of PDT-based combination therapies in the context of acquired drug resistance."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38281877\", \"sentence_id\": 0, \"text\": \"Poly (ADP-ribose) polymerase inhibitors (PARPi) represent an option in selected cases of metastatic castration-resistant prostate cancer (mCRPC).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38281877", "sentence_id": 0, "text": "Poly (ADP-ribose) polymerase inhibitors (PARPi) represent an option in selected cases of metastatic castration-resistant prostate cancer (mCRPC)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38281877\", \"sentence_id\": 1, \"text\": \"The aim of the present systematic review and meta-analysis is to evaluate the efficacy and safety of approved (Olaparib, Rucaparib) and investigational (Talazoparib, Niraparib, Veliparib) PARPi in mCRPC patients.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38281877", "sentence_id": 1, "text": "The aim of the present systematic review and meta-analysis is to evaluate the efficacy and safety of approved (Olaparib, Rucaparib) and investigational (Talazoparib, Niraparib, Veliparib) PARPi in mCRPC patients."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38281877\", \"sentence_id\": 2, \"text\": \"Three databases were queried for studies analyzing oncological outcomes and adverse events of mCRPC patients receiving PARPi.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38281877", "sentence_id": 2, "text": "Three databases were queried for studies analyzing oncological outcomes and adverse events of mCRPC patients receiving PARPi."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38281877\", \"sentence_id\": 3, \"text\": \"Primary outcome was a PSA decline \u2265 50% from baseline.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38281877", "sentence_id": 3, "text": "Primary outcome was a PSA decline \u2265 50% from baseline."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38281877\", \"sentence_id\": 4, \"text\": \"Secondary outcomes were objective response rate, progression-free survival (PFS), radiological PFS, overall survival (OS), conversion of circulating tumor cell count, and time to PSA progression.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38281877", "sentence_id": 4, "text": "Secondary outcomes were objective response rate, progression-free survival (PFS), radiological PFS, overall survival (OS), conversion of circulating tumor cell count, and time to PSA progression."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38281877\", \"sentence_id\": 5, \"text\": \"The number and rate of any grade adverse events (AEs), grade \u2265 3 AEs, and most common grade \u2265 3 AEs were registered.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38281877", "sentence_id": 5, "text": "The number and rate of any grade adverse events (AEs), grade \u2265 3 AEs, and most common grade \u2265 3 AEs were registered."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38281877\", \"sentence_id\": 6, \"text\": \"A subanalysis of outcomes per mutation type, prospective trials, and studies adopting combination therapies was performed.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38281877", "sentence_id": 6, "text": "A subanalysis of outcomes per mutation type, prospective trials, and studies adopting combination therapies was performed."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38281877\", \"sentence_id\": 7, \"text\": \"Overall, 31 studies were included in this systematic review, 28 of which are available for meta-analysis.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38281877", "sentence_id": 7, "text": "Overall, 31 studies were included in this systematic review, 28 of which are available for meta-analysis."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38281877\", \"sentence_id\": 8, \"text\": \"The most frequently investigated drug was Olaparib.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38281877", "sentence_id": 8, "text": "The most frequently investigated drug was Olaparib."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38281877\", \"sentence_id\": 9, \"text\": \"The most frequent mutation was BRCA2.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38281877", "sentence_id": 9, "text": "The most frequent mutation was BRCA2."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38281877\", \"sentence_id\": 10, \"text\": \"A PSA decline rate of 43% (95% CI 0.32-0.54) was observed in the overall population.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38281877", "sentence_id": 10, "text": "A PSA decline rate of 43% (95% CI 0.32-0.54) was observed in the overall population."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38281877\", \"sentence_id\": 11, \"text\": \"Mean OS was 15.9 (95% CI 12.9-19.0) months.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38281877", "sentence_id": 11, "text": "Mean OS was 15.9 (95% CI 12.9-19.0) months."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38281877\", \"sentence_id\": 12, \"text\": \"In BRCA2 patients, PSA decline rate was 66% (95% CI 0.57-0.7) and OS 23.4 months (95% CI 22.8-24.1).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38281877", "sentence_id": 12, "text": "In BRCA2 patients, PSA decline rate was 66% (95% CI 0.57-0.7) and OS 23.4 months (95% CI 22.8-24.1)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38281877\", \"sentence_id\": 13, \"text\": \"Half of the patients suffered from grade 3 and 4 AEs (0.50 [95% CI 0.39-0.60]).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38281877", "sentence_id": 13, "text": "Half of the patients suffered from grade 3 and 4 AEs (0.50 [95% CI 0.39-0.60])."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38281877\", \"sentence_id\": 14, \"text\": \"Most common AEs were hematological, the most frequent being anemia (21.5%).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38281877", "sentence_id": 14, "text": "Most common AEs were hematological, the most frequent being anemia (21.5%)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38281877\", \"sentence_id\": 15, \"text\": \"PARP inhibitors represent a viable option for mCRPC patients.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38281877", "sentence_id": 15, "text": "PARP inhibitors represent a viable option for mCRPC patients."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38281877\", \"sentence_id\": 16, \"text\": \"Current evidence suggests an increased effectiveness in homologous recombination repair (HRR) gene mutation carriers, especially BRCA2.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38281877", "sentence_id": 16, "text": "Current evidence suggests an increased effectiveness in homologous recombination repair (HRR) gene mutation carriers, especially BRCA2."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38205078\", \"sentence_id\": 0, \"text\": \"The relatively high prevalence of alterations in the homologous recombination repair (HRR) pathway described in advanced prostate cancer provides a unique opportunity to develop therapeutic strategies that take advantage of the decreased tumor ability to repair DNA damage.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38205078", "sentence_id": 0, "text": "The relatively high prevalence of alterations in the homologous recombination repair (HRR) pathway described in advanced prostate cancer provides a unique opportunity to develop therapeutic strategies that take advantage of the decreased tumor ability to repair DNA damage."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38205078\", \"sentence_id\": 1, \"text\": \"Poly ADP-ribose polymerase (PARP) inhibitors have been demonstrated to improve the outcomes of metastatic castration-resistant prostate cancer (mCRPC) patients with HRR defects, particularly in those with\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38205078", "sentence_id": 1, "text": "Poly ADP-ribose polymerase (PARP) inhibitors have been demonstrated to improve the outcomes of metastatic castration-resistant prostate cancer (mCRPC) patients with HRR defects, particularly in those with"}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40115493\", \"sentence_id\": 0, \"text\": \"INTRODUCTION: Olaparib, rucaparib, niraparib, and talazoparib are poly (ADP-ribose) polymerase (PARP) inhibitors (PARPi) targeted at recombination.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40115493", "sentence_id": 0, "text": "INTRODUCTION: Olaparib, rucaparib, niraparib, and talazoparib are poly (ADP-ribose) polymerase (PARP) inhibitors (PARPi) targeted at recombination."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40115493\", \"sentence_id\": 1, \"text\": \"To gain a comprehensive understanding of the mechanism of action of PARPi, scientists conducted research involving numerous studies that provided evidence regarding their efficacy and safety.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40115493", "sentence_id": 1, "text": "To gain a comprehensive understanding of the mechanism of action of PARPi, scientists conducted research involving numerous studies that provided evidence regarding their efficacy and safety."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40115493\", \"sentence_id\": 2, \"text\": \"MATERIAL AND METHODS: A literature review was performed using the PubMed\\nRESULTS: PARP inhibitors like olaparib, rucaparib, niraparib, and talazoparib show promise in mCRPC, particularly for patients with specific genetic mutations (\\nCONCLUSIONS: Despite PARPi already being recognized as the standard treatment for mCRPC, further research is crucial to optimize their efficacy and safety, particularly in the context of combination therapies and use in the early stages of the disease.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "40115493", "sentence_id": 2, "text": "MATERIAL AND METHODS: A literature review was performed using the PubMed\nRESULTS: PARP inhibitors like olaparib, rucaparib, niraparib, and talazoparib show promise in mCRPC, particularly for patients with specific genetic mutations (\nCONCLUSIONS: Despite PARPi already being recognized as the standard treatment for mCRPC, further research is crucial to optimize their efficacy and safety, particularly in the context of combination therapies and use in the early stages of the disease."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38107827\", \"sentence_id\": 0, \"text\": \"Ewing's sarcoma (ES) is a bone and soft tissue tumor that mainly occurs at a young age.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38107827", "sentence_id": 0, "text": "Ewing's sarcoma (ES) is a bone and soft tissue tumor that mainly occurs at a young age."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38107827\", \"sentence_id\": 1, \"text\": \"The underlying cause of Ewing's sarcoma is the formation of fusion proteins between\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38107827", "sentence_id": 1, "text": "The underlying cause of Ewing's sarcoma is the formation of fusion proteins between"}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38073492\", \"sentence_id\": 0, \"text\": \"The treatment landscape for castration-resistant prostate cancer (mCRPC) is undergoing significant advancements, particularly with the emergence of poly(ADP-ribose) polymerase inhibitors and their recent US FDA authorizations.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38073492", "sentence_id": 0, "text": "The treatment landscape for castration-resistant prostate cancer (mCRPC) is undergoing significant advancements, particularly with the emergence of poly(ADP-ribose) polymerase inhibitors and their recent US FDA authorizations."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38073492\", \"sentence_id\": 1, \"text\": \"The combination of olaparib with abiraterone and prednisone/prednisolone has gained approval for mCRPC patients harboring confirmed\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38073492", "sentence_id": 1, "text": "The combination of olaparib with abiraterone and prednisone/prednisolone has gained approval for mCRPC patients harboring confirmed"}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38049622\", \"sentence_id\": 0, \"text\": \"Preclinical evidence has suggested an interplay between the androgen receptor, which largely drives the growth of prostate cancer cells, and poly(ADP-ribose) polymerase.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38049622", "sentence_id": 0, "text": "Preclinical evidence has suggested an interplay between the androgen receptor, which largely drives the growth of prostate cancer cells, and poly(ADP-ribose) polymerase."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38049622\", \"sentence_id\": 1, \"text\": \"This association provides a rationale for their co-inhibition for the treatment of metastatic castration-resistant prostate cancer (mCRPC), an area of unmet medical need.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38049622", "sentence_id": 1, "text": "This association provides a rationale for their co-inhibition for the treatment of metastatic castration-resistant prostate cancer (mCRPC), an area of unmet medical need."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38049622\", \"sentence_id\": 2, \"text\": \"The phase 3 TALAPRO-2 study investigated combining the poly(ADP-ribose) polymerase inhibitor talazoparib with enzalutamide versus enzalutamide alone as first-line treatment of mCRPC.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38049622", "sentence_id": 2, "text": "The phase 3 TALAPRO-2 study investigated combining the poly(ADP-ribose) polymerase inhibitor talazoparib with enzalutamide versus enzalutamide alone as first-line treatment of mCRPC."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38049622\", \"sentence_id\": 3, \"text\": \"Patients were prospectively assessed for tumor alterations in DNA damage response genes involved in homologous recombination repair (HRR).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38049622", "sentence_id": 3, "text": "Patients were prospectively assessed for tumor alterations in DNA damage response genes involved in homologous recombination repair (HRR)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38049622\", \"sentence_id\": 4, \"text\": \"Two cohorts were enrolled sequentially: an all-comers cohort that was enrolled first (cohort 1; N\u2009=\u2009805 (169 were HRR-deficient)), followed by an HRR-deficient-only cohort (cohort 2; N\u2009=\u2009230).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38049622", "sentence_id": 4, "text": "Two cohorts were enrolled sequentially: an all-comers cohort that was enrolled first (cohort 1; N\u2009=\u2009805 (169 were HRR-deficient)), followed by an HRR-deficient-only cohort (cohort 2; N\u2009=\u2009230)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38049622\", \"sentence_id\": 5, \"text\": \"We present results from the alpha-controlled primary analysis for the combined HRR-deficient population (N\u2009=\u2009399).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38049622", "sentence_id": 5, "text": "We present results from the alpha-controlled primary analysis for the combined HRR-deficient population (N\u2009=\u2009399)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38049622\", \"sentence_id\": 6, \"text\": \"Patients were randomized in a 1:1 ratio to talazoparib or placebo, plus enzalutamide.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38049622", "sentence_id": 6, "text": "Patients were randomized in a 1:1 ratio to talazoparib or placebo, plus enzalutamide."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38049622\", \"sentence_id\": 7, \"text\": \"The primary endpoint, radiographic progression-free survival, was met (median not reached at the time of the analysis for the talazoparib group versus 13.8 months for the placebo group; hazard ratio, 0.45; 95% confidence interval, 0.33 to 0.61; P\u2009<\u20090.0001).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38049622", "sentence_id": 7, "text": "The primary endpoint, radiographic progression-free survival, was met (median not reached at the time of the analysis for the talazoparib group versus 13.8 months for the placebo group; hazard ratio, 0.45; 95% confidence interval, 0.33 to 0.61; P\u2009<\u20090.0001)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38049622\", \"sentence_id\": 8, \"text\": \"Data for overall survival, a key secondary endpoint, are immature but favor talazoparib (hazard ratio, 0.69; 95% confidence interval, 0.46 to 1.03; P\u2009=\u20090.07).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38049622", "sentence_id": 8, "text": "Data for overall survival, a key secondary endpoint, are immature but favor talazoparib (hazard ratio, 0.69; 95% confidence interval, 0.46 to 1.03; P\u2009=\u20090.07)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38049622\", \"sentence_id\": 9, \"text\": \"Common adverse events in the talazoparib group were anemia, fatigue and neutropenia.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38049622", "sentence_id": 9, "text": "Common adverse events in the talazoparib group were anemia, fatigue and neutropenia."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38049622\", \"sentence_id\": 10, \"text\": \"Combining talazoparib with enzalutamide significantly improved radiographic progression-free survival in patients with mCRPC harboring HRR gene alterations, supporting talazoparib plus enzalutamide as a potential first-line treatment for these patients.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38049622", "sentence_id": 10, "text": "Combining talazoparib with enzalutamide significantly improved radiographic progression-free survival in patients with mCRPC harboring HRR gene alterations, supporting talazoparib plus enzalutamide as a potential first-line treatment for these patients."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"38049622\", \"sentence_id\": 11, \"text\": \"ClinicalTrials.gov Identifier: NCT03395197 .\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "38049622", "sentence_id": 11, "text": "ClinicalTrials.gov Identifier: NCT03395197 ."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37993604\", \"sentence_id\": 0, \"text\": \"BACKGROUND: PARP inhibitors (PARPis) are effective treatment options for patients with metastatic castration-resistant prostate cancer (mCRPC) as single agents or in combination with androgen receptor-targeted agents (ARTA).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37993604", "sentence_id": 0, "text": "BACKGROUND: PARP inhibitors (PARPis) are effective treatment options for patients with metastatic castration-resistant prostate cancer (mCRPC) as single agents or in combination with androgen receptor-targeted agents (ARTA)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37993604\", \"sentence_id\": 1, \"text\": \"However, a clinically relevant adverse effect of these agents is hematological toxicity, a typical class adverse event (AE), which can lead to treatment modifications and discontinuations.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37993604", "sentence_id": 1, "text": "However, a clinically relevant adverse effect of these agents is hematological toxicity, a typical class adverse event (AE), which can lead to treatment modifications and discontinuations."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37993604\", \"sentence_id\": 2, \"text\": \"OBJECTIVE: We aimed to analyze the risk of hematological AEs, including anemia, neutropenia, and thrombocytopenia secondary to PARPi treatments in mCRPC.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37993604", "sentence_id": 2, "text": "OBJECTIVE: We aimed to analyze the risk of hematological AEs, including anemia, neutropenia, and thrombocytopenia secondary to PARPi treatments in mCRPC."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37993604\", \"sentence_id\": 3, \"text\": \"PATIENTS AND METHODS: This systematic review and meta-analysis followed the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) statement.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37993604", "sentence_id": 3, "text": "PATIENTS AND METHODS: This systematic review and meta-analysis followed the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) statement."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37993604\", \"sentence_id\": 4, \"text\": \"We systematically searched the PubMed, EMBASE, and Cochrane databases, the American Society of Clinical Oncology (ASCO), and the European Society of Medical Oncology (ESMO) meeting abstracts for clinical trials concerning the use of PARPis, both as single agents and in combination, in patients with mCRPC.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37993604", "sentence_id": 4, "text": "We systematically searched the PubMed, EMBASE, and Cochrane databases, the American Society of Clinical Oncology (ASCO), and the European Society of Medical Oncology (ESMO) meeting abstracts for clinical trials concerning the use of PARPis, both as single agents and in combination, in patients with mCRPC."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37993604\", \"sentence_id\": 5, \"text\": \"The search deadline was 30 June, 2023.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37993604", "sentence_id": 5, "text": "The search deadline was 30 June, 2023."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37993604\", \"sentence_id\": 6, \"text\": \"We analyzed the pooled incidence of all grades of and \u2265 G3 anemia, neutropenia, and thrombocytopenia.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37993604", "sentence_id": 6, "text": "We analyzed the pooled incidence of all grades of and \u2265 G3 anemia, neutropenia, and thrombocytopenia."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37993604\", \"sentence_id\": 7, \"text\": \"We subsequently calculated risk ratios (RRs) for all grades of and \u2265 G3 AEs of PARPis versus non-PARPis from randomized clinical trials (RCTs).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37993604", "sentence_id": 7, "text": "We subsequently calculated risk ratios (RRs) for all grades of and \u2265 G3 AEs of PARPis versus non-PARPis from randomized clinical trials (RCTs)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37993604\", \"sentence_id\": 8, \"text\": \"RESULTS: Eleven phase 2/3 trials with olaparib, niraparib, rucaparib, and talazoparib administered as single agents or combined with ARTA were selected.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37993604", "sentence_id": 8, "text": "RESULTS: Eleven phase 2/3 trials with olaparib, niraparib, rucaparib, and talazoparib administered as single agents or combined with ARTA were selected."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37993604\", \"sentence_id\": 9, \"text\": \"Anemia was the most common all grades (38.6%) and \u2265 G3 AE (24.9%).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37993604", "sentence_id": 9, "text": "Anemia was the most common all grades (38.6%) and \u2265 G3 AE (24.9%)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37993604\", \"sentence_id\": 10, \"text\": \"In the analysis of relative risk, six RCTs were included.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37993604", "sentence_id": 10, "text": "In the analysis of relative risk, six RCTs were included."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37993604\", \"sentence_id\": 11, \"text\": \"The administration of PARPis significantly increased the risk of developing all grades of anemia (RR = 2.44), neutropenia (RR = 3.15), and thrombocytopenia (RR = 4.66) compared with non-PARPis.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37993604", "sentence_id": 11, "text": "The administration of PARPis significantly increased the risk of developing all grades of anemia (RR = 2.44), neutropenia (RR = 3.15), and thrombocytopenia (RR = 4.66) compared with non-PARPis."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37993604\", \"sentence_id\": 12, \"text\": \"Similarly, a significant increase in the risk of \u2265 G3 anemia (RR = 5.73) and thrombocytopenia (RR = 5.44), and a not significant increased risk of neutropenia (RR = 3.41), were detected.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37993604", "sentence_id": 12, "text": "Similarly, a significant increase in the risk of \u2265 G3 anemia (RR = 5.73) and thrombocytopenia (RR = 5.44), and a not significant increased risk of neutropenia (RR = 3.41), were detected."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37993604\", \"sentence_id\": 13, \"text\": \"CONCLUSIONS: In mCRPC, PARPis increase the risk of hematological toxicity compared with other treatments, both as single agents or combined with ARTA (high-quality evidence).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37993604", "sentence_id": 13, "text": "CONCLUSIONS: In mCRPC, PARPis increase the risk of hematological toxicity compared with other treatments, both as single agents or combined with ARTA (high-quality evidence)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37993604\", \"sentence_id\": 14, \"text\": \"Clinicians should be aware of this risk and the correct management, especially with the expected increased PARPis use in mCRPC.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37993604", "sentence_id": 14, "text": "Clinicians should be aware of this risk and the correct management, especially with the expected increased PARPis use in mCRPC."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37978072\", \"sentence_id\": 0, \"text\": \"Metastatic castration-resistant prostate cancer (mCRPC) is a\u00a0heterogeneous disease with varying clinical and molecular subtypes.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37978072", "sentence_id": 0, "text": "Metastatic castration-resistant prostate cancer (mCRPC) is a\u00a0heterogeneous disease with varying clinical and molecular subtypes."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37978072\", \"sentence_id\": 1, \"text\": \"Almost one-third of patients have abnormalities in homologous recombinant repair genes.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37978072", "sentence_id": 1, "text": "Almost one-third of patients have abnormalities in homologous recombinant repair genes."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37978072\", \"sentence_id\": 2, \"text\": \"Again, about one third of these mutations affect the BReast CAncer\u00a01 or\u00a02 (BRCA\u00a01 or BRCA\u00a02) genes, which generally render tumours receptive to treatment with poly(adenosine diphosphate-ribose) polymerase inhibitors (PARPi).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37978072", "sentence_id": 2, "text": "Again, about one third of these mutations affect the BReast CAncer\u00a01 or\u00a02 (BRCA\u00a01 or BRCA\u00a02) genes, which generally render tumours receptive to treatment with poly(adenosine diphosphate-ribose) polymerase inhibitors (PARPi)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37978072\", \"sentence_id\": 3, \"text\": \"In 2020 the PARPi olaparib was approved for the treatment of mCRPC after progression with a\u00a0new hormonal drug (androgen receptor signaling pathway inhibitors, ARPi).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37978072", "sentence_id": 3, "text": "In 2020 the PARPi olaparib was approved for the treatment of mCRPC after progression with a\u00a0new hormonal drug (androgen receptor signaling pathway inhibitors, ARPi)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37978072\", \"sentence_id\": 4, \"text\": \"In 2022 and 2023 approval of two combination therapies followed, each combining a\u00a0PARPi and an ARPi (olaparib plus abiraterone and niraparib plus abiraterone).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37978072", "sentence_id": 4, "text": "In 2022 and 2023 approval of two combination therapies followed, each combining a\u00a0PARPi and an ARPi (olaparib plus abiraterone and niraparib plus abiraterone)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37978072\", \"sentence_id\": 5, \"text\": \"The combination of talazoparib plus enzalutamide will be approved soon.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37978072", "sentence_id": 5, "text": "The combination of talazoparib plus enzalutamide will be approved soon."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37978072\", \"sentence_id\": 6, \"text\": \"This article introduces the pivotal clinical trials that led to the approval of the respective substances, reports the side effects that may occur during therapy with PARPi plus ARPi, and offers recommendations for management of these side effects.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37978072", "sentence_id": 6, "text": "This article introduces the pivotal clinical trials that led to the approval of the respective substances, reports the side effects that may occur during therapy with PARPi plus ARPi, and offers recommendations for management of these side effects."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37958444\", \"sentence_id\": 0, \"text\": \"Current common treatments for castration-resistant prostate cancer (CRPC) typically belong to one of three major categories: next-generation anti-androgen therapies (NGAT) including enzalutamide, abiraterone acetate, apalutamide, and darolutamide; taxane therapy represented by docetaxel; and PARP inhibitors (PARPi) like olaparib.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37958444", "sentence_id": 0, "text": "Current common treatments for castration-resistant prostate cancer (CRPC) typically belong to one of three major categories: next-generation anti-androgen therapies (NGAT) including enzalutamide, abiraterone acetate, apalutamide, and darolutamide; taxane therapy represented by docetaxel; and PARP inhibitors (PARPi) like olaparib."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37958444\", \"sentence_id\": 1, \"text\": \"Although these treatments have shown efficacy and have improved outcomes for many patients, some do not survive due to the emergence of therapeutic resistance.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37958444", "sentence_id": 1, "text": "Although these treatments have shown efficacy and have improved outcomes for many patients, some do not survive due to the emergence of therapeutic resistance."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37958444\", \"sentence_id\": 2, \"text\": \"The clinical landscape is further complicated by limited knowledge about how the sequence of treatments impacts the development of therapeutic cross-resistance in CRPC.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37958444", "sentence_id": 2, "text": "The clinical landscape is further complicated by limited knowledge about how the sequence of treatments impacts the development of therapeutic cross-resistance in CRPC."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37958444\", \"sentence_id\": 3, \"text\": \"We have developed multiple CRPC models of acquired therapeutic resistance cell sublines from C4-2B cells.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37958444", "sentence_id": 3, "text": "We have developed multiple CRPC models of acquired therapeutic resistance cell sublines from C4-2B cells."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37958444\", \"sentence_id\": 4, \"text\": \"These include C4-2B MDVR, C4-2B AbiR, C4-2B ApaR, C4-2B DaroR, TaxR, and 2B-olapR, which are resistant to enzalutamide, abiraterone, apalutamide, darolutamide, docetaxel, and olaparib, respectively.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37958444", "sentence_id": 4, "text": "These include C4-2B MDVR, C4-2B AbiR, C4-2B ApaR, C4-2B DaroR, TaxR, and 2B-olapR, which are resistant to enzalutamide, abiraterone, apalutamide, darolutamide, docetaxel, and olaparib, respectively."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37958444\", \"sentence_id\": 5, \"text\": \"These models are instrumental for analyzing gene expression and assessing responses to various treatments.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37958444", "sentence_id": 5, "text": "These models are instrumental for analyzing gene expression and assessing responses to various treatments."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37958444\", \"sentence_id\": 6, \"text\": \"Our findings reveal distinct cross-resistance characteristics among NGAT-resistant cell sublines.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37958444", "sentence_id": 6, "text": "Our findings reveal distinct cross-resistance characteristics among NGAT-resistant cell sublines."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37958444\", \"sentence_id\": 7, \"text\": \"Specifically, resistance to enzalutamide induces resistance to abiraterone and vice versa, while maintaining sensitivity to taxanes and olaparib.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37958444", "sentence_id": 7, "text": "Specifically, resistance to enzalutamide induces resistance to abiraterone and vice versa, while maintaining sensitivity to taxanes and olaparib."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37958444\", \"sentence_id\": 8, \"text\": \"Conversely, cells with acquired resistance to docetaxel exhibit cross-resistance to both cabazitaxel and olaparib but retain sensitivity to NGATs like enzalutamide and abiraterone.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37958444", "sentence_id": 8, "text": "Conversely, cells with acquired resistance to docetaxel exhibit cross-resistance to both cabazitaxel and olaparib but retain sensitivity to NGATs like enzalutamide and abiraterone."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37958444\", \"sentence_id\": 9, \"text\": \"OlapR cells, significantly resistant to olaparib compared to parental cells, are still responsive to NGATs and docetaxel.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37958444", "sentence_id": 9, "text": "OlapR cells, significantly resistant to olaparib compared to parental cells, are still responsive to NGATs and docetaxel."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37958444\", \"sentence_id\": 10, \"text\": \"Moreover, OlapR models display cross-resistance to other clinically relevant PARP inhibitors, including rucaparib, niraparib, and talazoparib.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37958444", "sentence_id": 10, "text": "Moreover, OlapR models display cross-resistance to other clinically relevant PARP inhibitors, including rucaparib, niraparib, and talazoparib."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37958444\", \"sentence_id\": 11, \"text\": \"RNA-sequencing analyses have revealed a complex network of altered gene expressions that influence signaling pathways, energy metabolism, and apoptotic signaling, pivotal to cancer's evolution and progression.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37958444", "sentence_id": 11, "text": "RNA-sequencing analyses have revealed a complex network of altered gene expressions that influence signaling pathways, energy metabolism, and apoptotic signaling, pivotal to cancer's evolution and progression."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37958444\", \"sentence_id\": 12, \"text\": \"The data indicate that resistance mechanisms are distinct among different drug classes.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37958444", "sentence_id": 12, "text": "The data indicate that resistance mechanisms are distinct among different drug classes."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37958444\", \"sentence_id\": 13, \"text\": \"Notably, NGAT-resistant sublines exhibited a significant downregulation of androgen-regulated genes, contrasting to the stable expression noted in olaparib and docetaxel-resistant sublines.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37958444", "sentence_id": 13, "text": "Notably, NGAT-resistant sublines exhibited a significant downregulation of androgen-regulated genes, contrasting to the stable expression noted in olaparib and docetaxel-resistant sublines."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37958444\", \"sentence_id\": 14, \"text\": \"These results may have clinical implications by showing that treatments of one class can be sequenced with those from another class, but caution should be taken when sequencing drugs of the same class.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37958444", "sentence_id": 14, "text": "These results may have clinical implications by showing that treatments of one class can be sequenced with those from another class, but caution should be taken when sequencing drugs of the same class."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37882449\", \"sentence_id\": 0, \"text\": \"Poly(ADP-ribose) polymerase inhibitors in combination with androgen-receptor signaling inhibitors are a promising therapeutic option for patients with metastatic castration-sensitive prostate cancer (mCSPC) and homologous recombination repair (HRR) gene alterations.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37882449", "sentence_id": 0, "text": "Poly(ADP-ribose) polymerase inhibitors in combination with androgen-receptor signaling inhibitors are a promising therapeutic option for patients with metastatic castration-sensitive prostate cancer (mCSPC) and homologous recombination repair (HRR) gene alterations."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37882449\", \"sentence_id\": 1, \"text\": \"Here, we describe the design and rationale of the multinational, phase III, TALAPRO-3 study comparing talazoparib plus enzalutamide versus placebo plus enzalutamide in patients with mCSPC and HRR gene alterations.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37882449", "sentence_id": 1, "text": "Here, we describe the design and rationale of the multinational, phase III, TALAPRO-3 study comparing talazoparib plus enzalutamide versus placebo plus enzalutamide in patients with mCSPC and HRR gene alterations."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37882449\", \"sentence_id\": 2, \"text\": \"The primary end point is investigator-assessed radiographic progression-free survival (rPFS) per RECIST 1.1 in soft tissue, or per PCWG3 criteria in bone.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37882449", "sentence_id": 2, "text": "The primary end point is investigator-assessed radiographic progression-free survival (rPFS) per RECIST 1.1 in soft tissue, or per PCWG3 criteria in bone."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37882449\", \"sentence_id\": 3, \"text\": \"The TALAPRO-3 study will demonstrate whether the addition of talazoparib can improve the efficacy of enzalutamide as assessed by rPFS in patients with mCSPC and HRR gene alterations undergoing androgen deprivation therapy.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37882449", "sentence_id": 3, "text": "The TALAPRO-3 study will demonstrate whether the addition of talazoparib can improve the efficacy of enzalutamide as assessed by rPFS in patients with mCSPC and HRR gene alterations undergoing androgen deprivation therapy."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37835597\", \"sentence_id\": 0, \"text\": \"BACKGROUND: Poly ADP-ribose polymerase inhibitors (PARPis) are an important class of therapeutics for metastatic castration-resistant prostate cancer (mCRPC).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37835597", "sentence_id": 0, "text": "BACKGROUND: Poly ADP-ribose polymerase inhibitors (PARPis) are an important class of therapeutics for metastatic castration-resistant prostate cancer (mCRPC)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37835597\", \"sentence_id\": 1, \"text\": \"Unlike hormone-based treatments for mCRPC, PARPis are not without drug-related hematological adverse events.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37835597", "sentence_id": 1, "text": "Unlike hormone-based treatments for mCRPC, PARPis are not without drug-related hematological adverse events."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37835597\", \"sentence_id\": 2, \"text\": \"OBJECTIVE: To review the evidence on hematological toxicities, including anemia, thrombocytopenia, and neutropenia from PARPis in prostate cancer.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37835597", "sentence_id": 2, "text": "OBJECTIVE: To review the evidence on hematological toxicities, including anemia, thrombocytopenia, and neutropenia from PARPis in prostate cancer."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37835597\", \"sentence_id\": 3, \"text\": \"STUDY METHODOLOGY: A systematic review and meta-analysis using the PRISMA guidelines was performed for phase II and III randomized controlled trials (RCTs) of PARPis in prostate cancer.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37835597", "sentence_id": 3, "text": "STUDY METHODOLOGY: A systematic review and meta-analysis using the PRISMA guidelines was performed for phase II and III randomized controlled trials (RCTs) of PARPis in prostate cancer."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37835597\", \"sentence_id\": 4, \"text\": \"PubMed, Embase, and Ovid All EBM reviews-Cochrane were queried from inception to 9 June 2023.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37835597", "sentence_id": 4, "text": "PubMed, Embase, and Ovid All EBM reviews-Cochrane were queried from inception to 9 June 2023."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37835597\", \"sentence_id\": 5, \"text\": \"The Mantel-Haenszel method was used to report risk ratios (RR) and 95% confidence intervals (CI) for all-grade and high-grade anemia, thrombocytopenia, and neutropenia toxicities.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37835597", "sentence_id": 5, "text": "The Mantel-Haenszel method was used to report risk ratios (RR) and 95% confidence intervals (CI) for all-grade and high-grade anemia, thrombocytopenia, and neutropenia toxicities."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37835597\", \"sentence_id\": 6, \"text\": \"RESULTS: The systematic review retrieved eight phase II and III RCTs; specifically, eight were included in the anemia, five in the all-grade thrombocytopenia and neutropenia, and four in the high-grade thrombocytopenia and neutropenia outcomes.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37835597", "sentence_id": 6, "text": "RESULTS: The systematic review retrieved eight phase II and III RCTs; specifically, eight were included in the anemia, five in the all-grade thrombocytopenia and neutropenia, and four in the high-grade thrombocytopenia and neutropenia outcomes."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37835597\", \"sentence_id\": 7, \"text\": \"Compared to a placebo and/or other non-PARPi treatments, PARPi use was associated with an increased risk of all-grade anemia (RR, 3.37; 95% CI, 2.37-4.79;\\nCONCLUSION: PARPis were associated with an increased risk of hematological AEs.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37835597", "sentence_id": 7, "text": "Compared to a placebo and/or other non-PARPi treatments, PARPi use was associated with an increased risk of all-grade anemia (RR, 3.37; 95% CI, 2.37-4.79;\nCONCLUSION: PARPis were associated with an increased risk of hematological AEs."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37835597\", \"sentence_id\": 8, \"text\": \"Future studies with more pooled RCTs will enhance this understanding and continue to inform patient-physician shared decision-making.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37835597", "sentence_id": 8, "text": "Future studies with more pooled RCTs will enhance this understanding and continue to inform patient-physician shared decision-making."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37835597\", \"sentence_id\": 9, \"text\": \"Future studies may also have a role in improving the current management strategies for these AEs.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37835597", "sentence_id": 9, "text": "Future studies may also have a role in improving the current management strategies for these AEs."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37722977\", \"sentence_id\": 0, \"text\": \"CONTEXT: Testing for mutations in Breast Cancer Gene 1/2 (BRCA) has emerged as a novel decision-making tool for clinicians.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37722977", "sentence_id": 0, "text": "CONTEXT: Testing for mutations in Breast Cancer Gene 1/2 (BRCA) has emerged as a novel decision-making tool for clinicians."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37722977\", \"sentence_id\": 1, \"text\": \"Patients with metastatic castration-resistant prostate cancer (mCRPC) harboring pathogenic BRCA mutations can benefit from poly (ADP-ribose) polymerase inhibitor (PARPi) and platinum treatments, whereas the impact of the mutation on sensitivity to cabazitaxel and prostate-specific membrane antigen (PSMA)-ligand therapy is currently unknown.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37722977", "sentence_id": 1, "text": "Patients with metastatic castration-resistant prostate cancer (mCRPC) harboring pathogenic BRCA mutations can benefit from poly (ADP-ribose) polymerase inhibitor (PARPi) and platinum treatments, whereas the impact of the mutation on sensitivity to cabazitaxel and prostate-specific membrane antigen (PSMA)-ligand therapy is currently unknown."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37722977\", \"sentence_id\": 2, \"text\": \"OBJECTIVE: To assess the efficacy of PARPi, platinum, cabazitaxel, and PSMA-ligand therapies in BRCA-positive mCRPC.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37722977", "sentence_id": 2, "text": "OBJECTIVE: To assess the efficacy of PARPi, platinum, cabazitaxel, and PSMA-ligand therapies in BRCA-positive mCRPC."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37722977\", \"sentence_id\": 3, \"text\": \"EVIDENCE ACQUISITION: Databases were queried in February 2022.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37722977", "sentence_id": 3, "text": "EVIDENCE ACQUISITION: Databases were queried in February 2022."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37722977\", \"sentence_id\": 4, \"text\": \"We performed data synthesis by using both proportional and individual patient data.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37722977", "sentence_id": 4, "text": "We performed data synthesis by using both proportional and individual patient data."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37722977\", \"sentence_id\": 5, \"text\": \"For prostate-specific antigen (PSA) response rate (\u226550% decrease from baseline [PSA50]) evaluation, we pooled event rates with 95% confidence intervals (CIs).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37722977", "sentence_id": 5, "text": "For prostate-specific antigen (PSA) response rate (\u226550% decrease from baseline [PSA50]) evaluation, we pooled event rates with 95% confidence intervals (CIs)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37722977\", \"sentence_id\": 6, \"text\": \"Progression-free (PFS) and overall (OS) survival analyses with individual patient data were performed with the mixed-effect Cox proportional hazard model and single-arm random-effect analysis, providing pooled medians.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37722977", "sentence_id": 6, "text": "Progression-free (PFS) and overall (OS) survival analyses with individual patient data were performed with the mixed-effect Cox proportional hazard model and single-arm random-effect analysis, providing pooled medians."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37722977\", \"sentence_id\": 7, \"text\": \"EVIDENCE SYNTHESIS: We included 23 eligible studies with 901 BRCA-positive mCRPC patients.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37722977", "sentence_id": 7, "text": "EVIDENCE SYNTHESIS: We included 23 eligible studies with 901 BRCA-positive mCRPC patients."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37722977\", \"sentence_id\": 8, \"text\": \"PSA50 response rates for PARPi and platinum were 69% (CI: 53-82%), and 74% (CI: 49-90%), respectively.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37722977", "sentence_id": 8, "text": "PSA50 response rates for PARPi and platinum were 69% (CI: 53-82%), and 74% (CI: 49-90%), respectively."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37722977\", \"sentence_id\": 9, \"text\": \"Analyses of OS data showed no difference between PARPi and platinum treatments (hazard ratio: 0.86; CI: 0.49-1.52; p\u00a0=\u00a00.6).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37722977", "sentence_id": 9, "text": "Analyses of OS data showed no difference between PARPi and platinum treatments (hazard ratio: 0.86; CI: 0.49-1.52; p\u00a0=\u00a00.6)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37722977\", \"sentence_id\": 10, \"text\": \"The single-arm OS and PFS analyses revealed similarities among different PARPis; pooled PFS and OS medians were 9.7 mo (CI: 8.1-12.5) and 17.4 mo (CI: 12.7-20.1), respectively.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37722977", "sentence_id": 10, "text": "The single-arm OS and PFS analyses revealed similarities among different PARPis; pooled PFS and OS medians were 9.7 mo (CI: 8.1-12.5) and 17.4 mo (CI: 12.7-20.1), respectively."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37722977\", \"sentence_id\": 11, \"text\": \"CONCLUSIONS: Our data revealed that different PARPis were similarly effective in terms of PFS and OS.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37722977", "sentence_id": 11, "text": "CONCLUSIONS: Our data revealed that different PARPis were similarly effective in terms of PFS and OS."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37722977\", \"sentence_id\": 12, \"text\": \"Moreover, we found that PARPi and platinum therapy were comparable in terms of PSA50 response rate and OS, highlighting that platinum is a valid treatment option for BRCA-positive mCRPC patients.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37722977", "sentence_id": 12, "text": "Moreover, we found that PARPi and platinum therapy were comparable in terms of PSA50 response rate and OS, highlighting that platinum is a valid treatment option for BRCA-positive mCRPC patients."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37722977\", \"sentence_id\": 13, \"text\": \"However, prospective interventional studies comparing these agents are essential to provide a higher level of evidence.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37722977", "sentence_id": 13, "text": "However, prospective interventional studies comparing these agents are essential to provide a higher level of evidence."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37722977\", \"sentence_id\": 14, \"text\": \"PATIENT SUMMARY: In this report, we found that different poly (ADP-ribose) polymerase inhibitors had similar efficacy, and platinum was a valid treatment option in BRCA-positive metastatic castration-resistant prostate cancer patients.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37722977", "sentence_id": 14, "text": "PATIENT SUMMARY: In this report, we found that different poly (ADP-ribose) polymerase inhibitors had similar efficacy, and platinum was a valid treatment option in BRCA-positive metastatic castration-resistant prostate cancer patients."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37689306\", \"sentence_id\": 0, \"text\": \"PARP inhibitors (PARPi) are transforming the current treatment landscape of metastatic castration-resistant prostate cancer.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37689306", "sentence_id": 0, "text": "PARP inhibitors (PARPi) are transforming the current treatment landscape of metastatic castration-resistant prostate cancer."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37689306\", \"sentence_id\": 1, \"text\": \"By reanalysing published data on olaparib, talazoparib, rucaparib and niraparib, we provide a concise overview of responses by molecular subgroup.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37689306", "sentence_id": 1, "text": "By reanalysing published data on olaparib, talazoparib, rucaparib and niraparib, we provide a concise overview of responses by molecular subgroup."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37689306\", \"sentence_id\": 2, \"text\": \"As monotherapy, all PARPi showed comparable efficacy and the same hierarchy in responsiveness: patients with tumours harbouring aberrations in BRCA1 or BRCA2 (BRCAm) evidently demonstrate superior responses when compared to aberrations in other homologous recombination repair (HRR) related genes.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37689306", "sentence_id": 2, "text": "As monotherapy, all PARPi showed comparable efficacy and the same hierarchy in responsiveness: patients with tumours harbouring aberrations in BRCA1 or BRCA2 (BRCAm) evidently demonstrate superior responses when compared to aberrations in other homologous recombination repair (HRR) related genes."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37689306\", \"sentence_id\": 3, \"text\": \"Niraparib seems to cause more grade \u22653 adverse events in comparison to other PARPi.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37689306", "sentence_id": 3, "text": "Niraparib seems to cause more grade \u22653 adverse events in comparison to other PARPi."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37689306\", \"sentence_id\": 4, \"text\": \"PARPi have also been combined with androgen-receptor signalling inhibitors (ARSI) for both patients with tumours harbouring aberrations in HRR genes (HRRm), and molecularly unselected patients.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37689306", "sentence_id": 4, "text": "PARPi have also been combined with androgen-receptor signalling inhibitors (ARSI) for both patients with tumours harbouring aberrations in HRR genes (HRRm), and molecularly unselected patients."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37689306\", \"sentence_id\": 5, \"text\": \"Compared to wildtype, BRCAm patients responded best, followed by HRRm.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37689306", "sentence_id": 5, "text": "Compared to wildtype, BRCAm patients responded best, followed by HRRm."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37689306\", \"sentence_id\": 6, \"text\": \"Olaparib-abiraterone, niraparib-abiraterone, and talazoparib-enzalutamide all prolonged progression-free survival compared to an ARSI alone in HRRm patients.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37689306", "sentence_id": 6, "text": "Olaparib-abiraterone, niraparib-abiraterone, and talazoparib-enzalutamide all prolonged progression-free survival compared to an ARSI alone in HRRm patients."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37689306\", \"sentence_id\": 7, \"text\": \"In the non-HRRm subgroup, only olaparib-abiraterone and talazoparib-enzalutamide were effective.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37689306", "sentence_id": 7, "text": "In the non-HRRm subgroup, only olaparib-abiraterone and talazoparib-enzalutamide were effective."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37689306\", \"sentence_id\": 8, \"text\": \"Results for the combination of rucaparib with enzalutamide are yet to be reported.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37689306", "sentence_id": 8, "text": "Results for the combination of rucaparib with enzalutamide are yet to be reported."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37689306\", \"sentence_id\": 9, \"text\": \"The rate of grade \u22653 adverse events for the combination regimens is 10-30% higher when compared to an ARSI alone.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37689306", "sentence_id": 9, "text": "The rate of grade \u22653 adverse events for the combination regimens is 10-30% higher when compared to an ARSI alone."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37689306\", \"sentence_id\": 10, \"text\": \"Given the limited efficacy in unselected patients, these PARPi-ARSI combinations may be best reserved for selected patients.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37689306", "sentence_id": 10, "text": "Given the limited efficacy in unselected patients, these PARPi-ARSI combinations may be best reserved for selected patients."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37605459\", \"sentence_id\": 0, \"text\": \"Poly(ADP-ribose) polymerase inhibitors (PARPi) have significant efficacy in treating BRCA-deficient cancers, although resistance development remains an unsolved challenge.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37605459", "sentence_id": 0, "text": "Poly(ADP-ribose) polymerase inhibitors (PARPi) have significant efficacy in treating BRCA-deficient cancers, although resistance development remains an unsolved challenge."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37605459\", \"sentence_id\": 1, \"text\": \"Herein, a series of phthalazin-1(2\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37605459", "sentence_id": 1, "text": "Herein, a series of phthalazin-1(2"}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37574390\", \"sentence_id\": 0, \"text\": \"CONTEXT: PARP inhibitors (PARPi) are established treatments for metastatic castration-resistant prostate cancer (mCRPC) with homologous recombination repair (HRR) deficiency after androgen receptor signalling inhibitor (ARSI) failure.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37574390", "sentence_id": 0, "text": "CONTEXT: PARP inhibitors (PARPi) are established treatments for metastatic castration-resistant prostate cancer (mCRPC) with homologous recombination repair (HRR) deficiency after androgen receptor signalling inhibitor (ARSI) failure."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37574390\", \"sentence_id\": 1, \"text\": \"New PARPi\u00a0+\u00a0ARSI combinations have been tested in all comers, although their clinical relevance in HRR-proficient tumours remains uncertain.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37574390", "sentence_id": 1, "text": "New PARPi\u00a0+\u00a0ARSI combinations have been tested in all comers, although their clinical relevance in HRR-proficient tumours remains uncertain."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37574390\", \"sentence_id\": 2, \"text\": \"OBJECTIVE: To quantitatively synthesise evidence from randomised trials assessing the efficacy and safety of PARPi\u00a0+\u00a0ARSI combinations for first-line treatment of mCRPC.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37574390", "sentence_id": 2, "text": "OBJECTIVE: To quantitatively synthesise evidence from randomised trials assessing the efficacy and safety of PARPi\u00a0+\u00a0ARSI combinations for first-line treatment of mCRPC."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37574390\", \"sentence_id\": 3, \"text\": \"EVIDENCE ACQUISITION: We searched the PubMed, EMBASE, SCOPUS, and Cochrane Library databases up to February 28, 2023.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37574390", "sentence_id": 3, "text": "EVIDENCE ACQUISITION: We searched the PubMed, EMBASE, SCOPUS, and Cochrane Library databases up to February 28, 2023."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37574390\", \"sentence_id\": 4, \"text\": \"Randomised controlled trials (RCTs) comparing PARPi\u00a0+\u00a0ARSI versus placebo\u00a0+\u00a0ARSI for first-line treatment of mCRPC were eligible.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37574390", "sentence_id": 4, "text": "Randomised controlled trials (RCTs) comparing PARPi\u00a0+\u00a0ARSI versus placebo\u00a0+\u00a0ARSI for first-line treatment of mCRPC were eligible."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37574390\", \"sentence_id\": 5, \"text\": \"Two reviewers independently performed screening and data extraction and assessed the risk of bias, while a third reviewer evaluated the eligibility criteria.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37574390", "sentence_id": 5, "text": "Two reviewers independently performed screening and data extraction and assessed the risk of bias, while a third reviewer evaluated the eligibility criteria."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37574390\", \"sentence_id\": 6, \"text\": \"EVIDENCE SYNTHESIS: Overall, three phase 3 RCTs were included in the systematic review: PROPEL, MAGNITUDE, and TALAPRO-2.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37574390", "sentence_id": 6, "text": "EVIDENCE SYNTHESIS: Overall, three phase 3 RCTs were included in the systematic review: PROPEL, MAGNITUDE, and TALAPRO-2."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37574390\", \"sentence_id\": 7, \"text\": \"A total of 2601 patients with mCRPC were enrolled.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37574390", "sentence_id": 7, "text": "A total of 2601 patients with mCRPC were enrolled."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37574390\", \"sentence_id\": 8, \"text\": \"Two of these trials (PROPEL and TALAPRO-2) assessed the radiographic progression-free survival benefit of PARPi\u00a0+\u00a0ARSI for first-line treatment of mCRPC, independent of HRR status.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37574390", "sentence_id": 8, "text": "Two of these trials (PROPEL and TALAPRO-2) assessed the radiographic progression-free survival benefit of PARPi\u00a0+\u00a0ARSI for first-line treatment of mCRPC, independent of HRR status."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37574390\", \"sentence_id\": 9, \"text\": \"The pooled hazard ratio was 0.62 (95% confidence interval 0.53-0.72).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37574390", "sentence_id": 9, "text": "The pooled hazard ratio was 0.62 (95% confidence interval 0.53-0.72)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37574390\", \"sentence_id\": 10, \"text\": \"The pooled hazard ratio for overall survival was 0.84 (95% confidence interval 0.72-0.98), indicating a 16% reduction in the risk of death among patients who received the combination.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37574390", "sentence_id": 10, "text": "The pooled hazard ratio for overall survival was 0.84 (95% confidence interval 0.72-0.98), indicating a 16% reduction in the risk of death among patients who received the combination."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37574390\", \"sentence_id\": 11, \"text\": \"CONCLUSIONS: Results from this meta-analysis support the use of ARSI\u00a0+\u00a0PARPi combinations in biomarker-unselected mCRPC.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37574390", "sentence_id": 11, "text": "CONCLUSIONS: Results from this meta-analysis support the use of ARSI\u00a0+\u00a0PARPi combinations in biomarker-unselected mCRPC."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37574390\", \"sentence_id\": 12, \"text\": \"However, such combinations might be less clinically relevant in HRR-proficient cancers, especially considering the change in treatment landscape for mCRPC.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37574390", "sentence_id": 12, "text": "However, such combinations might be less clinically relevant in HRR-proficient cancers, especially considering the change in treatment landscape for mCRPC."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37574390\", \"sentence_id\": 13, \"text\": \"PATIENT SUMMARY: We looked at outcomes from trials testing combinations of two classes of drugs (PARP inhibitors and ARSI) in advanced prostate cancer.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37574390", "sentence_id": 13, "text": "PATIENT SUMMARY: We looked at outcomes from trials testing combinations of two classes of drugs (PARP inhibitors and ARSI) in advanced prostate cancer."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37574390\", \"sentence_id\": 14, \"text\": \"We found that these combinations seem to work regardless of gene mutations identified as biomarkers of response to PARP inhibitors when used on their own.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37574390", "sentence_id": 14, "text": "We found that these combinations seem to work regardless of gene mutations identified as biomarkers of response to PARP inhibitors when used on their own."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37485452\", \"sentence_id\": 0, \"text\": \"Glioblastoma (GBM), the most prevalent brain tumor, is one of the least treatable malignancies due to its propensity for intracranial spread, high proliferative potential, and innate resistance to radiation and chemotherapy.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37485452", "sentence_id": 0, "text": "Glioblastoma (GBM), the most prevalent brain tumor, is one of the least treatable malignancies due to its propensity for intracranial spread, high proliferative potential, and innate resistance to radiation and chemotherapy."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37485452\", \"sentence_id\": 1, \"text\": \"Current GBM therapy is limited due to unfavorable, non-specific therapeutic effects in healthy cells and the difficulty of small molecules to penetrate the blood brain barrier (BBB) and reach the tumor microenvironment.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37485452", "sentence_id": 1, "text": "Current GBM therapy is limited due to unfavorable, non-specific therapeutic effects in healthy cells and the difficulty of small molecules to penetrate the blood brain barrier (BBB) and reach the tumor microenvironment."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37485452\", \"sentence_id\": 2, \"text\": \"Adding PARP-1 inhibitors inhibit DNA repair enzymes thereby increasing the cytotoxicity of anticancer agents.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37485452", "sentence_id": 2, "text": "Adding PARP-1 inhibitors inhibit DNA repair enzymes thereby increasing the cytotoxicity of anticancer agents."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37485452\", \"sentence_id\": 3, \"text\": \"Hence, we aimed to discover potential naturally occurring PARP-1 inhibitors that can be utilized in the treatment of glioma by using multiple in silico tools like molecular docking, absorption, distribution, metabolism, and excretion (ADME) profile, pharmacophore modeling, and molecular dynamic (MD) simulations.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37485452", "sentence_id": 3, "text": "Hence, we aimed to discover potential naturally occurring PARP-1 inhibitors that can be utilized in the treatment of glioma by using multiple in silico tools like molecular docking, absorption, distribution, metabolism, and excretion (ADME) profile, pharmacophore modeling, and molecular dynamic (MD) simulations."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37485452\", \"sentence_id\": 4, \"text\": \"Among 43 phytocompounds we screened, two of them (Ellagic acid and Naringin) were discovered to be bound to the catalytic site of PARP-1 with an affinity more remarkable than commercially available PARP-1 inhibitors (Talazoparib, Niraparib, and Rucaparib) except Olaparib.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37485452", "sentence_id": 4, "text": "Among 43 phytocompounds we screened, two of them (Ellagic acid and Naringin) were discovered to be bound to the catalytic site of PARP-1 with an affinity more remarkable than commercially available PARP-1 inhibitors (Talazoparib, Niraparib, and Rucaparib) except Olaparib."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37485452\", \"sentence_id\": 5, \"text\": \"The molecular interactions were analyzed, and data shows that bound entity attained a conserved domain via hydrogen bond interactions, polar interactions, and \u03c0-\u03c0 stacking.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37485452", "sentence_id": 5, "text": "The molecular interactions were analyzed, and data shows that bound entity attained a conserved domain via hydrogen bond interactions, polar interactions, and \u03c0-\u03c0 stacking."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37485452\", \"sentence_id\": 6, \"text\": \"Pharmacophore modeling studies showed electronic and steric features of ligands responsible for supramolecular interaction with PARP-1.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37485452", "sentence_id": 6, "text": "Pharmacophore modeling studies showed electronic and steric features of ligands responsible for supramolecular interaction with PARP-1."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37485452\", \"sentence_id\": 7, \"text\": \"ADME properties were studied, to assess drug-likeness, hydrophilic nature, hydrophobicity, brain permeability, and oral bioavailability of the natural PARP-1 inhibitors.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37485452", "sentence_id": 7, "text": "ADME properties were studied, to assess drug-likeness, hydrophilic nature, hydrophobicity, brain permeability, and oral bioavailability of the natural PARP-1 inhibitors."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37485452\", \"sentence_id\": 8, \"text\": \"The simulation study demonstrated the development of a stable complex between Naringin, Ellagic acid, and PARP-1 protein.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37485452", "sentence_id": 8, "text": "The simulation study demonstrated the development of a stable complex between Naringin, Ellagic acid, and PARP-1 protein."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37485452\", \"sentence_id\": 9, \"text\": \"Moreover, cell culture studies and animal investigations are essential to determine pharmacokinetics and pharmacodynamics.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37485452", "sentence_id": 9, "text": "Moreover, cell culture studies and animal investigations are essential to determine pharmacokinetics and pharmacodynamics."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37441599\", \"sentence_id\": 0, \"text\": \"Poly ADP ribose polymerase (PARP) inhibitors are mainly used in treating BRCA-mutant cancers, and their application in novel therapies to expand their benefit is of interest in personalized medicine.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37441599", "sentence_id": 0, "text": "Poly ADP ribose polymerase (PARP) inhibitors are mainly used in treating BRCA-mutant cancers, and their application in novel therapies to expand their benefit is of interest in personalized medicine."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37441599\", \"sentence_id\": 1, \"text\": \"A recent report showed that pharmacological targeting of PARP increases the sensitivity of cancer cells to EGFR inhibition, but the therapeutic value of this combination has not been fully determined.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37441599", "sentence_id": 1, "text": "A recent report showed that pharmacological targeting of PARP increases the sensitivity of cancer cells to EGFR inhibition, but the therapeutic value of this combination has not been fully determined."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37441599\", \"sentence_id\": 2, \"text\": \"We propose a strategy of combining PARP inhibitors with bispecific antibodies that target both EGFR and Notch signalling, highlighting the difficulties posed by deregulation of Notch signalling and the enrichment of cancer stem cells (CSCs) during therapy.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37441599", "sentence_id": 2, "text": "We propose a strategy of combining PARP inhibitors with bispecific antibodies that target both EGFR and Notch signalling, highlighting the difficulties posed by deregulation of Notch signalling and the enrichment of cancer stem cells (CSCs) during therapy."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37441599\", \"sentence_id\": 3, \"text\": \"In the present study, we showed that although PARP plus EGFR targeting led to more penetrant and durable responses in the non-small cell lung cancer (NSCLC) PDX model, it influenced the enrichment of stem-like cells and their relative proportion.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37441599", "sentence_id": 3, "text": "In the present study, we showed that although PARP plus EGFR targeting led to more penetrant and durable responses in the non-small cell lung cancer (NSCLC) PDX model, it influenced the enrichment of stem-like cells and their relative proportion."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37441599\", \"sentence_id\": 4, \"text\": \"Stem-like cells were significantly inhibited in vitro and in vivo by EGFR/Notch-targeting bispecific antibodies.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37441599", "sentence_id": 4, "text": "Stem-like cells were significantly inhibited in vitro and in vivo by EGFR/Notch-targeting bispecific antibodies."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37441599\", \"sentence_id\": 5, \"text\": \"These bispecific antibodies were effective in PDX models and showed promise in cell line models of NSCLC, where they delayed the development of acquired resistance to cetuximab and talazoparib.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37441599", "sentence_id": 5, "text": "These bispecific antibodies were effective in PDX models and showed promise in cell line models of NSCLC, where they delayed the development of acquired resistance to cetuximab and talazoparib."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37441599\", \"sentence_id\": 6, \"text\": \"Moreover, combining EGFR/Notch-targeting bispecific antibodies and talazoparib had a more substantial antitumour effect than the combination of talazoparib and cetuximab in a broad spectrum of epithelial tumours.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37441599", "sentence_id": 6, "text": "Moreover, combining EGFR/Notch-targeting bispecific antibodies and talazoparib had a more substantial antitumour effect than the combination of talazoparib and cetuximab in a broad spectrum of epithelial tumours."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37441599\", \"sentence_id\": 7, \"text\": \"EGFR/Notch bispecific antibodies decrease the subpopulation of stem-like cells, reduce the frequency of tumour-initiating cells, and downregulate mesenchymal gene expression.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37441599", "sentence_id": 7, "text": "EGFR/Notch bispecific antibodies decrease the subpopulation of stem-like cells, reduce the frequency of tumour-initiating cells, and downregulate mesenchymal gene expression."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37441599\", \"sentence_id\": 8, \"text\": \"These findings suggest that combining EGFR and Notch signalling blockade can potentially increase the response to PARP blockade.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37441599", "sentence_id": 8, "text": "These findings suggest that combining EGFR and Notch signalling blockade can potentially increase the response to PARP blockade."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37392863\", \"sentence_id\": 0, \"text\": \"Poly (ADPRibose) Polymerase inhibitor (PARPi) are clinically approved for the treatment of BRCA-mutated hereditary breast and ovarian cancers with homologous recombination (HR) deficiency, based on synthetic lethality concept.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37392863", "sentence_id": 0, "text": "Poly (ADPRibose) Polymerase inhibitor (PARPi) are clinically approved for the treatment of BRCA-mutated hereditary breast and ovarian cancers with homologous recombination (HR) deficiency, based on synthetic lethality concept."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37392863\", \"sentence_id\": 1, \"text\": \"However, \u223c90% of breast cancers are BRCA-wild type; they repair PARPi mediated damage through HR, leading to intrinsic de novo resistance.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37392863", "sentence_id": 1, "text": "However, \u223c90% of breast cancers are BRCA-wild type; they repair PARPi mediated damage through HR, leading to intrinsic de novo resistance."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37392863\", \"sentence_id\": 2, \"text\": \"Hence, there is an unmet need of exploring novel targets in HR-proficient aggressive breast cancers for PARPi treatment.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37392863", "sentence_id": 2, "text": "Hence, there is an unmet need of exploring novel targets in HR-proficient aggressive breast cancers for PARPi treatment."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37392863\", \"sentence_id\": 3, \"text\": \"RECQL5 physically interacts and disrupts RAD51 from pre-synaptic filaments, aiding HR resolution, replication fork protection and preventing illegitimate recombination.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37392863", "sentence_id": 3, "text": "RECQL5 physically interacts and disrupts RAD51 from pre-synaptic filaments, aiding HR resolution, replication fork protection and preventing illegitimate recombination."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37392863\", \"sentence_id\": 4, \"text\": \"In the current investigation, we show that targeted inhibition of HR by stabilization of RAD51-RECQL5 complex by a pharmacological inhibitor of RECQL5 (4a; 1,3,4-oxadiazole derivative) in the presence of PARPi [talazoparib (BMN673)] leads to abolition of functional HR with uncontrolled activation of NHEJ repair.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37392863", "sentence_id": 4, "text": "In the current investigation, we show that targeted inhibition of HR by stabilization of RAD51-RECQL5 complex by a pharmacological inhibitor of RECQL5 (4a; 1,3,4-oxadiazole derivative) in the presence of PARPi [talazoparib (BMN673)] leads to abolition of functional HR with uncontrolled activation of NHEJ repair."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37392863\", \"sentence_id\": 5, \"text\": \"This was assessed by GFP based NHEJ reporter assay, KU80 recruitment and in vitro NHEJ based plasmid ligation assay.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37392863", "sentence_id": 5, "text": "This was assessed by GFP based NHEJ reporter assay, KU80 recruitment and in vitro NHEJ based plasmid ligation assay."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37392863\", \"sentence_id\": 6, \"text\": \"Concomitant treatment with talazoparib and 4a generates copious amounts of replication stress, prolonged cell cycle arrest, extensive double strand breaks (DSBs) and mitotic catastrophe, leading to sensitization of HR-proficient breast cancers.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37392863", "sentence_id": 6, "text": "Concomitant treatment with talazoparib and 4a generates copious amounts of replication stress, prolonged cell cycle arrest, extensive double strand breaks (DSBs) and mitotic catastrophe, leading to sensitization of HR-proficient breast cancers."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37392863\", \"sentence_id\": 7, \"text\": \"Suppression of NHEJ activity abolishes 4a-mediated sensitization of breast cancers to PARPi treatment.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37392863", "sentence_id": 7, "text": "Suppression of NHEJ activity abolishes 4a-mediated sensitization of breast cancers to PARPi treatment."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37392863\", \"sentence_id\": 8, \"text\": \"Imperatively, 4a was ineffective against normal mammary epithelial cells, which expresses low RECQL5 vis-\u00e0-vis breast cancer cells.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37392863", "sentence_id": 8, "text": "Imperatively, 4a was ineffective against normal mammary epithelial cells, which expresses low RECQL5 vis-\u00e0-vis breast cancer cells."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37392863\", \"sentence_id\": 9, \"text\": \"Moreover, functional inhibition of RECQL5 suppresses metastatic potential of breast cancer cells in response to PARPi.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37392863", "sentence_id": 9, "text": "Moreover, functional inhibition of RECQL5 suppresses metastatic potential of breast cancer cells in response to PARPi."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37392863\", \"sentence_id\": 10, \"text\": \"Together, we identified RECQL5 as a novel pharmacological target for expanding PARPi based treatment horizon for HR-proficient cancers.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37392863", "sentence_id": 10, "text": "Together, we identified RECQL5 as a novel pharmacological target for expanding PARPi based treatment horizon for HR-proficient cancers."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37372475\", \"sentence_id\": 0, \"text\": \"The inhibition of histone deacetylases (HDACs) holds promise as a potential anti-cancer therapy as histone and non-histone protein acetylation is frequently disrupted in cancer, leading to cancer initiation and progression.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37372475", "sentence_id": 0, "text": "The inhibition of histone deacetylases (HDACs) holds promise as a potential anti-cancer therapy as histone and non-histone protein acetylation is frequently disrupted in cancer, leading to cancer initiation and progression."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37372475\", \"sentence_id\": 1, \"text\": \"Additionally, the use of a histone deacetylase inhibitor (HDACi) such as the class I HDAC inhibitor-valproic acid (VPA) has been shown to enhance the effectiveness of DNA-damaging factors, such as cisplatin or radiation.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37372475", "sentence_id": 1, "text": "Additionally, the use of a histone deacetylase inhibitor (HDACi) such as the class I HDAC inhibitor-valproic acid (VPA) has been shown to enhance the effectiveness of DNA-damaging factors, such as cisplatin or radiation."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37372475\", \"sentence_id\": 2, \"text\": \"In this study, we found that the use of VPA in combination with talazoparib (BMN-673-PARP1 inhibitor-PARPi) and/or Dacarbazine (DTIC-alkylating agent) resulted in an increased rate of DNA double strand breaks (DSBs) and reduced survival (while not affecting primary melanocytes) and the proliferation of melanoma cells.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37372475", "sentence_id": 2, "text": "In this study, we found that the use of VPA in combination with talazoparib (BMN-673-PARP1 inhibitor-PARPi) and/or Dacarbazine (DTIC-alkylating agent) resulted in an increased rate of DNA double strand breaks (DSBs) and reduced survival (while not affecting primary melanocytes) and the proliferation of melanoma cells."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37372475\", \"sentence_id\": 3, \"text\": \"Furthermore, the pharmacological inhibition of class I HDACs sensitizes melanoma cells to apoptosis following exposure to DTIC and BMN-673.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37372475", "sentence_id": 3, "text": "Furthermore, the pharmacological inhibition of class I HDACs sensitizes melanoma cells to apoptosis following exposure to DTIC and BMN-673."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37372475\", \"sentence_id\": 4, \"text\": \"In addition, the inhibition of HDACs causes the sensitization of melanoma cells to DTIV and BMN-673 in melanoma xenografts in vivo.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37372475", "sentence_id": 4, "text": "In addition, the inhibition of HDACs causes the sensitization of melanoma cells to DTIV and BMN-673 in melanoma xenografts in vivo."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37372475\", \"sentence_id\": 5, \"text\": \"At the mRNA and protein level, the histone deacetylase inhibitor downregulated RAD51 and FANCD2.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37372475", "sentence_id": 5, "text": "At the mRNA and protein level, the histone deacetylase inhibitor downregulated RAD51 and FANCD2."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37372475\", \"sentence_id\": 6, \"text\": \"This study aims to demonstrate that combining an HDACi, alkylating agent and PARPi could potentially enhance the treatment of melanoma, which is commonly recognized as being among the most aggressive malignant tumors.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37372475", "sentence_id": 6, "text": "This study aims to demonstrate that combining an HDACi, alkylating agent and PARPi could potentially enhance the treatment of melanoma, which is commonly recognized as being among the most aggressive malignant tumors."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37372475\", \"sentence_id\": 7, \"text\": \"The findings presented here point to a scenario in which HDACs, via enhancing the HR-dependent repair of DSBs created during the processing of DNA lesions, are essential nodes in the resistance of malignant melanoma cells to methylating agent-based therapies.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37372475", "sentence_id": 7, "text": "The findings presented here point to a scenario in which HDACs, via enhancing the HR-dependent repair of DSBs created during the processing of DNA lesions, are essential nodes in the resistance of malignant melanoma cells to methylating agent-based therapies."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37304006\", \"sentence_id\": 0, \"text\": \"PARP inhibitors have proven to be effective in conjunction with conventional therapeutics in the treatment of various solid as well as hematologic malignancies, particularly when the tumors are deficient in DNA repair pathways.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37304006", "sentence_id": 0, "text": "PARP inhibitors have proven to be effective in conjunction with conventional therapeutics in the treatment of various solid as well as hematologic malignancies, particularly when the tumors are deficient in DNA repair pathways."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37304006\", \"sentence_id\": 1, \"text\": \"However, as the case with other chemotherapeutic agents, their effectiveness is often compromised by the development of resistance.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37304006", "sentence_id": 1, "text": "However, as the case with other chemotherapeutic agents, their effectiveness is often compromised by the development of resistance."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37304006\", \"sentence_id\": 2, \"text\": \"PARP inhibitors have consistently been reported to promote autophagy, a process that maintains cellular homeostasis and acts as an energy source by the degradation and reutilization of damaged subcellular organelles and proteins.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37304006", "sentence_id": 2, "text": "PARP inhibitors have consistently been reported to promote autophagy, a process that maintains cellular homeostasis and acts as an energy source by the degradation and reutilization of damaged subcellular organelles and proteins."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37304006\", \"sentence_id\": 3, \"text\": \"Autophagy can exhibit different functional properties, the most prominent being cytoprotective.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37304006", "sentence_id": 3, "text": "Autophagy can exhibit different functional properties, the most prominent being cytoprotective."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37304006\", \"sentence_id\": 4, \"text\": \"In addition, both cytotoxic and non-protective functions forms have also been identified.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37304006", "sentence_id": 4, "text": "In addition, both cytotoxic and non-protective functions forms have also been identified."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37304006\", \"sentence_id\": 5, \"text\": \"In this review, we explore the available literature regarding the different roles of autophagy in response to clinically-used PARP inhibitors, highlighting the possibility of targeting autophagy as an adjuvant therapy to potentially increase the effectiveness of PARP inhibition and to overcome the development of resistance.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37304006", "sentence_id": 5, "text": "In this review, we explore the available literature regarding the different roles of autophagy in response to clinically-used PARP inhibitors, highlighting the possibility of targeting autophagy as an adjuvant therapy to potentially increase the effectiveness of PARP inhibition and to overcome the development of resistance."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37285865\", \"sentence_id\": 0, \"text\": \"BACKGROUND: Co-inhibition of poly(ADP-ribose) polymerase (PARP) and androgen receptor activity might result in antitumour efficacy irrespective of alterations in DNA damage repair genes involved in homologous recombination repair (HRR).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37285865", "sentence_id": 0, "text": "BACKGROUND: Co-inhibition of poly(ADP-ribose) polymerase (PARP) and androgen receptor activity might result in antitumour efficacy irrespective of alterations in DNA damage repair genes involved in homologous recombination repair (HRR)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37285865\", \"sentence_id\": 1, \"text\": \"We aimed to compare the efficacy and safety of talazoparib (a PARP inhibitor) plus enzalutamide (an androgen receptor blocker) versus enzalutamide alone in patients with metastatic castration-resistant prostate cancer (mCRPC).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37285865", "sentence_id": 1, "text": "We aimed to compare the efficacy and safety of talazoparib (a PARP inhibitor) plus enzalutamide (an androgen receptor blocker) versus enzalutamide alone in patients with metastatic castration-resistant prostate cancer (mCRPC)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37285865\", \"sentence_id\": 2, \"text\": \"METHODS: TALAPRO-2 is a randomised, double-blind, phase 3 trial of talazoparib plus enzalutamide versus placebo plus enzalutamide as first-line therapy in men (age \u226518 years [\u226520 years in Japan]) with asymptomatic or mildly symptomatic mCRPC receiving ongoing androgen deprivation therapy.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37285865", "sentence_id": 2, "text": "METHODS: TALAPRO-2 is a randomised, double-blind, phase 3 trial of talazoparib plus enzalutamide versus placebo plus enzalutamide as first-line therapy in men (age \u226518 years [\u226520 years in Japan]) with asymptomatic or mildly symptomatic mCRPC receiving ongoing androgen deprivation therapy."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37285865\", \"sentence_id\": 3, \"text\": \"Patients were enrolled from 223 hospitals, cancer centres, and medical centres in 26 countries in North America, Europe, Israel, South America, South Africa, and the Asia-Pacific region.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37285865", "sentence_id": 3, "text": "Patients were enrolled from 223 hospitals, cancer centres, and medical centres in 26 countries in North America, Europe, Israel, South America, South Africa, and the Asia-Pacific region."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37285865\", \"sentence_id\": 4, \"text\": \"Patients were prospectively assessed for HRR gene alterations in tumour tissue and randomly assigned (1:1) to talazoparib 0\u00b75 mg or placebo, plus enzalutamide 160 mg, administered orally once daily.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37285865", "sentence_id": 4, "text": "Patients were prospectively assessed for HRR gene alterations in tumour tissue and randomly assigned (1:1) to talazoparib 0\u00b75 mg or placebo, plus enzalutamide 160 mg, administered orally once daily."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37285865\", \"sentence_id\": 5, \"text\": \"Randomisation was stratified by HRR gene alteration status (deficient vs non-deficient or unknown) and previous treatment with life-prolonging therapy (docetaxel or abiraterone, or both: yes vs no) in the castration-sensitive setting.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37285865", "sentence_id": 5, "text": "Randomisation was stratified by HRR gene alteration status (deficient vs non-deficient or unknown) and previous treatment with life-prolonging therapy (docetaxel or abiraterone, or both: yes vs no) in the castration-sensitive setting."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37285865\", \"sentence_id\": 6, \"text\": \"The sponsor, patients, and investigators were masked to talazoparib or placebo, while enzalutamide was open-label.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37285865", "sentence_id": 6, "text": "The sponsor, patients, and investigators were masked to talazoparib or placebo, while enzalutamide was open-label."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37285865\", \"sentence_id\": 7, \"text\": \"The primary endpoint was radiographic progression-free survival (rPFS) by blinded independent central review, evaluated in the intention-to-treat population.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37285865", "sentence_id": 7, "text": "The primary endpoint was radiographic progression-free survival (rPFS) by blinded independent central review, evaluated in the intention-to-treat population."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37285865\", \"sentence_id\": 8, \"text\": \"Safety was evaluated in all patients who received at least one dose of study drug.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37285865", "sentence_id": 8, "text": "Safety was evaluated in all patients who received at least one dose of study drug."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37285865\", \"sentence_id\": 9, \"text\": \"This study is registered with ClinicalTrials.gov (NCT03395197) and is ongoing.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37285865", "sentence_id": 9, "text": "This study is registered with ClinicalTrials.gov (NCT03395197) and is ongoing."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37285865\", \"sentence_id\": 10, \"text\": \"FINDINGS: Between Jan 7, 2019, and Sept 17, 2020, 805 patients were enrolled and randomly assigned (402 to the talazoparib group and 403 to the placebo group).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37285865", "sentence_id": 10, "text": "FINDINGS: Between Jan 7, 2019, and Sept 17, 2020, 805 patients were enrolled and randomly assigned (402 to the talazoparib group and 403 to the placebo group)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37285865\", \"sentence_id\": 11, \"text\": \"Median follow-up for rPFS was 24\u00b79 months (IQR 21\u00b79-30\u00b72) for the talazoparib group and 24\u00b76 months (14\u00b74-30\u00b72) for the placebo group.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37285865", "sentence_id": 11, "text": "Median follow-up for rPFS was 24\u00b79 months (IQR 21\u00b79-30\u00b72) for the talazoparib group and 24\u00b76 months (14\u00b74-30\u00b72) for the placebo group."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37285865\", \"sentence_id\": 12, \"text\": \"At the planned primary analysis, median rPFS was not reached (95% CI 27\u00b75 months-not reached) for talazoparib plus enzalutamide and 21\u00b79 months (16\u00b76-25\u00b71) for placebo plus enzalutamide (hazard ratio 0\u00b763; 95% CI 0\u00b751-0\u00b778; p<0\u00b70001).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37285865", "sentence_id": 12, "text": "At the planned primary analysis, median rPFS was not reached (95% CI 27\u00b75 months-not reached) for talazoparib plus enzalutamide and 21\u00b79 months (16\u00b76-25\u00b71) for placebo plus enzalutamide (hazard ratio 0\u00b763; 95% CI 0\u00b751-0\u00b778; p<0\u00b70001)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37285865\", \"sentence_id\": 13, \"text\": \"In the talazoparib group, the most common treatment-emergent adverse events were anaemia, neutropenia, and fatigue; the most common grade 3-4 event was anaemia (185 [46%] of 398 patients), which improved after dose reduction, and only 33 (8%) of 398 patients discontinued talazoparib due to anaemia.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37285865", "sentence_id": 13, "text": "In the talazoparib group, the most common treatment-emergent adverse events were anaemia, neutropenia, and fatigue; the most common grade 3-4 event was anaemia (185 [46%] of 398 patients), which improved after dose reduction, and only 33 (8%) of 398 patients discontinued talazoparib due to anaemia."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37285865\", \"sentence_id\": 14, \"text\": \"Treatment-related deaths occurred in no patients in the talazoparib group and two patients (<1%) in the placebo group.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37285865", "sentence_id": 14, "text": "Treatment-related deaths occurred in no patients in the talazoparib group and two patients (<1%) in the placebo group."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37285865\", \"sentence_id\": 15, \"text\": \"INTERPRETATION: Talazoparib plus enzalutamide resulted in clinically meaningful and statistically significant improvement in rPFS versus standard of care enzalutamide as first-line treatment for patients with mCRPC.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37285865", "sentence_id": 15, "text": "INTERPRETATION: Talazoparib plus enzalutamide resulted in clinically meaningful and statistically significant improvement in rPFS versus standard of care enzalutamide as first-line treatment for patients with mCRPC."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37285865\", \"sentence_id\": 16, \"text\": \"Final overall survival data and additional long-term safety follow-up will further clarify the clinical benefit of the treatment combination in patients with and without tumour HRR gene alterations.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37285865", "sentence_id": 16, "text": "Final overall survival data and additional long-term safety follow-up will further clarify the clinical benefit of the treatment combination in patients with and without tumour HRR gene alterations."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37285865\", \"sentence_id\": 17, \"text\": \"FUNDING: Pfizer.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37285865", "sentence_id": 17, "text": "FUNDING: Pfizer."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37228496\", \"sentence_id\": 0, \"text\": \"BACKGROUND: Ovarian cancer has long been known to be the deadliest cancer associated with the female reproductive system.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37228496", "sentence_id": 0, "text": "BACKGROUND: Ovarian cancer has long been known to be the deadliest cancer associated with the female reproductive system."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37228496\", \"sentence_id\": 1, \"text\": \"More than 15% of ovarian cancer patients have a defective BRCA-mediated homologous recombination repair pathway that can be therapeutically targeted with PARP inhibitors (PARPi), such as Talazoparib (TLZ).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37228496", "sentence_id": 1, "text": "More than 15% of ovarian cancer patients have a defective BRCA-mediated homologous recombination repair pathway that can be therapeutically targeted with PARP inhibitors (PARPi), such as Talazoparib (TLZ)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37228496\", \"sentence_id\": 2, \"text\": \"The expansion of TLZ clinical approval beyond breast cancer has been hindered due to the highly potent systemic side effects resembling chemotherapeutics.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37228496", "sentence_id": 2, "text": "The expansion of TLZ clinical approval beyond breast cancer has been hindered due to the highly potent systemic side effects resembling chemotherapeutics."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37228496\", \"sentence_id\": 3, \"text\": \"Here we report the development of a novel TLZ-loaded PLGA implant (InCeT-TLZ) that sustainedly releases TLZ directly into the peritoneal (i.p.) cavity to treat patient-mimicking BRCA-mutated metastatic ovarian cancer (mOC).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37228496", "sentence_id": 3, "text": "Here we report the development of a novel TLZ-loaded PLGA implant (InCeT-TLZ) that sustainedly releases TLZ directly into the peritoneal (i.p.) cavity to treat patient-mimicking BRCA-mutated metastatic ovarian cancer (mOC)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37228496\", \"sentence_id\": 4, \"text\": \"METHODS: InCeT-TLZ was fabricated by dissolving TLZ and PLGA in chloroform, followed by extrusion and evaporation.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37228496", "sentence_id": 4, "text": "METHODS: InCeT-TLZ was fabricated by dissolving TLZ and PLGA in chloroform, followed by extrusion and evaporation."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37228496\", \"sentence_id\": 5, \"text\": \"Drug loading and release were confirmed by HPLC.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37228496", "sentence_id": 5, "text": "Drug loading and release were confirmed by HPLC."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37228496\", \"sentence_id\": 6, \"text\": \"The\\nRESULTS: Biodegradable InCeT-TLZ administered intraperitoneally releases 66 \u03bcg of TLZ over 25 days.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37228496", "sentence_id": 6, "text": "The\nRESULTS: Biodegradable InCeT-TLZ administered intraperitoneally releases 66 \u03bcg of TLZ over 25 days."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37228496\", \"sentence_id\": 7, \"text\": \"CONCLUSION: Compared to intraperitoneal PARPi injection, the InCeT-TLZ better inhibits tumor growth, delays the ascites formation, and prolongs the overall survival of treated mice, which could be a promising therapy option that benefits thousands of women diagnosed with ovarian cancer.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37228496", "sentence_id": 7, "text": "CONCLUSION: Compared to intraperitoneal PARPi injection, the InCeT-TLZ better inhibits tumor growth, delays the ascites formation, and prolongs the overall survival of treated mice, which could be a promising therapy option that benefits thousands of women diagnosed with ovarian cancer."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37171721\", \"sentence_id\": 0, \"text\": \"Talazoparib, a poly(ADP-ribose) polymerase inhibitor, has demonstrated efficacy in the treatment of advanced breast and prostate cancers in Western populations.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37171721", "sentence_id": 0, "text": "Talazoparib, a poly(ADP-ribose) polymerase inhibitor, has demonstrated efficacy in the treatment of advanced breast and prostate cancers in Western populations."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37171721\", \"sentence_id\": 1, \"text\": \"This open-label, phase 1 study investigated the pharmacokinetics, safety, and antitumor activity of talazoparib monotherapy in Chinese patients with advanced solid tumors.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37171721", "sentence_id": 1, "text": "This open-label, phase 1 study investigated the pharmacokinetics, safety, and antitumor activity of talazoparib monotherapy in Chinese patients with advanced solid tumors."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37171721\", \"sentence_id\": 2, \"text\": \"Molecularly unselected patients (\u226518 years) with advanced solid tumors resistant to standard therapy received talazoparib (oral, 1 mg once daily).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37171721", "sentence_id": 2, "text": "Molecularly unselected patients (\u226518 years) with advanced solid tumors resistant to standard therapy received talazoparib (oral, 1 mg once daily)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37171721\", \"sentence_id\": 3, \"text\": \"Primary endpoint was characterization of single-dose and steady-state pharmacokinetics.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37171721", "sentence_id": 3, "text": "Primary endpoint was characterization of single-dose and steady-state pharmacokinetics."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37171721\", \"sentence_id\": 4, \"text\": \"Secondary endpoints evaluated safety, unconfirmed objective response rate (ORR), and duration of response.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37171721", "sentence_id": 4, "text": "Secondary endpoints evaluated safety, unconfirmed objective response rate (ORR), and duration of response."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37171721\", \"sentence_id\": 5, \"text\": \"The safety population comprised 15 Chinese patients (median [range] age 53.0 [31.0-72.0] years).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37171721", "sentence_id": 5, "text": "The safety population comprised 15 Chinese patients (median [range] age 53.0 [31.0-72.0] years)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37171721\", \"sentence_id\": 6, \"text\": \"Single-dose median time to first occurrence of maximum observed concentration was 1.9 h; concentrations then declined with a mean terminal half-life (t\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37171721", "sentence_id": 6, "text": "Single-dose median time to first occurrence of maximum observed concentration was 1.9 h; concentrations then declined with a mean terminal half-life (t"}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37077937\", \"sentence_id\": 0, \"text\": \"UNLABELLED: The ADP-ribosyltransferase PARP7 modulates protein function by conjugating ADP-ribose to the side chains of acceptor amino acids.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37077937", "sentence_id": 0, "text": "UNLABELLED: The ADP-ribosyltransferase PARP7 modulates protein function by conjugating ADP-ribose to the side chains of acceptor amino acids."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37077937\", \"sentence_id\": 1, \"text\": \"PARP7 has been shown to affect gene expression in prostate cancer cells and certain other cell types by mechanisms that include transcription factor ADP-ribosylation.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37077937", "sentence_id": 1, "text": "PARP7 has been shown to affect gene expression in prostate cancer cells and certain other cell types by mechanisms that include transcription factor ADP-ribosylation."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37077937\", \"sentence_id\": 2, \"text\": \"Here, we use a recently developed catalytic inhibitor to PARP7, RBN2397, to study the effects of PARP7 inhibition in androgen receptor (AR)-positive and AR-negative prostate cancer cells.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37077937", "sentence_id": 2, "text": "Here, we use a recently developed catalytic inhibitor to PARP7, RBN2397, to study the effects of PARP7 inhibition in androgen receptor (AR)-positive and AR-negative prostate cancer cells."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37077937\", \"sentence_id\": 3, \"text\": \"We find that RBN2397 has nanomolar potency for inhibiting androgen-induced ADP-ribosylation of the AR.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37077937", "sentence_id": 3, "text": "We find that RBN2397 has nanomolar potency for inhibiting androgen-induced ADP-ribosylation of the AR."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37077937\", \"sentence_id\": 4, \"text\": \"RBN2397 inhibits the growth of prostate cancer cells in culture when cells are treated with ligands that activate the AR, or the aryl hydrocarbon receptor, and induce PARP7 expression.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37077937", "sentence_id": 4, "text": "RBN2397 inhibits the growth of prostate cancer cells in culture when cells are treated with ligands that activate the AR, or the aryl hydrocarbon receptor, and induce PARP7 expression."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37077937\", \"sentence_id\": 5, \"text\": \"We show that the growth-inhibitory effects of RBN2397 are distinct from its enhancement of IFN signaling recently shown to promote tumor immunogenicity.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37077937", "sentence_id": 5, "text": "We show that the growth-inhibitory effects of RBN2397 are distinct from its enhancement of IFN signaling recently shown to promote tumor immunogenicity."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37077937\", \"sentence_id\": 6, \"text\": \"RBN2397 treatment also induces trapping of PARP7 in a detergent-resistant fraction within the nucleus, which is reminiscent of how inhibitors such as talazoparib affect PARP1 compartmentalization.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37077937", "sentence_id": 6, "text": "RBN2397 treatment also induces trapping of PARP7 in a detergent-resistant fraction within the nucleus, which is reminiscent of how inhibitors such as talazoparib affect PARP1 compartmentalization."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37077937\", \"sentence_id\": 7, \"text\": \"Because PARP7 is expressed in AR-negative metastatic tumors and RBN2397 can affect cancer cells through multiple mechanisms, PARP7 may be an actionable target in advanced prostate cancer.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37077937", "sentence_id": 7, "text": "Because PARP7 is expressed in AR-negative metastatic tumors and RBN2397 can affect cancer cells through multiple mechanisms, PARP7 may be an actionable target in advanced prostate cancer."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37077937\", \"sentence_id\": 8, \"text\": \"SIGNIFICANCE: RBN2397 is a potent and selective inhibitor of PARP7 that reduces the growth of prostate cancer cells, including a model for treatment-emergent neuroendocrine prostate cancer.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37077937", "sentence_id": 8, "text": "SIGNIFICANCE: RBN2397 is a potent and selective inhibitor of PARP7 that reduces the growth of prostate cancer cells, including a model for treatment-emergent neuroendocrine prostate cancer."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"37077937\", \"sentence_id\": 9, \"text\": \"RBN2397 induces PARP7 trapping on chromatin, suggesting its mechanism of action might be similar to clinically used PARP1 inhibitors.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "37077937", "sentence_id": 9, "text": "RBN2397 induces PARP7 trapping on chromatin, suggesting its mechanism of action might be similar to clinically used PARP1 inhibitors."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36993449\", \"sentence_id\": 0, \"text\": \"UNLABELLED: Prostate cancer (PCa) is the second leading cause of cancer death for men in the United States.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36993449", "sentence_id": 0, "text": "UNLABELLED: Prostate cancer (PCa) is the second leading cause of cancer death for men in the United States."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36993449\", \"sentence_id\": 1, \"text\": \"While organ-confined disease has reasonable expectation of cure, metastatic PCa is universally fatal upon recurrence during hormone therapy, a stage termed castration-resistant prostate cancer (CRPC).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36993449", "sentence_id": 1, "text": "While organ-confined disease has reasonable expectation of cure, metastatic PCa is universally fatal upon recurrence during hormone therapy, a stage termed castration-resistant prostate cancer (CRPC)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36993449\", \"sentence_id\": 2, \"text\": \"Until such time as molecularly defined subtypes can be identified and targeted using precision medicine, it is necessary to investigate new therapies that may apply to the CRPC population as a whole.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36993449", "sentence_id": 2, "text": "Until such time as molecularly defined subtypes can be identified and targeted using precision medicine, it is necessary to investigate new therapies that may apply to the CRPC population as a whole."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36993449\", \"sentence_id\": 3, \"text\": \"The administration of ascorbate, more commonly known as ascorbic acid or Vitamin C, has proved lethal to and highly selective for a variety of cancer cell types.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36993449", "sentence_id": 3, "text": "The administration of ascorbate, more commonly known as ascorbic acid or Vitamin C, has proved lethal to and highly selective for a variety of cancer cell types."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36993449\", \"sentence_id\": 4, \"text\": \"There are several mechanisms currently under investigation to explain how ascorbate exerts anti-cancer effects.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36993449", "sentence_id": 4, "text": "There are several mechanisms currently under investigation to explain how ascorbate exerts anti-cancer effects."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36993449\", \"sentence_id\": 5, \"text\": \"A simplified model depicts ascorbate as a pro-drug for reactive oxygen species (ROS), which accumulate intracellularly and generate DNA damage.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36993449", "sentence_id": 5, "text": "A simplified model depicts ascorbate as a pro-drug for reactive oxygen species (ROS), which accumulate intracellularly and generate DNA damage."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36993449\", \"sentence_id\": 6, \"text\": \"It was therefore hypothesized that poly(ADP-ribose) polymerase (PARP) inhibitors, by inhibiting DNA damage repair, would augment the toxicity of ascorbate.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36993449", "sentence_id": 6, "text": "It was therefore hypothesized that poly(ADP-ribose) polymerase (PARP) inhibitors, by inhibiting DNA damage repair, would augment the toxicity of ascorbate."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36993449\", \"sentence_id\": 7, \"text\": \"RESULTS: Two distinct CRPC models were found to be sensitive to physiologically relevant doses of ascorbate.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36993449", "sentence_id": 7, "text": "RESULTS: Two distinct CRPC models were found to be sensitive to physiologically relevant doses of ascorbate."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36993449\", \"sentence_id\": 8, \"text\": \"Moreover, additional studies indicate that ascorbate inhibits CRPC growth\\nCONCLUSIONS: These data indicate that pharmacological ascorbate is an effective monotherapy at physiological concentrations and kills CRPC cells.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36993449", "sentence_id": 8, "text": "Moreover, additional studies indicate that ascorbate inhibits CRPC growth\nCONCLUSIONS: These data indicate that pharmacological ascorbate is an effective monotherapy at physiological concentrations and kills CRPC cells."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36993449\", \"sentence_id\": 9, \"text\": \"Ascorbate-induced tumor cell death was associated with disruption of cellular energy dynamics and accumulation of DNA damage.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36993449", "sentence_id": 9, "text": "Ascorbate-induced tumor cell death was associated with disruption of cellular energy dynamics and accumulation of DNA damage."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36993449\", \"sentence_id\": 10, \"text\": \"The addition of PARP inhibition increased the extent of DNA damage and proved effective at slowing CRPC growth both\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36993449", "sentence_id": 10, "text": "The addition of PARP inhibition increased the extent of DNA damage and proved effective at slowing CRPC growth both"}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36980735\", \"sentence_id\": 0, \"text\": \"Poly-adenosine diphosphate-ribose polymerase plays an essential role in cell function by regulating apoptosis, genomic stability and DNA repair.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36980735", "sentence_id": 0, "text": "Poly-adenosine diphosphate-ribose polymerase plays an essential role in cell function by regulating apoptosis, genomic stability and DNA repair."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36980735\", \"sentence_id\": 1, \"text\": \"PARPi is a promising drug class that has gained significant traction in the last decade with good outcomes in different cancers.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36980735", "sentence_id": 1, "text": "PARPi is a promising drug class that has gained significant traction in the last decade with good outcomes in different cancers."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36980735\", \"sentence_id\": 2, \"text\": \"Several trials have sought to test its effectiveness in metastatic castration resistant prostate cancer (mCRPC).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36980735", "sentence_id": 2, "text": "Several trials have sought to test its effectiveness in metastatic castration resistant prostate cancer (mCRPC)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36980735\", \"sentence_id\": 3, \"text\": \"We conducted a comprehensive literature review to evaluate the current role of PARPi in this setting.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36980735", "sentence_id": 3, "text": "We conducted a comprehensive literature review to evaluate the current role of PARPi in this setting."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36980735\", \"sentence_id\": 4, \"text\": \"To this effect, we conducted queries in the PubMed, Embase and Cochrane databases.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36980735", "sentence_id": 4, "text": "To this effect, we conducted queries in the PubMed, Embase and Cochrane databases."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36980735\", \"sentence_id\": 5, \"text\": \"We reviewed and compared all major contemporary publications on the topic.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36980735", "sentence_id": 5, "text": "We reviewed and compared all major contemporary publications on the topic."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36980735\", \"sentence_id\": 6, \"text\": \"In particular, recent phase II and III studies have also demonstrated the benefits of olaparib, rucaparib, niraparib, talazoparib in CRPC.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36980735", "sentence_id": 6, "text": "In particular, recent phase II and III studies have also demonstrated the benefits of olaparib, rucaparib, niraparib, talazoparib in CRPC."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36980735\", \"sentence_id\": 7, \"text\": \"Drug effectiveness has been assessed through radiological progression or overall response.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36980735", "sentence_id": 7, "text": "Drug effectiveness has been assessed through radiological progression or overall response."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36980735\", \"sentence_id\": 8, \"text\": \"Given the notion of synthetic lethality and potential synergy with other oncological therapies, several trials are looking to integrate PARPi in combined therapies.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36980735", "sentence_id": 8, "text": "Given the notion of synthetic lethality and potential synergy with other oncological therapies, several trials are looking to integrate PARPi in combined therapies."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36980735\", \"sentence_id\": 9, \"text\": \"There remains ongoing controversy on the need for genetic screening prior to treatment initiation as well as the optimal patient population, which would benefit most from PARPi.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36980735", "sentence_id": 9, "text": "There remains ongoing controversy on the need for genetic screening prior to treatment initiation as well as the optimal patient population, which would benefit most from PARPi."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36980735\", \"sentence_id\": 10, \"text\": \"PARPi is an important asset in the oncological arsenal for mCRPC.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36980735", "sentence_id": 10, "text": "PARPi is an important asset in the oncological arsenal for mCRPC."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36980735\", \"sentence_id\": 11, \"text\": \"New combinations with PARPi may improve outcomes in earlier phases of prostate cancer.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36980735", "sentence_id": 11, "text": "New combinations with PARPi may improve outcomes in earlier phases of prostate cancer."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36838818\", \"sentence_id\": 0, \"text\": \"The protein PARP1, which plays a crucial role in DNA repair processes, is an attractive target for cancer therapy, especially for BRCA-deficient cancers.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36838818", "sentence_id": 0, "text": "The protein PARP1, which plays a crucial role in DNA repair processes, is an attractive target for cancer therapy, especially for BRCA-deficient cancers."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36838818\", \"sentence_id\": 1, \"text\": \"To overcome the acquired drug resistance of PARP1,\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36838818", "sentence_id": 1, "text": "To overcome the acquired drug resistance of PARP1,"}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36729612\", \"sentence_id\": 0, \"text\": \"BACKGROUND: Chondrosarcomas are well known for their resistance to conventional chemotherapy and radiotherapy treatment regimens, which is particularly detrimental in patients who have unresectable tumors.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36729612", "sentence_id": 0, "text": "BACKGROUND: Chondrosarcomas are well known for their resistance to conventional chemotherapy and radiotherapy treatment regimens, which is particularly detrimental in patients who have unresectable tumors."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36729612\", \"sentence_id\": 1, \"text\": \"Recently, inhibition of poly(ADP-ribose) polymerase (PARP) by talazoparib was shown to sensitize chondrosarcoma cell lines to chemotherapy (temozolomide) or radiotherapy, irrespective of isocitrate dehydrogenase (IDH) mutation status.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36729612", "sentence_id": 1, "text": "Recently, inhibition of poly(ADP-ribose) polymerase (PARP) by talazoparib was shown to sensitize chondrosarcoma cell lines to chemotherapy (temozolomide) or radiotherapy, irrespective of isocitrate dehydrogenase (IDH) mutation status."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36729612\", \"sentence_id\": 2, \"text\": \"Because two-dimensionally grown cell lines have limitations and may not accurately represent the clinical response to drug treatment, we aimed to use a more representative three-dimensional alginate spheroid chondrosarcoma model.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36729612", "sentence_id": 2, "text": "Because two-dimensionally grown cell lines have limitations and may not accurately represent the clinical response to drug treatment, we aimed to use a more representative three-dimensional alginate spheroid chondrosarcoma model."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36729612\", \"sentence_id\": 3, \"text\": \"It is important to test therapeutic agents in vitro before testing them in animals or humans; therefore, we aimed to determine the effectiveness of a PARP inhibitor in reducing the viability of chondrosarcoma spheroids.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36729612", "sentence_id": 3, "text": "It is important to test therapeutic agents in vitro before testing them in animals or humans; therefore, we aimed to determine the effectiveness of a PARP inhibitor in reducing the viability of chondrosarcoma spheroids."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36729612\", \"sentence_id\": 4, \"text\": \"Using a more stringent, complex in vitro model refines future therapeutic options for further investigation in animal models, increasing efficiency, reducing unnecessary animal use, and saving time and cost.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36729612", "sentence_id": 4, "text": "Using a more stringent, complex in vitro model refines future therapeutic options for further investigation in animal models, increasing efficiency, reducing unnecessary animal use, and saving time and cost."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36729612\", \"sentence_id\": 5, \"text\": \"QUESTIONS/PURPOSES: (1) Does talazoparib treatment slow or inhibit the growth of chondrosarcoma spheroids, and does an increased treatment duration change the drug's effect?\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36729612", "sentence_id": 5, "text": "QUESTIONS/PURPOSES: (1) Does talazoparib treatment slow or inhibit the growth of chondrosarcoma spheroids, and does an increased treatment duration change the drug's effect?"}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36729612\", \"sentence_id\": 6, \"text\": \"(2) Does talazoparib work in synergy with temozolomide treatment to reduce the viability of chondrosarcoma spheroids?\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36729612", "sentence_id": 6, "text": "(2) Does talazoparib work in synergy with temozolomide treatment to reduce the viability of chondrosarcoma spheroids?"}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36729612\", \"sentence_id\": 7, \"text\": \"(3) Does talazoparib work in synergy with radiotherapy treatment to reduce the viability of chondrosarcoma spheroids?\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36729612", "sentence_id": 7, "text": "(3) Does talazoparib work in synergy with radiotherapy treatment to reduce the viability of chondrosarcoma spheroids?"}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36729612\", \"sentence_id\": 8, \"text\": \"METHODS: Three representative conventional chondrosarcoma cell lines (CH2879 [IDH wildtype], JJ012 [IDH1 mutant], and SW1353 [IDH2 mutant]) were cultured as alginate spheroids and treated with talazoparib (0.001 to 10 \u00b5M), temozolomide (0.01 to 100 \u00b5M), or combinations of these drugs for 3, 7, and 14 days, representing different stages of spheroid growth.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36729612", "sentence_id": 8, "text": "METHODS: Three representative conventional chondrosarcoma cell lines (CH2879 [IDH wildtype], JJ012 [IDH1 mutant], and SW1353 [IDH2 mutant]) were cultured as alginate spheroids and treated with talazoparib (0.001 to 10 \u00b5M), temozolomide (0.01 to 100 \u00b5M), or combinations of these drugs for 3, 7, and 14 days, representing different stages of spheroid growth."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36729612\", \"sentence_id\": 9, \"text\": \"The cell lines were selected to represent a variety of IDH mutation statuses and were previously validated in spheroid culturing.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36729612", "sentence_id": 9, "text": "The cell lines were selected to represent a variety of IDH mutation statuses and were previously validated in spheroid culturing."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36729612\", \"sentence_id\": 10, \"text\": \"Temozolomide was chosen because of its previous success when combined with PARP inhibitors, dissimilar to other commonly used chemotherapies.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36729612", "sentence_id": 10, "text": "Temozolomide was chosen because of its previous success when combined with PARP inhibitors, dissimilar to other commonly used chemotherapies."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36729612\", \"sentence_id\": 11, \"text\": \"The effect on spheroid viability was assessed using three cell viability assays.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36729612", "sentence_id": 11, "text": "The effect on spheroid viability was assessed using three cell viability assays."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36729612\", \"sentence_id\": 12, \"text\": \"Additionally, spheroid count, morphology, proliferation, and apoptosis were assessed.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36729612", "sentence_id": 12, "text": "Additionally, spheroid count, morphology, proliferation, and apoptosis were assessed."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36729612\", \"sentence_id\": 13, \"text\": \"The effect of talazoparib (5 to 10 nM) combined with \u01b4-radiation applied using a 137 C source (0 to 6 Gy) was assessed as surviving fractions by counting the number of spheroids (three).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36729612", "sentence_id": 13, "text": "The effect of talazoparib (5 to 10 nM) combined with \u01b4-radiation applied using a 137 C source (0 to 6 Gy) was assessed as surviving fractions by counting the number of spheroids (three)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36729612\", \"sentence_id\": 14, \"text\": \"The therapeutic synergy of low-concentration talazoparib (5 to 10 nM) with temozolomide or radiotherapy was determined by calculating Excess over Bliss scores.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36729612", "sentence_id": 14, "text": "The therapeutic synergy of low-concentration talazoparib (5 to 10 nM) with temozolomide or radiotherapy was determined by calculating Excess over Bliss scores."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36729612\", \"sentence_id\": 15, \"text\": \"RESULTS: Talazoparib treatment reduced the spheroid viability of all three cell lines after 14 days (IC 50 \u00b1 SD of CH2879: 0.1 \u00b1 0.03 \u00b5M, fold change: 220; JJ012: 12 \u00b1 1.4 \u00b5M, fold change: 4.8; and SW1353: 1.0 \u00b1 0.2 \u00b5M, fold change: 154), compared with 3-day treatments of mature spheroids.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36729612", "sentence_id": 15, "text": "RESULTS: Talazoparib treatment reduced the spheroid viability of all three cell lines after 14 days (IC 50 \u00b1 SD of CH2879: 0.1 \u00b1 0.03 \u00b5M, fold change: 220; JJ012: 12 \u00b1 1.4 \u00b5M, fold change: 4.8; and SW1353: 1.0 \u00b1 0.2 \u00b5M, fold change: 154), compared with 3-day treatments of mature spheroids."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36729612\", \"sentence_id\": 16, \"text\": \"After 14 days of treatment, the Excess over Bliss scores for 100 \u00b5M temozolomide and talazoparib indicated synergistic efficacy (Excess over Bliss scores: CH2879 59% [lower 95% CI 52%], JJ012 18% [lower 95% CI 8%], and SW1353 55% [lower 95% CI 25%]) of this combination treatment.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36729612", "sentence_id": 16, "text": "After 14 days of treatment, the Excess over Bliss scores for 100 \u00b5M temozolomide and talazoparib indicated synergistic efficacy (Excess over Bliss scores: CH2879 59% [lower 95% CI 52%], JJ012 18% [lower 95% CI 8%], and SW1353 55% [lower 95% CI 25%]) of this combination treatment."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36729612\", \"sentence_id\": 17, \"text\": \"A stable synergistic effect of talazoparib and radiotherapy was present only in JJ012 spheroids at a 4G\u01b4 radiation dose (Excess over Bliss score: 22% [lower 95% CI 6%]).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36729612", "sentence_id": 17, "text": "A stable synergistic effect of talazoparib and radiotherapy was present only in JJ012 spheroids at a 4G\u01b4 radiation dose (Excess over Bliss score: 22% [lower 95% CI 6%])."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36729612\", \"sentence_id\": 18, \"text\": \"CONCLUSION: In our study, long-term PARP inhibition was more effective than short-term treatment, and only one of the three chondrosarcoma spheroid lines was sensitive to combined PARP inhibition and radiotherapy.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36729612", "sentence_id": 18, "text": "CONCLUSION: In our study, long-term PARP inhibition was more effective than short-term treatment, and only one of the three chondrosarcoma spheroid lines was sensitive to combined PARP inhibition and radiotherapy."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36729612\", \"sentence_id\": 19, \"text\": \"These findings suggest subsequent animal studies should focus on long-term PARP inhibition, and temozolomide combined with talazoparib has a higher chance of success than combination with radiotherapy.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36729612", "sentence_id": 19, "text": "These findings suggest subsequent animal studies should focus on long-term PARP inhibition, and temozolomide combined with talazoparib has a higher chance of success than combination with radiotherapy."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36729612\", \"sentence_id\": 20, \"text\": \"CLINICAL RELEVANCE: Combination treatment of talazoparib and temozolomide was effective in reducing the viability of chondrosarcoma spheroids and spheroid growth, regardless of IDH mutation status, providing rationale to replicate this treatment combination in an animal chondrosarcoma model.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36729612", "sentence_id": 20, "text": "CLINICAL RELEVANCE: Combination treatment of talazoparib and temozolomide was effective in reducing the viability of chondrosarcoma spheroids and spheroid growth, regardless of IDH mutation status, providing rationale to replicate this treatment combination in an animal chondrosarcoma model."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36598514\", \"sentence_id\": 0, \"text\": \"Cyclin-dependent kinase 4/6 (CDK4/6) inhibitors provide promising results for treating hormone receptor-positive breast cancer.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36598514", "sentence_id": 0, "text": "Cyclin-dependent kinase 4/6 (CDK4/6) inhibitors provide promising results for treating hormone receptor-positive breast cancer."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36598514\", \"sentence_id\": 1, \"text\": \"However, the efficacy of CDK4/6 inhibitors remains uncertain in triple negative breast cancer (TNBC) patients with particularly carrying RB-deficient tumors.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36598514", "sentence_id": 1, "text": "However, the efficacy of CDK4/6 inhibitors remains uncertain in triple negative breast cancer (TNBC) patients with particularly carrying RB-deficient tumors."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36598514\", \"sentence_id\": 2, \"text\": \"Poly-(ADP-ribose) polymerase (PARP) inhibitors offer a therapeutic strategy for the treatment of BRCA-mutated TNBC patients.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36598514", "sentence_id": 2, "text": "Poly-(ADP-ribose) polymerase (PARP) inhibitors offer a therapeutic strategy for the treatment of BRCA-mutated TNBC patients."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36598514\", \"sentence_id\": 3, \"text\": \"However, the acquired drug resistance, changes in the cell cycle regulation, and DNA damage repair have demonstrated the necessity for developing new combination strategies.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36598514", "sentence_id": 3, "text": "However, the acquired drug resistance, changes in the cell cycle regulation, and DNA damage repair have demonstrated the necessity for developing new combination strategies."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36598514\", \"sentence_id\": 4, \"text\": \"This preclinical study assessed a combinatory treatment of the CDK4/6 inhibitor abemaciclib with PARP inhibitors talazoparib (TAL) in HCC1937 BRCA-mutated RB-deficient TNBC cells and TAL-resistant HCC1937-R cells through WST-1 analysis, annexin V, cell cycle, acridine orange/propidium iodide staining, RT-PCR, and apoptosis array.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36598514", "sentence_id": 4, "text": "This preclinical study assessed a combinatory treatment of the CDK4/6 inhibitor abemaciclib with PARP inhibitors talazoparib (TAL) in HCC1937 BRCA-mutated RB-deficient TNBC cells and TAL-resistant HCC1937-R cells through WST-1 analysis, annexin V, cell cycle, acridine orange/propidium iodide staining, RT-PCR, and apoptosis array."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36598514\", \"sentence_id\": 5, \"text\": \"Our findings revealed that abemaciclib and TAL combination synergistically suppressed the growth of TNBC cells and overcame TAL resistance through G0/G1 arrest and the activity of both intrinsic and extrinsic apoptotic pathways.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36598514", "sentence_id": 5, "text": "Our findings revealed that abemaciclib and TAL combination synergistically suppressed the growth of TNBC cells and overcame TAL resistance through G0/G1 arrest and the activity of both intrinsic and extrinsic apoptotic pathways."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36598514\", \"sentence_id\": 6, \"text\": \"These preliminary results suggest that the combination of abemaciclib and TAL could expand the use of these inhibitors in BRCA mutated and RB deficient TNBC patients and potentially overcomes PARP inhibitors resistance.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36598514", "sentence_id": 6, "text": "These preliminary results suggest that the combination of abemaciclib and TAL could expand the use of these inhibitors in BRCA mutated and RB deficient TNBC patients and potentially overcomes PARP inhibitors resistance."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36520320\", \"sentence_id\": 0, \"text\": \"The normal colorectal mucosa undergoes precancerous lesions that can develop over time into colorectal cancer (CRC).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36520320", "sentence_id": 0, "text": "The normal colorectal mucosa undergoes precancerous lesions that can develop over time into colorectal cancer (CRC)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36520320\", \"sentence_id\": 1, \"text\": \"In the stage of precancerous lesions, DNA replication stress may lead to genome instability.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36520320", "sentence_id": 1, "text": "In the stage of precancerous lesions, DNA replication stress may lead to genome instability."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36520320\", \"sentence_id\": 2, \"text\": \"We have performed whole-exome sequencing on genomic DNA obtained from three cases of CRC tissues and identified a novel frameshift mutation of DNA damage inducible 1 homolog 2 gene (DDI2, c.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36520320", "sentence_id": 2, "text": "We have performed whole-exome sequencing on genomic DNA obtained from three cases of CRC tissues and identified a novel frameshift mutation of DNA damage inducible 1 homolog 2 gene (DDI2, c."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36520320\", \"sentence_id\": 3, \"text\": \"854 del T).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36520320", "sentence_id": 3, "text": "854 del T)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36520320\", \"sentence_id\": 4, \"text\": \"To date, there is no direct evidence that DDI2 is involved in the carcinogenesis of CRC.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36520320", "sentence_id": 4, "text": "To date, there is no direct evidence that DDI2 is involved in the carcinogenesis of CRC."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36520320\", \"sentence_id\": 5, \"text\": \"In this study, we demonstrated that DDI2 is upregulated in the early stage of CRC based on clinical samples and public databases.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36520320", "sentence_id": 5, "text": "In this study, we demonstrated that DDI2 is upregulated in the early stage of CRC based on clinical samples and public databases."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36520320\", \"sentence_id\": 6, \"text\": \"We also found that 5FU, a standard chemotherapeutic agent for CRC treatment, increased DDI2 mRNA levels in a dose-dependent manner.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36520320", "sentence_id": 6, "text": "We also found that 5FU, a standard chemotherapeutic agent for CRC treatment, increased DDI2 mRNA levels in a dose-dependent manner."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36520320\", \"sentence_id\": 7, \"text\": \"Depression of DDI2 inhibited CRC cell proliferation, migration and invasion both in vitro and in vivo.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36520320", "sentence_id": 7, "text": "Depression of DDI2 inhibited CRC cell proliferation, migration and invasion both in vitro and in vivo."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36520320\", \"sentence_id\": 8, \"text\": \"Transcriptome sequencing revealed that DDI2 was involved in the mitogen-activated protein kinase (MAPK) pathway.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36520320", "sentence_id": 8, "text": "Transcriptome sequencing revealed that DDI2 was involved in the mitogen-activated protein kinase (MAPK) pathway."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36520320\", \"sentence_id\": 9, \"text\": \"Furthermore, DDI2 resists a MAPK kinase (MEK) inhibitor (trametinib) and a PolyADP-ribose polymerase 1 (PARP1) inhibitor (talazoparib) induced apoptosis in CRC cells.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36520320", "sentence_id": 9, "text": "Furthermore, DDI2 resists a MAPK kinase (MEK) inhibitor (trametinib) and a PolyADP-ribose polymerase 1 (PARP1) inhibitor (talazoparib) induced apoptosis in CRC cells."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36520320\", \"sentence_id\": 10, \"text\": \"Thus, our results indicate that DDI2 may play a vital role in the carcinogenesis of CRC and could serve as a promising therapeutic target for CRC.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36520320", "sentence_id": 10, "text": "Thus, our results indicate that DDI2 may play a vital role in the carcinogenesis of CRC and could serve as a promising therapeutic target for CRC."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36497408\", \"sentence_id\": 0, \"text\": \"Approximately a quarter of men with metastatic castrate resistant prostate cancer (mCRPC) have alterations in homologous recombination repair (HRR).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36497408", "sentence_id": 0, "text": "Approximately a quarter of men with metastatic castrate resistant prostate cancer (mCRPC) have alterations in homologous recombination repair (HRR)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36497408\", \"sentence_id\": 1, \"text\": \"These patients exhibit enhanced sensitivity to poly(ADP-ribose) polymerase (PARP) inhibitors.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36497408", "sentence_id": 1, "text": "These patients exhibit enhanced sensitivity to poly(ADP-ribose) polymerase (PARP) inhibitors."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36497408\", \"sentence_id\": 2, \"text\": \"Leveraging the synthetic lethality between PARP inhibition and HRR deficiency, studies have established marked clinical benefit and a survival advantage from PARP inhibitors (PARPi) in mCRPC, most notably in cancers with\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36497408", "sentence_id": 2, "text": "Leveraging the synthetic lethality between PARP inhibition and HRR deficiency, studies have established marked clinical benefit and a survival advantage from PARP inhibitors (PARPi) in mCRPC, most notably in cancers with"}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36430819\", \"sentence_id\": 0, \"text\": \"Talazoparib (Talzenna) is a novel poly (adenosine diphosphate-ribose) polymerase (PARP) inhibitor that is clinically used for the therapy of breast cancer.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36430819", "sentence_id": 0, "text": "Talazoparib (Talzenna) is a novel poly (adenosine diphosphate-ribose) polymerase (PARP) inhibitor that is clinically used for the therapy of breast cancer."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36430819\", \"sentence_id\": 1, \"text\": \"Furthermore, the drug has shown antitumor activity against different cancer types, including non-small cell lung cancer (NSCLC).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36430819", "sentence_id": 1, "text": "Furthermore, the drug has shown antitumor activity against different cancer types, including non-small cell lung cancer (NSCLC)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36430819\", \"sentence_id\": 2, \"text\": \"In this work, we investigated the possible inhibitory interactions of talazoparib toward selected ATP-binding cassette (ABC) drug efflux transporters and cytochrome P450 biotransformation enzymes (CYPs) and evaluated its position in multidrug resistance (MDR).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36430819", "sentence_id": 2, "text": "In this work, we investigated the possible inhibitory interactions of talazoparib toward selected ATP-binding cassette (ABC) drug efflux transporters and cytochrome P450 biotransformation enzymes (CYPs) and evaluated its position in multidrug resistance (MDR)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36430819\", \"sentence_id\": 3, \"text\": \"In accumulation studies, talazoparib interacted with the ABCC1 and ABCG2 transporters, but there were no significant effects on ABCB1.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36430819", "sentence_id": 3, "text": "In accumulation studies, talazoparib interacted with the ABCC1 and ABCG2 transporters, but there were no significant effects on ABCB1."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36430819\", \"sentence_id\": 4, \"text\": \"Furthermore, incubation assays revealed a negligible capacity of the tested drug to inhibit clinically relevant CYPs.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36430819", "sentence_id": 4, "text": "Furthermore, incubation assays revealed a negligible capacity of the tested drug to inhibit clinically relevant CYPs."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36430819\", \"sentence_id\": 5, \"text\": \"In in vitro drug combination experiments, talazoparib synergistically reversed daunorubicin and mitoxantrone resistance in cells with ABCC1 and ABCG2 expression, respectively.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36430819", "sentence_id": 5, "text": "In in vitro drug combination experiments, talazoparib synergistically reversed daunorubicin and mitoxantrone resistance in cells with ABCC1 and ABCG2 expression, respectively."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36430819\", \"sentence_id\": 6, \"text\": \"Importantly, the position of an effective MDR modulator was further confirmed in drug combinations performed in ex vivo NSCLC patients-derived explants, whereas the possible victim role was refuted in comparative proliferation experiments.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36430819", "sentence_id": 6, "text": "Importantly, the position of an effective MDR modulator was further confirmed in drug combinations performed in ex vivo NSCLC patients-derived explants, whereas the possible victim role was refuted in comparative proliferation experiments."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36430819\", \"sentence_id\": 7, \"text\": \"In addition, talazoparib had no significant effects on the mRNA-level expressions of MDR-related ABC transporters in the MCF-7 cellular model.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36430819", "sentence_id": 7, "text": "In addition, talazoparib had no significant effects on the mRNA-level expressions of MDR-related ABC transporters in the MCF-7 cellular model."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36430819\", \"sentence_id\": 8, \"text\": \"In summary, our study presents a comprehensive overview on the pharmacokinetic drug-drug interactions (DDI) profile of talazoparib.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36430819", "sentence_id": 8, "text": "In summary, our study presents a comprehensive overview on the pharmacokinetic drug-drug interactions (DDI) profile of talazoparib."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36430819\", \"sentence_id\": 9, \"text\": \"Moreover, we introduced talazoparib as an efficient MDR antagonist.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36430819", "sentence_id": 9, "text": "Moreover, we introduced talazoparib as an efficient MDR antagonist."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36428712\", \"sentence_id\": 0, \"text\": \"BMN673 is a relatively new PARP inhibitor (PARPi) that exhibits superior efficacy in vitro compared to olaparib and other clinically relevant PARPi.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36428712", "sentence_id": 0, "text": "BMN673 is a relatively new PARP inhibitor (PARPi) that exhibits superior efficacy in vitro compared to olaparib and other clinically relevant PARPi."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36428712\", \"sentence_id\": 1, \"text\": \"BMN673, similar to most clinical PARPi, inhibits the catalytic activities of PARP-1 and PARP-2 and shows impressive anticancer potential as monotherapy in several pre-clinical and clinical studies.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36428712", "sentence_id": 1, "text": "BMN673, similar to most clinical PARPi, inhibits the catalytic activities of PARP-1 and PARP-2 and shows impressive anticancer potential as monotherapy in several pre-clinical and clinical studies."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36428712\", \"sentence_id\": 2, \"text\": \"Tumor resistance to PARPi poses a significant challenge in the clinic.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36428712", "sentence_id": 2, "text": "Tumor resistance to PARPi poses a significant challenge in the clinic."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36428712\", \"sentence_id\": 3, \"text\": \"Thus, combining PARPi with other treatment modalities, such as radiotherapy (RT), is being actively pursued to overcome such resistance.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36428712", "sentence_id": 3, "text": "Thus, combining PARPi with other treatment modalities, such as radiotherapy (RT), is being actively pursued to overcome such resistance."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36428712\", \"sentence_id\": 4, \"text\": \"However, the modest to intermediate radiosensitization exerted by olaparib, rucaparib, and veliparib, limits the rationale and the scope of such combinations.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36428712", "sentence_id": 4, "text": "However, the modest to intermediate radiosensitization exerted by olaparib, rucaparib, and veliparib, limits the rationale and the scope of such combinations."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36428712\", \"sentence_id\": 5, \"text\": \"The recently reported strong radiosensitizing potential of BMN673 forecasts a paradigm shift on this front.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36428712", "sentence_id": 5, "text": "The recently reported strong radiosensitizing potential of BMN673 forecasts a paradigm shift on this front."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36428712\", \"sentence_id\": 6, \"text\": \"Evidence accumulates that BMN673 may radiosensitize via unique mechanisms causing profound shifts in the balance among DNA double-strand break (DSB) repair pathways.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36428712", "sentence_id": 6, "text": "Evidence accumulates that BMN673 may radiosensitize via unique mechanisms causing profound shifts in the balance among DNA double-strand break (DSB) repair pathways."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36428712\", \"sentence_id\": 7, \"text\": \"According to one of the emerging models, BMN673 strongly inhibits classical non-homologous end-joining (c-NHEJ) and increases reciprocally and profoundly DSB end-resection, enhancing error-prone DSB processing that robustly potentiates cell killing.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36428712", "sentence_id": 7, "text": "According to one of the emerging models, BMN673 strongly inhibits classical non-homologous end-joining (c-NHEJ) and increases reciprocally and profoundly DSB end-resection, enhancing error-prone DSB processing that robustly potentiates cell killing."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36428712\", \"sentence_id\": 8, \"text\": \"In this review, we outline and summarize the work that helped to formulate this model of BMN673 action on DSB repair, analyze the causes of radiosensitization and discuss its potential as a radiosensitizer in the clinic.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36428712", "sentence_id": 8, "text": "In this review, we outline and summarize the work that helped to formulate this model of BMN673 action on DSB repair, analyze the causes of radiosensitization and discuss its potential as a radiosensitizer in the clinic."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36428712\", \"sentence_id\": 9, \"text\": \"Finally, we highlight strategies for combining BMN673 with other inhibitors of DNA damage response for further improvements.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36428712", "sentence_id": 9, "text": "Finally, we highlight strategies for combining BMN673 with other inhibitors of DNA damage response for further improvements."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36411744\", \"sentence_id\": 0, \"text\": \"Prostate cancer is one of the most common types of cancer worldwide and has strong genetic associations.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36411744", "sentence_id": 0, "text": "Prostate cancer is one of the most common types of cancer worldwide and has strong genetic associations."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36411744\", \"sentence_id\": 1, \"text\": \"This is important for the development of therapeutics for the condition, as metastatic castrate-resistant prostate cancer (mCRPC) is resistant to standard androgen deprivation therapy (ADT) and has a relatively poor prognosis.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36411744", "sentence_id": 1, "text": "This is important for the development of therapeutics for the condition, as metastatic castrate-resistant prostate cancer (mCRPC) is resistant to standard androgen deprivation therapy (ADT) and has a relatively poor prognosis."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36411744\", \"sentence_id\": 2, \"text\": \"We conducted a literature review on rucaparib, a poly(adenosine diphosphate-ribose) polymerase (PARP) inhibitor that is currently indicated for the treatment of patients with mCRPC who harbor mutations in BRCA1/2 (homologous recombination repair [HRR] genes) and who have already tried androgen receptor-axis-targeted therapies (ARAT) and a taxane chemotherapy.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36411744", "sentence_id": 2, "text": "We conducted a literature review on rucaparib, a poly(adenosine diphosphate-ribose) polymerase (PARP) inhibitor that is currently indicated for the treatment of patients with mCRPC who harbor mutations in BRCA1/2 (homologous recombination repair [HRR] genes) and who have already tried androgen receptor-axis-targeted therapies (ARAT) and a taxane chemotherapy."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36411744\", \"sentence_id\": 3, \"text\": \"We describe rucaparib's FDA approval, which was based on the results of the single-arm, open-label, Phase II TRITON2 clinical trial, which found an objective response rate (ORR) of 43.5%, a duration of response (DOR) of over six months in length and an acceptable safety profile.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36411744", "sentence_id": 3, "text": "We describe rucaparib's FDA approval, which was based on the results of the single-arm, open-label, Phase II TRITON2 clinical trial, which found an objective response rate (ORR) of 43.5%, a duration of response (DOR) of over six months in length and an acceptable safety profile."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36411744\", \"sentence_id\": 4, \"text\": \"Rucaparib's dosage and clinical considerations for use were also discussed.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36411744", "sentence_id": 4, "text": "Rucaparib's dosage and clinical considerations for use were also discussed."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36411744\", \"sentence_id\": 5, \"text\": \"We also compared rucaparib's use and safety profile with Olaparib, niraparib and talazoparib, three other PARP inhibitors tested for the treatment of mCRPC.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36411744", "sentence_id": 5, "text": "We also compared rucaparib's use and safety profile with Olaparib, niraparib and talazoparib, three other PARP inhibitors tested for the treatment of mCRPC."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36411744\", \"sentence_id\": 6, \"text\": \"Overall, initial results show that the safety profile of all four drugs in mCRPC was relatively similar, and further testing is currently indicated for all four.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36411744", "sentence_id": 6, "text": "Overall, initial results show that the safety profile of all four drugs in mCRPC was relatively similar, and further testing is currently indicated for all four."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36411744\", \"sentence_id\": 7, \"text\": \"Differences in their metabolism, however, also warrant further research.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36411744", "sentence_id": 7, "text": "Differences in their metabolism, however, also warrant further research."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36411744\", \"sentence_id\": 8, \"text\": \"The clinical validity of rucaparib will be tested by the follow-up TRITON3 clinical trial, which is comparing the effect of rucaparib compared to standard therapies for mCRPC harboring BRCA1/2 or ATM mutations.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36411744", "sentence_id": 8, "text": "The clinical validity of rucaparib will be tested by the follow-up TRITON3 clinical trial, which is comparing the effect of rucaparib compared to standard therapies for mCRPC harboring BRCA1/2 or ATM mutations."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36411744\", \"sentence_id\": 9, \"text\": \"Other than TRITON3, other clinical trials are testing rucaparib's ability against other cancers (prostate or otherwise) with HRR mutations, and also the efficacy of combination therapies involving rucaparib.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36411744", "sentence_id": 9, "text": "Other than TRITON3, other clinical trials are testing rucaparib's ability against other cancers (prostate or otherwise) with HRR mutations, and also the efficacy of combination therapies involving rucaparib."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36411744\", \"sentence_id\": 10, \"text\": \"Finally, more research is needed to elucidate rucaparib's effect on HRR mutations other than BRCA1/2.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36411744", "sentence_id": 10, "text": "Finally, more research is needed to elucidate rucaparib's effect on HRR mutations other than BRCA1/2."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36411744\", \"sentence_id\": 11, \"text\": \"Advancements in understanding the genetic landscape of mCRPC will also assist in understanding rucaparib's full therapeutic potential.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36411744", "sentence_id": 11, "text": "Advancements in understanding the genetic landscape of mCRPC will also assist in understanding rucaparib's full therapeutic potential."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36405946\", \"sentence_id\": 0, \"text\": \"BACKGROUND: Next-generation sequencing (NGS) has proven to be a key implementation to understanding biological pathways involved in cancer.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36405946", "sentence_id": 0, "text": "BACKGROUND: Next-generation sequencing (NGS) has proven to be a key implementation to understanding biological pathways involved in cancer."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36405946\", \"sentence_id\": 1, \"text\": \"In daily practice, the identification of somatic and germline mutations has allowed physicians to gather relevant information to make therapeutic decisions and benefit patients.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36405946", "sentence_id": 1, "text": "In daily practice, the identification of somatic and germline mutations has allowed physicians to gather relevant information to make therapeutic decisions and benefit patients."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36405946\", \"sentence_id\": 2, \"text\": \"Importantly, somatic mutations provide targeted opportunities for treatment and reveal resistance mechanisms to understand patients' tumour evolution.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36405946", "sentence_id": 2, "text": "Importantly, somatic mutations provide targeted opportunities for treatment and reveal resistance mechanisms to understand patients' tumour evolution."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36405946\", \"sentence_id\": 3, \"text\": \"Scanty data in clinical trials and in a real-world setting is available regarding the utility of poly(ADP-ribose) polymerase inhibitors in pathogenic or likely-pathogenic somatic breast cancer gene 1/2 (BRCA1/2) mutations and/or germline or somatic Homologous Recombination-Related Gene mutations in advanced breast cancer (ABC).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36405946", "sentence_id": 3, "text": "Scanty data in clinical trials and in a real-world setting is available regarding the utility of poly(ADP-ribose) polymerase inhibitors in pathogenic or likely-pathogenic somatic breast cancer gene 1/2 (BRCA1/2) mutations and/or germline or somatic Homologous Recombination-Related Gene mutations in advanced breast cancer (ABC)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36405946\", \"sentence_id\": 4, \"text\": \"CASE REPORT: Here we report a real-life case of a 47-year-old postmenopausal woman with hormone receptor-positive (HR-positive) Epidermal growth factor receptor 2 (HER2)-negative metastatic BC that had poor response to classic therapeutic strategies for HR+/HER2- ABC.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36405946", "sentence_id": 4, "text": "CASE REPORT: Here we report a real-life case of a 47-year-old postmenopausal woman with hormone receptor-positive (HR-positive) Epidermal growth factor receptor 2 (HER2)-negative metastatic BC that had poor response to classic therapeutic strategies for HR+/HER2- ABC."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36405946\", \"sentence_id\": 5, \"text\": \"At this point, the possibility of using NGS to guide the treatment was decided in a Molecular Tumour Board (MTB), and the patient had a major response to talazoparib targeting a non-germline BRCA2 mutation.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36405946", "sentence_id": 5, "text": "At this point, the possibility of using NGS to guide the treatment was decided in a Molecular Tumour Board (MTB), and the patient had a major response to talazoparib targeting a non-germline BRCA2 mutation."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36405946\", \"sentence_id\": 6, \"text\": \"CONCLUSION: Undoubtedly, more information regarding the cost effectiveness of NGS is needed to develop adequate reimbursement policies for this technology.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36405946", "sentence_id": 6, "text": "CONCLUSION: Undoubtedly, more information regarding the cost effectiveness of NGS is needed to develop adequate reimbursement policies for this technology."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36405946\", \"sentence_id\": 7, \"text\": \"It should be highlighted that the generalisation of MTBs and the implementation of molecular screening programmes are greatly needed in our region to gain more knowledge of somatic mutations implicated in the Hispanic and Latin-American population with BC diagnosis.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36405946", "sentence_id": 7, "text": "It should be highlighted that the generalisation of MTBs and the implementation of molecular screening programmes are greatly needed in our region to gain more knowledge of somatic mutations implicated in the Hispanic and Latin-American population with BC diagnosis."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36405946\", \"sentence_id\": 8, \"text\": \"Recently presented results of randomised studies may support the evaluation of somatic mutations with NGS to find targeted therapies for ABC patients.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36405946", "sentence_id": 8, "text": "Recently presented results of randomised studies may support the evaluation of somatic mutations with NGS to find targeted therapies for ABC patients."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36394867\", \"sentence_id\": 0, \"text\": \"IMPORTANCE: Nonclinical studies suggest that the combination of poly(ADP-ribose) polymerase and programmed cell death 1/programmed cell death-ligand 1 inhibitors has enhanced antitumor activity; however, the patient populations that may benefit from this combination have not been identified.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36394867", "sentence_id": 0, "text": "IMPORTANCE: Nonclinical studies suggest that the combination of poly(ADP-ribose) polymerase and programmed cell death 1/programmed cell death-ligand 1 inhibitors has enhanced antitumor activity; however, the patient populations that may benefit from this combination have not been identified."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36394867\", \"sentence_id\": 1, \"text\": \"OBJECTIVE: To evaluate whether the combination of avelumab and talazoparib is effective in patients with pathogenic BRCA1/2 or ATM alterations, regardless of tumor type.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36394867", "sentence_id": 1, "text": "OBJECTIVE: To evaluate whether the combination of avelumab and talazoparib is effective in patients with pathogenic BRCA1/2 or ATM alterations, regardless of tumor type."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36394867\", \"sentence_id\": 2, \"text\": \"DESIGN, SETTING, AND PARTICIPANTS: In this pan-cancer tumor-agnostic phase 2b nonrandomized controlled trial, patients with advanced BRCA1/2-altered or ATM-altered solid tumors were enrolled into 2 respective parallel cohorts.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36394867", "sentence_id": 2, "text": "DESIGN, SETTING, AND PARTICIPANTS: In this pan-cancer tumor-agnostic phase 2b nonrandomized controlled trial, patients with advanced BRCA1/2-altered or ATM-altered solid tumors were enrolled into 2 respective parallel cohorts."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36394867\", \"sentence_id\": 3, \"text\": \"The study was conducted from July 2, 2018, to April 12, 2020, at 42 institutions in 9 countries.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36394867", "sentence_id": 3, "text": "The study was conducted from July 2, 2018, to April 12, 2020, at 42 institutions in 9 countries."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36394867\", \"sentence_id\": 4, \"text\": \"INTERVENTIONS: Patients received 800 mg of avelumab every 2 weeks and 1 mg of talazoparib once daily.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36394867", "sentence_id": 4, "text": "INTERVENTIONS: Patients received 800 mg of avelumab every 2 weeks and 1 mg of talazoparib once daily."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36394867\", \"sentence_id\": 5, \"text\": \"MAIN OUTCOMES AND MEASURES: The primary end point was confirmed objective response (OR) per RECIST 1.1 by blinded independent central review.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36394867", "sentence_id": 5, "text": "MAIN OUTCOMES AND MEASURES: The primary end point was confirmed objective response (OR) per RECIST 1.1 by blinded independent central review."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36394867\", \"sentence_id\": 6, \"text\": \"RESULTS: A total of 200 patients (median [range] age, 59.0 [26.0-89.0] years; 132 [66.0%] women; 15 [7.5%] Asian, 11 [5.5%] African American, and 154 [77.0%] White participants) were enrolled: 159 (79.5%) in the BRCA1/2 cohort and 41 (20.5%) in the ATM cohort.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36394867", "sentence_id": 6, "text": "RESULTS: A total of 200 patients (median [range] age, 59.0 [26.0-89.0] years; 132 [66.0%] women; 15 [7.5%] Asian, 11 [5.5%] African American, and 154 [77.0%] White participants) were enrolled: 159 (79.5%) in the BRCA1/2 cohort and 41 (20.5%) in the ATM cohort."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36394867\", \"sentence_id\": 7, \"text\": \"The confirmed OR rate was 26.4% (42 patients, including 9 complete responses [5.7%]) in the BRCA1/2 cohort and 4.9% (2 patients) in the ATM cohort.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36394867", "sentence_id": 7, "text": "The confirmed OR rate was 26.4% (42 patients, including 9 complete responses [5.7%]) in the BRCA1/2 cohort and 4.9% (2 patients) in the ATM cohort."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36394867\", \"sentence_id\": 8, \"text\": \"In the BRCA1/2 cohort, responses were more frequent (OR rate, 30.3%; 95% CI, 22.2%-39.3%, including 8 complete responses [6.7%]) and more durable (median duration of response: 10.9 months [95% CI, 6.2 months to not estimable]) in tumor types associated with increased heritable cancer risk (ie, BRCA1/2-associated cancer types, such as ovarian, breast, prostate, and pancreatic cancers) and in uterine leiomyosarcoma (objective response in 3 of 3 patients and with ongoing responses greater than 24 months) compared with non-BRCA-associated cancer types.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36394867", "sentence_id": 8, "text": "In the BRCA1/2 cohort, responses were more frequent (OR rate, 30.3%; 95% CI, 22.2%-39.3%, including 8 complete responses [6.7%]) and more durable (median duration of response: 10.9 months [95% CI, 6.2 months to not estimable]) in tumor types associated with increased heritable cancer risk (ie, BRCA1/2-associated cancer types, such as ovarian, breast, prostate, and pancreatic cancers) and in uterine leiomyosarcoma (objective response in 3 of 3 patients and with ongoing responses greater than 24 months) compared with non-BRCA-associated cancer types."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36394867\", \"sentence_id\": 9, \"text\": \"Responses in the BRCA1/2 cohort were numerically higher for patients with tumor mutational burden of 10 or more mutations per megabase (mut/Mb) vs less than 10 mut/Mb.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36394867", "sentence_id": 9, "text": "Responses in the BRCA1/2 cohort were numerically higher for patients with tumor mutational burden of 10 or more mutations per megabase (mut/Mb) vs less than 10 mut/Mb."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36394867\", \"sentence_id\": 10, \"text\": \"The combination was well tolerated, with no new safety signals identified.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36394867", "sentence_id": 10, "text": "The combination was well tolerated, with no new safety signals identified."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36394867\", \"sentence_id\": 11, \"text\": \"CONCLUSIONS AND RELEVANCE: In this phase 2b nonrandomized controlled trial, neither the BRCA1/2 nor ATM cohort met the prespecified OR rate of 40%.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36394867", "sentence_id": 11, "text": "CONCLUSIONS AND RELEVANCE: In this phase 2b nonrandomized controlled trial, neither the BRCA1/2 nor ATM cohort met the prespecified OR rate of 40%."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36394867\", \"sentence_id\": 12, \"text\": \"Antitumor activity for the combination of avelumab and talazoparib in patients with BRCA1/2 alterations was observed in some patients with BRCA1/2-associated tumor types and uterine leiomyosarcoma; benefit was minimal in non-BRCA-associated cancer types.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36394867", "sentence_id": 12, "text": "Antitumor activity for the combination of avelumab and talazoparib in patients with BRCA1/2 alterations was observed in some patients with BRCA1/2-associated tumor types and uterine leiomyosarcoma; benefit was minimal in non-BRCA-associated cancer types."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36394867\", \"sentence_id\": 13, \"text\": \"TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03565991.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36394867", "sentence_id": 13, "text": "TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03565991."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36394849\", \"sentence_id\": 0, \"text\": \"IMPORTANCE: Preclinical data suggest that poly(ADP-ribose) polymerase (PARP) inhibitors have synergistic activity when combined with immune checkpoint inhibitors (ICIs); however, it is unknown which tumor types or molecular subtypes may benefit from this combination.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36394849", "sentence_id": 0, "text": "IMPORTANCE: Preclinical data suggest that poly(ADP-ribose) polymerase (PARP) inhibitors have synergistic activity when combined with immune checkpoint inhibitors (ICIs); however, it is unknown which tumor types or molecular subtypes may benefit from this combination."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36394849\", \"sentence_id\": 1, \"text\": \"OBJECTIVE: To investigate responses associated with the combination of avelumab and talazoparib in different tumor types and/or molecular subtypes.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36394849", "sentence_id": 1, "text": "OBJECTIVE: To investigate responses associated with the combination of avelumab and talazoparib in different tumor types and/or molecular subtypes."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36394849\", \"sentence_id\": 2, \"text\": \"DESIGN, SETTING, AND PARTICIPANTS: In this phase 1b and 2 basket nonrandomized controlled trial, patients with advanced solid tumors were enrolled in the following cohorts: non-small cell lung cancer (NSCLC); DNA damage response (DDR)-positive NSCLC; triple-negative breast cancer (TNBC); hormone receptor-positive, human epidermal growth factor receptor 2 (ERBB2)-negative, DDR-positive breast cancer; recurrent, platinum-sensitive ovarian cancer (OC); recurrent, platinum-sensitive, BRCA1/2-altered OC; urothelial cancer; metastatic castration-resistant prostate cancer (mCRPC); DDR-positive mCRPC; and BRCA1/2- or ATM-altered solid tumors.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36394849", "sentence_id": 2, "text": "DESIGN, SETTING, AND PARTICIPANTS: In this phase 1b and 2 basket nonrandomized controlled trial, patients with advanced solid tumors were enrolled in the following cohorts: non-small cell lung cancer (NSCLC); DNA damage response (DDR)-positive NSCLC; triple-negative breast cancer (TNBC); hormone receptor-positive, human epidermal growth factor receptor 2 (ERBB2)-negative, DDR-positive breast cancer; recurrent, platinum-sensitive ovarian cancer (OC); recurrent, platinum-sensitive, BRCA1/2-altered OC; urothelial cancer; metastatic castration-resistant prostate cancer (mCRPC); DDR-positive mCRPC; and BRCA1/2- or ATM-altered solid tumors."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36394849\", \"sentence_id\": 3, \"text\": \"Data were analyzed between June 17, 2021, and August 6, 2021.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36394849", "sentence_id": 3, "text": "Data were analyzed between June 17, 2021, and August 6, 2021."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36394849\", \"sentence_id\": 4, \"text\": \"INTERVENTIONS: All patients in phases 1b and 2 received avelumab plus talazoparib.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36394849", "sentence_id": 4, "text": "INTERVENTIONS: All patients in phases 1b and 2 received avelumab plus talazoparib."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36394849\", \"sentence_id\": 5, \"text\": \"MAIN OUTCOMES AND MEASURES: The phase 1b primary end point was dose-limiting toxic effects.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36394849", "sentence_id": 5, "text": "MAIN OUTCOMES AND MEASURES: The phase 1b primary end point was dose-limiting toxic effects."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36394849\", \"sentence_id\": 6, \"text\": \"The phase 2 primary end point was objective response, measured as objective response rate (ORR).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36394849", "sentence_id": 6, "text": "The phase 2 primary end point was objective response, measured as objective response rate (ORR)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36394849\", \"sentence_id\": 7, \"text\": \"Secondary end points included safety, time to response, duration of response (DOR), progression-free survival, time to prostate-specific antigen progression and PSA response of 50% or greater (for mCRPC), cancer antigen 125 response (for OC), pharmacokinetics, immunogenicity, and biomarkers.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36394849", "sentence_id": 7, "text": "Secondary end points included safety, time to response, duration of response (DOR), progression-free survival, time to prostate-specific antigen progression and PSA response of 50% or greater (for mCRPC), cancer antigen 125 response (for OC), pharmacokinetics, immunogenicity, and biomarkers."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36394849\", \"sentence_id\": 8, \"text\": \"RESULTS: A total of 223 patients (mean [SD] age, 63.2 [11.0] years; 117 [52.5%] men) were treated, including 12 patients in phase 1b and 211 patients in phase 2.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36394849", "sentence_id": 8, "text": "RESULTS: A total of 223 patients (mean [SD] age, 63.2 [11.0] years; 117 [52.5%] men) were treated, including 12 patients in phase 1b and 211 patients in phase 2."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36394849\", \"sentence_id\": 9, \"text\": \"The recommended phase 2 dose was avelumab 800 mg every 2 weeks plus talazoparib 1 mg once daily.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36394849", "sentence_id": 9, "text": "The recommended phase 2 dose was avelumab 800 mg every 2 weeks plus talazoparib 1 mg once daily."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36394849\", \"sentence_id\": 10, \"text\": \"In phase 2, the ORR was 18.2% (95% CI, 5.2%-40.3%) in patients with TNBC; 34.8% (95% CI, 16.4%-57.3%) in patients with HR-positive, ERBB2-negative, and DDR-positive BC; and 63.6% (95% CI, 30.8%-89.1%) in patients with platinum-sensitive, BRCA1/2-altered OC.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36394849", "sentence_id": 10, "text": "In phase 2, the ORR was 18.2% (95% CI, 5.2%-40.3%) in patients with TNBC; 34.8% (95% CI, 16.4%-57.3%) in patients with HR-positive, ERBB2-negative, and DDR-positive BC; and 63.6% (95% CI, 30.8%-89.1%) in patients with platinum-sensitive, BRCA1/2-altered OC."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36394849\", \"sentence_id\": 11, \"text\": \"Responses occurred more frequently in patients with BRCA1/2-altered tumors.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36394849", "sentence_id": 11, "text": "Responses occurred more frequently in patients with BRCA1/2-altered tumors."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36394849\", \"sentence_id\": 12, \"text\": \"Durable responses were observed in patients with TNBC (median [range] DOR, 11.1 [3.4-20.4] months); HR-positive, ERBB2-negative, and DDR-positive BC (median [range] DOR, 15.7 [3.9 to \u226520.6] months); and BRCA1/2-altered OC (median DOR not reached; range, 5.6 to \u226518.4 months).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36394849", "sentence_id": 12, "text": "Durable responses were observed in patients with TNBC (median [range] DOR, 11.1 [3.4-20.4] months); HR-positive, ERBB2-negative, and DDR-positive BC (median [range] DOR, 15.7 [3.9 to \u226520.6] months); and BRCA1/2-altered OC (median DOR not reached; range, 5.6 to \u226518.4 months)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36394849\", \"sentence_id\": 13, \"text\": \"The most common grade 3 or greater treatment-related adverse events were anemia (75 patients [33.6%]), thrombocytopenia (48 patients [21.5%]), and neutropenia (31 patients [13.9%]).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36394849", "sentence_id": 13, "text": "The most common grade 3 or greater treatment-related adverse events were anemia (75 patients [33.6%]), thrombocytopenia (48 patients [21.5%]), and neutropenia (31 patients [13.9%])."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36394849\", \"sentence_id\": 14, \"text\": \"CONCLUSIONS AND RELEVANCE: This nonrandomized controlled trial found that ORRs for avelumab plus talazoparib were comparable with those with PARP inhibitor or ICI monotherapy.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36394849", "sentence_id": 14, "text": "CONCLUSIONS AND RELEVANCE: This nonrandomized controlled trial found that ORRs for avelumab plus talazoparib were comparable with those with PARP inhibitor or ICI monotherapy."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36394849\", \"sentence_id\": 15, \"text\": \"Prolonged DOR in patients with TNBC; HR-positive, ERBB2-negative, and DDR-positive BC; and BRCA1/2-altered OC warrant further investigation in randomized clinical trials.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36394849", "sentence_id": 15, "text": "Prolonged DOR in patients with TNBC; HR-positive, ERBB2-negative, and DDR-positive BC; and BRCA1/2-altered OC warrant further investigation in randomized clinical trials."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36394849\", \"sentence_id\": 16, \"text\": \"These data highlight the importance of prospective patient selection in future studies of ICI and PARP-inhibitor combinations.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36394849", "sentence_id": 16, "text": "These data highlight the importance of prospective patient selection in future studies of ICI and PARP-inhibitor combinations."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36394849\", \"sentence_id\": 17, \"text\": \"TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03330405.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36394849", "sentence_id": 17, "text": "TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03330405."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36288893\", \"sentence_id\": 0, \"text\": \"BACKGROUND/AIM: Tumor cell lines are essential tools in understanding the molecular mechanisms underlying cancer biology and therapeutic responses.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36288893", "sentence_id": 0, "text": "BACKGROUND/AIM: Tumor cell lines are essential tools in understanding the molecular mechanisms underlying cancer biology and therapeutic responses."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36288893\", \"sentence_id\": 1, \"text\": \"Poly (ADP-ribose) polymerase inhibitors (PARPi) kill tumor cells harboring pathogenic mutations of BRCA DNA repair-associated genes 1/2 (BRCA1/2) and are approved to treat ovarian and metastatic breast cancer.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36288893", "sentence_id": 1, "text": "Poly (ADP-ribose) polymerase inhibitors (PARPi) kill tumor cells harboring pathogenic mutations of BRCA DNA repair-associated genes 1/2 (BRCA1/2) and are approved to treat ovarian and metastatic breast cancer."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36288893\", \"sentence_id\": 2, \"text\": \"Loss of heterozygosity (LOH) of the wild-type BRCA1/2 locus is suspected to increase cellular response to PARPi.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36288893", "sentence_id": 2, "text": "Loss of heterozygosity (LOH) of the wild-type BRCA1/2 locus is suspected to increase cellular response to PARPi."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36288893\", \"sentence_id\": 3, \"text\": \"To better elucidate the molecular mechanisms underlying PARPi sensitivity and resistance, this study assessed the responses of various pathogenic BRCA1/2-mutant cell lines to the PARPi talazoparib.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36288893", "sentence_id": 3, "text": "To better elucidate the molecular mechanisms underlying PARPi sensitivity and resistance, this study assessed the responses of various pathogenic BRCA1/2-mutant cell lines to the PARPi talazoparib."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36288893\", \"sentence_id\": 4, \"text\": \"MATERIALS AND METHODS: Mutant cell lines were extracted and cultured from four surgically resected, human breast cancer specimens with different pathogenic BRCA1/2, one normal breast specimen and one ovarian cancer specimen.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36288893", "sentence_id": 4, "text": "MATERIALS AND METHODS: Mutant cell lines were extracted and cultured from four surgically resected, human breast cancer specimens with different pathogenic BRCA1/2, one normal breast specimen and one ovarian cancer specimen."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36288893\", \"sentence_id\": 5, \"text\": \"Mutation analysis was performed on all cell lines using genomic DNA extraction and polymerase chain reaction.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36288893", "sentence_id": 5, "text": "Mutation analysis was performed on all cell lines using genomic DNA extraction and polymerase chain reaction."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36288893\", \"sentence_id\": 6, \"text\": \"Following treatment with talazoparib, cell growth was assessed using tetrazolium salt and half-maximal inhibitory concentration values were determined.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36288893", "sentence_id": 6, "text": "Following treatment with talazoparib, cell growth was assessed using tetrazolium salt and half-maximal inhibitory concentration values were determined."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36288893\", \"sentence_id\": 7, \"text\": \"RESULTS: A partial correlation between different variants of pathogenic BRCA1/2 mutation and talazoparib susceptibility was found, with five of the cell lines exhibiting sensitivity to talazoparib.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36288893", "sentence_id": 7, "text": "RESULTS: A partial correlation between different variants of pathogenic BRCA1/2 mutation and talazoparib susceptibility was found, with five of the cell lines exhibiting sensitivity to talazoparib."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36288893\", \"sentence_id\": 8, \"text\": \"The most sensitive cell-line to talazoparib had LOH for BRCA1, while the breast cancer cell line harboring BRCA2 LOH was resistant to talazoparib.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36288893", "sentence_id": 8, "text": "The most sensitive cell-line to talazoparib had LOH for BRCA1, while the breast cancer cell line harboring BRCA2 LOH was resistant to talazoparib."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36288893\", \"sentence_id\": 9, \"text\": \"CONCLUSION: This study suggests that LOH does not necessarily correlate with PARPi efficacy.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36288893", "sentence_id": 9, "text": "CONCLUSION: This study suggests that LOH does not necessarily correlate with PARPi efficacy."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36288893\", \"sentence_id\": 10, \"text\": \"These results lay a foundation for future studies to utilize these novel cell lines to further elucidate the underlying molecular mechanisms of PARPi resistance and reveal new potential drug targets.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36288893", "sentence_id": 10, "text": "These results lay a foundation for future studies to utilize these novel cell lines to further elucidate the underlying molecular mechanisms of PARPi resistance and reveal new potential drug targets."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36285641\", \"sentence_id\": 0, \"text\": \"INTRODUCTION: PARP inhibition in prostate cancer has become a standard-of-care option for men with metastatic castration-resistant prostate cancer (mCRPC) with deficiency in homologous recombination repair (HRRd).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36285641", "sentence_id": 0, "text": "INTRODUCTION: PARP inhibition in prostate cancer has become a standard-of-care option for men with metastatic castration-resistant prostate cancer (mCRPC) with deficiency in homologous recombination repair (HRRd)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36285641\", \"sentence_id\": 1, \"text\": \"The benefit varies based upon the characteristics of the PARP inhibitor used and the underlying HRR defect.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36285641", "sentence_id": 1, "text": "The benefit varies based upon the characteristics of the PARP inhibitor used and the underlying HRR defect."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36285641\", \"sentence_id\": 2, \"text\": \"Optimal patient selection remains a clinical challenge, and investigations are underway to identify effective combination therapies to expand the population that benefits.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36285641", "sentence_id": 2, "text": "Optimal patient selection remains a clinical challenge, and investigations are underway to identify effective combination therapies to expand the population that benefits."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36285641\", \"sentence_id\": 3, \"text\": \"AREAS COVERED: We review the clinical development of the FDA-approved PARP inhibitors olaparib and rucaparib.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36285641", "sentence_id": 3, "text": "AREAS COVERED: We review the clinical development of the FDA-approved PARP inhibitors olaparib and rucaparib."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36285641\", \"sentence_id\": 4, \"text\": \"Additionally, we explore the status of other PARP inhibitors that remain experimental in prostate cancer, based upon review of published abstracts, articles, and clinicaltrials.gov.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36285641", "sentence_id": 4, "text": "Additionally, we explore the status of other PARP inhibitors that remain experimental in prostate cancer, based upon review of published abstracts, articles, and clinicaltrials.gov."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36285641\", \"sentence_id\": 5, \"text\": \"Most new studies, including phase 3 trials for talazoparib and rucaparib, involve combinations with novel androgen receptor signaling inhibitors.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36285641", "sentence_id": 5, "text": "Most new studies, including phase 3 trials for talazoparib and rucaparib, involve combinations with novel androgen receptor signaling inhibitors."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36285641\", \"sentence_id\": 6, \"text\": \"We review the landscape of emerging PARP inhibitor-based combination therapies.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36285641", "sentence_id": 6, "text": "We review the landscape of emerging PARP inhibitor-based combination therapies."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36285641\", \"sentence_id\": 7, \"text\": \"EXPERT OPINION: For men with\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36285641", "sentence_id": 7, "text": "EXPERT OPINION: For men with"}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36124924\", \"sentence_id\": 0, \"text\": \"BACKGROUND: The phase II TALAPRO-1 study (NCT03148795) demonstrated durable antitumor activity in men with heavily pretreated metastatic castration-resistant prostate cancer (mCRPC).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36124924", "sentence_id": 0, "text": "BACKGROUND: The phase II TALAPRO-1 study (NCT03148795) demonstrated durable antitumor activity in men with heavily pretreated metastatic castration-resistant prostate cancer (mCRPC)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36124924\", \"sentence_id\": 1, \"text\": \"Here, we detail the safety profile of talazoparib.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36124924", "sentence_id": 1, "text": "Here, we detail the safety profile of talazoparib."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36124924\", \"sentence_id\": 2, \"text\": \"PATIENTS AND METHODS: Men received talazoparib 1 mg/day (moderate renal impairment 0.75 mg/day) orally until radiographic progression, unacceptable toxicity, investigator decision, consent withdrawal, or death.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36124924", "sentence_id": 2, "text": "PATIENTS AND METHODS: Men received talazoparib 1 mg/day (moderate renal impairment 0.75 mg/day) orally until radiographic progression, unacceptable toxicity, investigator decision, consent withdrawal, or death."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36124924\", \"sentence_id\": 3, \"text\": \"Adverse events (AEs) were evaluated: incidence, severity, timing, duration, potential overlap of selected AEs, dose modifications/discontinuations due to AEs, and new clinically significant changes in laboratory values and vital signs.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36124924", "sentence_id": 3, "text": "Adverse events (AEs) were evaluated: incidence, severity, timing, duration, potential overlap of selected AEs, dose modifications/discontinuations due to AEs, and new clinically significant changes in laboratory values and vital signs."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36124924\", \"sentence_id\": 4, \"text\": \"RESULTS: In the safety population (N = 127; median age 69.0 years), 95.3% (121/127) experienced all-cause treatment-emergent adverse events (TEAEs).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36124924", "sentence_id": 4, "text": "RESULTS: In the safety population (N = 127; median age 69.0 years), 95.3% (121/127) experienced all-cause treatment-emergent adverse events (TEAEs)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36124924\", \"sentence_id\": 5, \"text\": \"Most common were anemia (48.8% [62/127]), nausea (33.1% [42/127]), decreased appetite (28.3% [36/127]), and asthenia (23.6% [30/127]).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36124924", "sentence_id": 5, "text": "Most common were anemia (48.8% [62/127]), nausea (33.1% [42/127]), decreased appetite (28.3% [36/127]), and asthenia (23.6% [30/127])."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36124924\", \"sentence_id\": 6, \"text\": \"Nonhematologic TEAEs were generally grades 1 and 2.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36124924", "sentence_id": 6, "text": "Nonhematologic TEAEs were generally grades 1 and 2."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36124924\", \"sentence_id\": 7, \"text\": \"No grade 5 TEAEs or deaths were treatment-related.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36124924", "sentence_id": 7, "text": "No grade 5 TEAEs or deaths were treatment-related."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36124924\", \"sentence_id\": 8, \"text\": \"Hematologic TEAEs typically occurred during the first 4-5 months of treatment.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36124924", "sentence_id": 8, "text": "Hematologic TEAEs typically occurred during the first 4-5 months of treatment."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36124924\", \"sentence_id\": 9, \"text\": \"The median duration of grade 3-4 anemia, neutropenia, and thrombocytopenia was limited to 7-12 days.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36124924", "sentence_id": 9, "text": "The median duration of grade 3-4 anemia, neutropenia, and thrombocytopenia was limited to 7-12 days."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36124924\", \"sentence_id\": 10, \"text\": \"No grade 4 events of anemia or neutropenia occurred.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36124924", "sentence_id": 10, "text": "No grade 4 events of anemia or neutropenia occurred."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36124924\", \"sentence_id\": 11, \"text\": \"Neither BRCA status nor alteration origin significantly impacted the safety profile.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36124924", "sentence_id": 11, "text": "Neither BRCA status nor alteration origin significantly impacted the safety profile."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36124924\", \"sentence_id\": 12, \"text\": \"The median (range) treatment duration was 6.1 (0.4-24.9) months; treatment duration did not impact the incidence of anemia.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36124924", "sentence_id": 12, "text": "The median (range) treatment duration was 6.1 (0.4-24.9) months; treatment duration did not impact the incidence of anemia."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36124924\", \"sentence_id\": 13, \"text\": \"Only 3 of the 15 (11.8% [15/127]) permanent treatment discontinuations were due to hematologic TEAEs (thrombocytopenia 1.6% [2/127]; leukopenia 0.8% [1/127]).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36124924", "sentence_id": 13, "text": "Only 3 of the 15 (11.8% [15/127]) permanent treatment discontinuations were due to hematologic TEAEs (thrombocytopenia 1.6% [2/127]; leukopenia 0.8% [1/127])."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36124924\", \"sentence_id\": 14, \"text\": \"CONCLUSION: Common TEAEs associated with talazoparib could be managed through dose modifications/supportive care.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36124924", "sentence_id": 14, "text": "CONCLUSION: Common TEAEs associated with talazoparib could be managed through dose modifications/supportive care."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36124924\", \"sentence_id\": 15, \"text\": \"Demonstrated efficacy and a manageable safety profile support continued evaluation of talazoparib in mCRPC.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36124924", "sentence_id": 15, "text": "Demonstrated efficacy and a manageable safety profile support continued evaluation of talazoparib in mCRPC."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36124924\", \"sentence_id\": 16, \"text\": \"CLINICALTRIALS.GOV IDENTIFIER: NCT03148795.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36124924", "sentence_id": 16, "text": "CLINICALTRIALS.GOV IDENTIFIER: NCT03148795."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36051614\", \"sentence_id\": 0, \"text\": \"PARP inhibitors were recently introduced as a novel targeted therapy for biomarker positive metastatic castration resistant prostate cancer (mCRPC) patients, a population that inevitably acquires resistance to existing standard care regimens.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36051614", "sentence_id": 0, "text": "PARP inhibitors were recently introduced as a novel targeted therapy for biomarker positive metastatic castration resistant prostate cancer (mCRPC) patients, a population that inevitably acquires resistance to existing standard care regimens."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36051614\", \"sentence_id\": 1, \"text\": \"Olaparib and rucaparib are now FDA-approved for mCRPC, while talazoparib and niraparib are advancing through the clinical stage of development.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36051614", "sentence_id": 1, "text": "Olaparib and rucaparib are now FDA-approved for mCRPC, while talazoparib and niraparib are advancing through the clinical stage of development."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36051614\", \"sentence_id\": 2, \"text\": \"We highlight the recent results of the GALAHAD trial testing the efficacy of niraparib in mCRPC patients with DNA damage repair gene defects and compare its performance to key PARP inhibitor trials (PROFOUND, olaparib; TRITON2, rucaparib; TALAPRO-1, talazoparib).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36051614", "sentence_id": 2, "text": "We highlight the recent results of the GALAHAD trial testing the efficacy of niraparib in mCRPC patients with DNA damage repair gene defects and compare its performance to key PARP inhibitor trials (PROFOUND, olaparib; TRITON2, rucaparib; TALAPRO-1, talazoparib)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"36051614\", \"sentence_id\": 3, \"text\": \"Finally, we briefly discuss recent updates on emerging PARP inhibitor and androgen receptor targeting combination trials as a novel treatment strategy for upfront treatment of mCRPC and in earlier disease settings.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "36051614", "sentence_id": 3, "text": "Finally, we briefly discuss recent updates on emerging PARP inhibitor and androgen receptor targeting combination trials as a novel treatment strategy for upfront treatment of mCRPC and in earlier disease settings."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35989659\", \"sentence_id\": 0, \"text\": \"Poly(ADP-ribose) polymerase inhibitors (PARPi) are approved as monotherapies in\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35989659", "sentence_id": 0, "text": "Poly(ADP-ribose) polymerase inhibitors (PARPi) are approved as monotherapies in"}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35950899\", \"sentence_id\": 0, \"text\": \"WHAT IS THIS SUMMARY ABOUT?: This summary describes the design of an ongoing research study (also known as a clinical trial) called TALAPRO-2.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35950899", "sentence_id": 0, "text": "WHAT IS THIS SUMMARY ABOUT?: This summary describes the design of an ongoing research study (also known as a clinical trial) called TALAPRO-2."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35950899\", \"sentence_id\": 1, \"text\": \"The TALAPRO-2 trial is testing the combination of two medicines called talazoparib and enzalutamide as a first treatment in adult men with metastatic castration-resistant prostate cancer.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35950899", "sentence_id": 1, "text": "The TALAPRO-2 trial is testing the combination of two medicines called talazoparib and enzalutamide as a first treatment in adult men with metastatic castration-resistant prostate cancer."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35950899\", \"sentence_id\": 2, \"text\": \"The study began in December 2017 and has enrolled 1037 adult men with metastatic castration-resistant prostate cancer from 26 countries.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35950899", "sentence_id": 2, "text": "The study began in December 2017 and has enrolled 1037 adult men with metastatic castration-resistant prostate cancer from 26 countries."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35950899\", \"sentence_id\": 3, \"text\": \"WHAT IS METASTATIC CASTRATION-RESISTANT PROSTATE CANCER?: Metastatic castration-resistant prostate cancer is a type of cancer that has advanced beyond the prostate and continues to grow even when testosterone levels in the blood are suppressed.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35950899", "sentence_id": 3, "text": "WHAT IS METASTATIC CASTRATION-RESISTANT PROSTATE CANCER?: Metastatic castration-resistant prostate cancer is a type of cancer that has advanced beyond the prostate and continues to grow even when testosterone levels in the blood are suppressed."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35950899\", \"sentence_id\": 4, \"text\": \"WHICH MEDICINES ARE BEING TESTED?: The combination of talazoparib plus enzalutamide will be compared with enzalutamide plus placebo.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35950899", "sentence_id": 4, "text": "WHICH MEDICINES ARE BEING TESTED?: The combination of talazoparib plus enzalutamide will be compared with enzalutamide plus placebo."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35950899\", \"sentence_id\": 5, \"text\": \"Enzalutamide is approved to treat men with prostate cancer.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35950899", "sentence_id": 5, "text": "Enzalutamide is approved to treat men with prostate cancer."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35950899\", \"sentence_id\": 6, \"text\": \"Talazoparib is not approved to treat men with prostate cancer.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35950899", "sentence_id": 6, "text": "Talazoparib is not approved to treat men with prostate cancer."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35950899\", \"sentence_id\": 7, \"text\": \"A placebo does not contain any active ingredients and is also known as a sugar pill.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35950899", "sentence_id": 7, "text": "A placebo does not contain any active ingredients and is also known as a sugar pill."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35950899\", \"sentence_id\": 8, \"text\": \"WHAT ARE THE AIMS OF THE TALAPRO-2 TRIAL?: The TALAPRO-2 trial will find out if combining talazoparib with enzalutamide increases the length of time the men in the study live without their cancer getting worse compared with enzalutamide plus placebo.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35950899", "sentence_id": 8, "text": "WHAT ARE THE AIMS OF THE TALAPRO-2 TRIAL?: The TALAPRO-2 trial will find out if combining talazoparib with enzalutamide increases the length of time the men in the study live without their cancer getting worse compared with enzalutamide plus placebo."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35950899\", \"sentence_id\": 9, \"text\": \"The study will also measure how long men in the study live and any side effects the men have while they are taking the study medicines.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35950899", "sentence_id": 9, "text": "The study will also measure how long men in the study live and any side effects the men have while they are taking the study medicines."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35950899\", \"sentence_id\": 10, \"text\": \"Researchers are also testing the DNA from the tumor cells of all men in the study to find out if they have faulty DNA repair genes.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35950899", "sentence_id": 10, "text": "Researchers are also testing the DNA from the tumor cells of all men in the study to find out if they have faulty DNA repair genes."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35900726\", \"sentence_id\": 0, \"text\": \"IMPORTANCE: Although the activity of pembrolizumab and lenvatinib (the only US Food and Drug Administration-approved immunotherapy for mismatch repair proficient endometrial cancer [MMRP EC]) is compelling, there are no biomarkers of response and most patients do not tolerate, do not respond to, or develop resistance to this regimen, highlighting the need for additional, potentially biomarker-driven therapeutic approaches for patients with recurrent MMRP EC.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35900726", "sentence_id": 0, "text": "IMPORTANCE: Although the activity of pembrolizumab and lenvatinib (the only US Food and Drug Administration-approved immunotherapy for mismatch repair proficient endometrial cancer [MMRP EC]) is compelling, there are no biomarkers of response and most patients do not tolerate, do not respond to, or develop resistance to this regimen, highlighting the need for additional, potentially biomarker-driven therapeutic approaches for patients with recurrent MMRP EC."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35900726\", \"sentence_id\": 1, \"text\": \"OBJECTIVE: To assess the potential positive outcomes and safety of the combination of the polyadenosine diphosphate-ribose polymerase inhibitor talazoparib and the programmed cell death ligand 1 (PD-L1) inhibitor avelumab in recurrent MMRP EC.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35900726", "sentence_id": 1, "text": "OBJECTIVE: To assess the potential positive outcomes and safety of the combination of the polyadenosine diphosphate-ribose polymerase inhibitor talazoparib and the programmed cell death ligand 1 (PD-L1) inhibitor avelumab in recurrent MMRP EC."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35900726\", \"sentence_id\": 2, \"text\": \"DESIGN, SETTINGS, AND PARTICIPANTS: This investigator-initiated, open-label, single-arm, 2-stage, phase 2 study nonrandomized controlled trial patients at 4 institutions in the US.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35900726", "sentence_id": 2, "text": "DESIGN, SETTINGS, AND PARTICIPANTS: This investigator-initiated, open-label, single-arm, 2-stage, phase 2 study nonrandomized controlled trial patients at 4 institutions in the US."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35900726\", \"sentence_id\": 3, \"text\": \"Key eligibility criteria included measurable disease, unlimited prior therapies, and all endometrial cancer histologies.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35900726", "sentence_id": 3, "text": "Key eligibility criteria included measurable disease, unlimited prior therapies, and all endometrial cancer histologies."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35900726\", \"sentence_id\": 4, \"text\": \"INTERVENTIONS: Talazoparib, 1 mg, orally, daily, and avelumab, 10 mg/kg, intravenously, every 2 weeks, were administered until disease progression or unacceptable toxic effects.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35900726", "sentence_id": 4, "text": "INTERVENTIONS: Talazoparib, 1 mg, orally, daily, and avelumab, 10 mg/kg, intravenously, every 2 weeks, were administered until disease progression or unacceptable toxic effects."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35900726\", \"sentence_id\": 5, \"text\": \"MAIN OUTCOMES AND MEASURES: Statistical considerations were developed for 2 coprimary objectives of objective response rate and rate of progression-free survival at 6 months, with a 2-stage design that allowed for early discontinuation for futility.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35900726", "sentence_id": 5, "text": "MAIN OUTCOMES AND MEASURES: Statistical considerations were developed for 2 coprimary objectives of objective response rate and rate of progression-free survival at 6 months, with a 2-stage design that allowed for early discontinuation for futility."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35900726\", \"sentence_id\": 6, \"text\": \"Prespecified exploratory objectives included the association of immunogenomic features (determined by targeted-panel next-generation sequencing and immunohistochemistry) with activity.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35900726", "sentence_id": 6, "text": "Prespecified exploratory objectives included the association of immunogenomic features (determined by targeted-panel next-generation sequencing and immunohistochemistry) with activity."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35900726\", \"sentence_id\": 7, \"text\": \"RESULTS: Thirty-five female patients (mean [SD] age, 67.9 [8.41] years) received protocol therapy; 9 (25.7%) derived clinical benefit after meeting at least 1 of the 2 coprimary end points.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35900726", "sentence_id": 7, "text": "RESULTS: Thirty-five female patients (mean [SD] age, 67.9 [8.41] years) received protocol therapy; 9 (25.7%) derived clinical benefit after meeting at least 1 of the 2 coprimary end points."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35900726\", \"sentence_id\": 8, \"text\": \"Four patients (11.4%) exhibited confirmed objective response rates (4 partial responses), and 8 (22.9%) survived progression free at 6 months.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35900726", "sentence_id": 8, "text": "Four patients (11.4%) exhibited confirmed objective response rates (4 partial responses), and 8 (22.9%) survived progression free at 6 months."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35900726\", \"sentence_id\": 9, \"text\": \"The most common grade 3 and 4 treatment-related toxic effects were anemia (16 [46%]), thrombocytopenia (10 [29%]), and neutropenia (4 [11%]); no patient discontinued receipt of therapy because of toxic effects.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35900726", "sentence_id": 9, "text": "The most common grade 3 and 4 treatment-related toxic effects were anemia (16 [46%]), thrombocytopenia (10 [29%]), and neutropenia (4 [11%]); no patient discontinued receipt of therapy because of toxic effects."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35900726\", \"sentence_id\": 10, \"text\": \"Tumors with homologous recombination repair alterations were associated with clinical benefit from treatment with avelumab and talazoparib.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35900726", "sentence_id": 10, "text": "Tumors with homologous recombination repair alterations were associated with clinical benefit from treatment with avelumab and talazoparib."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35900726\", \"sentence_id\": 11, \"text\": \"Tumor mutational burden, tumor-infiltrating lymphocytes, and PD-L1 status were not associated with clinical benefit.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35900726", "sentence_id": 11, "text": "Tumor mutational burden, tumor-infiltrating lymphocytes, and PD-L1 status were not associated with clinical benefit."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35900726\", \"sentence_id\": 12, \"text\": \"CONCLUSIONS AND RELEVANCE: The results of this nonrandomized controlled trial suggest that treatment with avelumab and talazoparib demonstrated a favorable toxic effect profile and met the predetermined criteria to be considered worthy of further evaluation in MMRP EC.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35900726", "sentence_id": 12, "text": "CONCLUSIONS AND RELEVANCE: The results of this nonrandomized controlled trial suggest that treatment with avelumab and talazoparib demonstrated a favorable toxic effect profile and met the predetermined criteria to be considered worthy of further evaluation in MMRP EC."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35900726\", \"sentence_id\": 13, \"text\": \"Immunogenomic profiling provided insights that may inform ongoing and future studies of polyadenosine diphosphate-ribose polymerase and PD-L1 inhibitor combinations in endometrial cancer.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35900726", "sentence_id": 13, "text": "Immunogenomic profiling provided insights that may inform ongoing and future studies of polyadenosine diphosphate-ribose polymerase and PD-L1 inhibitor combinations in endometrial cancer."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35900726\", \"sentence_id\": 14, \"text\": \"TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02912572.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35900726", "sentence_id": 14, "text": "TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02912572."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35864202\", \"sentence_id\": 0, \"text\": \"The synthetic lethal association between BRCA deficiency and poly (ADP-ribose) polymerase (PARP) inhibition supports PARP inhibitor (PARPi) clinical efficacy in BRCA-mutated tumors.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35864202", "sentence_id": 0, "text": "The synthetic lethal association between BRCA deficiency and poly (ADP-ribose) polymerase (PARP) inhibition supports PARP inhibitor (PARPi) clinical efficacy in BRCA-mutated tumors."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35864202\", \"sentence_id\": 1, \"text\": \"PARPis also demonstrate activity in non-BRCA mutated tumors presumably through induction of PARP1-DNA trapping.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35864202", "sentence_id": 1, "text": "PARPis also demonstrate activity in non-BRCA mutated tumors presumably through induction of PARP1-DNA trapping."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35864202\", \"sentence_id\": 2, \"text\": \"Despite pronounced clinical response, therapeutic resistance to PARPis inevitably develops.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35864202", "sentence_id": 2, "text": "Despite pronounced clinical response, therapeutic resistance to PARPis inevitably develops."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35864202\", \"sentence_id\": 3, \"text\": \"An abundance of knowledge has been built around resistance mechanisms in BRCA-mutated tumors, however, parallel understanding in non-BRCA mutated settings remains insufficient.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35864202", "sentence_id": 3, "text": "An abundance of knowledge has been built around resistance mechanisms in BRCA-mutated tumors, however, parallel understanding in non-BRCA mutated settings remains insufficient."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35864202\", \"sentence_id\": 4, \"text\": \"In this study, we find a strong correlation between the epithelial-mesenchymal transition (EMT) signature and resistance to a clinical PARPi, Talazoparib, in non-BRCA mutated tumor cells.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35864202", "sentence_id": 4, "text": "In this study, we find a strong correlation between the epithelial-mesenchymal transition (EMT) signature and resistance to a clinical PARPi, Talazoparib, in non-BRCA mutated tumor cells."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35864202\", \"sentence_id\": 5, \"text\": \"Genetic profiling demonstrates that SNAI2, a master EMT transcription factor, is transcriptionally induced by Talazoparib treatment or PARP1 depletion and this induction is partially responsible for the emerging resistance.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35864202", "sentence_id": 5, "text": "Genetic profiling demonstrates that SNAI2, a master EMT transcription factor, is transcriptionally induced by Talazoparib treatment or PARP1 depletion and this induction is partially responsible for the emerging resistance."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35864202\", \"sentence_id\": 6, \"text\": \"Mechanistically, we find that the PARP1 protein directly binds to SNAI2 gene promoter and suppresses its transcription.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35864202", "sentence_id": 6, "text": "Mechanistically, we find that the PARP1 protein directly binds to SNAI2 gene promoter and suppresses its transcription."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35864202\", \"sentence_id\": 7, \"text\": \"Talazoparib treatment or PARP1 depletion lifts PARP1-mediated suppression and increases chromatin accessibility around SNAI2 promoters, thus driving SNAI2 transcription and drug resistance.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35864202", "sentence_id": 7, "text": "Talazoparib treatment or PARP1 depletion lifts PARP1-mediated suppression and increases chromatin accessibility around SNAI2 promoters, thus driving SNAI2 transcription and drug resistance."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35864202\", \"sentence_id\": 8, \"text\": \"We also find that depletion of the chromatin remodeler CHD1L suppresses SNAI2 expression and reverts acquired resistance to Talazoparib.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35864202", "sentence_id": 8, "text": "We also find that depletion of the chromatin remodeler CHD1L suppresses SNAI2 expression and reverts acquired resistance to Talazoparib."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35864202\", \"sentence_id\": 9, \"text\": \"The PARP1/CHD1L/SNAI2 transcription axis might be therapeutically targeted to re-sensitize Talazoparib in non-BRCA mutated tumors.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35864202", "sentence_id": 9, "text": "The PARP1/CHD1L/SNAI2 transcription axis might be therapeutically targeted to re-sensitize Talazoparib in non-BRCA mutated tumors."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35750582\", \"sentence_id\": 0, \"text\": \"BACKGROUND: Talazoparib has shown antitumor activity with a manageable safety profile in men with metastatic castration-resistant prostate cancer (mCRPC) and DNA damage response (DDR)/homologous recombination repair (HRR) alterations.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35750582", "sentence_id": 0, "text": "BACKGROUND: Talazoparib has shown antitumor activity with a manageable safety profile in men with metastatic castration-resistant prostate cancer (mCRPC) and DNA damage response (DDR)/homologous recombination repair (HRR) alterations."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35750582\", \"sentence_id\": 1, \"text\": \"OBJECTIVE: To evaluate patient-reported health-related quality of life (HRQoL) and pain in patients who received talazoparib in the TALAPRO-1 study, with a special interest in patients harboring breast cancer susceptibility gene 1 or 2 (BRCA1/2) mutations.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35750582", "sentence_id": 1, "text": "OBJECTIVE: To evaluate patient-reported health-related quality of life (HRQoL) and pain in patients who received talazoparib in the TALAPRO-1 study, with a special interest in patients harboring breast cancer susceptibility gene 1 or 2 (BRCA1/2) mutations."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35750582\", \"sentence_id\": 2, \"text\": \"DESIGN, SETTING, AND PARTICIPANTS: TALAPRO-1 is a single-arm, phase 2 study in men with mCRPC DDR alterations either directly or indirectly involved in HRR, who previously received one to two taxane-based chemotherapy regimens for advanced prostate cancer and whose mCRPC progressed on one or more novel hormonal agents.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35750582", "sentence_id": 2, "text": "DESIGN, SETTING, AND PARTICIPANTS: TALAPRO-1 is a single-arm, phase 2 study in men with mCRPC DDR alterations either directly or indirectly involved in HRR, who previously received one to two taxane-based chemotherapy regimens for advanced prostate cancer and whose mCRPC progressed on one or more novel hormonal agents."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35750582\", \"sentence_id\": 3, \"text\": \"OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Men completed the European Quality-of-life Five-dimension Five-level scale (EQ-5D-5L), EQ-5D visual analog scale (VAS), and Brief Pain Inventory-Short Form at predefined time points during the study.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35750582", "sentence_id": 3, "text": "OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Men completed the European Quality-of-life Five-dimension Five-level scale (EQ-5D-5L), EQ-5D visual analog scale (VAS), and Brief Pain Inventory-Short Form at predefined time points during the study."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35750582\", \"sentence_id\": 4, \"text\": \"The patient-reported outcome (PRO) population included men who completed a baseline and one or more postbaseline assessments before study end.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35750582", "sentence_id": 4, "text": "The patient-reported outcome (PRO) population included men who completed a baseline and one or more postbaseline assessments before study end."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35750582\", \"sentence_id\": 5, \"text\": \"Longitudinal mixed-effect models assuming an unstructured covariance matrix were used to estimate the mean (95% confidence interval [CI]) change from baseline for pain and general health status measurements among all patients and patients with BRCA1/2 mutations.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35750582", "sentence_id": 5, "text": "Longitudinal mixed-effect models assuming an unstructured covariance matrix were used to estimate the mean (95% confidence interval [CI]) change from baseline for pain and general health status measurements among all patients and patients with BRCA1/2 mutations."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35750582\", \"sentence_id\": 6, \"text\": \"RESULTS AND LIMITATIONS: In the 97 men in the PRO population treated with talazoparib (BRCA1/2, n\u00a0=\u00a056), the mean (95% CI) EQ-5D-5L Index improved (all patients, 0.05 [0.01, 0.08]; BRCA1/2 subset, 0.07 [0.03, 0.10]), as did the EQ-5D VAS scores (all patients, 5.42 [2.65, 8.18]; BRCA1/2 subset, 4.74 [1.07, 8.41]).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35750582", "sentence_id": 6, "text": "RESULTS AND LIMITATIONS: In the 97 men in the PRO population treated with talazoparib (BRCA1/2, n\u00a0=\u00a056), the mean (95% CI) EQ-5D-5L Index improved (all patients, 0.05 [0.01, 0.08]; BRCA1/2 subset, 0.07 [0.03, 0.10]), as did the EQ-5D VAS scores (all patients, 5.42 [2.65, 8.18]; BRCA1/2 subset, 4.74 [1.07, 8.41])."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35750582\", \"sentence_id\": 7, \"text\": \"Improvements in the estimated overall change from baseline (95% CI) in the mean worst pain were observed in all patients (-1.08 [-1.52, -0.65]) and the BRCA1/2 subset (-1.15 [-1.67, -0.62]).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35750582", "sentence_id": 7, "text": "Improvements in the estimated overall change from baseline (95% CI) in the mean worst pain were observed in all patients (-1.08 [-1.52, -0.65]) and the BRCA1/2 subset (-1.15 [-1.67, -0.62])."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35750582\", \"sentence_id\": 8, \"text\": \"The probability of not having had experienced deterioration of worst pain by month 12 was 84% for all patients and 83% for the BRCA1/2 subset.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35750582", "sentence_id": 8, "text": "The probability of not having had experienced deterioration of worst pain by month 12 was 84% for all patients and 83% for the BRCA1/2 subset."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35750582\", \"sentence_id\": 9, \"text\": \"CONCLUSIONS: In heavily pretreated men with mCRPC and DDR/HRR alterations, talazoparib was associated with improved HRQoL in all patients and the BRCA1/2 subset.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35750582", "sentence_id": 9, "text": "CONCLUSIONS: In heavily pretreated men with mCRPC and DDR/HRR alterations, talazoparib was associated with improved HRQoL in all patients and the BRCA1/2 subset."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35750582\", \"sentence_id\": 10, \"text\": \"In both patient groups, worst pain improved from baseline and the probability of not experiencing a deterioration in worst pain with talazoparib was high.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35750582", "sentence_id": 10, "text": "In both patient groups, worst pain improved from baseline and the probability of not experiencing a deterioration in worst pain with talazoparib was high."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35750582\", \"sentence_id\": 11, \"text\": \"PATIENT SUMMARY: We show that talazoparib was associated at least with no change or improvements in health-related quality of life (HRQoL) and pain burden in men with metastatic castration-resistant prostate cancer and DNA damage response/homologous recombination repair gene alterations in the TALAPRO-1 study.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35750582", "sentence_id": 11, "text": "PATIENT SUMMARY: We show that talazoparib was associated at least with no change or improvements in health-related quality of life (HRQoL) and pain burden in men with metastatic castration-resistant prostate cancer and DNA damage response/homologous recombination repair gene alterations in the TALAPRO-1 study."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35750582\", \"sentence_id\": 12, \"text\": \"These findings in patient-reported HRQoL and pain complement the antitumor activity and tolerability profile of talazoparib.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35750582", "sentence_id": 12, "text": "These findings in patient-reported HRQoL and pain complement the antitumor activity and tolerability profile of talazoparib."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35725817\", \"sentence_id\": 0, \"text\": \"Loss of phosphatase and tensin homolog (PTEN) impairs DNA double-strand repair and confers sensitivity to poly (ADP-ribose) polymerase inhibitors (PARPis).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35725817", "sentence_id": 0, "text": "Loss of phosphatase and tensin homolog (PTEN) impairs DNA double-strand repair and confers sensitivity to poly (ADP-ribose) polymerase inhibitors (PARPis)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35725817\", \"sentence_id\": 1, \"text\": \"However, PARPis also hyperactivate the MAPK and PI3K/AKT/mTOR pathways in PTEN-deficient endometrial carcinoma (EC), which allows the emergence of PARPi resistance.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35725817", "sentence_id": 1, "text": "However, PARPis also hyperactivate the MAPK and PI3K/AKT/mTOR pathways in PTEN-deficient endometrial carcinoma (EC), which allows the emergence of PARPi resistance."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35725817\", \"sentence_id\": 2, \"text\": \"BCL-2-associated death promoter (BAD), integrates the common cell survival effects of the RAS/MEK/MAPK and PI3K/AKT/mTOR pathways.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35725817", "sentence_id": 2, "text": "BCL-2-associated death promoter (BAD), integrates the common cell survival effects of the RAS/MEK/MAPK and PI3K/AKT/mTOR pathways."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35725817\", \"sentence_id\": 3, \"text\": \"Herein, it was observed that increased BADSer99 (BADS99) phosphorylation in EC cells was significantly associated with PTEN-deficient status.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35725817", "sentence_id": 3, "text": "Herein, it was observed that increased BADSer99 (BADS99) phosphorylation in EC cells was significantly associated with PTEN-deficient status."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35725817\", \"sentence_id\": 4, \"text\": \"Forced expression of phosphorylation deficient human BADS99A in PTEN-deficient EC cells significantly increased CASPASE 3/7 activity and decreased EC cell viability.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35725817", "sentence_id": 4, "text": "Forced expression of phosphorylation deficient human BADS99A in PTEN-deficient EC cells significantly increased CASPASE 3/7 activity and decreased EC cell viability."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35725817\", \"sentence_id\": 5, \"text\": \"Using NPB as a pharmacological inhibitor of pBADS99 phosphorylation, it was demonstrated that NPB synergized with PARPis (Olaparib, Rucaparib and Talazoparib) to enhance PARPi IC\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35725817", "sentence_id": 5, "text": "Using NPB as a pharmacological inhibitor of pBADS99 phosphorylation, it was demonstrated that NPB synergized with PARPis (Olaparib, Rucaparib and Talazoparib) to enhance PARPi IC"}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35636395\", \"sentence_id\": 0, \"text\": \"In mammalian cells, DNA damage response initiates repair by error-free homologous recombination (HRR) or by error-prone non-homologous end joining (NHEJ).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35636395", "sentence_id": 0, "text": "In mammalian cells, DNA damage response initiates repair by error-free homologous recombination (HRR) or by error-prone non-homologous end joining (NHEJ)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35636395\", \"sentence_id\": 1, \"text\": \"DNA damage is detected by PARP proteins that facilitate this repair, both in normal cells and in cancer cells.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35636395", "sentence_id": 1, "text": "DNA damage is detected by PARP proteins that facilitate this repair, both in normal cells and in cancer cells."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35636395\", \"sentence_id\": 2, \"text\": \"Cells containing BRCA1/2 mutations have an HRR-deficient repair mechanism which may result in unrepaired one-ended double-strand breaks and stalled replication forks, considered as the most lethal cell damage.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35636395", "sentence_id": 2, "text": "Cells containing BRCA1/2 mutations have an HRR-deficient repair mechanism which may result in unrepaired one-ended double-strand breaks and stalled replication forks, considered as the most lethal cell damage."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35636395\", \"sentence_id\": 3, \"text\": \"Here, we review the state of the art of the role of Poly (ADP-ribose) polymerase (PARP) inhibitors as a precision-targeted anticancer drug in BRCA1/2-mutated female breast cancer.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35636395", "sentence_id": 3, "text": "Here, we review the state of the art of the role of Poly (ADP-ribose) polymerase (PARP) inhibitors as a precision-targeted anticancer drug in BRCA1/2-mutated female breast cancer."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35636395\", \"sentence_id\": 4, \"text\": \"Although knowledge is incomplete, it is assumed that the main role of the archetype PARP1 in the cell nucleus is to detect and adhere to single-strand breaks.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35636395", "sentence_id": 4, "text": "Although knowledge is incomplete, it is assumed that the main role of the archetype PARP1 in the cell nucleus is to detect and adhere to single-strand breaks."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35636395\", \"sentence_id\": 5, \"text\": \"This mediates possible damage repair, after which cells may continue replication; this process is called synthetic lethality.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35636395", "sentence_id": 5, "text": "This mediates possible damage repair, after which cells may continue replication; this process is called synthetic lethality."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35636395\", \"sentence_id\": 6, \"text\": \"As for PARP clinical monotherapy, progression-free survival has been observed using the FDA- and EMA-approved drugs olaparib and talazoparib.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35636395", "sentence_id": 6, "text": "As for PARP clinical monotherapy, progression-free survival has been observed using the FDA- and EMA-approved drugs olaparib and talazoparib."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35636395\", \"sentence_id\": 7, \"text\": \"In the case of combined drug therapy, a synergy has been demonstrated between veliparib and platinum drugs.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35636395", "sentence_id": 7, "text": "In the case of combined drug therapy, a synergy has been demonstrated between veliparib and platinum drugs."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35636395\", \"sentence_id\": 8, \"text\": \"Information regarding adverse effects is limited, but hematological effects have been described.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35636395", "sentence_id": 8, "text": "Information regarding adverse effects is limited, but hematological effects have been described."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35636395\", \"sentence_id\": 9, \"text\": \"However, there is need for multicenter trials, preferably conducted without commercial guidance and funding.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35636395", "sentence_id": 9, "text": "However, there is need for multicenter trials, preferably conducted without commercial guidance and funding."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35636395\", \"sentence_id\": 10, \"text\": \"Some of the available trials reported resistance to PARP inhibitors.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35636395", "sentence_id": 10, "text": "Some of the available trials reported resistance to PARP inhibitors."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35636395\", \"sentence_id\": 11, \"text\": \"In this review, we also describe the various causes of resistance to PARP inhibitors and research indicating how resistance can be overcome.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35636395", "sentence_id": 11, "text": "In this review, we also describe the various causes of resistance to PARP inhibitors and research indicating how resistance can be overcome."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35538088\", \"sentence_id\": 0, \"text\": \"Germline mutations in BRCA1 or BRCA2 exist in ~2-7% of breast cancer patients, which has led to the approval of PARP inhibitors in the advanced setting.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35538088", "sentence_id": 0, "text": "Germline mutations in BRCA1 or BRCA2 exist in ~2-7% of breast cancer patients, which has led to the approval of PARP inhibitors in the advanced setting."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35538088\", \"sentence_id\": 1, \"text\": \"We have previously reported a phase II neoadjuvant trial of single agent talazoparib for patients with germline BRCA pathogenic variants with a pathologic complete response (pCR) rate of 53%.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35538088", "sentence_id": 1, "text": "We have previously reported a phase II neoadjuvant trial of single agent talazoparib for patients with germline BRCA pathogenic variants with a pathologic complete response (pCR) rate of 53%."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35538088\", \"sentence_id\": 2, \"text\": \"As nearly half of the patients treated did not have pCR, better strategies are needed to overcome treatment resistance.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35538088", "sentence_id": 2, "text": "As nearly half of the patients treated did not have pCR, better strategies are needed to overcome treatment resistance."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35538088\", \"sentence_id\": 3, \"text\": \"To this end, we conducted multi-omic analysis of 13 treatment na\u00efve breast cancer tumors from patients that went on to receive single-agent neoadjuvant talazoparib.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35538088", "sentence_id": 3, "text": "To this end, we conducted multi-omic analysis of 13 treatment na\u00efve breast cancer tumors from patients that went on to receive single-agent neoadjuvant talazoparib."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35538088\", \"sentence_id\": 4, \"text\": \"We looked for biomarkers that were predictive of response (assessed by residual cancer burden) after 6 months of therapy.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35538088", "sentence_id": 4, "text": "We looked for biomarkers that were predictive of response (assessed by residual cancer burden) after 6 months of therapy."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35538088\", \"sentence_id\": 5, \"text\": \"We found that all resistant tumors exhibited either the loss of SHLD2, expression of a hypoxia signature, or expression of a stem cell signature.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35538088", "sentence_id": 5, "text": "We found that all resistant tumors exhibited either the loss of SHLD2, expression of a hypoxia signature, or expression of a stem cell signature."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35538088\", \"sentence_id\": 6, \"text\": \"These results indicate that the deep analysis of pre-treatment tumors can identify biomarkers that are predictive of response to talazoparib and potentially other PARP inhibitors, and provides a framework that will allow for better selection of patients for treatment, as well as a roadmap for the development of novel combination therapies to prevent emergence of resistance.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35538088", "sentence_id": 6, "text": "These results indicate that the deep analysis of pre-treatment tumors can identify biomarkers that are predictive of response to talazoparib and potentially other PARP inhibitors, and provides a framework that will allow for better selection of patients for treatment, as well as a roadmap for the development of novel combination therapies to prevent emergence of resistance."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35511402\", \"sentence_id\": 0, \"text\": \"Up to 25% of patients with metastatic prostate cancer present with germline or somatic DNA damage repair alterations, some of which are associated with aggressive disease and poor outcomes.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35511402", "sentence_id": 0, "text": "Up to 25% of patients with metastatic prostate cancer present with germline or somatic DNA damage repair alterations, some of which are associated with aggressive disease and poor outcomes."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35511402\", \"sentence_id\": 1, \"text\": \"New data have brought poly(ADP-ribose) polymerase (PARP) inhibitors into sharp focus in the treatment of metastatic castrate-resistant prostate cancer (mCRPC).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35511402", "sentence_id": 1, "text": "New data have brought poly(ADP-ribose) polymerase (PARP) inhibitors into sharp focus in the treatment of metastatic castrate-resistant prostate cancer (mCRPC)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35511402\", \"sentence_id\": 2, \"text\": \"Olaparib improved survival after at least one new hormonal therapy (NHT) in a cohort of patients harboring BRCA1, BRCA2 or ATM mutations in the PROfound trial, while rucaparib, talazoparib and niraparib demonstrated compelling activity in phase II trials.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35511402", "sentence_id": 2, "text": "Olaparib improved survival after at least one new hormonal therapy (NHT) in a cohort of patients harboring BRCA1, BRCA2 or ATM mutations in the PROfound trial, while rucaparib, talazoparib and niraparib demonstrated compelling activity in phase II trials."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35511402\", \"sentence_id\": 3, \"text\": \"While patients with prostate cancer and BRCA1 or BRCA2 mutations may derive greatest benefit of PARP inhibition, the magnitude of benefit seems much lower in the context of most other homologous recombination gene mutations.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35511402", "sentence_id": 3, "text": "While patients with prostate cancer and BRCA1 or BRCA2 mutations may derive greatest benefit of PARP inhibition, the magnitude of benefit seems much lower in the context of most other homologous recombination gene mutations."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35511402\", \"sentence_id\": 4, \"text\": \"Several PARP inhibitors are currently developed in combination with conventional therapy, including chemotherapy, NHT, and alpha-particle emitters, at different disease stages.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35511402", "sentence_id": 4, "text": "Several PARP inhibitors are currently developed in combination with conventional therapy, including chemotherapy, NHT, and alpha-particle emitters, at different disease stages."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35511402\", \"sentence_id\": 5, \"text\": \"Herein, we review the rationale for PARP inhibition in patients with prostate cancer, discuss the impact of PARP inhibitors on outcomes, and explore underlying challenges for future developments.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35511402", "sentence_id": 5, "text": "Herein, we review the rationale for PARP inhibition in patients with prostate cancer, discuss the impact of PARP inhibitors on outcomes, and explore underlying challenges for future developments."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35485878\", \"sentence_id\": 0, \"text\": \"BACKGROUND: PARP inhibitors (PARPi) have recently emerged as a new treatment option for several solid tumors, including metastatic castration-resistant prostate cancer (mCRPC).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35485878", "sentence_id": 0, "text": "BACKGROUND: PARP inhibitors (PARPi) have recently emerged as a new treatment option for several solid tumors, including metastatic castration-resistant prostate cancer (mCRPC)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35485878\", \"sentence_id\": 1, \"text\": \"However, several grade 3-4 adverse events have been reported during PARPi administration, leading to limitations in treatment adherence.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35485878", "sentence_id": 1, "text": "However, several grade 3-4 adverse events have been reported during PARPi administration, leading to limitations in treatment adherence."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35485878\", \"sentence_id\": 2, \"text\": \"METHODS: Herein, we conducted a meta-analysis aimed at analyzing the incidence rate of commonly reported grade 3-4 adverse events, dose reduction, and treatment discontinuation in mCRPC patients treated with PARPi monotherapy.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35485878", "sentence_id": 2, "text": "METHODS: Herein, we conducted a meta-analysis aimed at analyzing the incidence rate of commonly reported grade 3-4 adverse events, dose reduction, and treatment discontinuation in mCRPC patients treated with PARPi monotherapy."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35485878\", \"sentence_id\": 3, \"text\": \"RESULTS: Incidence rate with 95% confidence intervals (CIs) of grade 3-4 toxicities, dose reduction, and treatment discontinuation were calculated.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35485878", "sentence_id": 3, "text": "RESULTS: Incidence rate with 95% confidence intervals (CIs) of grade 3-4 toxicities, dose reduction, and treatment discontinuation were calculated."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35485878\", \"sentence_id\": 4, \"text\": \"Six trials involving 752 mCRPC patients were available for the meta-analysis.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35485878", "sentence_id": 4, "text": "Six trials involving 752 mCRPC patients were available for the meta-analysis."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35485878\", \"sentence_id\": 5, \"text\": \"According to our results, anemia was the most frequently observed grade 3-4 toxicity (24.1%), and dose reduction (26.9%) and treatment discontinuation (14.1%) were common events during PARPi treatment.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35485878", "sentence_id": 5, "text": "According to our results, anemia was the most frequently observed grade 3-4 toxicity (24.1%), and dose reduction (26.9%) and treatment discontinuation (14.1%) were common events during PARPi treatment."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35485878\", \"sentence_id\": 6, \"text\": \"CONCLUSIONS: Clinicians should carefully consider these risks, especially taking into account that the use of PARPi in mCRPC patients is expected to rise in the near future.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35485878", "sentence_id": 6, "text": "CONCLUSIONS: Clinicians should carefully consider these risks, especially taking into account that the use of PARPi in mCRPC patients is expected to rise in the near future."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35435784\", \"sentence_id\": 0, \"text\": \"INTRODUCTION: Poly (ADP-ribose) polymerase inhibitors (PARPis) are an exciting class of agents that have shown efficacy, particularly for BRCA-mutant triple-negative breast cancer (TNBC) and high-grade serous ovarian cancer (HGSOC).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35435784", "sentence_id": 0, "text": "INTRODUCTION: Poly (ADP-ribose) polymerase inhibitors (PARPis) are an exciting class of agents that have shown efficacy, particularly for BRCA-mutant triple-negative breast cancer (TNBC) and high-grade serous ovarian cancer (HGSOC)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35435784\", \"sentence_id\": 1, \"text\": \"However, most patients who receive PARPi as their standard of care therapy inevitably develop resistance and this underscores the need to identify additional targets that can circumvent such resistance.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35435784", "sentence_id": 1, "text": "However, most patients who receive PARPi as their standard of care therapy inevitably develop resistance and this underscores the need to identify additional targets that can circumvent such resistance."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35435784\", \"sentence_id\": 2, \"text\": \"Combination treatment strategies have been developed in preclinical and clinical studies to address the challenges of efficacy and resistance.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35435784", "sentence_id": 2, "text": "Combination treatment strategies have been developed in preclinical and clinical studies to address the challenges of efficacy and resistance."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35435784\", \"sentence_id\": 3, \"text\": \"AREAS COVERED: This review examines completed or ongoing clinical trials of PARPi mono- and combination therapies.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35435784", "sentence_id": 3, "text": "AREAS COVERED: This review examines completed or ongoing clinical trials of PARPi mono- and combination therapies."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35435784\", \"sentence_id\": 4, \"text\": \"PARPi monotherapy in HER2 negative breast (HR+ and TNBC subtypes) and ovarian cancer is a focal point.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35435784", "sentence_id": 4, "text": "PARPi monotherapy in HER2 negative breast (HR+ and TNBC subtypes) and ovarian cancer is a focal point."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35435784\", \"sentence_id\": 5, \"text\": \"The authors propose potential strategies that might overcome resistance to PARPi and discuss key questions and future directions.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35435784", "sentence_id": 5, "text": "The authors propose potential strategies that might overcome resistance to PARPi and discuss key questions and future directions."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35435784\", \"sentence_id\": 6, \"text\": \"EXPERT OPINION: While the advent of PARPis has significantly improved the treatment of tumors with defects in DNA damage and repair pathways, careful patient selection will be essential to enhance these treatments.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35435784", "sentence_id": 6, "text": "EXPERT OPINION: While the advent of PARPis has significantly improved the treatment of tumors with defects in DNA damage and repair pathways, careful patient selection will be essential to enhance these treatments."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35435784\", \"sentence_id\": 7, \"text\": \"The identification of molecular biomarkers to predict disease response and progression is an endeavor.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35435784", "sentence_id": 7, "text": "The identification of molecular biomarkers to predict disease response and progression is an endeavor."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35343197\", \"sentence_id\": 0, \"text\": \"Human epidermal growth factor receptor 2 (HER2)-negative subset is the most heterogeneous group of metastatic breast cancers (MBCs) as it includes both hormone receptor (HR)-positive and HR-negative breast cancer (or TNBC), which have different therapies and treatment challenges.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35343197", "sentence_id": 0, "text": "Human epidermal growth factor receptor 2 (HER2)-negative subset is the most heterogeneous group of metastatic breast cancers (MBCs) as it includes both hormone receptor (HR)-positive and HR-negative breast cancer (or TNBC), which have different therapies and treatment challenges."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35343197\", \"sentence_id\": 1, \"text\": \"Though endocrine therapy (ET) remains the treatment backbone in HR-positive HER2-negative cases, about 40% of the patients show intrinsic or acquired resistance to ET due to multiple mechanisms.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35343197", "sentence_id": 1, "text": "Though endocrine therapy (ET) remains the treatment backbone in HR-positive HER2-negative cases, about 40% of the patients show intrinsic or acquired resistance to ET due to multiple mechanisms."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35343197\", \"sentence_id\": 2, \"text\": \"Combining different therapies such as ET and other targeted therapies with or without chemotherapy fails to give continued benefit, unlike cyclin-dependent kinase (CDK) 4/6 inhibitors that have shown a great benefit.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35343197", "sentence_id": 2, "text": "Combining different therapies such as ET and other targeted therapies with or without chemotherapy fails to give continued benefit, unlike cyclin-dependent kinase (CDK) 4/6 inhibitors that have shown a great benefit."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35343197\", \"sentence_id\": 3, \"text\": \"TNBC has conventionally been treated ineffectively with systemic chemotherapy.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35343197", "sentence_id": 3, "text": "TNBC has conventionally been treated ineffectively with systemic chemotherapy."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35343197\", \"sentence_id\": 4, \"text\": \"Recently, poly (ADP-ribose) polymerase inhibitors (PARPi) have emerged for HER2-negative breast cancer (BC) patients, including TNBC.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35343197", "sentence_id": 4, "text": "Recently, poly (ADP-ribose) polymerase inhibitors (PARPi) have emerged for HER2-negative breast cancer (BC) patients, including TNBC."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35343197\", \"sentence_id\": 5, \"text\": \"Olaparib and talazoparib have recently been approved in germline BRCA-mutated (gBRCAm) HER2-negative MBC.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35343197", "sentence_id": 5, "text": "Olaparib and talazoparib have recently been approved in germline BRCA-mutated (gBRCAm) HER2-negative MBC."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35343197\", \"sentence_id\": 6, \"text\": \"Additionally, ongoing trials of PARPi in combination with various therapies are expected to provide more and better treatment options for gBRCAm HER2-negative breast cancer.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35343197", "sentence_id": 6, "text": "Additionally, ongoing trials of PARPi in combination with various therapies are expected to provide more and better treatment options for gBRCAm HER2-negative breast cancer."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35343196\", \"sentence_id\": 0, \"text\": \"Standard therapy for advanced ovarian cancer (OC) consists of radical debulking cytoreductive surgery followed by adjuvant chemotherapy.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35343196", "sentence_id": 0, "text": "Standard therapy for advanced ovarian cancer (OC) consists of radical debulking cytoreductive surgery followed by adjuvant chemotherapy."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35343196\", \"sentence_id\": 1, \"text\": \"An important risk factor for OC is genetic predisposition, with BRCA1 or BRCA2 mutations accounting for the majority of hereditary OC.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35343196", "sentence_id": 1, "text": "An important risk factor for OC is genetic predisposition, with BRCA1 or BRCA2 mutations accounting for the majority of hereditary OC."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35343196\", \"sentence_id\": 2, \"text\": \"Mutation in BRCA ultimately causes accumulation of genetic alterations because of the failure of cells to arrest and repair DNA damage or to undergo apoptosis, resulting in tumorigenesis.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35343196", "sentence_id": 2, "text": "Mutation in BRCA ultimately causes accumulation of genetic alterations because of the failure of cells to arrest and repair DNA damage or to undergo apoptosis, resulting in tumorigenesis."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35343196\", \"sentence_id\": 3, \"text\": \"Poly (ADP-ribose) polymerase (PARP) inhibitors have emerged as a promising approach for managing BRCA-associated cancers, especially high-grade OC and breast cancers.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35343196", "sentence_id": 3, "text": "Poly (ADP-ribose) polymerase (PARP) inhibitors have emerged as a promising approach for managing BRCA-associated cancers, especially high-grade OC and breast cancers."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35343196\", \"sentence_id\": 4, \"text\": \"They lead to synthetic lethality in BRCA-mutated cells by stalling the replication forks in homologous recombination-deficient (HR) cells.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35343196", "sentence_id": 4, "text": "They lead to synthetic lethality in BRCA-mutated cells by stalling the replication forks in homologous recombination-deficient (HR) cells."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35343196\", \"sentence_id\": 5, \"text\": \"Four PARP inhibitors (olaparib, niraparib, rucaparib, and talazoparib) are currently approved by the Food and Drug Administration for OC, breast, and pancreatic cancer indications and are being evaluated for other BRCA-associated cancers.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35343196", "sentence_id": 5, "text": "Four PARP inhibitors (olaparib, niraparib, rucaparib, and talazoparib) are currently approved by the Food and Drug Administration for OC, breast, and pancreatic cancer indications and are being evaluated for other BRCA-associated cancers."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35343196\", \"sentence_id\": 6, \"text\": \"Despite their clinical efficacy, cancer cells generally develop resistance to them through several mechanisms.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35343196", "sentence_id": 6, "text": "Despite their clinical efficacy, cancer cells generally develop resistance to them through several mechanisms."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35343196\", \"sentence_id\": 7, \"text\": \"Understanding these mechanisms is crucial for developing strategies to counter resistance and identify the basic mechanisms of DNA damage response.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35343196", "sentence_id": 7, "text": "Understanding these mechanisms is crucial for developing strategies to counter resistance and identify the basic mechanisms of DNA damage response."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35343196\", \"sentence_id\": 8, \"text\": \"This review focuses on the mechanism of action of PARP inhibitors, understanding various causes of resistance, and building strategies to overcome PARP inhibitor resistance.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35343196", "sentence_id": 8, "text": "This review focuses on the mechanism of action of PARP inhibitors, understanding various causes of resistance, and building strategies to overcome PARP inhibitor resistance."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35281113\", \"sentence_id\": 0, \"text\": \"Triple-negative breast cancer (TNBC) is a highly aggressive disease with historically poor outcomes, primarily due to the lack of effective targeted therapies.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35281113", "sentence_id": 0, "text": "Triple-negative breast cancer (TNBC) is a highly aggressive disease with historically poor outcomes, primarily due to the lack of effective targeted therapies."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35281113\", \"sentence_id\": 1, \"text\": \"Here, we established a drug sensitivity prediction model based on the homologous recombination deficiency (HRD) using 83 TNBC patients from TCGA.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35281113", "sentence_id": 1, "text": "Here, we established a drug sensitivity prediction model based on the homologous recombination deficiency (HRD) using 83 TNBC patients from TCGA."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35281113\", \"sentence_id\": 2, \"text\": \"Through analyzing the effect of HRD status on response efficacy of anticancer drugs and elucidating its related mechanisms of action, we found rucaparib (PARP inhibitor) and doxorubicin (anthracycline) sensitive in HR-deficient patients, while paclitaxel sensitive in the HR-proficient.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35281113", "sentence_id": 2, "text": "Through analyzing the effect of HRD status on response efficacy of anticancer drugs and elucidating its related mechanisms of action, we found rucaparib (PARP inhibitor) and doxorubicin (anthracycline) sensitive in HR-deficient patients, while paclitaxel sensitive in the HR-proficient."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35281113\", \"sentence_id\": 3, \"text\": \"Further, we identified a HRD signature based on gene expression data and constructed a transcriptomic HRD score, for analyzing the functional association between anticancer drug perturbation and HRD.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35281113", "sentence_id": 3, "text": "Further, we identified a HRD signature based on gene expression data and constructed a transcriptomic HRD score, for analyzing the functional association between anticancer drug perturbation and HRD."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35281113\", \"sentence_id\": 4, \"text\": \"The results revealed that CHIR99021 (GSK3 inhibitor) and doxorubicin have similar expression perturbation patterns with HRD, and talazoparib (PARP inhibitor) could kill tumor cells by reversing the HRD activity.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35281113", "sentence_id": 4, "text": "The results revealed that CHIR99021 (GSK3 inhibitor) and doxorubicin have similar expression perturbation patterns with HRD, and talazoparib (PARP inhibitor) could kill tumor cells by reversing the HRD activity."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35281113\", \"sentence_id\": 5, \"text\": \"Genomic characteristics indicated that doxorubicin inhibited tumor cells growth by hindering the process of DNA damage repair, while the resistance of cisplatin was related to the activation of angiogenesis and epithelial-mesenchymal transition.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35281113", "sentence_id": 5, "text": "Genomic characteristics indicated that doxorubicin inhibited tumor cells growth by hindering the process of DNA damage repair, while the resistance of cisplatin was related to the activation of angiogenesis and epithelial-mesenchymal transition."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35281113\", \"sentence_id\": 6, \"text\": \"The negative correlation of HRD signature score could interpret the association of doxorubicin pIC50 with worse chemotherapy response and shorter survival of TNBC patients.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35281113", "sentence_id": 6, "text": "The negative correlation of HRD signature score could interpret the association of doxorubicin pIC50 with worse chemotherapy response and shorter survival of TNBC patients."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35281113\", \"sentence_id\": 7, \"text\": \"In summary, these findings explain the applicability of anticancer drugs in TNBC and underscore the importance of HRD in promoting personalized treatment development.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35281113", "sentence_id": 7, "text": "In summary, these findings explain the applicability of anticancer drugs in TNBC and underscore the importance of HRD in promoting personalized treatment development."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35247877\", \"sentence_id\": 0, \"text\": \"UNLABELLED: BRCA1-mediated homologous recombination is an important DNA repair mechanism that is the target of FDA-approved PARP inhibitors, yet details of BRCA1-mediated functions remain to be fully elucidated.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35247877", "sentence_id": 0, "text": "UNLABELLED: BRCA1-mediated homologous recombination is an important DNA repair mechanism that is the target of FDA-approved PARP inhibitors, yet details of BRCA1-mediated functions remain to be fully elucidated."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35247877\", \"sentence_id\": 1, \"text\": \"Similarly, immune checkpoint molecules are targets of FDA-approved cancer immunotherapies, but the biological and mechanistic consequences of their application are incompletely understood.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35247877", "sentence_id": 1, "text": "Similarly, immune checkpoint molecules are targets of FDA-approved cancer immunotherapies, but the biological and mechanistic consequences of their application are incompletely understood."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35247877\", \"sentence_id\": 2, \"text\": \"We show here that the immune checkpoint molecule PD-L1 regulates homologous recombination in cancer cells by promoting BRCA1 nuclear foci formation and DNA end resection.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35247877", "sentence_id": 2, "text": "We show here that the immune checkpoint molecule PD-L1 regulates homologous recombination in cancer cells by promoting BRCA1 nuclear foci formation and DNA end resection."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35247877\", \"sentence_id\": 3, \"text\": \"Genetic depletion of tumor PD-L1 reduced homologous recombination, increased nonhomologous end joining, and elicited synthetic lethality to PARP inhibitors olaparib and talazoparib in vitro in some, but not all, BRCA1 wild-type tumor cells.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35247877", "sentence_id": 3, "text": "Genetic depletion of tumor PD-L1 reduced homologous recombination, increased nonhomologous end joining, and elicited synthetic lethality to PARP inhibitors olaparib and talazoparib in vitro in some, but not all, BRCA1 wild-type tumor cells."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35247877\", \"sentence_id\": 4, \"text\": \"In vivo, genetic depletion of tumor PD-L1 rendered olaparib-resistant tumors sensitive to olaparib.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35247877", "sentence_id": 4, "text": "In vivo, genetic depletion of tumor PD-L1 rendered olaparib-resistant tumors sensitive to olaparib."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35247877\", \"sentence_id\": 5, \"text\": \"In contrast, anti-PD-L1 immune checkpoint blockade neither enhanced olaparib synthetic lethality nor improved its efficacy in vitro or in wild-type mice.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35247877", "sentence_id": 5, "text": "In contrast, anti-PD-L1 immune checkpoint blockade neither enhanced olaparib synthetic lethality nor improved its efficacy in vitro or in wild-type mice."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35247877\", \"sentence_id\": 6, \"text\": \"Tumor PD-L1 did not alter expression of BRCA1 or its cofactor BARD1 but instead coimmunoprecipitated with BARD1 and increased BRCA1 nuclear accumulation.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35247877", "sentence_id": 6, "text": "Tumor PD-L1 did not alter expression of BRCA1 or its cofactor BARD1 but instead coimmunoprecipitated with BARD1 and increased BRCA1 nuclear accumulation."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35247877\", \"sentence_id\": 7, \"text\": \"Tumor PD-L1 depletion enhanced tumor CCL5 expression and TANK-binding kinase 1 activation in vitro, similar to known immune-potentiating effects of PARP inhibitors.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35247877", "sentence_id": 7, "text": "Tumor PD-L1 depletion enhanced tumor CCL5 expression and TANK-binding kinase 1 activation in vitro, similar to known immune-potentiating effects of PARP inhibitors."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35247877\", \"sentence_id\": 8, \"text\": \"Collectively, these data define immune-dependent and immune-independent effects of PARP inhibitor treatment and genetic tumor PD-L1 depletion.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35247877", "sentence_id": 8, "text": "Collectively, these data define immune-dependent and immune-independent effects of PARP inhibitor treatment and genetic tumor PD-L1 depletion."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35247877\", \"sentence_id\": 9, \"text\": \"Moreover, they implicate a tumor cell-intrinsic, immune checkpoint-independent function of PD-L1 in cancer cell BRCA1-mediated DNA damage repair with translational potential, including as a treatment response biomarker.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35247877", "sentence_id": 9, "text": "Moreover, they implicate a tumor cell-intrinsic, immune checkpoint-independent function of PD-L1 in cancer cell BRCA1-mediated DNA damage repair with translational potential, including as a treatment response biomarker."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35247877\", \"sentence_id\": 10, \"text\": \"SIGNIFICANCE: PD-L1 upregulates BRCA1-mediated homologous recombination, and PD-L1-deficient tumors exhibit BRCAness by manifesting synthetic lethality in response to PARP inhibitors, revealing an exploitable therapeutic vulnerability and a candidate treatment response biomarker.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35247877", "sentence_id": 10, "text": "SIGNIFICANCE: PD-L1 upregulates BRCA1-mediated homologous recombination, and PD-L1-deficient tumors exhibit BRCAness by manifesting synthetic lethality in response to PARP inhibitors, revealing an exploitable therapeutic vulnerability and a candidate treatment response biomarker."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35247877\", \"sentence_id\": 11, \"text\": \"See related commentary by Hanks, p.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35247877", "sentence_id": 11, "text": "See related commentary by Hanks, p."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35247877\", \"sentence_id\": 12, \"text\": \"2069.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35247877", "sentence_id": 12, "text": "2069."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35163586\", \"sentence_id\": 0, \"text\": \"Triple-negative breast cancer (TNBC) is associated with high recurrence rates, high incidence of distant metastases, and poor overall survival (OS).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35163586", "sentence_id": 0, "text": "Triple-negative breast cancer (TNBC) is associated with high recurrence rates, high incidence of distant metastases, and poor overall survival (OS)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35163586\", \"sentence_id\": 1, \"text\": \"Taxane and anthracycline-containing chemotherapy (CT) is currently the main systemic treatment option for TNBC, while platinum-based chemotherapy showed promising results in the neoadjuvant and metastatic settings.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35163586", "sentence_id": 1, "text": "Taxane and anthracycline-containing chemotherapy (CT) is currently the main systemic treatment option for TNBC, while platinum-based chemotherapy showed promising results in the neoadjuvant and metastatic settings."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35163586\", \"sentence_id\": 2, \"text\": \"An early arising of intrinsic or acquired CT resistance is common and represents the main hurdle for successful TNBC treatment.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35163586", "sentence_id": 2, "text": "An early arising of intrinsic or acquired CT resistance is common and represents the main hurdle for successful TNBC treatment."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35163586\", \"sentence_id\": 3, \"text\": \"Numerous mechanisms were uncovered that can lead to the development of chemoresistance.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35163586", "sentence_id": 3, "text": "Numerous mechanisms were uncovered that can lead to the development of chemoresistance."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35163586\", \"sentence_id\": 4, \"text\": \"These include cancer stem cells (CSCs) induction after neoadjuvant chemotherapy (NACT), ATP-binding cassette (ABC) transporters, hypoxia and avoidance of apoptosis, single factors such as tyrosine kinase receptors (EGFR, IGFR1), a disintegrin and metalloproteinase 10 (ADAM10), and a few pathological molecular pathways.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35163586", "sentence_id": 4, "text": "These include cancer stem cells (CSCs) induction after neoadjuvant chemotherapy (NACT), ATP-binding cassette (ABC) transporters, hypoxia and avoidance of apoptosis, single factors such as tyrosine kinase receptors (EGFR, IGFR1), a disintegrin and metalloproteinase 10 (ADAM10), and a few pathological molecular pathways."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35163586\", \"sentence_id\": 5, \"text\": \"Some biomarkers capable of predicting resistance to specific chemotherapeutic agents were identified and are expected to be validated in future studies for a more accurate selection of drugs to be employed and for a more tailored approach, both in neoadjuvant and advanced settings.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35163586", "sentence_id": 5, "text": "Some biomarkers capable of predicting resistance to specific chemotherapeutic agents were identified and are expected to be validated in future studies for a more accurate selection of drugs to be employed and for a more tailored approach, both in neoadjuvant and advanced settings."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35163586\", \"sentence_id\": 6, \"text\": \"Recently, based on specific biomarkers, some therapies were tailored to TNBC subsets and became available in clinical practice: olaparib and talazoparib for\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35163586", "sentence_id": 6, "text": "Recently, based on specific biomarkers, some therapies were tailored to TNBC subsets and became available in clinical practice: olaparib and talazoparib for"}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35098099\", \"sentence_id\": 0, \"text\": \"Current therapy is ineffective for relapsed and metastatic Ewing sarcoma (EwS) owing to development of drug resistance.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35098099", "sentence_id": 0, "text": "Current therapy is ineffective for relapsed and metastatic Ewing sarcoma (EwS) owing to development of drug resistance."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35098099\", \"sentence_id\": 1, \"text\": \"Macromolecular prodrugs potentially lead to lower drug exposure in normal tissues and reduced toxicity.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35098099", "sentence_id": 1, "text": "Macromolecular prodrugs potentially lead to lower drug exposure in normal tissues and reduced toxicity."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35098099\", \"sentence_id\": 2, \"text\": \"We evaluated the efficacy of PEGylated talazoparib (PEG\u223cTLZ), a PARP1 inhibitor, alone or in combination with the DNA-alkylating agent temozolomide (TMZ) in EwS and other pediatric tumors using conventional testing or single-mouse trial (SMT).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35098099", "sentence_id": 2, "text": "We evaluated the efficacy of PEGylated talazoparib (PEG\u223cTLZ), a PARP1 inhibitor, alone or in combination with the DNA-alkylating agent temozolomide (TMZ) in EwS and other pediatric tumors using conventional testing or single-mouse trial (SMT)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35098099\", \"sentence_id\": 3, \"text\": \"A single dose of PEG\u223cTLZ (10\u00a0\u03bcmol/kg on day 0) combined with 5 daily doses of TMZ (40\u00a0mg/kg starting on day 3/4) produced minimal toxicity, and the combination achieved maintained complete response in EwS and glioblastoma models.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35098099", "sentence_id": 3, "text": "A single dose of PEG\u223cTLZ (10\u00a0\u03bcmol/kg on day 0) combined with 5 daily doses of TMZ (40\u00a0mg/kg starting on day 3/4) produced minimal toxicity, and the combination achieved maintained complete response in EwS and glioblastoma models."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35098099\", \"sentence_id\": 4, \"text\": \"The SMT trial with the 3-day interval between PEG\u223cTLZ and TMZ resulted in objective responses in EwS and other xenografts.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35098099", "sentence_id": 4, "text": "The SMT trial with the 3-day interval between PEG\u223cTLZ and TMZ resulted in objective responses in EwS and other xenografts."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35098099\", \"sentence_id\": 5, \"text\": \"Thus, PEG\u223cTLZ\u00a0+ TMZ demonstrated a broad range of activity in pediatric solid tumor models.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35098099", "sentence_id": 5, "text": "Thus, PEG\u223cTLZ\u00a0+ TMZ demonstrated a broad range of activity in pediatric solid tumor models."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35098099\", \"sentence_id\": 6, \"text\": \"Furthermore, the therapeutic window of PEG\u223cTLZ\u00a0+ TMZ was enhanced compared with the free-TLZ combination.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35098099", "sentence_id": 6, "text": "Furthermore, the therapeutic window of PEG\u223cTLZ\u00a0+ TMZ was enhanced compared with the free-TLZ combination."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35091444\", \"sentence_id\": 0, \"text\": \"PURPOSE: Patients with acute myeloid leukemia (AML) unfit for, or resistant to, intensive chemotherapy are often treated with DNA methyltransferase inhibitors (DNMTi).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35091444", "sentence_id": 0, "text": "PURPOSE: Patients with acute myeloid leukemia (AML) unfit for, or resistant to, intensive chemotherapy are often treated with DNA methyltransferase inhibitors (DNMTi)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35091444\", \"sentence_id\": 1, \"text\": \"Novel combinations may increase efficacy.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35091444", "sentence_id": 1, "text": "Novel combinations may increase efficacy."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35091444\", \"sentence_id\": 2, \"text\": \"In addition to demethylating CpG island gene promoter regions, DNMTis enhance PARP1 recruitment and tight binding to chromatin, preventing PARP-mediated DNA repair, downregulating homologous recombination (HR) DNA repair, and sensitizing cells to PARP inhibitor (PARPi).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35091444", "sentence_id": 2, "text": "In addition to demethylating CpG island gene promoter regions, DNMTis enhance PARP1 recruitment and tight binding to chromatin, preventing PARP-mediated DNA repair, downregulating homologous recombination (HR) DNA repair, and sensitizing cells to PARP inhibitor (PARPi)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35091444\", \"sentence_id\": 3, \"text\": \"We previously demonstrated DNMTi and PARPi combination efficacy in AML in vitro and in vivo.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35091444", "sentence_id": 3, "text": "We previously demonstrated DNMTi and PARPi combination efficacy in AML in vitro and in vivo."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35091444\", \"sentence_id\": 4, \"text\": \"Here, we report a phase I clinical trial combining the DNMTi decitabine and the PARPi talazoparib in relapsed/refractory AML.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35091444", "sentence_id": 4, "text": "Here, we report a phase I clinical trial combining the DNMTi decitabine and the PARPi talazoparib in relapsed/refractory AML."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35091444\", \"sentence_id\": 5, \"text\": \"PATIENTS AND METHODS: Decitabine and talazoparib doses were escalated using a 3 + 3 design.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35091444", "sentence_id": 5, "text": "PATIENTS AND METHODS: Decitabine and talazoparib doses were escalated using a 3 + 3 design."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35091444\", \"sentence_id\": 6, \"text\": \"Pharmacodynamic studies were performed on cycle 1 days 1 (pretreatment), 5 and 8 blood blasts.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35091444", "sentence_id": 6, "text": "Pharmacodynamic studies were performed on cycle 1 days 1 (pretreatment), 5 and 8 blood blasts."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35091444\", \"sentence_id\": 7, \"text\": \"RESULTS: Doses were escalated in seven cohorts [25 patients, including 22 previously treated with DNMTi(s)] to a recommended phase II dose combination of decitabine 20 mg/m2 intravenously daily for 5 or 10 days and talazoparib 1 mg orally daily for 28 days, in 28-day cycles.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35091444", "sentence_id": 7, "text": "RESULTS: Doses were escalated in seven cohorts [25 patients, including 22 previously treated with DNMTi(s)] to a recommended phase II dose combination of decitabine 20 mg/m2 intravenously daily for 5 or 10 days and talazoparib 1 mg orally daily for 28 days, in 28-day cycles."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35091444\", \"sentence_id\": 8, \"text\": \"Grade 3-5 events included fever in 19 patients and lung infections in 15, attributed to AML.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35091444", "sentence_id": 8, "text": "Grade 3-5 events included fever in 19 patients and lung infections in 15, attributed to AML."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35091444\", \"sentence_id\": 9, \"text\": \"Responses included complete remission with incomplete count recovery in two patients (8%) and hematologic improvement in three.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35091444", "sentence_id": 9, "text": "Responses included complete remission with incomplete count recovery in two patients (8%) and hematologic improvement in three."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35091444\", \"sentence_id\": 10, \"text\": \"Pharmacodynamic studies showed the expected DNA demethylation, increased PARP trapping in chromatin, increased \u03b3H2AX foci, and decreased HR activity in responders.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35091444", "sentence_id": 10, "text": "Pharmacodynamic studies showed the expected DNA demethylation, increased PARP trapping in chromatin, increased \u03b3H2AX foci, and decreased HR activity in responders."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35091444\", \"sentence_id\": 11, \"text\": \"\u03b3H2AX foci increased significantly with increasing talazoparib doses combined with 20 mg/m2 decitabine.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35091444", "sentence_id": 11, "text": "\u03b3H2AX foci increased significantly with increasing talazoparib doses combined with 20 mg/m2 decitabine."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35091444\", \"sentence_id\": 12, \"text\": \"CONCLUSIONS: Decitabine/talazoparib combination was well tolerated.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35091444", "sentence_id": 12, "text": "CONCLUSIONS: Decitabine/talazoparib combination was well tolerated."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35091444\", \"sentence_id\": 13, \"text\": \"Expected pharmacodynamic effects occurred, especially in responders.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35091444", "sentence_id": 13, "text": "Expected pharmacodynamic effects occurred, especially in responders."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35086956\", \"sentence_id\": 0, \"text\": \"PARP inhibition represents the dawn of precision medicine for treating prostate cancer.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35086956", "sentence_id": 0, "text": "PARP inhibition represents the dawn of precision medicine for treating prostate cancer."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35086956\", \"sentence_id\": 1, \"text\": \"Despite this advance, questions remain regarding the use of PARP inhibitors (PARPi) for the treatment of this disease, including (i) how specifically do PARPi-sensitive tumor cells respond to treatment, and (ii) how does PARPi resistance develop?\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35086956", "sentence_id": 1, "text": "Despite this advance, questions remain regarding the use of PARP inhibitors (PARPi) for the treatment of this disease, including (i) how specifically do PARPi-sensitive tumor cells respond to treatment, and (ii) how does PARPi resistance develop?"}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35086956\", \"sentence_id\": 2, \"text\": \"To address these questions, we characterized response to olaparib in sensitive LNCaP and C4-2B cells and developed two olaparib-resistant derivative cell line models from each, termed LN-OlapR and 2B-OlapR, respectively.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35086956", "sentence_id": 2, "text": "To address these questions, we characterized response to olaparib in sensitive LNCaP and C4-2B cells and developed two olaparib-resistant derivative cell line models from each, termed LN-OlapR and 2B-OlapR, respectively."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35086956\", \"sentence_id\": 3, \"text\": \"OlapR cells possess distinct morphology from parental cells and display robust resistance to olaparib and other clinically relevant PARPis, including rucaparib, niraparib, and talazoparib.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35086956", "sentence_id": 3, "text": "OlapR cells possess distinct morphology from parental cells and display robust resistance to olaparib and other clinically relevant PARPis, including rucaparib, niraparib, and talazoparib."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35086956\", \"sentence_id\": 4, \"text\": \"In LNCaP and C4-2B cells, we found that olaparib induces massive DNA damage, leading to activation of the G2-M checkpoint, activation of p53, and cell-cycle arrest.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35086956", "sentence_id": 4, "text": "In LNCaP and C4-2B cells, we found that olaparib induces massive DNA damage, leading to activation of the G2-M checkpoint, activation of p53, and cell-cycle arrest."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35086956\", \"sentence_id\": 5, \"text\": \"Furthermore, our data suggest that G2-M checkpoint activation leads to both cell death and senescence associated with p21 activity.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35086956", "sentence_id": 5, "text": "Furthermore, our data suggest that G2-M checkpoint activation leads to both cell death and senescence associated with p21 activity."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35086956\", \"sentence_id\": 6, \"text\": \"In contrast, both LN-OlapR and 2B-OlapR cells do not arrest at G2-M and display a markedly blunted response to olaparib treatment.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35086956", "sentence_id": 6, "text": "In contrast, both LN-OlapR and 2B-OlapR cells do not arrest at G2-M and display a markedly blunted response to olaparib treatment."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35086956\", \"sentence_id\": 7, \"text\": \"Interestingly, both OlapR cell lines harbor increased DNA damage relative to parental cells, suggesting that OlapR cells accumulate and manage persistent DNA damage during acquisition of resistance, likely through augmenting DNA repair capacity.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35086956", "sentence_id": 7, "text": "Interestingly, both OlapR cell lines harbor increased DNA damage relative to parental cells, suggesting that OlapR cells accumulate and manage persistent DNA damage during acquisition of resistance, likely through augmenting DNA repair capacity."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35086956\", \"sentence_id\": 8, \"text\": \"Further impairing DNA repair through CDK1 inhibition enhances DNA damage, induces cell death, and sensitizes OlapR cells to olaparib treatment.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35086956", "sentence_id": 8, "text": "Further impairing DNA repair through CDK1 inhibition enhances DNA damage, induces cell death, and sensitizes OlapR cells to olaparib treatment."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35086956\", \"sentence_id\": 9, \"text\": \"Our data together further our understanding of PARPi treatment and provide a cellular platform system for the study of response and resistance to PARP inhibition.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35086956", "sentence_id": 9, "text": "Our data together further our understanding of PARPi treatment and provide a cellular platform system for the study of response and resistance to PARP inhibition."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35080190\", \"sentence_id\": 0, \"text\": \"PARP inhibitors in combination with androgen receptor-targeted therapy have demonstrated potential in the treatment of metastatic castration-resistant prostate cancer (mCRPC).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35080190", "sentence_id": 0, "text": "PARP inhibitors in combination with androgen receptor-targeted therapy have demonstrated potential in the treatment of metastatic castration-resistant prostate cancer (mCRPC)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35080190\", \"sentence_id\": 1, \"text\": \"Here, we describe the design and rationale of the multinational, phase\u00a0III, two-part TALAPRO-2 study comparing talazoparib plus enzalutamide versus placebo plus enzalutamide as a first-line treatment for patients with mCRPC with or without DNA damage response (DDR) alterations.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35080190", "sentence_id": 1, "text": "Here, we describe the design and rationale of the multinational, phase\u00a0III, two-part TALAPRO-2 study comparing talazoparib plus enzalutamide versus placebo plus enzalutamide as a first-line treatment for patients with mCRPC with or without DNA damage response (DDR) alterations."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35080190\", \"sentence_id\": 2, \"text\": \"This study has two co-primary end points: radiographic progression-free survival (rPFS) by blinded independent clinical review in all-comers (cohort\u00a01) and in patients with DDR alterations (cohort 2).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35080190", "sentence_id": 2, "text": "This study has two co-primary end points: radiographic progression-free survival (rPFS) by blinded independent clinical review in all-comers (cohort\u00a01) and in patients with DDR alterations (cohort 2)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35080190\", \"sentence_id\": 3, \"text\": \"TALAPRO-2 will demonstrate whether talazoparib plus enzalutamide can significantly improve the efficacy of enzalutamide in terms of rPFS in both molecularly unselected and DDR-deficient patients with mCRPC (NCT03395197).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35080190", "sentence_id": 3, "text": "TALAPRO-2 will demonstrate whether talazoparib plus enzalutamide can significantly improve the efficacy of enzalutamide in terms of rPFS in both molecularly unselected and DDR-deficient patients with mCRPC (NCT03395197)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"35080190\", \"sentence_id\": 4, \"text\": \"Clinical Trial Registration: NCT03395197\u00a0(ClinicalTrials.gov).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "35080190", "sentence_id": 4, "text": "Clinical Trial Registration: NCT03395197\u00a0(ClinicalTrials.gov)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34979367\", \"sentence_id\": 0, \"text\": \"Epidermal growth factor receptor (EGFR) is a validated drug target for cancer chemotherapy.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34979367", "sentence_id": 0, "text": "Epidermal growth factor receptor (EGFR) is a validated drug target for cancer chemotherapy."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34979367\", \"sentence_id\": 1, \"text\": \"Mutations in EGFR are directly linked with the development of drug resistance and this has led for the development of newer drugs in quest for more efficacious inhibitors.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34979367", "sentence_id": 1, "text": "Mutations in EGFR are directly linked with the development of drug resistance and this has led for the development of newer drugs in quest for more efficacious inhibitors."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34979367\", \"sentence_id\": 2, \"text\": \"The current research is focused on identifying potential and safe molecules as EGFR inhibitors by using both structure and ligand based computational approaches.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34979367", "sentence_id": 2, "text": "The current research is focused on identifying potential and safe molecules as EGFR inhibitors by using both structure and ligand based computational approaches."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34979367\", \"sentence_id\": 3, \"text\": \"In quest for finding newer moieties, we have developed a pharmacophore model utilizing drugs like lazertinib, osimertinib, nazartinib, avitinib, afatininb, and talazoparib that are known to inhibit EGFR along with their downstream signaling.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34979367", "sentence_id": 3, "text": "In quest for finding newer moieties, we have developed a pharmacophore model utilizing drugs like lazertinib, osimertinib, nazartinib, avitinib, afatininb, and talazoparib that are known to inhibit EGFR along with their downstream signaling."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34979367\", \"sentence_id\": 4, \"text\": \"Ligand-based pharmacophore model have been developed to screen the ZINC database through ZINCPharmer webserver.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34979367", "sentence_id": 4, "text": "Ligand-based pharmacophore model have been developed to screen the ZINC database through ZINCPharmer webserver."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34979367\", \"sentence_id\": 5, \"text\": \"The server has identified 9482 best possible ligands with high pharmacophoric similarity i.e., RMSD value less than 0.2\u00a0\u00c5.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34979367", "sentence_id": 5, "text": "The server has identified 9482 best possible ligands with high pharmacophoric similarity i.e., RMSD value less than 0.2\u00a0\u00c5."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34979367\", \"sentence_id\": 6, \"text\": \"The top 10 ligands with the criteria of dock score(s) and interactions were further subjected to in silico ADMET studies giving two plausible ligands that were further subjected to Molecular Dynamics and MM/PBSA free energy calculations to ensure stability to the target site.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34979367", "sentence_id": 6, "text": "The top 10 ligands with the criteria of dock score(s) and interactions were further subjected to in silico ADMET studies giving two plausible ligands that were further subjected to Molecular Dynamics and MM/PBSA free energy calculations to ensure stability to the target site."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34979367\", \"sentence_id\": 7, \"text\": \"Results deduced by in silico work in the current study may be corroborated biologically in the future.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34979367", "sentence_id": 7, "text": "Results deduced by in silico work in the current study may be corroborated biologically in the future."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34979367\", \"sentence_id\": 8, \"text\": \"The current work, therefore, provides ample opportunity for computational and medicinal chemists to work in allied areas to facilitate the design and development of novel and more efficacious EGFR inhibitors for future experimental studies.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34979367", "sentence_id": 8, "text": "The current work, therefore, provides ample opportunity for computational and medicinal chemists to work in allied areas to facilitate the design and development of novel and more efficacious EGFR inhibitors for future experimental studies."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34958867\", \"sentence_id\": 0, \"text\": \"Poly (ADP-ribose) polymerase (PARP) inhibitors provide a promising therapeutic strategy for triple-negative breast cancers (TNBCs) with BRCA1/2 mutation.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34958867", "sentence_id": 0, "text": "Poly (ADP-ribose) polymerase (PARP) inhibitors provide a promising therapeutic strategy for triple-negative breast cancers (TNBCs) with BRCA1/2 mutation."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34958867\", \"sentence_id\": 1, \"text\": \"However, acquire resistance mechanisms and genetic alterations limit the clinical efficacy of PARP inhibitors.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34958867", "sentence_id": 1, "text": "However, acquire resistance mechanisms and genetic alterations limit the clinical efficacy of PARP inhibitors."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34958867\", \"sentence_id\": 2, \"text\": \"The aberrant activation of phosphatidylinositol 3-kinase (PI3K) is a significant problem for cancer development and thus the inhibition of PI3K by PI3K inhibitors is a novel targeted therapy in advanced breast cancer.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34958867", "sentence_id": 2, "text": "The aberrant activation of phosphatidylinositol 3-kinase (PI3K) is a significant problem for cancer development and thus the inhibition of PI3K by PI3K inhibitors is a novel targeted therapy in advanced breast cancer."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34958867\", \"sentence_id\": 3, \"text\": \"Here, we, for the first time, investigated that the combined inhibition of PARP by Talazoparib (TAL) and PI3K by LY294002 synergistically inhibited proliferation of BRCA1 mutant HCC1937 TNBC cells through apoptosis, G0/G1 arrest, oxidative stress and increased DNA damage compared to drug alone.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34958867", "sentence_id": 3, "text": "Here, we, for the first time, investigated that the combined inhibition of PARP by Talazoparib (TAL) and PI3K by LY294002 synergistically inhibited proliferation of BRCA1 mutant HCC1937 TNBC cells through apoptosis, G0/G1 arrest, oxidative stress and increased DNA damage compared to drug alone."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34958867\", \"sentence_id\": 4, \"text\": \"Additionally, TAL and LY294002 combination could be a promising strategy for overcoming TAL resistance.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34958867", "sentence_id": 4, "text": "Additionally, TAL and LY294002 combination could be a promising strategy for overcoming TAL resistance."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34958867\", \"sentence_id\": 5, \"text\": \"Co-treatment of TAL with LY294002 considerably suppressed the activation of PI3K, Akt1 and mTOR expression and phosphorylated protein levels in TNBC cells and caused changes in the multiple kinase phosphorylation.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34958867", "sentence_id": 5, "text": "Co-treatment of TAL with LY294002 considerably suppressed the activation of PI3K, Akt1 and mTOR expression and phosphorylated protein levels in TNBC cells and caused changes in the multiple kinase phosphorylation."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34958867\", \"sentence_id\": 6, \"text\": \"Our findings revealed that the dual inhibition of PARP and PI3K might represent an effective therapeutic strategy for TNBC and potentially overcome TAL resistance.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34958867", "sentence_id": 6, "text": "Our findings revealed that the dual inhibition of PARP and PI3K might represent an effective therapeutic strategy for TNBC and potentially overcome TAL resistance."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34945003\", \"sentence_id\": 0, \"text\": \"Despite recent discoveries and therapeutic advances in aggressive myeloid neoplasms, there remains a pressing need for improved therapies.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34945003", "sentence_id": 0, "text": "Despite recent discoveries and therapeutic advances in aggressive myeloid neoplasms, there remains a pressing need for improved therapies."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34945003\", \"sentence_id\": 1, \"text\": \"For instance, in acute myeloid leukemia (AML), while most patients achieve a complete remission with conventional chemotherapy or the combination of a hypomethylating agent and venetoclax, de novo or acquired drug resistance often presents an insurmountable challenge, especially in older patients.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34945003", "sentence_id": 1, "text": "For instance, in acute myeloid leukemia (AML), while most patients achieve a complete remission with conventional chemotherapy or the combination of a hypomethylating agent and venetoclax, de novo or acquired drug resistance often presents an insurmountable challenge, especially in older patients."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34945003\", \"sentence_id\": 2, \"text\": \"Poly(ADP-ribose) polymerase (PARP) enzymes, PARP1 and PARP2, are involved in detecting DNA damage and repairing it through multiple pathways, including base excision repair, single-strand break repair, and double-strand break repair.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34945003", "sentence_id": 2, "text": "Poly(ADP-ribose) polymerase (PARP) enzymes, PARP1 and PARP2, are involved in detecting DNA damage and repairing it through multiple pathways, including base excision repair, single-strand break repair, and double-strand break repair."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34945003\", \"sentence_id\": 3, \"text\": \"In the context of AML, PARP inhibitors (PARPi) could potentially exploit the frequently dysfunctional DNA repair pathways that, similar to deficiencies in homologous recombination in\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34945003", "sentence_id": 3, "text": "In the context of AML, PARP inhibitors (PARPi) could potentially exploit the frequently dysfunctional DNA repair pathways that, similar to deficiencies in homologous recombination in"}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34906906\", \"sentence_id\": 0, \"text\": \"Poly (ADP-ribose) polymerase (PARP) inhibitors (PARPi) induce cell death by inhibiting the repair of DNA strand breaks binding to PARP and regulate immune cells functions.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34906906", "sentence_id": 0, "text": "Poly (ADP-ribose) polymerase (PARP) inhibitors (PARPi) induce cell death by inhibiting the repair of DNA strand breaks binding to PARP and regulate immune cells functions."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34906906\", \"sentence_id\": 1, \"text\": \"Toll-like receptors (TLRs) mediate the tumor microenvironment through the modulation of proinflammatory cytokines and chemokines.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34906906", "sentence_id": 1, "text": "Toll-like receptors (TLRs) mediate the tumor microenvironment through the modulation of proinflammatory cytokines and chemokines."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34906906\", \"sentence_id\": 2, \"text\": \"In this context, this study addressed the relationship between the efficacy of talazoparib (TAL) as a PARPi and the activation of TLR3 or TLR9 by Polyinosinic:polycytidylic acid (Poly I:C) or CpG oligodeoxynucleotides (CpG-ODN) stimulation, respectively in triple negative breast cancer (TNBC).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34906906", "sentence_id": 2, "text": "In this context, this study addressed the relationship between the efficacy of talazoparib (TAL) as a PARPi and the activation of TLR3 or TLR9 by Polyinosinic:polycytidylic acid (Poly I:C) or CpG oligodeoxynucleotides (CpG-ODN) stimulation, respectively in triple negative breast cancer (TNBC)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34906906\", \"sentence_id\": 3, \"text\": \"TAL alone and the combination of TAL with Poly I:C or CpG-ODN induced cell death were analyzed by water-soluble tetrazolium salt 1 (WST-1), Annexin V analysis, acridine orange staining and mRNA levels of caspase-3 and caspase-8 in HCC1937 and HCC1937-R (TAL resistant) TNBC cells.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34906906", "sentence_id": 3, "text": "TAL alone and the combination of TAL with Poly I:C or CpG-ODN induced cell death were analyzed by water-soluble tetrazolium salt 1 (WST-1), Annexin V analysis, acridine orange staining and mRNA levels of caspase-3 and caspase-8 in HCC1937 and HCC1937-R (TAL resistant) TNBC cells."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34906906\", \"sentence_id\": 4, \"text\": \"Additionally, the expression of TLR3, TLR9 and interferon regulatory factor 7 (IRF7) was observed with immunofluorescence staining and western blot analysis.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34906906", "sentence_id": 4, "text": "Additionally, the expression of TLR3, TLR9 and interferon regulatory factor 7 (IRF7) was observed with immunofluorescence staining and western blot analysis."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34906906\", \"sentence_id\": 5, \"text\": \"Our findings showed that TAL induced TLR3 and TLR9 activation and acted in synergy with TLR3 and TLR9 agonists in TNBC cells.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34906906", "sentence_id": 5, "text": "Our findings showed that TAL induced TLR3 and TLR9 activation and acted in synergy with TLR3 and TLR9 agonists in TNBC cells."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34906906\", \"sentence_id\": 6, \"text\": \"The stimulation of TLR3 or TLR9 and TAL treatment caused significantly more apoptosis in TNBC cells through the over-expression of caspase-3 and caspase-8.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34906906", "sentence_id": 6, "text": "The stimulation of TLR3 or TLR9 and TAL treatment caused significantly more apoptosis in TNBC cells through the over-expression of caspase-3 and caspase-8."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34906906\", \"sentence_id\": 7, \"text\": \"Additionally, TAL combined with Poly I:C or CpG-ODN more increased TLR3, TLR9 and IRF7 protein levels in HCC1937 cells and treatment with TAL and Poly I:C had greater potential for overcoming TAL resistance.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34906906", "sentence_id": 7, "text": "Additionally, TAL combined with Poly I:C or CpG-ODN more increased TLR3, TLR9 and IRF7 protein levels in HCC1937 cells and treatment with TAL and Poly I:C had greater potential for overcoming TAL resistance."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34906906\", \"sentence_id\": 8, \"text\": \"In conclusion, the combination of PARPi with TLR agonists may be a new therapeutic combined strategy for the effective immunotherapy of TNBC.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34906906", "sentence_id": 8, "text": "In conclusion, the combination of PARPi with TLR agonists may be a new therapeutic combined strategy for the effective immunotherapy of TNBC."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34778690\", \"sentence_id\": 0, \"text\": \"UNLABELLED: Two poly (ADP-ribose) polymerase (PARP) inhibitors (olaparib and rucaparib) are US Food and Drug Administration-approved for patients with metastatic castration-resistant prostate cancer (mCRPC) harboring\\nMETHODS: We conducted a multicenter retrospective analysis involving 12 sites.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34778690", "sentence_id": 0, "text": "UNLABELLED: Two poly (ADP-ribose) polymerase (PARP) inhibitors (olaparib and rucaparib) are US Food and Drug Administration-approved for patients with metastatic castration-resistant prostate cancer (mCRPC) harboring\nMETHODS: We conducted a multicenter retrospective analysis involving 12 sites."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34778690\", \"sentence_id\": 1, \"text\": \"We collected genomic and clinical data from 123 patients with\\nRESULTS: A total of 123 patients (13\\nCONCLUSION: PARP inhibitor efficacy is diminished in\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34778690", "sentence_id": 1, "text": "We collected genomic and clinical data from 123 patients with\nRESULTS: A total of 123 patients (13\nCONCLUSION: PARP inhibitor efficacy is diminished in"}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34769368\", \"sentence_id\": 0, \"text\": \"Glioblastoma represents the highest grade of brain tumors.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34769368", "sentence_id": 0, "text": "Glioblastoma represents the highest grade of brain tumors."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34769368\", \"sentence_id\": 1, \"text\": \"Despite maximal resection surgery associated with radiotherapy and concomitant followed by adjuvant chemotherapy with temozolomide (TMZ), patients have a very poor prognosis due to the rapid recurrence and the acquisition of resistance to TMZ.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34769368", "sentence_id": 1, "text": "Despite maximal resection surgery associated with radiotherapy and concomitant followed by adjuvant chemotherapy with temozolomide (TMZ), patients have a very poor prognosis due to the rapid recurrence and the acquisition of resistance to TMZ."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34769368\", \"sentence_id\": 2, \"text\": \"Here, initially considering that TMZ is a prodrug whose activation is pH-dependent, we explored the contribution of glioblastoma cell metabolism to TMZ resistance.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34769368", "sentence_id": 2, "text": "Here, initially considering that TMZ is a prodrug whose activation is pH-dependent, we explored the contribution of glioblastoma cell metabolism to TMZ resistance."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34769368\", \"sentence_id\": 3, \"text\": \"Using isogenic TMZ-sensitive and TMZ-resistant human glioblastoma cells, we report that the expression of O6-methylguanine DNA methyltransferase (MGMT), which is known to repair TMZ-induced DNA methylation, does not primarily account for TMZ resistance.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34769368", "sentence_id": 3, "text": "Using isogenic TMZ-sensitive and TMZ-resistant human glioblastoma cells, we report that the expression of O6-methylguanine DNA methyltransferase (MGMT), which is known to repair TMZ-induced DNA methylation, does not primarily account for TMZ resistance."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34769368\", \"sentence_id\": 4, \"text\": \"Rather, fitter mitochondria in TMZ-resistant glioblastoma cells are a direct cause of chemoresistance that can be targeted by inhibiting oxidative phosphorylation and/or autophagy/mitophagy.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34769368", "sentence_id": 4, "text": "Rather, fitter mitochondria in TMZ-resistant glioblastoma cells are a direct cause of chemoresistance that can be targeted by inhibiting oxidative phosphorylation and/or autophagy/mitophagy."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34769368\", \"sentence_id\": 5, \"text\": \"Unexpectedly, we found that PARP inhibitor olaparib, but not talazoparib, is also a mitochondrial Complex I inhibitor.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34769368", "sentence_id": 5, "text": "Unexpectedly, we found that PARP inhibitor olaparib, but not talazoparib, is also a mitochondrial Complex I inhibitor."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34769368\", \"sentence_id\": 6, \"text\": \"Hence, we propose that the anticancer activities of olaparib in glioblastoma and other cancer types combine DNA repair inhibition and impairment of cancer cell respiration.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34769368", "sentence_id": 6, "text": "Hence, we propose that the anticancer activities of olaparib in glioblastoma and other cancer types combine DNA repair inhibition and impairment of cancer cell respiration."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34729995\", \"sentence_id\": 0, \"text\": \"Poly-(ADP-ribose) polymerase (PARP) inhibitors act in cells with defects in homologous recombination DNA repair (HRR) caused by genomic aberrations such as\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34729995", "sentence_id": 0, "text": "Poly-(ADP-ribose) polymerase (PARP) inhibitors act in cells with defects in homologous recombination DNA repair (HRR) caused by genomic aberrations such as"}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34572748\", \"sentence_id\": 0, \"text\": \"The treatment landscape of advanced prostate cancer has completely changed during the last decades.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34572748", "sentence_id": 0, "text": "The treatment landscape of advanced prostate cancer has completely changed during the last decades."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34572748\", \"sentence_id\": 1, \"text\": \"Chemotherapy (docetaxel, cabazitaxel), androgen-receptor signaling inhibitors (ARSi) (abiraterone acetate, enzalutamide), and radium-223 have revolutionized the management of metastatic castration-resistant prostate cancer (mCRPC).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34572748", "sentence_id": 1, "text": "Chemotherapy (docetaxel, cabazitaxel), androgen-receptor signaling inhibitors (ARSi) (abiraterone acetate, enzalutamide), and radium-223 have revolutionized the management of metastatic castration-resistant prostate cancer (mCRPC)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34572748\", \"sentence_id\": 2, \"text\": \"Lutetium-177-PSMA-617 is also going to become another treatment option for these patients.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34572748", "sentence_id": 2, "text": "Lutetium-177-PSMA-617 is also going to become another treatment option for these patients."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34572748\", \"sentence_id\": 3, \"text\": \"In addition, docetaxel, abiraterone acetate, apalutamide, enzalutamide, and radiotherapy to primary tumor have demonstrated the ability to significantly prolong the survival of patients with metastatic hormone-sensitive prostate cancer (mHSPC).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34572748", "sentence_id": 3, "text": "In addition, docetaxel, abiraterone acetate, apalutamide, enzalutamide, and radiotherapy to primary tumor have demonstrated the ability to significantly prolong the survival of patients with metastatic hormone-sensitive prostate cancer (mHSPC)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34572748\", \"sentence_id\": 4, \"text\": \"Finally, apalutamide, enzalutamide, and darolutamide have recently provided impactful data in patients with nonmetastatic castration-resistant disease (nmCRPC).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34572748", "sentence_id": 4, "text": "Finally, apalutamide, enzalutamide, and darolutamide have recently provided impactful data in patients with nonmetastatic castration-resistant disease (nmCRPC)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34572748\", \"sentence_id\": 5, \"text\": \"However, which is the best treatment sequence for patients with advanced prostate cancer?\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34572748", "sentence_id": 5, "text": "However, which is the best treatment sequence for patients with advanced prostate cancer?"}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34572748\", \"sentence_id\": 6, \"text\": \"This comprehensive review aims at discussing the available literature data to identify the optimal sequencing approaches in patients with prostate cancer at different disease stages.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34572748", "sentence_id": 6, "text": "This comprehensive review aims at discussing the available literature data to identify the optimal sequencing approaches in patients with prostate cancer at different disease stages."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34572748\", \"sentence_id\": 7, \"text\": \"Our work also highlights the potential impact of predictive biomarkers in treatment sequencing and exploring the role of specific agents (i.e., olaparib, rucaparib, talazoparib, niraparib, and ipatasertib) in biomarker-selected populations of patients with prostate cancer (i.e., those harboring alterations in DNA damage and response genes or\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34572748", "sentence_id": 7, "text": "Our work also highlights the potential impact of predictive biomarkers in treatment sequencing and exploring the role of specific agents (i.e., olaparib, rucaparib, talazoparib, niraparib, and ipatasertib) in biomarker-selected populations of patients with prostate cancer (i.e., those harboring alterations in DNA damage and response genes or"}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34529761\", \"sentence_id\": 0, \"text\": \"Poly(ADP-ribose) polymerase 1 (PARP1) is a key mediator of various forms of DNA damage repair and plays an important role in the progression of several cancer types.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34529761", "sentence_id": 0, "text": "Poly(ADP-ribose) polymerase 1 (PARP1) is a key mediator of various forms of DNA damage repair and plays an important role in the progression of several cancer types."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34529761\", \"sentence_id\": 1, \"text\": \"The enzyme is activated by binding to DNA single-strand and double-strand breaks.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34529761", "sentence_id": 1, "text": "The enzyme is activated by binding to DNA single-strand and double-strand breaks."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34529761\", \"sentence_id\": 2, \"text\": \"Its contribution to chromatin remodeling makes PARP1 crucial for gene expression regulation.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34529761", "sentence_id": 2, "text": "Its contribution to chromatin remodeling makes PARP1 crucial for gene expression regulation."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34529761\", \"sentence_id\": 3, \"text\": \"Inhibition of its activity with small molecules leads to the synthetic lethal effect by impeding DNA repair in the treatment of cancer cells.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34529761", "sentence_id": 3, "text": "Inhibition of its activity with small molecules leads to the synthetic lethal effect by impeding DNA repair in the treatment of cancer cells."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34529761\", \"sentence_id\": 4, \"text\": \"At first, PARP1 inhibitors (PARPis) were developed to target breast cancer mutated cancer cells.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34529761", "sentence_id": 4, "text": "At first, PARP1 inhibitors (PARPis) were developed to target breast cancer mutated cancer cells."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34529761\", \"sentence_id\": 5, \"text\": \"Currently, PARPis are being studied to be used in a broader variety of patients either as single agents or in combination with chemotherapy, antiangiogenic agents, ionizing radiation, and immune checkpoint inhibitors.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34529761", "sentence_id": 5, "text": "Currently, PARPis are being studied to be used in a broader variety of patients either as single agents or in combination with chemotherapy, antiangiogenic agents, ionizing radiation, and immune checkpoint inhibitors."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34529761\", \"sentence_id\": 6, \"text\": \"Ongoing clinical trials on olaparib, rucaparib, niraparib, veliparib, and the recent talazoparib show the advantage of these agents in overcoming PARPi resistance and underline their efficacy in targeted treatment of several hematologic malignancies.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34529761", "sentence_id": 6, "text": "Ongoing clinical trials on olaparib, rucaparib, niraparib, veliparib, and the recent talazoparib show the advantage of these agents in overcoming PARPi resistance and underline their efficacy in targeted treatment of several hematologic malignancies."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34529761\", \"sentence_id\": 7, \"text\": \"In this review, focusing on the crucial role of PARP1 in physiological and pathological effects in myelodysplastic syndrome and acute myeloid leukemia, we give an outline of the enzyme's mechanisms of action and its role in the pathophysiology and prognosis of myelodysplastic syndrome/acute myeloid leukemia and we analyze the available data on the use of PARPis, highlighting their promising advances in clinical application.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34529761", "sentence_id": 7, "text": "In this review, focusing on the crucial role of PARP1 in physiological and pathological effects in myelodysplastic syndrome and acute myeloid leukemia, we give an outline of the enzyme's mechanisms of action and its role in the pathophysiology and prognosis of myelodysplastic syndrome/acute myeloid leukemia and we analyze the available data on the use of PARPis, highlighting their promising advances in clinical application."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34445211\", \"sentence_id\": 0, \"text\": \"Several poly (adenosine diphosphate-ribose) polymerase (PARP) inhibitors are now in clinical use for tumours with defects in BReast CAncer genes\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34445211", "sentence_id": 0, "text": "Several poly (adenosine diphosphate-ribose) polymerase (PARP) inhibitors are now in clinical use for tumours with defects in BReast CAncer genes"}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34413130\", \"sentence_id\": 0, \"text\": \"Monotherapy with PARP inhibitors is effective for the subset of castrate-resistant prostate cancer (CRPC) with defects in homologous recombination (HR) DNA repair.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34413130", "sentence_id": 0, "text": "Monotherapy with PARP inhibitors is effective for the subset of castrate-resistant prostate cancer (CRPC) with defects in homologous recombination (HR) DNA repair."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34413130\", \"sentence_id\": 1, \"text\": \"New treatments are required for the remaining tumors, and an emerging strategy is to combine PARP inhibitors with other therapies that induce DNA damage.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34413130", "sentence_id": 1, "text": "New treatments are required for the remaining tumors, and an emerging strategy is to combine PARP inhibitors with other therapies that induce DNA damage."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34413130\", \"sentence_id\": 2, \"text\": \"Here we tested whether PARP inhibitors are effective for HR-proficient CRPC, including androgen receptor (AR)-null tumors, when used in combination with CX-5461, a small molecule that inhibits RNA polymerase I transcription and activates the DNA damage response, and has antitumor activity in early phase I trials.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34413130", "sentence_id": 2, "text": "Here we tested whether PARP inhibitors are effective for HR-proficient CRPC, including androgen receptor (AR)-null tumors, when used in combination with CX-5461, a small molecule that inhibits RNA polymerase I transcription and activates the DNA damage response, and has antitumor activity in early phase I trials."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34413130\", \"sentence_id\": 3, \"text\": \"The combination of CX-5461 and talazoparib significantly decreased\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34413130", "sentence_id": 3, "text": "The combination of CX-5461 and talazoparib significantly decreased"}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34413129\", \"sentence_id\": 0, \"text\": \"Pediatric sarcomas represent a heterogeneous group of malignancies that exhibit variable response to DNA-damaging chemotherapy.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34413129", "sentence_id": 0, "text": "Pediatric sarcomas represent a heterogeneous group of malignancies that exhibit variable response to DNA-damaging chemotherapy."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34413129\", \"sentence_id\": 1, \"text\": \"Schlafen family member 11 protein (SLFN11) increases sensitivity to replicative stress and has been implicated as a potential biomarker to predict sensitivity to DNA-damaging agents (DDA).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34413129", "sentence_id": 1, "text": "Schlafen family member 11 protein (SLFN11) increases sensitivity to replicative stress and has been implicated as a potential biomarker to predict sensitivity to DNA-damaging agents (DDA)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34413129\", \"sentence_id\": 2, \"text\": \"SLFN11 expression was quantified in 220 children with solid tumors using IHC.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34413129", "sentence_id": 2, "text": "SLFN11 expression was quantified in 220 children with solid tumors using IHC."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34413129\", \"sentence_id\": 3, \"text\": \"Sensitivity to the PARP inhibitor talazoparib (TAL) and the topoisomerase I inhibitor irinotecan (IRN) was assessed in sarcoma cell lines, including SLFN11 knock-out (KO) and overexpression models, and a patient-derived orthotopic xenograft model (PDOX).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34413129", "sentence_id": 3, "text": "Sensitivity to the PARP inhibitor talazoparib (TAL) and the topoisomerase I inhibitor irinotecan (IRN) was assessed in sarcoma cell lines, including SLFN11 knock-out (KO) and overexpression models, and a patient-derived orthotopic xenograft model (PDOX)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34413129\", \"sentence_id\": 4, \"text\": \"SLFN11 was expressed in 69% of pediatric sarcoma sampled, including 90% and 100% of Ewing sarcoma and desmoplastic small round-cell tumors, respectively, although the magnitude of expression varied widely.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34413129", "sentence_id": 4, "text": "SLFN11 was expressed in 69% of pediatric sarcoma sampled, including 90% and 100% of Ewing sarcoma and desmoplastic small round-cell tumors, respectively, although the magnitude of expression varied widely."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34413129\", \"sentence_id\": 5, \"text\": \"In sarcoma cell lines, protein expression strongly correlated with response to TAL and IRN, with SLFN11 KO resulting in significant loss of sensitivity\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34413129", "sentence_id": 5, "text": "In sarcoma cell lines, protein expression strongly correlated with response to TAL and IRN, with SLFN11 KO resulting in significant loss of sensitivity"}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34388456\", \"sentence_id\": 0, \"text\": \"Ring-finger protein 126 (RNF126), an E3 ubiquitin ligase, plays crucial roles in various biological processes, including cell proliferation, DNA damage repair, and intracellular vesicle trafficking.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34388456", "sentence_id": 0, "text": "Ring-finger protein 126 (RNF126), an E3 ubiquitin ligase, plays crucial roles in various biological processes, including cell proliferation, DNA damage repair, and intracellular vesicle trafficking."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34388456\", \"sentence_id\": 1, \"text\": \"Whether RNF126 is modulated by posttranslational modifications is poorly understood.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34388456", "sentence_id": 1, "text": "Whether RNF126 is modulated by posttranslational modifications is poorly understood."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34388456\", \"sentence_id\": 2, \"text\": \"Here, we show that PARP1 interacts with and poly(ADP)ribosylates RNF126, which then recruits the PAR-binding E3 ubiquitin ligase CHFR to promote ubiquitination and degradation of RNF126.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34388456", "sentence_id": 2, "text": "Here, we show that PARP1 interacts with and poly(ADP)ribosylates RNF126, which then recruits the PAR-binding E3 ubiquitin ligase CHFR to promote ubiquitination and degradation of RNF126."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34388456\", \"sentence_id\": 3, \"text\": \"Moreover, RNF126 is required for the activation of ATR-Chk1 signaling induced by either irradiation (IR) or a PARP inhibitor (PARPi), and depletion of RNF126 increases the sensitivity of triple-negative breast cancer (TNBC) cells to PARPi treatment.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34388456", "sentence_id": 3, "text": "Moreover, RNF126 is required for the activation of ATR-Chk1 signaling induced by either irradiation (IR) or a PARP inhibitor (PARPi), and depletion of RNF126 increases the sensitivity of triple-negative breast cancer (TNBC) cells to PARPi treatment."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34388456\", \"sentence_id\": 4, \"text\": \"Our findings suggest that PARPi-mediated upregulation of RNF126 protein stability contributes to TNBC cell resistance to PARPi.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34388456", "sentence_id": 4, "text": "Our findings suggest that PARPi-mediated upregulation of RNF126 protein stability contributes to TNBC cell resistance to PARPi."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34388456\", \"sentence_id\": 5, \"text\": \"Therefore, targeting the E3 ubiquitin ligase RNF126 may be a novel treatment for overcoming the resistance of TNBC cells to PARPi in clinical trials.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34388456", "sentence_id": 5, "text": "Therefore, targeting the E3 ubiquitin ligase RNF126 may be a novel treatment for overcoming the resistance of TNBC cells to PARPi in clinical trials."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34388386\", \"sentence_id\": 0, \"text\": \"BACKGROUND: Poly(ADP-ribose) polymerase (PARP) inhibitors have antitumour activity against metastatic castration-resistant prostate cancers with DNA damage response (DDR) alterations in genes involved directly or indirectly in homologous recombination repair (HRR).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34388386", "sentence_id": 0, "text": "BACKGROUND: Poly(ADP-ribose) polymerase (PARP) inhibitors have antitumour activity against metastatic castration-resistant prostate cancers with DNA damage response (DDR) alterations in genes involved directly or indirectly in homologous recombination repair (HRR)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34388386\", \"sentence_id\": 1, \"text\": \"In this study, we assessed the PARP inhibitor talazoparib in metastatic castration-resistant prostate cancers with DDR-HRR alterations.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34388386", "sentence_id": 1, "text": "In this study, we assessed the PARP inhibitor talazoparib in metastatic castration-resistant prostate cancers with DDR-HRR alterations."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34388386\", \"sentence_id\": 2, \"text\": \"METHODS: In this open-label, phase 2 trial (TALAPRO-1), participants were recruited from 43 hospitals, cancer centres, and medical centres in Australia, Austria, Belgium, Brazil, France, Germany, Hungary, Italy, the Netherlands, Poland, Spain, South Korea, the UK, and the USA.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34388386", "sentence_id": 2, "text": "METHODS: In this open-label, phase 2 trial (TALAPRO-1), participants were recruited from 43 hospitals, cancer centres, and medical centres in Australia, Austria, Belgium, Brazil, France, Germany, Hungary, Italy, the Netherlands, Poland, Spain, South Korea, the UK, and the USA."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34388386\", \"sentence_id\": 3, \"text\": \"Patients were eligible if they were men aged 18 years or older with progressive, metastatic, castration-resistant prostate cancers of adenocarcinoma histology, measurable soft-tissue disease (per Response Evaluation Criteria in Solid Tumors version 1.1 [RECIST 1.1]), an Eastern Cooperative Oncology Group performance status of 0-2, DDR-HRR gene alterations reported to sensitise to PARP inhibitors (ie, ATM, ATR, BRCA1, BRCA2, CHEK2, FANCA, MLH1, MRE11A, NBN, PALB2, RAD51C), had received one or two taxane-based chemotherapy regimens for metastatic disease, and progressed on enzalutamide or abiraterone, or both, for metastatic castration-resistant prostate cancers.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34388386", "sentence_id": 3, "text": "Patients were eligible if they were men aged 18 years or older with progressive, metastatic, castration-resistant prostate cancers of adenocarcinoma histology, measurable soft-tissue disease (per Response Evaluation Criteria in Solid Tumors version 1.1 [RECIST 1.1]), an Eastern Cooperative Oncology Group performance status of 0-2, DDR-HRR gene alterations reported to sensitise to PARP inhibitors (ie, ATM, ATR, BRCA1, BRCA2, CHEK2, FANCA, MLH1, MRE11A, NBN, PALB2, RAD51C), had received one or two taxane-based chemotherapy regimens for metastatic disease, and progressed on enzalutamide or abiraterone, or both, for metastatic castration-resistant prostate cancers."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34388386\", \"sentence_id\": 4, \"text\": \"Eligible patients were given oral talazoparib (1 mg per day; or 0\u00b775 mg per day in patients with moderate renal impairment) until disease progression, unacceptable toxicity, investigator decision, withdrawal of consent, or death.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34388386", "sentence_id": 4, "text": "Eligible patients were given oral talazoparib (1 mg per day; or 0\u00b775 mg per day in patients with moderate renal impairment) until disease progression, unacceptable toxicity, investigator decision, withdrawal of consent, or death."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34388386\", \"sentence_id\": 5, \"text\": \"The primary endpoint was confirmed objective response rate, defined as best overall soft-tissue response of complete or partial response per RECIST 1.1, by blinded independent central review.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34388386", "sentence_id": 5, "text": "The primary endpoint was confirmed objective response rate, defined as best overall soft-tissue response of complete or partial response per RECIST 1.1, by blinded independent central review."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34388386\", \"sentence_id\": 6, \"text\": \"The primary endpoint was assessed in patients who received study drug, had measurable soft-tissue disease, and had a gene alteration in one of the predefined DDR-HRR genes.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34388386", "sentence_id": 6, "text": "The primary endpoint was assessed in patients who received study drug, had measurable soft-tissue disease, and had a gene alteration in one of the predefined DDR-HRR genes."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34388386\", \"sentence_id\": 7, \"text\": \"Safety was assessed in all patients who received at least one dose of the study drug.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34388386", "sentence_id": 7, "text": "Safety was assessed in all patients who received at least one dose of the study drug."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34388386\", \"sentence_id\": 8, \"text\": \"This study is registered with ClinicalTrials.gov, NCT03148795, and is ongoing.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34388386", "sentence_id": 8, "text": "This study is registered with ClinicalTrials.gov, NCT03148795, and is ongoing."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34388386\", \"sentence_id\": 9, \"text\": \"FINDINGS: Between Oct 18, 2017, and March 20, 2020, 128 patients were enrolled, of whom 127 received at least one dose of talazoparib (safety population) and 104 had measurable soft-tissue disease (antitumour activity population).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34388386", "sentence_id": 9, "text": "FINDINGS: Between Oct 18, 2017, and March 20, 2020, 128 patients were enrolled, of whom 127 received at least one dose of talazoparib (safety population) and 104 had measurable soft-tissue disease (antitumour activity population)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34388386\", \"sentence_id\": 10, \"text\": \"Data cutoff for this analysis was Sept 4, 2020.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34388386", "sentence_id": 10, "text": "Data cutoff for this analysis was Sept 4, 2020."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34388386\", \"sentence_id\": 11, \"text\": \"After a median follow-up of 16\u00b74 months (IQR 11\u00b71-22\u00b71), the objective response rate was 29\u00b78% (31 of 104 patients; 95% CI 21\u00b72-39\u00b76).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34388386", "sentence_id": 11, "text": "After a median follow-up of 16\u00b74 months (IQR 11\u00b71-22\u00b71), the objective response rate was 29\u00b78% (31 of 104 patients; 95% CI 21\u00b72-39\u00b76)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34388386\", \"sentence_id\": 12, \"text\": \"The most common grade 3-4 treatment-emergent adverse events were anaemia (39 [31%] of 127 patients), thrombocytopenia (11 [9%]), and neutropenia (ten [8%]).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34388386", "sentence_id": 12, "text": "The most common grade 3-4 treatment-emergent adverse events were anaemia (39 [31%] of 127 patients), thrombocytopenia (11 [9%]), and neutropenia (ten [8%])."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34388386\", \"sentence_id\": 13, \"text\": \"Serious treatment-emergent adverse events were reported in 43 (34%) patients.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34388386", "sentence_id": 13, "text": "Serious treatment-emergent adverse events were reported in 43 (34%) patients."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34388386\", \"sentence_id\": 14, \"text\": \"There were no treatment-related deaths.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34388386", "sentence_id": 14, "text": "There were no treatment-related deaths."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34388386\", \"sentence_id\": 15, \"text\": \"INTERPRETATION: Talazoparib showed durable antitumour activity in men with advanced metastatic castration-resistant prostate cancers with DDR-HRR gene alterations who had been heavily pretreated.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34388386", "sentence_id": 15, "text": "INTERPRETATION: Talazoparib showed durable antitumour activity in men with advanced metastatic castration-resistant prostate cancers with DDR-HRR gene alterations who had been heavily pretreated."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34388386\", \"sentence_id\": 16, \"text\": \"The favourable benefit-risk profile supports the study of talazoparib in larger, randomised clinical trials, including in patients with non-BRCA alterations.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34388386", "sentence_id": 16, "text": "The favourable benefit-risk profile supports the study of talazoparib in larger, randomised clinical trials, including in patients with non-BRCA alterations."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34388386\", \"sentence_id\": 17, \"text\": \"FUNDING: Pfizer/Medivation.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34388386", "sentence_id": 17, "text": "FUNDING: Pfizer/Medivation."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34377227\", \"sentence_id\": 0, \"text\": \"Genetic instability is a hallmark of cancer and, with the introduction of poly (ADP-ribose) polymerase (PARP) inhibitors, is a targetable feature of many tumors.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34377227", "sentence_id": 0, "text": "Genetic instability is a hallmark of cancer and, with the introduction of poly (ADP-ribose) polymerase (PARP) inhibitors, is a targetable feature of many tumors."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34377227\", \"sentence_id\": 1, \"text\": \"Currently, two PARP inhibitors, olaparib and rucaparib, have received approval as monotherapy by the Food and Drug Administration for the treatment of men with castration resistant prostate cancer with selected mutations involving the homologous recombination (HR) pathway.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34377227", "sentence_id": 1, "text": "Currently, two PARP inhibitors, olaparib and rucaparib, have received approval as monotherapy by the Food and Drug Administration for the treatment of men with castration resistant prostate cancer with selected mutations involving the homologous recombination (HR) pathway."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34377227\", \"sentence_id\": 2, \"text\": \"However, it is currently debated whether an HR mutation is a prerequisite for response or if patients with HR-proficient mCRPC may also benefit from their use when combined with other targeted or immunotherapeutic agents.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34377227", "sentence_id": 2, "text": "However, it is currently debated whether an HR mutation is a prerequisite for response or if patients with HR-proficient mCRPC may also benefit from their use when combined with other targeted or immunotherapeutic agents."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34377227\", \"sentence_id\": 3, \"text\": \"Several large phase III trials of PARP inhibitors with novel androgen axis inhibitors in groups of unselected patients are underway.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34377227", "sentence_id": 3, "text": "Several large phase III trials of PARP inhibitors with novel androgen axis inhibitors in groups of unselected patients are underway."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34377227\", \"sentence_id\": 4, \"text\": \"Additionally, there are several early phase trials combining PARP inhibitors with radioligands or immunecheckpoint inhibitors.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34377227", "sentence_id": 4, "text": "Additionally, there are several early phase trials combining PARP inhibitors with radioligands or immunecheckpoint inhibitors."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34377227\", \"sentence_id\": 5, \"text\": \"Here we discuss the currently ongoing or recently concluded trials of PARP inhibitor based combinatorial therapies in unselected patients with mCRPC, the rationale behind these trials, and how these may impact the treatment paradigm in men with mCRPC.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34377227", "sentence_id": 5, "text": "Here we discuss the currently ongoing or recently concluded trials of PARP inhibitor based combinatorial therapies in unselected patients with mCRPC, the rationale behind these trials, and how these may impact the treatment paradigm in men with mCRPC."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34309473\", \"sentence_id\": 0, \"text\": \"INTRODUCTION:\\nAREAS COVERED: In this review, the authors highlight the relevant clinical trials of talazoparib, as well as, safety, tolerability, and quality of life considerations.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34309473", "sentence_id": 0, "text": "INTRODUCTION:\nAREAS COVERED: In this review, the authors highlight the relevant clinical trials of talazoparib, as well as, safety, tolerability, and quality of life considerations."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34309473\", \"sentence_id\": 1, \"text\": \"They also examine putative response and resistance mechanisms, and rational combinatorial therapeutic strategies under development.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34309473", "sentence_id": 1, "text": "They also examine putative response and resistance mechanisms, and rational combinatorial therapeutic strategies under development."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34309473\", \"sentence_id\": 2, \"text\": \"EXPERT OPINION: Talazoparib has been a major advance in the treatment of germline\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34309473", "sentence_id": 2, "text": "EXPERT OPINION: Talazoparib has been a major advance in the treatment of germline"}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34160752\", \"sentence_id\": 0, \"text\": \"BACKGROUND: Talazoparib is a poly(ADP-ribose) polymerase enzyme inhibitor.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34160752", "sentence_id": 0, "text": "BACKGROUND: Talazoparib is a poly(ADP-ribose) polymerase enzyme inhibitor."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34160752\", \"sentence_id\": 1, \"text\": \"This open-label, non-randomized, phase 1 study of talazoparib investigated the safety, pharmacokinetics, and preliminary antitumor activity in Japanese patients with locally advanced or metastatic solid tumors, regardless of mutations in DNA damage repair-related genes, who are resistant to/ineligible for standard therapies.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34160752", "sentence_id": 1, "text": "This open-label, non-randomized, phase 1 study of talazoparib investigated the safety, pharmacokinetics, and preliminary antitumor activity in Japanese patients with locally advanced or metastatic solid tumors, regardless of mutations in DNA damage repair-related genes, who are resistant to/ineligible for standard therapies."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34160752\", \"sentence_id\": 2, \"text\": \"METHODS: Patients received talazoparib dosed orally at 0.75 or 1\u00a0mg once daily using a modified 3\u2009+\u20093 dose-escalation scheme.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34160752", "sentence_id": 2, "text": "METHODS: Patients received talazoparib dosed orally at 0.75 or 1\u00a0mg once daily using a modified 3\u2009+\u20093 dose-escalation scheme."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34160752\", \"sentence_id\": 3, \"text\": \"Primary endpoint was dose-limiting toxicities during the first cycle of talazoparib.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34160752", "sentence_id": 3, "text": "Primary endpoint was dose-limiting toxicities during the first cycle of talazoparib."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34160752\", \"sentence_id\": 4, \"text\": \"RESULTS: Nine patients (median age 62.0\u00a0years) were included: 3 and 6 patients at the 0.75 and 1.0\u00a0mg once-daily dose levels, respectively.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34160752", "sentence_id": 4, "text": "RESULTS: Nine patients (median age 62.0\u00a0years) were included: 3 and 6 patients at the 0.75 and 1.0\u00a0mg once-daily dose levels, respectively."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34160752\", \"sentence_id\": 5, \"text\": \"No dose-limiting toxicities were reported.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34160752", "sentence_id": 5, "text": "No dose-limiting toxicities were reported."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34160752\", \"sentence_id\": 6, \"text\": \"The most commonly reported treatment-emergent adverse events (\u22652 patients) were anemia, stomatitis, maculopapular rash, platelet count decreased, neutrophil count decreased, and alanine aminotransferase increased.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34160752", "sentence_id": 6, "text": "The most commonly reported treatment-emergent adverse events (\u22652 patients) were anemia, stomatitis, maculopapular rash, platelet count decreased, neutrophil count decreased, and alanine aminotransferase increased."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34160752\", \"sentence_id\": 7, \"text\": \"Three patients had grade\u2009\u2265\u20093 treatment-emergent adverse events (anemia, brain metastases [1 patient each], and neutrophil and white blood cell count decreased [same patient]).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34160752", "sentence_id": 7, "text": "Three patients had grade\u2009\u2265\u20093 treatment-emergent adverse events (anemia, brain metastases [1 patient each], and neutrophil and white blood cell count decreased [same patient])."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34160752\", \"sentence_id\": 8, \"text\": \"Two patients temporarily discontinued treatment due to a treatment-emergent adverse event, and 1 patient required a dose reduction for neutrophil count decreased (all at 1\u00a0mg once daily).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34160752", "sentence_id": 8, "text": "Two patients temporarily discontinued treatment due to a treatment-emergent adverse event, and 1 patient required a dose reduction for neutrophil count decreased (all at 1\u00a0mg once daily)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34160752\", \"sentence_id\": 9, \"text\": \"Talazoparib exposure (C\\nCONCLUSIONS: Single-agent talazoparib was well tolerated and had preliminary antitumor activity in Japanese patients with advanced solid tumors.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34160752", "sentence_id": 9, "text": "Talazoparib exposure (C\nCONCLUSIONS: Single-agent talazoparib was well tolerated and had preliminary antitumor activity in Japanese patients with advanced solid tumors."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34160752\", \"sentence_id\": 10, \"text\": \"ClinicalTrials.gov identifier: NCT03343054 (November 17, 2017).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34160752", "sentence_id": 10, "text": "ClinicalTrials.gov identifier: NCT03343054 (November 17, 2017)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34025781\", \"sentence_id\": 0, \"text\": \"Pancreatic ductal adenocarcinoma (PDAC) accounts for about 3% of all cancers in the United States and about 7% of all cancer deaths.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34025781", "sentence_id": 0, "text": "Pancreatic ductal adenocarcinoma (PDAC) accounts for about 3% of all cancers in the United States and about 7% of all cancer deaths."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34025781\", \"sentence_id\": 1, \"text\": \"Despite the lower prevalence relative to other solid tumors, it is one of the leading causes of cancer-related death in the US.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34025781", "sentence_id": 1, "text": "Despite the lower prevalence relative to other solid tumors, it is one of the leading causes of cancer-related death in the US."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34025781\", \"sentence_id\": 2, \"text\": \"PDAC is highly resistant to chemotherapy as well as radiation therapy.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34025781", "sentence_id": 2, "text": "PDAC is highly resistant to chemotherapy as well as radiation therapy."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34025781\", \"sentence_id\": 3, \"text\": \"Current standard-of-care chemotherapeutic regimens provide transient disease control but eventually tumors develop chemoresistance.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34025781", "sentence_id": 3, "text": "Current standard-of-care chemotherapeutic regimens provide transient disease control but eventually tumors develop chemoresistance."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"34025781\", \"sentence_id\": 4, \"text\": \"Tumors that are deficient in DNA damage repair mechanisms such as\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "34025781", "sentence_id": 4, "text": "Tumors that are deficient in DNA damage repair mechanisms such as"}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33923231\", \"sentence_id\": 0, \"text\": \"The use of cyclin-dependent kinase 4/6 (CDK4/6) inhibitors represents a potent strategy for cancer therapy.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33923231", "sentence_id": 0, "text": "The use of cyclin-dependent kinase 4/6 (CDK4/6) inhibitors represents a potent strategy for cancer therapy."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33923231\", \"sentence_id\": 1, \"text\": \"Due to the complex molecular network that regulates cell cycle progression, cancer cells often acquire resistance mechanisms against these inhibitors.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33923231", "sentence_id": 1, "text": "Due to the complex molecular network that regulates cell cycle progression, cancer cells often acquire resistance mechanisms against these inhibitors."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33923231\", \"sentence_id\": 2, \"text\": \"Previously, our group identified molecular factors conferring resistance to CDK4/6 inhibition in bladder cancer (BLCA) that also included components within the DNA repair pathway.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33923231", "sentence_id": 2, "text": "Previously, our group identified molecular factors conferring resistance to CDK4/6 inhibition in bladder cancer (BLCA) that also included components within the DNA repair pathway."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33923231\", \"sentence_id\": 3, \"text\": \"In this study, we validated whether a combinatory treatment approach of the CDK4/6 inhibitor Palbociclib with Poly-(ADP-Ribose) Polymerase (PARP) inhibitors improves therapy response in BLCA.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33923231", "sentence_id": 3, "text": "In this study, we validated whether a combinatory treatment approach of the CDK4/6 inhibitor Palbociclib with Poly-(ADP-Ribose) Polymerase (PARP) inhibitors improves therapy response in BLCA."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33923231\", \"sentence_id\": 4, \"text\": \"First, a comparison of PARP inhibitors Talazoparib and Olaparib showed superior efficacy of Talazoparib in vitro and displayed high antitumor activity in xenografts in the chicken chorioallantoic membrane (CAM) model.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33923231", "sentence_id": 4, "text": "First, a comparison of PARP inhibitors Talazoparib and Olaparib showed superior efficacy of Talazoparib in vitro and displayed high antitumor activity in xenografts in the chicken chorioallantoic membrane (CAM) model."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33923231\", \"sentence_id\": 5, \"text\": \"Moreover, the combination of Talazoparib and the CDK4/6 inhibitor Palbociclib synergistically reduced tumor growth in Retinoblastoma protein (RB)-positive BLCA in vitro and in a CAM model, an effect that relies on Palbociclib-induced cell cycle arrest in G0/G1-phase complemented by a G2 arrest induced by Talazoparib.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33923231", "sentence_id": 5, "text": "Moreover, the combination of Talazoparib and the CDK4/6 inhibitor Palbociclib synergistically reduced tumor growth in Retinoblastoma protein (RB)-positive BLCA in vitro and in a CAM model, an effect that relies on Palbociclib-induced cell cycle arrest in G0/G1-phase complemented by a G2 arrest induced by Talazoparib."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33923231\", \"sentence_id\": 6, \"text\": \"Interestingly, Talazoparib-induced apoptosis was reduced by Palbociclib.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33923231", "sentence_id": 6, "text": "Interestingly, Talazoparib-induced apoptosis was reduced by Palbociclib."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33923231\", \"sentence_id\": 7, \"text\": \"The combination of Palbociclib and Talazoparib effectively enhances BLCA therapy, and RB is a molecular biomarker of response to this treatment regimen.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33923231", "sentence_id": 7, "text": "The combination of Palbociclib and Talazoparib effectively enhances BLCA therapy, and RB is a molecular biomarker of response to this treatment regimen."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33852339\", \"sentence_id\": 0, \"text\": \"PURPOSE: Poly (ADP-ribose) polymerase inhibitors (PARPi) have proven efficacy in treatment of BReast CAncer (\\nPATIENTS AND METHODS: We analyzed all consecutive patients who received PARPi.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33852339", "sentence_id": 0, "text": "PURPOSE: Poly (ADP-ribose) polymerase inhibitors (PARPi) have proven efficacy in treatment of BReast CAncer (\nPATIENTS AND METHODS: We analyzed all consecutive patients who received PARPi."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33852339\", \"sentence_id\": 1, \"text\": \"The efficacy of PARPi monotherapy was assessed in patients with relapsed high-grade serous ovarian carcinoma with g\\nRESULTS: Between July 1, 2015, and June 30, 2019, 28 patients with ovarian cancer received PARPi.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33852339", "sentence_id": 1, "text": "The efficacy of PARPi monotherapy was assessed in patients with relapsed high-grade serous ovarian carcinoma with g\nRESULTS: Between July 1, 2015, and June 30, 2019, 28 patients with ovarian cancer received PARPi."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33852339\", \"sentence_id\": 2, \"text\": \"At the time of data censoring (September 30, 2019), four (14.3%) patients are still on treatment.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33852339", "sentence_id": 2, "text": "At the time of data censoring (September 30, 2019), four (14.3%) patients are still on treatment."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33852339\", \"sentence_id\": 3, \"text\": \"Median age was 54.5 years (range, 39-75 years).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33852339", "sentence_id": 3, "text": "Median age was 54.5 years (range, 39-75 years)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33852339\", \"sentence_id\": 4, \"text\": \"Median number of previous lines of chemotherapy received was three (range, 1-6).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33852339", "sentence_id": 4, "text": "Median number of previous lines of chemotherapy received was three (range, 1-6)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33852339\", \"sentence_id\": 5, \"text\": \"Eleven platinum-sensitive patients received the drug as maintenance (five in complete response and six in partial response after chemotherapy), whereas 17 (60.7%) had platinum-resistant progressive disease while starting the drug.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33852339", "sentence_id": 5, "text": "Eleven platinum-sensitive patients received the drug as maintenance (five in complete response and six in partial response after chemotherapy), whereas 17 (60.7%) had platinum-resistant progressive disease while starting the drug."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33852339\", \"sentence_id\": 6, \"text\": \"In PROC, objective response rate (complete response plus partial response) was 47%, median progression-free survival was 8.2 months (5.3-11.3), and overall survival was 14.9 months (11.2-18.5).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33852339", "sentence_id": 6, "text": "In PROC, objective response rate (complete response plus partial response) was 47%, median progression-free survival was 8.2 months (5.3-11.3), and overall survival was 14.9 months (11.2-18.5)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33852339\", \"sentence_id\": 7, \"text\": \"No new side effects were observed.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33852339", "sentence_id": 7, "text": "No new side effects were observed."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33852339\", \"sentence_id\": 8, \"text\": \"CONCLUSION: This is the first study from India evaluating PARPi in platinum-resistant ovarian cancer.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33852339", "sentence_id": 8, "text": "CONCLUSION: This is the first study from India evaluating PARPi in platinum-resistant ovarian cancer."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33852339\", \"sentence_id\": 9, \"text\": \"This study suggests that PARPi is a viable treatment option in patients with PROC with gBRCAm.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33852339", "sentence_id": 9, "text": "This study suggests that PARPi is a viable treatment option in patients with PROC with gBRCAm."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33852339\", \"sentence_id\": 10, \"text\": \"This should be further evaluated in randomized clinical trial.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33852339", "sentence_id": 10, "text": "This should be further evaluated in randomized clinical trial."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33820831\", \"sentence_id\": 0, \"text\": \"Arsenic trioxide (ATO) is an anticancer agent used for the treatment ofacute promyelocytic leukemia (APL).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33820831", "sentence_id": 0, "text": "Arsenic trioxide (ATO) is an anticancer agent used for the treatment ofacute promyelocytic leukemia (APL)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33820831\", \"sentence_id\": 1, \"text\": \"However, 5%-10% of patients fail to respond or experience disease relapse.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33820831", "sentence_id": 1, "text": "However, 5%-10% of patients fail to respond or experience disease relapse."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33820831\", \"sentence_id\": 2, \"text\": \"Based on poly(ADP-ribose) polymerase (PARP) 1 involvement in the processing of DNA demethylation, here we have tested the in vitro susceptibility of ATO-resistant clones (derived from the human APL cell line NB4) to PARP inhibitors (PARPi) in combination with hypomethylating agents (azacitidine and decitabine) or high-dose vitamin C (ascorbate), which induces 5-hydroxymethylcytosine (5hmC)-mediated DNA demethylation.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33820831", "sentence_id": 2, "text": "Based on poly(ADP-ribose) polymerase (PARP) 1 involvement in the processing of DNA demethylation, here we have tested the in vitro susceptibility of ATO-resistant clones (derived from the human APL cell line NB4) to PARP inhibitors (PARPi) in combination with hypomethylating agents (azacitidine and decitabine) or high-dose vitamin C (ascorbate), which induces 5-hydroxymethylcytosine (5hmC)-mediated DNA demethylation."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33820831\", \"sentence_id\": 3, \"text\": \"ATO-sensitive and -resistant APL cell clones were generated and initially analyzed for their susceptibility to five clinically used PARPi (olaparib, niraparib, rucaparib, veliparib, and talazoparib).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33820831", "sentence_id": 3, "text": "ATO-sensitive and -resistant APL cell clones were generated and initially analyzed for their susceptibility to five clinically used PARPi (olaparib, niraparib, rucaparib, veliparib, and talazoparib)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33820831\", \"sentence_id\": 4, \"text\": \"The obtained PARPi IC\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33820831", "sentence_id": 4, "text": "The obtained PARPi IC"}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33803654\", \"sentence_id\": 0, \"text\": \"Muscle-invasive urothelial carcinoma (UC) is treated with cisplatin-based chemotherapy, which is only moderately efficient, mostly due to development of resistance.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33803654", "sentence_id": 0, "text": "Muscle-invasive urothelial carcinoma (UC) is treated with cisplatin-based chemotherapy, which is only moderately efficient, mostly due to development of resistance."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33803654\", \"sentence_id\": 1, \"text\": \"New therapy approaches are therefore urgently needed.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33803654", "sentence_id": 1, "text": "New therapy approaches are therefore urgently needed."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33803654\", \"sentence_id\": 2, \"text\": \"Epigenetic alterations due to frequent mutations in epigenetic regulators contribute to development of the disease and to treatment resistance, and provide targets for novel drug combination therapies.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33803654", "sentence_id": 2, "text": "Epigenetic alterations due to frequent mutations in epigenetic regulators contribute to development of the disease and to treatment resistance, and provide targets for novel drug combination therapies."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33803654\", \"sentence_id\": 3, \"text\": \"Here, we determined the cytotoxic impact of the second-generation bromodomain protein inhibitor (BETi) PLX51107 on UC cell lines (UCC) and normal HBLAK control cells.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33803654", "sentence_id": 3, "text": "Here, we determined the cytotoxic impact of the second-generation bromodomain protein inhibitor (BETi) PLX51107 on UC cell lines (UCC) and normal HBLAK control cells."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33803654\", \"sentence_id\": 4, \"text\": \"PLX51107 inhibited proliferation, induced apoptosis, and acted synergistically with the histone deacetylase inhibitor romidepsin.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33803654", "sentence_id": 4, "text": "PLX51107 inhibited proliferation, induced apoptosis, and acted synergistically with the histone deacetylase inhibitor romidepsin."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33803654\", \"sentence_id\": 5, \"text\": \"While PLX51107 caused significant DNA damage, DNA damage signaling and DNA repair were impeded, a state defined as BRCAness.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33803654", "sentence_id": 5, "text": "While PLX51107 caused significant DNA damage, DNA damage signaling and DNA repair were impeded, a state defined as BRCAness."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33803654\", \"sentence_id\": 6, \"text\": \"Accordingly, the drug strongly synergized with cisplatin more efficiently than romidepsin, and with the PARP inhibitor talazoparib to inhibit proliferation and induce cell death in UCC.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33803654", "sentence_id": 6, "text": "Accordingly, the drug strongly synergized with cisplatin more efficiently than romidepsin, and with the PARP inhibitor talazoparib to inhibit proliferation and induce cell death in UCC."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33803654\", \"sentence_id\": 7, \"text\": \"Thus, a BETi can be used to \\\"episensitize\\\" UC cells to cytotoxic chemotherapy and inhibitors of DNA repair by inducing BRCAness in non BRCA1/2 mutated cancers.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33803654", "sentence_id": 7, "text": "Thus, a BETi can be used to \"episensitize\" UC cells to cytotoxic chemotherapy and inhibitors of DNA repair by inducing BRCAness in non BRCA1/2 mutated cancers."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33803654\", \"sentence_id\": 8, \"text\": \"In clinical applications, the synergy between PLX51107 and other drugs should permit significant dosage reductions to minimize effects on normal tissues.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33803654", "sentence_id": 8, "text": "In clinical applications, the synergy between PLX51107 and other drugs should permit significant dosage reductions to minimize effects on normal tissues."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33767780\", \"sentence_id\": 0, \"text\": \"The use of the PARP inhibitors (PARPi) in the treatment of breast cancer (BC) with germine mutations has evolved over the years, and further research has been done in order to broaden the horizon of this treatment strategy.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33767780", "sentence_id": 0, "text": "The use of the PARP inhibitors (PARPi) in the treatment of breast cancer (BC) with germine mutations has evolved over the years, and further research has been done in order to broaden the horizon of this treatment strategy."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33767780\", \"sentence_id\": 1, \"text\": \"Therefore the aim of this paper is to review the efficiency of PARPi in the treatment of BRCA 1/2-mutated locally advanced and metastatic Her-2/net negative BC mentioning their side effects, mechanism of resistance and future directions.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33767780", "sentence_id": 1, "text": "Therefore the aim of this paper is to review the efficiency of PARPi in the treatment of BRCA 1/2-mutated locally advanced and metastatic Her-2/net negative BC mentioning their side effects, mechanism of resistance and future directions."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33767780\", \"sentence_id\": 2, \"text\": \"Inhibition of PARP transforms single-strand breaks into double-strand breaks (DBS), the accumulation of the latter causing cell death (cell apoptosis).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33767780", "sentence_id": 2, "text": "Inhibition of PARP transforms single-strand breaks into double-strand breaks (DBS), the accumulation of the latter causing cell death (cell apoptosis)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33767780\", \"sentence_id\": 3, \"text\": \"The Olympia AD phase III trial demonstrated a statistically significant progression-free survival rate (PFS) when using the PARPi olaparib in metastatic BC with germline BRCA1/2 mutations without any benefit of the overall survival rate.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33767780", "sentence_id": 3, "text": "The Olympia AD phase III trial demonstrated a statistically significant progression-free survival rate (PFS) when using the PARPi olaparib in metastatic BC with germline BRCA1/2 mutations without any benefit of the overall survival rate."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33767780\", \"sentence_id\": 4, \"text\": \"PARPi therapy is associated with acceptable responsive rates and progression-free survival rates in locally advanced and metastatic BRCA1/2 associated BC through mechanisms that enhance and increase the sensitivity to chemotherapeutic or target agents as they induce a synthetic lethality and cell apoptosis.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33767780", "sentence_id": 4, "text": "PARPi therapy is associated with acceptable responsive rates and progression-free survival rates in locally advanced and metastatic BRCA1/2 associated BC through mechanisms that enhance and increase the sensitivity to chemotherapeutic or target agents as they induce a synthetic lethality and cell apoptosis."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33767780\", \"sentence_id\": 5, \"text\": \"The side effects are not significant, the most adverse effects being related to the hematological and gastrointestinal systems.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33767780", "sentence_id": 5, "text": "The side effects are not significant, the most adverse effects being related to the hematological and gastrointestinal systems."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33767780\", \"sentence_id\": 6, \"text\": \"Olaparib is currently approved in the first-line treatment of BRCA1/2 mutated Her-2/neu negative metastatic BC at an oral dose of 300 mg twice daily, while Talazoparib represents a category one recommendation in locally advanced and metastatic Her-2/neu negative BC in women with central nervous system metastases.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33767780", "sentence_id": 6, "text": "Olaparib is currently approved in the first-line treatment of BRCA1/2 mutated Her-2/neu negative metastatic BC at an oral dose of 300 mg twice daily, while Talazoparib represents a category one recommendation in locally advanced and metastatic Her-2/neu negative BC in women with central nervous system metastases."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33724122\", \"sentence_id\": 0, \"text\": \"INTRODUCTION: Poly (ADP-ribose) polymerase (PARP) inhibitors are being developed in maintenance and recurrence treatment settings of epithelial ovarian cancers (EOCs) with BRCA 1-2 gene mutation.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33724122", "sentence_id": 0, "text": "INTRODUCTION: Poly (ADP-ribose) polymerase (PARP) inhibitors are being developed in maintenance and recurrence treatment settings of epithelial ovarian cancers (EOCs) with BRCA 1-2 gene mutation."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33724122\", \"sentence_id\": 1, \"text\": \"PARP inhibitors are the first example of drugs targeting the loss of a gene suppressor: they block base-excision repair in the cancer cells, which have lost homologous recombination due to BRCA-mutation, resulting in loss of DNA repair and cell death, also known as synthetic lethality.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33724122", "sentence_id": 1, "text": "PARP inhibitors are the first example of drugs targeting the loss of a gene suppressor: they block base-excision repair in the cancer cells, which have lost homologous recombination due to BRCA-mutation, resulting in loss of DNA repair and cell death, also known as synthetic lethality."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33724122\", \"sentence_id\": 2, \"text\": \"AREAS COVERED: This article provides an overview of PARP inhibitors in OC treatment and also an extensive section on the combined strategies of PARP inhibitors, including approved as well as currently investigated drugs.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33724122", "sentence_id": 2, "text": "AREAS COVERED: This article provides an overview of PARP inhibitors in OC treatment and also an extensive section on the combined strategies of PARP inhibitors, including approved as well as currently investigated drugs."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33724122\", \"sentence_id\": 3, \"text\": \"It also offers a section on the use of predictive biomarkers for PARP inhibitors treatment.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33724122", "sentence_id": 3, "text": "It also offers a section on the use of predictive biomarkers for PARP inhibitors treatment."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33724122\", \"sentence_id\": 4, \"text\": \"Ongoing trials, including novel combinations, are discussed.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33724122", "sentence_id": 4, "text": "Ongoing trials, including novel combinations, are discussed."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33724122\", \"sentence_id\": 5, \"text\": \"EXPERT OPINION: In recent years, there is increasing evidence that PARP inhibitor therapy can have life-long percussion in the treatment of EOC, even if some questions have to be solved yet, such as its use in combination therapy, the possibility to retreat with a PARP inhibitor, and finally how to overcome a resistance mechanism to this therapy.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33724122", "sentence_id": 5, "text": "EXPERT OPINION: In recent years, there is increasing evidence that PARP inhibitor therapy can have life-long percussion in the treatment of EOC, even if some questions have to be solved yet, such as its use in combination therapy, the possibility to retreat with a PARP inhibitor, and finally how to overcome a resistance mechanism to this therapy."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33724122\", \"sentence_id\": 6, \"text\": \"In this way, PARP inhibitors can obtain an important role in making a personalized therapeutic program in the case of first-line, neoadjuvant, platinum-sensitive, and resistant high-grade serous OC treatment.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33724122", "sentence_id": 6, "text": "In this way, PARP inhibitors can obtain an important role in making a personalized therapeutic program in the case of first-line, neoadjuvant, platinum-sensitive, and resistant high-grade serous OC treatment."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33710464\", \"sentence_id\": 0, \"text\": \"G-quadruplexes (G4s) are DNA or RNA structures formed by guanine-rich repeating sequences.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33710464", "sentence_id": 0, "text": "G-quadruplexes (G4s) are DNA or RNA structures formed by guanine-rich repeating sequences."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33710464\", \"sentence_id\": 1, \"text\": \"Recently, G4s have become a highly attractive therapeutic target for BRCA-deficient cancers.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33710464", "sentence_id": 1, "text": "Recently, G4s have become a highly attractive therapeutic target for BRCA-deficient cancers."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33710464\", \"sentence_id\": 2, \"text\": \"Here, we show that a substituted quinolone amide compound, MTR-106, stabilizes DNA G-quadruplexes in vitro.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33710464", "sentence_id": 2, "text": "Here, we show that a substituted quinolone amide compound, MTR-106, stabilizes DNA G-quadruplexes in vitro."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33710464\", \"sentence_id\": 3, \"text\": \"MTR-106 displayed significant antiproliferative activity in homologous recombination repair (HR)-deficient and PARP inhibitor (PARPi)-resistant cancer cells.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33710464", "sentence_id": 3, "text": "MTR-106 displayed significant antiproliferative activity in homologous recombination repair (HR)-deficient and PARP inhibitor (PARPi)-resistant cancer cells."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33710464\", \"sentence_id\": 4, \"text\": \"Moreover, MTR-106 increased DNA damage and promoted cell cycle arrest and apoptosis to inhibit cell growth.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33710464", "sentence_id": 4, "text": "Moreover, MTR-106 increased DNA damage and promoted cell cycle arrest and apoptosis to inhibit cell growth."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33710464\", \"sentence_id\": 5, \"text\": \"Importantly, its oral and i.v.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33710464", "sentence_id": 5, "text": "Importantly, its oral and i.v."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33710464\", \"sentence_id\": 6, \"text\": \"administration significantly impaired tumor growth in BRCA-deficient xenograft mouse models.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33710464", "sentence_id": 6, "text": "administration significantly impaired tumor growth in BRCA-deficient xenograft mouse models."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33710464\", \"sentence_id\": 7, \"text\": \"However, MTR-106 showed modest activity against talazoparib-resistant xenograft models.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33710464", "sentence_id": 7, "text": "However, MTR-106 showed modest activity against talazoparib-resistant xenograft models."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33710464\", \"sentence_id\": 8, \"text\": \"In rats, the drug rapidly distributes to tissues within 5\u00a0min, and its average concentrations were 12-fold higher in the tissues than in the plasma.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33710464", "sentence_id": 8, "text": "In rats, the drug rapidly distributes to tissues within 5\u00a0min, and its average concentrations were 12-fold higher in the tissues than in the plasma."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33710464\", \"sentence_id\": 9, \"text\": \"Overall, we identified MTR-106 as a novel G-quadruplex stabilizer with high tissue distribution, and it may serve as a potential anticancer agent.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33710464", "sentence_id": 9, "text": "Overall, we identified MTR-106 as a novel G-quadruplex stabilizer with high tissue distribution, and it may serve as a potential anticancer agent."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33691794\", \"sentence_id\": 0, \"text\": \"BACKGROUND: Non-small cell lung carcinoma (NSCLC) is a leading cause of cancer-related death and represents a major health burden worldwide.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33691794", "sentence_id": 0, "text": "BACKGROUND: Non-small cell lung carcinoma (NSCLC) is a leading cause of cancer-related death and represents a major health burden worldwide."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33691794\", \"sentence_id\": 1, \"text\": \"Current therapies for NSCLC include chemotherapy, immunotherapy, and targeted molecular agents such as tyrosine kinase inhibitors and epigenetic drugs such as DNA methyltransferase inhibitors.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33691794", "sentence_id": 1, "text": "Current therapies for NSCLC include chemotherapy, immunotherapy, and targeted molecular agents such as tyrosine kinase inhibitors and epigenetic drugs such as DNA methyltransferase inhibitors."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33691794\", \"sentence_id\": 2, \"text\": \"However, survival rates remain low for patients with NSCLC, especially those with metastatic disease.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33691794", "sentence_id": 2, "text": "However, survival rates remain low for patients with NSCLC, especially those with metastatic disease."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33691794\", \"sentence_id\": 3, \"text\": \"A major cause for therapeutic failure is drug resistance, highlighting the need for novel therapies and combination strategies.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33691794", "sentence_id": 3, "text": "A major cause for therapeutic failure is drug resistance, highlighting the need for novel therapies and combination strategies."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33691794\", \"sentence_id\": 4, \"text\": \"Given that epigenetic modulators such as protein arginine methyltransferases (PRMTs) are frequently overexpressed in cancers, PRMT inhibitors are a promising class of cancer therapeutics.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33691794", "sentence_id": 4, "text": "Given that epigenetic modulators such as protein arginine methyltransferases (PRMTs) are frequently overexpressed in cancers, PRMT inhibitors are a promising class of cancer therapeutics."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33691794\", \"sentence_id\": 5, \"text\": \"We screened a library of epigenetic and anticancer drugs to identify compounds that would synergize with MS023, a type I PRMT inhibitor, in decreasing the viability of methylthioadenosine phosphorylase (MTAP)-negative NSCLC cells.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33691794", "sentence_id": 5, "text": "We screened a library of epigenetic and anticancer drugs to identify compounds that would synergize with MS023, a type I PRMT inhibitor, in decreasing the viability of methylthioadenosine phosphorylase (MTAP)-negative NSCLC cells."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33691794\", \"sentence_id\": 6, \"text\": \"RESULTS: Among 181 compounds, we identified PARP inhibitors (PARPi) as having a strong synergistic interaction with type I PRMT inhibition.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33691794", "sentence_id": 6, "text": "RESULTS: Among 181 compounds, we identified PARP inhibitors (PARPi) as having a strong synergistic interaction with type I PRMT inhibition."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33691794\", \"sentence_id\": 7, \"text\": \"The combination of MS023 and the PARP inhibitor BMN-673 (Talazoparib) demonstrated strong synergistic interaction at low nanomolar concentrations in MTAP-negative NSCLC cell lines A549, SK-LU-1 and HCC4006.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33691794", "sentence_id": 7, "text": "The combination of MS023 and the PARP inhibitor BMN-673 (Talazoparib) demonstrated strong synergistic interaction at low nanomolar concentrations in MTAP-negative NSCLC cell lines A549, SK-LU-1 and HCC4006."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33691794\", \"sentence_id\": 8, \"text\": \"The re-introduction of MTAP decreased the sensitivity of the combination therapy in A549.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33691794", "sentence_id": 8, "text": "The re-introduction of MTAP decreased the sensitivity of the combination therapy in A549."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33691794\", \"sentence_id\": 9, \"text\": \"The combination therapy resulted in elevated \u03b3-H2AX foci indicating increased DNA damage causing decreased cell viability.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33691794", "sentence_id": 9, "text": "The combination therapy resulted in elevated \u03b3-H2AX foci indicating increased DNA damage causing decreased cell viability."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33691794\", \"sentence_id\": 10, \"text\": \"Lastly, the combination therapy was effective in PARPi resistant ovarian cancer cells, suggesting that type I PRMT inhibitors could mitigate PARPi resistance, thus potentially having an important clinical impact for cancer treatment.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33691794", "sentence_id": 10, "text": "Lastly, the combination therapy was effective in PARPi resistant ovarian cancer cells, suggesting that type I PRMT inhibitors could mitigate PARPi resistance, thus potentially having an important clinical impact for cancer treatment."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33691794\", \"sentence_id\": 11, \"text\": \"CONCLUSIONS: These findings identify a novel cancer drug combination therapy, which is more potent than the separate single-agent therapies.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33691794", "sentence_id": 11, "text": "CONCLUSIONS: These findings identify a novel cancer drug combination therapy, which is more potent than the separate single-agent therapies."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33691794\", \"sentence_id\": 12, \"text\": \"Thus, combining PARP inhibitors and type I PRMT inhibitors represents a new therapeutic opportunity for MTAP-negative NSCLC and certain cancer cells resistant to PARP inhibitors.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33691794", "sentence_id": 12, "text": "Thus, combining PARP inhibitors and type I PRMT inhibitors represents a new therapeutic opportunity for MTAP-negative NSCLC and certain cancer cells resistant to PARP inhibitors."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33536335\", \"sentence_id\": 0, \"text\": \"Schlafen-11 (SLFN11) inactivation in \u223c50% of cancer cells confers broad chemoresistance.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33536335", "sentence_id": 0, "text": "Schlafen-11 (SLFN11) inactivation in \u223c50% of cancer cells confers broad chemoresistance."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33536335\", \"sentence_id\": 1, \"text\": \"To identify therapeutic targets and underlying molecular mechanisms for overcoming chemoresistance, we performed an unbiased genome-wide RNAi screen in\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33536335", "sentence_id": 1, "text": "To identify therapeutic targets and underlying molecular mechanisms for overcoming chemoresistance, we performed an unbiased genome-wide RNAi screen in"}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33490218\", \"sentence_id\": 0, \"text\": \"Epithelial ovarian cancer (EOC) is the fifth leading cause of cancer mortality among women, potentially due to ineffectiveness of screening tests for early detection.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33490218", "sentence_id": 0, "text": "Epithelial ovarian cancer (EOC) is the fifth leading cause of cancer mortality among women, potentially due to ineffectiveness of screening tests for early detection."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33490218\", \"sentence_id\": 1, \"text\": \"Patients typically present with advanced disease at diagnosis, whereas, up to 80% relapse and the estimated median progression-free survival (PFS) is approximately 12-18 months.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33490218", "sentence_id": 1, "text": "Patients typically present with advanced disease at diagnosis, whereas, up to 80% relapse and the estimated median progression-free survival (PFS) is approximately 12-18 months."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33490218\", \"sentence_id\": 2, \"text\": \"Increased knowledge on the molecular biology of EOC resulted in the development of several targeted therapies, including poly(ADP-ribose) polymerase (PARP) inhibitors.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33490218", "sentence_id": 2, "text": "Increased knowledge on the molecular biology of EOC resulted in the development of several targeted therapies, including poly(ADP-ribose) polymerase (PARP) inhibitors."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33490218\", \"sentence_id\": 3, \"text\": \"These agents have changed the therapeutic approach of the EOC and exploit homologous recombination (HR) deficiency through synthetic lethality, especially in breast cancer genes 1 and 2 (\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33490218", "sentence_id": 3, "text": "These agents have changed the therapeutic approach of the EOC and exploit homologous recombination (HR) deficiency through synthetic lethality, especially in breast cancer genes 1 and 2 ("}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33473172\", \"sentence_id\": 0, \"text\": \"BACKGROUND: Poly(ADP-ribose) polymerase inhibitors (PARPi) target tumours defective in homologous recombination (HR).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33473172", "sentence_id": 0, "text": "BACKGROUND: Poly(ADP-ribose) polymerase inhibitors (PARPi) target tumours defective in homologous recombination (HR)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33473172\", \"sentence_id\": 1, \"text\": \"Most BRCA-wild-type (WT) HR-proficient breast cancers are intrinsically resistant to PARP inhibitors, e.g., talazoparib.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33473172", "sentence_id": 1, "text": "Most BRCA-wild-type (WT) HR-proficient breast cancers are intrinsically resistant to PARP inhibitors, e.g., talazoparib."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33473172\", \"sentence_id\": 2, \"text\": \"We evaluated the role of autophagy in this de novo resistance and determined the underlying mechanism to overcome this.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33473172", "sentence_id": 2, "text": "We evaluated the role of autophagy in this de novo resistance and determined the underlying mechanism to overcome this."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33473172\", \"sentence_id\": 3, \"text\": \"METHODS: Autophagosome formation and autophagic flux were assessed by evaluating endogenous LC3-II levels and ectopic expression of EGFP-LC3 and mRFP-EGFP-LC3 in breast cancer cells.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33473172", "sentence_id": 3, "text": "METHODS: Autophagosome formation and autophagic flux were assessed by evaluating endogenous LC3-II levels and ectopic expression of EGFP-LC3 and mRFP-EGFP-LC3 in breast cancer cells."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33473172\", \"sentence_id\": 4, \"text\": \"Autophagy-defective cells were generated by genetic depletion of BECN1, ATG5, p62/SQSTM1 and LAMP1 by using CRISPR-Cas9 double nickase system.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33473172", "sentence_id": 4, "text": "Autophagy-defective cells were generated by genetic depletion of BECN1, ATG5, p62/SQSTM1 and LAMP1 by using CRISPR-Cas9 double nickase system."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33473172\", \"sentence_id\": 5, \"text\": \"The response of PARPi was evaluated in autophagy-proficient and -defective breast cancer cells and in xenograft SCID-mice model.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33473172", "sentence_id": 5, "text": "The response of PARPi was evaluated in autophagy-proficient and -defective breast cancer cells and in xenograft SCID-mice model."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33473172\", \"sentence_id\": 6, \"text\": \"RESULTS: Pro-survival autophagy was significantly enhanced upon talazoparib treatment in BRCA-WT breast cancer cell lines.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33473172", "sentence_id": 6, "text": "RESULTS: Pro-survival autophagy was significantly enhanced upon talazoparib treatment in BRCA-WT breast cancer cell lines."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33473172\", \"sentence_id\": 7, \"text\": \"Autophagy-deficient cells were hypersensitive to talazoparib.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33473172", "sentence_id": 7, "text": "Autophagy-deficient cells were hypersensitive to talazoparib."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33473172\", \"sentence_id\": 8, \"text\": \"Targeting autophagy synergistically enhanced the therapeutic efficacy of talazoparib in BRCA1-WT breast cancer cells in vitro and in vivo xenograft tumour mouse model.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33473172", "sentence_id": 8, "text": "Targeting autophagy synergistically enhanced the therapeutic efficacy of talazoparib in BRCA1-WT breast cancer cells in vitro and in vivo xenograft tumour mouse model."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33473172\", \"sentence_id\": 9, \"text\": \"Mechanistically, autophagy inhibition by chloroquine promoted deleterious NHEJ mediated DSB-repair, leading to extensive genomic instability and mitotic catastrophe.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33473172", "sentence_id": 9, "text": "Mechanistically, autophagy inhibition by chloroquine promoted deleterious NHEJ mediated DSB-repair, leading to extensive genomic instability and mitotic catastrophe."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33473172\", \"sentence_id\": 10, \"text\": \"CONCLUSIONS: Autophagy confers de novo resistance to PARP inhibitor, talazoparib.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33473172", "sentence_id": 10, "text": "CONCLUSIONS: Autophagy confers de novo resistance to PARP inhibitor, talazoparib."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33473172\", \"sentence_id\": 11, \"text\": \"Autophagy inhibition improves the therapeutic outcome of PARPi treatment in preclinical mice model, bearing HR-proficient breast tumours, warranting its usage in the clinical settings.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33473172", "sentence_id": 11, "text": "Autophagy inhibition improves the therapeutic outcome of PARPi treatment in preclinical mice model, bearing HR-proficient breast tumours, warranting its usage in the clinical settings."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33412559\", \"sentence_id\": 0, \"text\": \"Triple negative breast cancer (TNBC) represents approximately 10-15% of all breast cancers and has a poor outcome as it lacks a receptor target for therapy, and TNBC is frequently associated with a germline mutation of BRCA1.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33412559", "sentence_id": 0, "text": "Triple negative breast cancer (TNBC) represents approximately 10-15% of all breast cancers and has a poor outcome as it lacks a receptor target for therapy, and TNBC is frequently associated with a germline mutation of BRCA1."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33412559\", \"sentence_id\": 1, \"text\": \"Poly (ADP-ribose) polymerase inhibitor (PARPi) drugs have demonstrated some effectiveness in treating BRCA1 or BRCA2 mutated breast and ovarian cancers but resistance to PARPi is common.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33412559", "sentence_id": 1, "text": "Poly (ADP-ribose) polymerase inhibitor (PARPi) drugs have demonstrated some effectiveness in treating BRCA1 or BRCA2 mutated breast and ovarian cancers but resistance to PARPi is common."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33412559\", \"sentence_id\": 2, \"text\": \"Published results found that resistance to Olaparib, a PARPi, can be due to downregulation of EMI1 and the consequent upregulation of the RAD51 recombinase.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33412559", "sentence_id": 2, "text": "Published results found that resistance to Olaparib, a PARPi, can be due to downregulation of EMI1 and the consequent upregulation of the RAD51 recombinase."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33412559\", \"sentence_id\": 3, \"text\": \"Using a tissue culture-based cell viability assay, we extended those observations to another PARPi and to other chemotherapy drugs that affect DNA repair or the cell cycle.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33412559", "sentence_id": 3, "text": "Using a tissue culture-based cell viability assay, we extended those observations to another PARPi and to other chemotherapy drugs that affect DNA repair or the cell cycle."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33412559\", \"sentence_id\": 4, \"text\": \"As we expected, EMI1 downregulation resulted in resistance to another PARPi drug, Talazoparib.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33412559", "sentence_id": 4, "text": "As we expected, EMI1 downregulation resulted in resistance to another PARPi drug, Talazoparib."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33412559\", \"sentence_id\": 5, \"text\": \"EMI1 downregulation also led to resistance to other cytotoxic drugs, Cisplatin and CHK1 inhibitor.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33412559", "sentence_id": 5, "text": "EMI1 downregulation also led to resistance to other cytotoxic drugs, Cisplatin and CHK1 inhibitor."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33412559\", \"sentence_id\": 6, \"text\": \"Notably, increasing the RAD51 protein expression only recapitulated some, but not all, of the effects of EMI1 depletion in conferring to the cell resistance to different PARPi and the other cytotoxic drugs.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33412559", "sentence_id": 6, "text": "Notably, increasing the RAD51 protein expression only recapitulated some, but not all, of the effects of EMI1 depletion in conferring to the cell resistance to different PARPi and the other cytotoxic drugs."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33412559\", \"sentence_id\": 7, \"text\": \"These results suggest that the downstream effects of EMI1 downregulation that contribute to PARPi resistance are increasing the concentration of RAD51 protein in the cell and blocking mitotic entry.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33412559", "sentence_id": 7, "text": "These results suggest that the downstream effects of EMI1 downregulation that contribute to PARPi resistance are increasing the concentration of RAD51 protein in the cell and blocking mitotic entry."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33412559\", \"sentence_id\": 8, \"text\": \"We found that combining CHK1 inhibitor with olaparib results in restoration of sensitivity even when EMI1 expression is downregulated.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33412559", "sentence_id": 8, "text": "We found that combining CHK1 inhibitor with olaparib results in restoration of sensitivity even when EMI1 expression is downregulated."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33412559\", \"sentence_id\": 9, \"text\": \"This combination therapy may be a means to overcome the PARPi resistance in BRCA1-deficient TNBC cells.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33412559", "sentence_id": 9, "text": "This combination therapy may be a means to overcome the PARPi resistance in BRCA1-deficient TNBC cells."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33339368\", \"sentence_id\": 0, \"text\": \"Small cell lung cancer (SCLC) is an aggressive type of lung cancer with high mortality that is caused by frequent relapses and acquired resistance.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33339368", "sentence_id": 0, "text": "Small cell lung cancer (SCLC) is an aggressive type of lung cancer with high mortality that is caused by frequent relapses and acquired resistance."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33339368\", \"sentence_id\": 1, \"text\": \"Despite that several target-based approaches with potential therapeutic impact on SCLC have been identified, numerous targeted drugs have not been successful in providing improvements in cancer patients when used as single agents.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33339368", "sentence_id": 1, "text": "Despite that several target-based approaches with potential therapeutic impact on SCLC have been identified, numerous targeted drugs have not been successful in providing improvements in cancer patients when used as single agents."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33339368\", \"sentence_id\": 2, \"text\": \"A combination of targeted therapies could be a strategy to induce maximum lethal effects on cancer cells.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33339368", "sentence_id": 2, "text": "A combination of targeted therapies could be a strategy to induce maximum lethal effects on cancer cells."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33339368\", \"sentence_id\": 3, \"text\": \"As a starting point in the development of new drug combination strategies for the treatment of SCLC, we performed a mid-throughput screening assay by treating a panel of SCLC cell lines with BETi or AKi in combination with PARPi or EZH2i.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33339368", "sentence_id": 3, "text": "As a starting point in the development of new drug combination strategies for the treatment of SCLC, we performed a mid-throughput screening assay by treating a panel of SCLC cell lines with BETi or AKi in combination with PARPi or EZH2i."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33339368\", \"sentence_id\": 4, \"text\": \"We observed drug synergy between I-BET762 and Talazoparib, BETi and PARPi, respectively, in SCLC cells.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33339368", "sentence_id": 4, "text": "We observed drug synergy between I-BET762 and Talazoparib, BETi and PARPi, respectively, in SCLC cells."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33339368\", \"sentence_id\": 5, \"text\": \"Combinatorial efficacy was observed in\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33339368", "sentence_id": 5, "text": "Combinatorial efficacy was observed in"}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33336070\", \"sentence_id\": 0, \"text\": \"Triple-negative breast cancer (TNBC) is a particularly aggressive subtype known for its extremely high drug resistance, progression, poor prognosis, and lack of clear therapeutic targets.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33336070", "sentence_id": 0, "text": "Triple-negative breast cancer (TNBC) is a particularly aggressive subtype known for its extremely high drug resistance, progression, poor prognosis, and lack of clear therapeutic targets."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33336070\", \"sentence_id\": 1, \"text\": \"Researchers are aiming to advance TNBC treatment worldwide.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33336070", "sentence_id": 1, "text": "Researchers are aiming to advance TNBC treatment worldwide."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33336070\", \"sentence_id\": 2, \"text\": \"In the past 2-3 years, more positive results have emerged in the clinical research on TNBC treatment.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33336070", "sentence_id": 2, "text": "In the past 2-3 years, more positive results have emerged in the clinical research on TNBC treatment."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33336070\", \"sentence_id\": 3, \"text\": \"Based on the results, several impressive drugs have been approved to benefit patients with TNBC, including the PARP inhibitors olaparib and talazoparib for germline BRCA mutation-associated breast cancer (gBRCAm-BC) and immunotherapy using the checkpoint inhibitor atezolizumab in combination with nab-paclitaxel for programmed cell death-ligand 1-positive (PD-L1+) advanced TNBC.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33336070", "sentence_id": 3, "text": "Based on the results, several impressive drugs have been approved to benefit patients with TNBC, including the PARP inhibitors olaparib and talazoparib for germline BRCA mutation-associated breast cancer (gBRCAm-BC) and immunotherapy using the checkpoint inhibitor atezolizumab in combination with nab-paclitaxel for programmed cell death-ligand 1-positive (PD-L1+) advanced TNBC."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33336070\", \"sentence_id\": 4, \"text\": \"Although neoadjuvant therapy has focused on combinations of systemic agents to optimize pathologically complete response, metastatic TNBC still has a poor prognosis.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33336070", "sentence_id": 4, "text": "Although neoadjuvant therapy has focused on combinations of systemic agents to optimize pathologically complete response, metastatic TNBC still has a poor prognosis."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33336070\", \"sentence_id\": 5, \"text\": \"Innovative multidrug combination systemic therapies based on neoadjuvants and adjuvants have led to significant improvements in outcomes, particularly over the past decade.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33336070", "sentence_id": 5, "text": "Innovative multidrug combination systemic therapies based on neoadjuvants and adjuvants have led to significant improvements in outcomes, particularly over the past decade."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33325624\", \"sentence_id\": 0, \"text\": \"Talazoparib (TAL) has been effectively used for the treatment of gBRCA1/2-mutated HER2-negative metastatic breast cancer.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33325624", "sentence_id": 0, "text": "Talazoparib (TAL) has been effectively used for the treatment of gBRCA1/2-mutated HER2-negative metastatic breast cancer."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33325624\", \"sentence_id\": 1, \"text\": \"However, acquired resistance to TAL remains a major challenge that impedes the clinical success of TAL treatment.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33325624", "sentence_id": 1, "text": "However, acquired resistance to TAL remains a major challenge that impedes the clinical success of TAL treatment."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33325624\", \"sentence_id\": 2, \"text\": \"Therefore, elucidation of proteins and pathways that contribute to or are affected by the TAL resistance is urgently needed to improve the treatment response and provide novel treatment strategies for advanced metastatic breast cancers.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33325624", "sentence_id": 2, "text": "Therefore, elucidation of proteins and pathways that contribute to or are affected by the TAL resistance is urgently needed to improve the treatment response and provide novel treatment strategies for advanced metastatic breast cancers."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33325624\", \"sentence_id\": 3, \"text\": \"Herein, we aimed to investigate the altered protein signatures in TAL-resistant triple-negative breast cancer (TNBC) cells by comparing with the TNBC parental cell line via proteomic analysis.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33325624", "sentence_id": 3, "text": "Herein, we aimed to investigate the altered protein signatures in TAL-resistant triple-negative breast cancer (TNBC) cells by comparing with the TNBC parental cell line via proteomic analysis."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33325624\", \"sentence_id\": 4, \"text\": \"After validation of TAL-resistance by WST-1 and Annexin V analysis, two-dimensional gel electrophoresis (2DE)-based proteomic analysis coupled to matrix-assisted laser desorption/ionization (MALDI)-time of flight (TOF) mass spectrometry was performed to identify differentially regulated proteins.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33325624", "sentence_id": 4, "text": "After validation of TAL-resistance by WST-1 and Annexin V analysis, two-dimensional gel electrophoresis (2DE)-based proteomic analysis coupled to matrix-assisted laser desorption/ionization (MALDI)-time of flight (TOF) mass spectrometry was performed to identify differentially regulated proteins."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33325624\", \"sentence_id\": 5, \"text\": \"The findings revealed the identities of 10 differentially regulated proteins in TAL-resistant TNBC cells whose bioinformatic analysis predicted changes in EGF/FGF signaling pathways as well as in the AMPK signaling pathway.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33325624", "sentence_id": 5, "text": "The findings revealed the identities of 10 differentially regulated proteins in TAL-resistant TNBC cells whose bioinformatic analysis predicted changes in EGF/FGF signaling pathways as well as in the AMPK signaling pathway."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33325624\", \"sentence_id\": 6, \"text\": \"In addition, phosphorylation/dephosphorylation dynamics were predicted to be altered in TAL-resistant cells.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33325624", "sentence_id": 6, "text": "In addition, phosphorylation/dephosphorylation dynamics were predicted to be altered in TAL-resistant cells."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33325624\", \"sentence_id\": 7, \"text\": \"The proteins identified in this study might be the targets to overcome TAL resistance for the treatment of TNBC.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33325624", "sentence_id": 7, "text": "The proteins identified in this study might be the targets to overcome TAL resistance for the treatment of TNBC."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33233320\", \"sentence_id\": 0, \"text\": \"Metastatic castration-resistant prostate cancer (mCRPC) is an incurable malignancy with a poor prognosis.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33233320", "sentence_id": 0, "text": "Metastatic castration-resistant prostate cancer (mCRPC) is an incurable malignancy with a poor prognosis."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33233320\", \"sentence_id\": 1, \"text\": \"Up to 30% of patients with mCRPC have mutations in homologous recombination repair (HRR) genes.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33233320", "sentence_id": 1, "text": "Up to 30% of patients with mCRPC have mutations in homologous recombination repair (HRR) genes."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33233320\", \"sentence_id\": 2, \"text\": \"Poly (ADP-ribose) polymerase (PARP) inhibitors take advantage of HRR deficiency to kill tumor cells based on the concept of synthetic lethality.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33233320", "sentence_id": 2, "text": "Poly (ADP-ribose) polymerase (PARP) inhibitors take advantage of HRR deficiency to kill tumor cells based on the concept of synthetic lethality."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33233320\", \"sentence_id\": 3, \"text\": \"Several PARP inhibitors (PARPis) have been successful in various malignancies with HRR gene mutations including BRCA1/2, especially in breast cancer and ovarian cancer.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33233320", "sentence_id": 3, "text": "Several PARP inhibitors (PARPis) have been successful in various malignancies with HRR gene mutations including BRCA1/2, especially in breast cancer and ovarian cancer."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33233320\", \"sentence_id\": 4, \"text\": \"More recently, olaparib and rucaparib were approved for mCRPC refractory to novel hormonal therapies, and other PARPis will likely follow.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33233320", "sentence_id": 4, "text": "More recently, olaparib and rucaparib were approved for mCRPC refractory to novel hormonal therapies, and other PARPis will likely follow."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33233320\", \"sentence_id\": 5, \"text\": \"This article highlights the mechanism of action of PARPis at the cellular level, the preclinical data regarding a proposed mechanism of action and the effectiveness of PARPis in cancer cell lines and animal models.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33233320", "sentence_id": 5, "text": "This article highlights the mechanism of action of PARPis at the cellular level, the preclinical data regarding a proposed mechanism of action and the effectiveness of PARPis in cancer cell lines and animal models."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33233320\", \"sentence_id\": 6, \"text\": \"The article expands on the clinical development of PARPis in mCRPC, discusses potential biomarkers that may predict successful tumor control, and summarizes present and future clinical research on PARPis in the metastatic disease landscape.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33233320", "sentence_id": 6, "text": "The article expands on the clinical development of PARPis in mCRPC, discusses potential biomarkers that may predict successful tumor control, and summarizes present and future clinical research on PARPis in the metastatic disease landscape."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33059228\", \"sentence_id\": 0, \"text\": \"Poly(ADP-ribose) polymerase (PARP) is a nuclear enzyme that plays a critical role in the repair of single-strand DNA damage via the base excision repair pathway.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33059228", "sentence_id": 0, "text": "Poly(ADP-ribose) polymerase (PARP) is a nuclear enzyme that plays a critical role in the repair of single-strand DNA damage via the base excision repair pathway."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33059228\", \"sentence_id\": 1, \"text\": \"PARP inhibitors have substantial single-agent antitumor activity by inducing synthetic lethality.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33059228", "sentence_id": 1, "text": "PARP inhibitors have substantial single-agent antitumor activity by inducing synthetic lethality."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33059228\", \"sentence_id\": 2, \"text\": \"They have also emerged as promising anticancer targeted therapies, especially in tumors harboring deleterious germline or somatic breast cancer susceptibility gene (BRCA) mutations.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33059228", "sentence_id": 2, "text": "They have also emerged as promising anticancer targeted therapies, especially in tumors harboring deleterious germline or somatic breast cancer susceptibility gene (BRCA) mutations."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33059228\", \"sentence_id\": 3, \"text\": \"PARP inhibition produces single-strand DNA breaks, which may be repaired by homologous recombination, a process partially dependent on BRCA1 and BRCA2.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33059228", "sentence_id": 3, "text": "PARP inhibition produces single-strand DNA breaks, which may be repaired by homologous recombination, a process partially dependent on BRCA1 and BRCA2."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33059228\", \"sentence_id\": 4, \"text\": \"The PARP inhibitors olaparib, veliparib, talazoparib, niraparib, and rucaparib have predominantly been studied in patients with breast or ovarian cancers associated with deleterious germline mutations in BRCA1 and BRCA2.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33059228", "sentence_id": 4, "text": "The PARP inhibitors olaparib, veliparib, talazoparib, niraparib, and rucaparib have predominantly been studied in patients with breast or ovarian cancers associated with deleterious germline mutations in BRCA1 and BRCA2."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33059228\", \"sentence_id\": 5, \"text\": \"Ongoing clinical trials are evaluating the role of PARP inhibitors alone and in combination with other therapies, including selective inhibitors against key targets involved in the DNA damage response.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33059228", "sentence_id": 5, "text": "Ongoing clinical trials are evaluating the role of PARP inhibitors alone and in combination with other therapies, including selective inhibitors against key targets involved in the DNA damage response."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33059228\", \"sentence_id\": 6, \"text\": \"In this review we summarize the use of PARP inhibitors in various tumor types, as well as possible approaches for overcoming resistance to PARP inhibitors.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33059228", "sentence_id": 6, "text": "In this review we summarize the use of PARP inhibitors in various tumor types, as well as possible approaches for overcoming resistance to PARP inhibitors."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33042619\", \"sentence_id\": 0, \"text\": \"Several poly(ADP ribose) polymerase (PARP) inhibitors (PARPi) have been approved for cancer therapy; however, intrinsic and acquired resistance has limited their efficacy in the clinic.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33042619", "sentence_id": 0, "text": "Several poly(ADP ribose) polymerase (PARP) inhibitors (PARPi) have been approved for cancer therapy; however, intrinsic and acquired resistance has limited their efficacy in the clinic."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33042619\", \"sentence_id\": 1, \"text\": \"In fact, cancer cells have developed multiple mechanisms to overcome PARPi cytotoxicity in even a single cancer cell.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33042619", "sentence_id": 1, "text": "In fact, cancer cells have developed multiple mechanisms to overcome PARPi cytotoxicity in even a single cancer cell."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33042619\", \"sentence_id\": 2, \"text\": \"In this study, we generated three PARPi-resistant BRCA2-deficient pancreatic Capan-1 variant cells using olaparib (Capan-1/OP), talazoparib (Capan-1/TP), and simmiparib (Capan-1/SP).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33042619", "sentence_id": 2, "text": "In this study, we generated three PARPi-resistant BRCA2-deficient pancreatic Capan-1 variant cells using olaparib (Capan-1/OP), talazoparib (Capan-1/TP), and simmiparib (Capan-1/SP)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"33042619\", \"sentence_id\": 3, \"text\": \"We identified novel mutations in intron 11 of\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "33042619", "sentence_id": 3, "text": "We identified novel mutations in intron 11 of"}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32982407\", \"sentence_id\": 0, \"text\": \"Poly (ADP-ribose) polymerase inhibitors (PARPi) are a unique class of antineoplastic agents that function by inducing synthetic lethality.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32982407", "sentence_id": 0, "text": "Poly (ADP-ribose) polymerase inhibitors (PARPi) are a unique class of antineoplastic agents that function by inducing synthetic lethality."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32982407\", \"sentence_id\": 1, \"text\": \"Synthetic lethality occurs when PARPi and either another agent or an underlying genetic alteration together lead to overwhelming DNA damage and ultimately cell death.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32982407", "sentence_id": 1, "text": "Synthetic lethality occurs when PARPi and either another agent or an underlying genetic alteration together lead to overwhelming DNA damage and ultimately cell death."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32982407\", \"sentence_id\": 2, \"text\": \"PARPi first showed promise as a cancer therapy in patients with\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32982407", "sentence_id": 2, "text": "PARPi first showed promise as a cancer therapy in patients with"}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32905466\", \"sentence_id\": 0, \"text\": \"Poly (ADP-ribose) polymerase (PARP) has recently emerged as a central mediator in cancer resistance against numerous anticancer agents to include chemotherapeutic agents such as microtubule targeting agents and DNA damaging agents.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32905466", "sentence_id": 0, "text": "Poly (ADP-ribose) polymerase (PARP) has recently emerged as a central mediator in cancer resistance against numerous anticancer agents to include chemotherapeutic agents such as microtubule targeting agents and DNA damaging agents."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32905466\", \"sentence_id\": 1, \"text\": \"Here, we describe AMXI-5001, a novel, highly potent dual PARP1/2 and microtubule polymerization inhibitor with favorable metabolic stability, oral bioavailability, and pharmacokinetic properties.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32905466", "sentence_id": 1, "text": "Here, we describe AMXI-5001, a novel, highly potent dual PARP1/2 and microtubule polymerization inhibitor with favorable metabolic stability, oral bioavailability, and pharmacokinetic properties."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32905466\", \"sentence_id\": 2, \"text\": \"The potency and selectivity of AMXI-5001 were determined by biochemical assays.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32905466", "sentence_id": 2, "text": "The potency and selectivity of AMXI-5001 were determined by biochemical assays."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32905466\", \"sentence_id\": 3, \"text\": \"Anticancer activity either as a single-agent or in combination with other antitumor agents was evaluated in vitro.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32905466", "sentence_id": 3, "text": "Anticancer activity either as a single-agent or in combination with other antitumor agents was evaluated in vitro."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32905466\", \"sentence_id\": 4, \"text\": \"In vivo antitumor activity as a single-agent was assessed in a triple-negative breast cancer (TNBC) model.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32905466", "sentence_id": 4, "text": "In vivo antitumor activity as a single-agent was assessed in a triple-negative breast cancer (TNBC) model."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32905466\", \"sentence_id\": 5, \"text\": \"AMXI-5001 demonstrates comparable IC50 inhibition against PARP and microtubule polymerization as clinical PARP inhibitors (Olaparib, Rucaparib, Niraparib, and Talazoparib) and the potent polymerization inhibitor (Vinblastine), respectively.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32905466", "sentence_id": 5, "text": "AMXI-5001 demonstrates comparable IC50 inhibition against PARP and microtubule polymerization as clinical PARP inhibitors (Olaparib, Rucaparib, Niraparib, and Talazoparib) and the potent polymerization inhibitor (Vinblastine), respectively."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32905466\", \"sentence_id\": 6, \"text\": \"In vitro, AMXI-5001 exhibited selective antitumor cytotoxicity across a wide variety of human cancer cells with much lower IC50s than existing clinical PARP1/2 inhibitors.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32905466", "sentence_id": 6, "text": "In vitro, AMXI-5001 exhibited selective antitumor cytotoxicity across a wide variety of human cancer cells with much lower IC50s than existing clinical PARP1/2 inhibitors."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32905466\", \"sentence_id\": 7, \"text\": \"AMXI-5001 is highly active in both BRCA mutated and wild type cancers.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32905466", "sentence_id": 7, "text": "AMXI-5001 is highly active in both BRCA mutated and wild type cancers."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32905466\", \"sentence_id\": 8, \"text\": \"AMXI-5001 is orally bioavailable.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32905466", "sentence_id": 8, "text": "AMXI-5001 is orally bioavailable."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32905466\", \"sentence_id\": 9, \"text\": \"AMXI-5001 elicited a remarkable In vivo preclinical anti-tumor activity in a BRCA mutated TNBC model.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32905466", "sentence_id": 9, "text": "AMXI-5001 elicited a remarkable In vivo preclinical anti-tumor activity in a BRCA mutated TNBC model."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32905466\", \"sentence_id\": 10, \"text\": \"Oral administration of AMXI-5001 induced complete regression of established tumors, including exceedingly large tumors.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32905466", "sentence_id": 10, "text": "Oral administration of AMXI-5001 induced complete regression of established tumors, including exceedingly large tumors."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32905466\", \"sentence_id\": 11, \"text\": \"AMXI-5001 resulted in superior anti-tumor effects compared to either single agent (PARP or microtubule) inhibitor or combination with both agents.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32905466", "sentence_id": 11, "text": "AMXI-5001 resulted in superior anti-tumor effects compared to either single agent (PARP or microtubule) inhibitor or combination with both agents."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32905466\", \"sentence_id\": 12, \"text\": \"AMXI-5001 will enter clinical trial testing soon and represents a promising, novel first in class dual PARP1/2 and microtubule polymerization inhibitor that delivers continuous and synchronous one-two punch cancer therapy with one molecule.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32905466", "sentence_id": 12, "text": "AMXI-5001 will enter clinical trial testing soon and represents a promising, novel first in class dual PARP1/2 and microtubule polymerization inhibitor that delivers continuous and synchronous one-two punch cancer therapy with one molecule."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32816949\", \"sentence_id\": 0, \"text\": \"PURPOSE: Pancreatic ductal adenocarcinoma (PDAC) arising in patients with a germline\\nEXPERIMENTAL DESIGN: We performed a seven-arm preclinical trial consisting of 471 mice, representing 12 unique PDAC patient-derived xenografts, of which nine were g\\nRESULTS: We found that biallelic inactivation of\\nCONCLUSIONS: In summary, we propose a predictive and prognostic model of g\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32816949", "sentence_id": 0, "text": "PURPOSE: Pancreatic ductal adenocarcinoma (PDAC) arising in patients with a germline\nEXPERIMENTAL DESIGN: We performed a seven-arm preclinical trial consisting of 471 mice, representing 12 unique PDAC patient-derived xenografts, of which nine were g\nRESULTS: We found that biallelic inactivation of\nCONCLUSIONS: In summary, we propose a predictive and prognostic model of g"}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32758032\", \"sentence_id\": 0, \"text\": \"INTRODUCTION: In prostate cancer , there has recently been an emerging interest in mutations in genes belonging to the homologous recombination repair (HRR) pathway and in the inhibition of poly (ADP-ribose) polymerase (PARP) proteins.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32758032", "sentence_id": 0, "text": "INTRODUCTION: In prostate cancer , there has recently been an emerging interest in mutations in genes belonging to the homologous recombination repair (HRR) pathway and in the inhibition of poly (ADP-ribose) polymerase (PARP) proteins."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32758032\", \"sentence_id\": 1, \"text\": \"AREAS COVERED: Mutations in the HRR genes, including BRCA1, BRCA2, and Ataxia-Telangiesctasia mutated (ATM), have been reported in prostate cancer, with different incidence in the localized and advanced settings.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32758032", "sentence_id": 1, "text": "AREAS COVERED: Mutations in the HRR genes, including BRCA1, BRCA2, and Ataxia-Telangiesctasia mutated (ATM), have been reported in prostate cancer, with different incidence in the localized and advanced settings."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32758032\", \"sentence_id\": 2, \"text\": \"The PARP enzyme complex is involved in repair of DNA damage and its inhibition causes the accumulation of DNA mutations in HRR deficient cells.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32758032", "sentence_id": 2, "text": "The PARP enzyme complex is involved in repair of DNA damage and its inhibition causes the accumulation of DNA mutations in HRR deficient cells."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32758032\", \"sentence_id\": 3, \"text\": \"Several PARP inhibitors (PARPi) are under development, such as olaparib, talazoparib, niraparib, rucaparib, and veliparib.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32758032", "sentence_id": 3, "text": "Several PARP inhibitors (PARPi) are under development, such as olaparib, talazoparib, niraparib, rucaparib, and veliparib."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32758032\", \"sentence_id\": 4, \"text\": \"In metastatic castration resistant prostate cancer (mCRPC), olaparib has been the most studied and its clinical efficacy has been validated in a phase III clinical trial.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32758032", "sentence_id": 4, "text": "In metastatic castration resistant prostate cancer (mCRPC), olaparib has been the most studied and its clinical efficacy has been validated in a phase III clinical trial."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32758032\", \"sentence_id\": 5, \"text\": \"Rucaparib and niraparib have also shown promising results in the preliminary analyzes of two phase II trials, while talazoparib is currently under development.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32758032", "sentence_id": 5, "text": "Rucaparib and niraparib have also shown promising results in the preliminary analyzes of two phase II trials, while talazoparib is currently under development."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32758032\", \"sentence_id\": 6, \"text\": \"EXPERT OPINION: PARPi have become part of the treatment of mCRPC.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32758032", "sentence_id": 6, "text": "EXPERT OPINION: PARPi have become part of the treatment of mCRPC."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32758032\", \"sentence_id\": 7, \"text\": \"Early results of combination therapy with PARPi and new hormonal therapy are promising and are supported by a strong biological rationale.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32758032", "sentence_id": 7, "text": "Early results of combination therapy with PARPi and new hormonal therapy are promising and are supported by a strong biological rationale."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32758032\", \"sentence_id\": 8, \"text\": \"Current results need to be validated in randomized phase III-controlled trials in order to translate the use of PARPi into real world practice.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32758032", "sentence_id": 8, "text": "Current results need to be validated in randomized phase III-controlled trials in order to translate the use of PARPi into real world practice."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32717529\", \"sentence_id\": 0, \"text\": \"Poly(ADP-ribose) Polymerase 1 (PARP1), one of the most investigated 18 membered PARP family enzymes, is involved in a variety of cellular functions including DNA damage repair, gene transcription and cell apoptosis.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32717529", "sentence_id": 0, "text": "Poly(ADP-ribose) Polymerase 1 (PARP1), one of the most investigated 18 membered PARP family enzymes, is involved in a variety of cellular functions including DNA damage repair, gene transcription and cell apoptosis."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32717529\", \"sentence_id\": 1, \"text\": \"PARP1 can form a PARP1(ADP-ribose) polymers, then bind to the DNA damage gap to recruit DNA repair proteins, and repair the break to maintain genomic stability.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32717529", "sentence_id": 1, "text": "PARP1 can form a PARP1(ADP-ribose) polymers, then bind to the DNA damage gap to recruit DNA repair proteins, and repair the break to maintain genomic stability."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32717529\", \"sentence_id\": 2, \"text\": \"PARP1 is highly expressed in tumor cells, so the inhibition of PARP1 can block DNA repair, promote tumor cell apoptosis, and exert antitumor activity.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32717529", "sentence_id": 2, "text": "PARP1 is highly expressed in tumor cells, so the inhibition of PARP1 can block DNA repair, promote tumor cell apoptosis, and exert antitumor activity."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32717529\", \"sentence_id\": 3, \"text\": \"To date, four PARP1 inhibitors namely olaparib, rucaparib, niraparib and talazoparib, have been approved by Food and Drug Administration (FDA) for treating ovarian cancer and breast cancer with BRCA1/2 mutation.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32717529", "sentence_id": 3, "text": "To date, four PARP1 inhibitors namely olaparib, rucaparib, niraparib and talazoparib, have been approved by Food and Drug Administration (FDA) for treating ovarian cancer and breast cancer with BRCA1/2 mutation."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32717529\", \"sentence_id\": 4, \"text\": \"These drugs have showed super advantages over conventional chemotherapeutic drugs with low hematological toxicity and slowly developed drug resistance.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32717529", "sentence_id": 4, "text": "These drugs have showed super advantages over conventional chemotherapeutic drugs with low hematological toxicity and slowly developed drug resistance."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32717529\", \"sentence_id\": 5, \"text\": \"In this article, we summarize and analyze the structure features of PARP1, the biological functions and antitumor mechanisms of PARP1 inhibitors.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32717529", "sentence_id": 5, "text": "In this article, we summarize and analyze the structure features of PARP1, the biological functions and antitumor mechanisms of PARP1 inhibitors."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32717529\", \"sentence_id\": 6, \"text\": \"Importantly, we suggest that establishing a new structure-activity relationship of developed PARP1 inhibitors via substructural searching and the matched molecular pair analysis would accelerate the process in finding more potent and safer PARP1 inhibitors.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32717529", "sentence_id": 6, "text": "Importantly, we suggest that establishing a new structure-activity relationship of developed PARP1 inhibitors via substructural searching and the matched molecular pair analysis would accelerate the process in finding more potent and safer PARP1 inhibitors."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32636098\", \"sentence_id\": 0, \"text\": \"Recent data have revealed antitumor activity for four PARP inhibitors, two of which (olaparib and rucaparib) are approved by the US Food and Drug Administration for metastatic castrate-resistant prostate cancer with selected DNA repair defects.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32636098", "sentence_id": 0, "text": "Recent data have revealed antitumor activity for four PARP inhibitors, two of which (olaparib and rucaparib) are approved by the US Food and Drug Administration for metastatic castrate-resistant prostate cancer with selected DNA repair defects."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32636098\", \"sentence_id\": 1, \"text\": \"Additional clinical trials are in progress for talazoparib, veliparib, and niraparib.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32636098", "sentence_id": 1, "text": "Additional clinical trials are in progress for talazoparib, veliparib, and niraparib."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32636098\", \"sentence_id\": 2, \"text\": \"More progress can be anticipated in the near future.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32636098", "sentence_id": 2, "text": "More progress can be anticipated in the near future."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32482307\", \"sentence_id\": 0, \"text\": \"Poly (ADP-ribose) polymerase (PARP) inhibitors, which induce synthetic lethality of BRCA mutant breast and ovarian cancers, are now under active exploration for treatment of acute leukemias, specifically acute myeloid leukemia (AML).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32482307", "sentence_id": 0, "text": "Poly (ADP-ribose) polymerase (PARP) inhibitors, which induce synthetic lethality of BRCA mutant breast and ovarian cancers, are now under active exploration for treatment of acute leukemias, specifically acute myeloid leukemia (AML)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32482307\", \"sentence_id\": 1, \"text\": \"Experimental data has revealed that DNA repair deficiencies similar to those found in BRCA mutant solid tumors function in malignant hematopoietic cells to enhance cell survival and promote therapy resistance.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32482307", "sentence_id": 1, "text": "Experimental data has revealed that DNA repair deficiencies similar to those found in BRCA mutant solid tumors function in malignant hematopoietic cells to enhance cell survival and promote therapy resistance."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32482307\", \"sentence_id\": 2, \"text\": \"Preclinical studies have demonstrated that inhibition of PARP with a variety of agents can dramatically enhance the efficacy of other therapeutic approaches including cytotoxic and epigenetic chemotherapy, small molecule inhibitors (IDH and FLT3 inhibitors) and antibody drug conjugates.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32482307", "sentence_id": 2, "text": "Preclinical studies have demonstrated that inhibition of PARP with a variety of agents can dramatically enhance the efficacy of other therapeutic approaches including cytotoxic and epigenetic chemotherapy, small molecule inhibitors (IDH and FLT3 inhibitors) and antibody drug conjugates."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32482307\", \"sentence_id\": 3, \"text\": \"This has led to early stage clinical trials of multiple PARP inhibitors (PARPi) for AML patients.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32482307", "sentence_id": 3, "text": "This has led to early stage clinical trials of multiple PARP inhibitors (PARPi) for AML patients."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32482307\", \"sentence_id\": 4, \"text\": \"Despite small patient numbers, evidence of modest clinical efficacy and tolerability in combinatorial regimens support the further development of PARP inhibition as a novel therapeutic strategy for AML, particularly in select molecular subsets (MLL rearranged, FLT3 and IDH1 mutant disease.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32482307", "sentence_id": 4, "text": "Despite small patient numbers, evidence of modest clinical efficacy and tolerability in combinatorial regimens support the further development of PARP inhibition as a novel therapeutic strategy for AML, particularly in select molecular subsets (MLL rearranged, FLT3 and IDH1 mutant disease."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32367009\", \"sentence_id\": 0, \"text\": \"BACKGROUND: A great number of DNA-damage repair (DDR) pathways have been recognized to be frequently dysregulated in advanced stages of prostate cancer.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32367009", "sentence_id": 0, "text": "BACKGROUND: A great number of DNA-damage repair (DDR) pathways have been recognized to be frequently dysregulated in advanced stages of prostate cancer."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32367009\", \"sentence_id\": 1, \"text\": \"DNA-repair defects in prostate cancer represents a clinically relevant disease subset.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32367009", "sentence_id": 1, "text": "DNA-repair defects in prostate cancer represents a clinically relevant disease subset."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32367009\", \"sentence_id\": 2, \"text\": \"Tumors whose ability to repair double-strand DNA breaks by homologous recombination is compromised, are highly sensitive to blockade of the repair of DNA single-strand breaks via the inhibition of the enzyme poly(ADP) ribose polymerase (PARP).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32367009", "sentence_id": 2, "text": "Tumors whose ability to repair double-strand DNA breaks by homologous recombination is compromised, are highly sensitive to blockade of the repair of DNA single-strand breaks via the inhibition of the enzyme poly(ADP) ribose polymerase (PARP)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32367009\", \"sentence_id\": 3, \"text\": \"METHODS: A systematic review of the literature has been conducted in January 2020 using PubMed Medline database in line with the recommendations from the PRISMA guidelines.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32367009", "sentence_id": 3, "text": "METHODS: A systematic review of the literature has been conducted in January 2020 using PubMed Medline database in line with the recommendations from the PRISMA guidelines."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32367009\", \"sentence_id\": 4, \"text\": \"The following string terms were used for searching clinical trial articles: castration resistant OR castrate resistance OR castration refractory AND prostate cancer AND PARP OR poly(ADP-ribose) polymerase inhibitor OR DNA-repair OR homologous recombination repair.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32367009", "sentence_id": 4, "text": "The following string terms were used for searching clinical trial articles: castration resistant OR castrate resistance OR castration refractory AND prostate cancer AND PARP OR poly(ADP-ribose) polymerase inhibitor OR DNA-repair OR homologous recombination repair."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32367009\", \"sentence_id\": 5, \"text\": \"On-going clinical trials with olaparib, niraparib, talazoparib, veliparib, and rucaparib in mCRPC were searched on the clinicalTrials.gov website.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32367009", "sentence_id": 5, "text": "On-going clinical trials with olaparib, niraparib, talazoparib, veliparib, and rucaparib in mCRPC were searched on the clinicalTrials.gov website."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32367009\", \"sentence_id\": 6, \"text\": \"RESULTS: From this research 176 articles were identified.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32367009", "sentence_id": 6, "text": "RESULTS: From this research 176 articles were identified."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32367009\", \"sentence_id\": 7, \"text\": \"After title screening and abstract reading, five papers and four abstract were considered for the systematic review.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32367009", "sentence_id": 7, "text": "After title screening and abstract reading, five papers and four abstract were considered for the systematic review."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32367009\", \"sentence_id\": 8, \"text\": \"Thirty-two clinical trials were also identified: from these 16 trials which did not include mCRPC patients or only prostate cancer patients, trials not yet recruiting and trials including radio-metabolic treatments were excluded.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32367009", "sentence_id": 8, "text": "Thirty-two clinical trials were also identified: from these 16 trials which did not include mCRPC patients or only prostate cancer patients, trials not yet recruiting and trials including radio-metabolic treatments were excluded."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32367009\", \"sentence_id\": 9, \"text\": \"Sixteen trials were included and discussed in the paper.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32367009", "sentence_id": 9, "text": "Sixteen trials were included and discussed in the paper."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32367009\", \"sentence_id\": 10, \"text\": \"CONCLUSIONS: Olaparib has been the first agent showing a benefit in terms of rPFS and ORR alone or in combination with abiraterone plus prednisone in patients with DDR deficiency prostate cancer.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32367009", "sentence_id": 10, "text": "CONCLUSIONS: Olaparib has been the first agent showing a benefit in terms of rPFS and ORR alone or in combination with abiraterone plus prednisone in patients with DDR deficiency prostate cancer."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32367009\", \"sentence_id\": 11, \"text\": \"Also rucaparib showed a benefit in terms of PSA response rate and ORR in patients with BRCA2 and BRCA1 mutation in a phase-II study.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32367009", "sentence_id": 11, "text": "Also rucaparib showed a benefit in terms of PSA response rate and ORR in patients with BRCA2 and BRCA1 mutation in a phase-II study."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32367009\", \"sentence_id\": 12, \"text\": \"Other phase-III clinical trials are evaluating niraparib and talazoparib, alone or in combination with AR signaling inhibitors.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32367009", "sentence_id": 12, "text": "Other phase-III clinical trials are evaluating niraparib and talazoparib, alone or in combination with AR signaling inhibitors."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32235451\", \"sentence_id\": 0, \"text\": \"Poly (ADP-ribose) polymerase inhibitors (PARPi) have proven to be beneficial to patients with metastatic breast cancer with BRCA1/2 (BReast CAncer type 1 and type 2 genes) mutations.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32235451", "sentence_id": 0, "text": "Poly (ADP-ribose) polymerase inhibitors (PARPi) have proven to be beneficial to patients with metastatic breast cancer with BRCA1/2 (BReast CAncer type 1 and type 2 genes) mutations."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32235451\", \"sentence_id\": 1, \"text\": \"However, certain PARPi in pre-clinical studies have been shown to inhibit cell growth and promote the death of breast cancer cells lacking mutations in BRCA1/2.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32235451", "sentence_id": 1, "text": "However, certain PARPi in pre-clinical studies have been shown to inhibit cell growth and promote the death of breast cancer cells lacking mutations in BRCA1/2."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32235451\", \"sentence_id\": 2, \"text\": \"Here, we examined the inhibitory potency of 13 different PARPi in 12 breast cancer cell lines with and without BRCA-mutations using cell viability assays.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32235451", "sentence_id": 2, "text": "Here, we examined the inhibitory potency of 13 different PARPi in 12 breast cancer cell lines with and without BRCA-mutations using cell viability assays."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32235451\", \"sentence_id\": 3, \"text\": \"The results showed that 5 of the 8 triple-negative breast cancer (TNBC) cell lines were susceptible to PARPi regardless of the BRCA-status.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32235451", "sentence_id": 3, "text": "The results showed that 5 of the 8 triple-negative breast cancer (TNBC) cell lines were susceptible to PARPi regardless of the BRCA-status."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32235451\", \"sentence_id\": 4, \"text\": \"The estrogen receptor (ER) negative/ human epidermal growth factor receptor 2 (HER2) positive (ER-/HER2+) cells, SKBR3 and JIMT1, showed high sensitivity to Talazoparib.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32235451", "sentence_id": 4, "text": "The estrogen receptor (ER) negative/ human epidermal growth factor receptor 2 (HER2) positive (ER-/HER2+) cells, SKBR3 and JIMT1, showed high sensitivity to Talazoparib."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32235451\", \"sentence_id\": 5, \"text\": \"Especially JIMT1, which is known to be resistant to trastuzumab, was responsive to Talazoparib at 0.002 \u00b5M.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32235451", "sentence_id": 5, "text": "Especially JIMT1, which is known to be resistant to trastuzumab, was responsive to Talazoparib at 0.002 \u00b5M."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32235451\", \"sentence_id\": 6, \"text\": \"Niraparib, Olaparib, and Rucaparib also demonstrated effective inhibitory potency in both advanced TNBC and ER-/HER2+ cells with and without BRCA-mutations.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32235451", "sentence_id": 6, "text": "Niraparib, Olaparib, and Rucaparib also demonstrated effective inhibitory potency in both advanced TNBC and ER-/HER2+ cells with and without BRCA-mutations."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32235451\", \"sentence_id\": 7, \"text\": \"In contrast, a BRCA-mutant TNBC line, HCC1937, was less sensitive to Talazoparib, Niraparib, Rucaparib, and not responsive to Olaparib.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32235451", "sentence_id": 7, "text": "In contrast, a BRCA-mutant TNBC line, HCC1937, was less sensitive to Talazoparib, Niraparib, Rucaparib, and not responsive to Olaparib."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32235451\", \"sentence_id\": 8, \"text\": \"Other PARPi such as UPF1069, NU1025, AZD2461, and PJ34HCl also showed potent inhibitory activity in specific breast cancer cells.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32235451", "sentence_id": 8, "text": "Other PARPi such as UPF1069, NU1025, AZD2461, and PJ34HCl also showed potent inhibitory activity in specific breast cancer cells."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32235451\", \"sentence_id\": 9, \"text\": \"Our data suggest that the benefit of PARPi therapy in breast cancer is beyond the BRCA-mutations, and equally effective on metastatic TNBC and ER-/HER2+ breast cancers.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32235451", "sentence_id": 9, "text": "Our data suggest that the benefit of PARPi therapy in breast cancer is beyond the BRCA-mutations, and equally effective on metastatic TNBC and ER-/HER2+ breast cancers."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32195033\", \"sentence_id\": 0, \"text\": \"The limited treatment options and therapeutic failure due to acquired resistance for patients with triple-negative breast cancer (TNBC) represent a significant challenge.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32195033", "sentence_id": 0, "text": "The limited treatment options and therapeutic failure due to acquired resistance for patients with triple-negative breast cancer (TNBC) represent a significant challenge."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32195033\", \"sentence_id\": 1, \"text\": \"Inhibitors against poly (ADP-ribose) polymerase (PARP), olaparib and talazoparib, were recently approved for the treatment of metastatic breast cancer (including TNBC) in patients with germline\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32195033", "sentence_id": 1, "text": "Inhibitors against poly (ADP-ribose) polymerase (PARP), olaparib and talazoparib, were recently approved for the treatment of metastatic breast cancer (including TNBC) in patients with germline"}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32053991\", \"sentence_id\": 0, \"text\": \"Breast cancer is the most commonly occurring cancer in women and the second most common cancer overall.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32053991", "sentence_id": 0, "text": "Breast cancer is the most commonly occurring cancer in women and the second most common cancer overall."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32053991\", \"sentence_id\": 1, \"text\": \"By the age of 80, the estimated risk for breast cancer for women with germline BRCA1 or BRCA2 mutations is around 80%.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32053991", "sentence_id": 1, "text": "By the age of 80, the estimated risk for breast cancer for women with germline BRCA1 or BRCA2 mutations is around 80%."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32053991\", \"sentence_id\": 2, \"text\": \"Genetically engineered BRCA1-deficient mouse models offer a unique opportunity to study the pathogenesis and therapy of triple negative breast cancer.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32053991", "sentence_id": 2, "text": "Genetically engineered BRCA1-deficient mouse models offer a unique opportunity to study the pathogenesis and therapy of triple negative breast cancer."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32053991\", \"sentence_id\": 3, \"text\": \"Here we present a newly established Brca1\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32053991", "sentence_id": 3, "text": "Here we present a newly established Brca1"}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32029455\", \"sentence_id\": 0, \"text\": \"Oxidative and replication stress underlie genomic instability of cancer cells.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32029455", "sentence_id": 0, "text": "Oxidative and replication stress underlie genomic instability of cancer cells."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32029455\", \"sentence_id\": 1, \"text\": \"Amplifying genomic instability through radiotherapy and chemotherapy has been a powerful but nonselective means of killing cancer cells.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32029455", "sentence_id": 1, "text": "Amplifying genomic instability through radiotherapy and chemotherapy has been a powerful but nonselective means of killing cancer cells."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32029455\", \"sentence_id\": 2, \"text\": \"Precision medicine has revolutionized cancer therapy by putting forth the concept of selective targeting of cancer cells.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32029455", "sentence_id": 2, "text": "Precision medicine has revolutionized cancer therapy by putting forth the concept of selective targeting of cancer cells."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32029455\", \"sentence_id\": 3, \"text\": \"Poly(ADP-ribose) polymerase (PARP) inhibitors represent a successful example of precision medicine as the first drugs targeting DNA damage response to have entered the clinic.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32029455", "sentence_id": 3, "text": "Poly(ADP-ribose) polymerase (PARP) inhibitors represent a successful example of precision medicine as the first drugs targeting DNA damage response to have entered the clinic."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32029455\", \"sentence_id\": 4, \"text\": \"PARP inhibitors act through synthetic lethality with mutations in DNA repair genes and were approved for the treatment of\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32029455", "sentence_id": 4, "text": "PARP inhibitors act through synthetic lethality with mutations in DNA repair genes and were approved for the treatment of"}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32017076\", \"sentence_id\": 0, \"text\": \"Herein, we investigated efflux pumps-mediated talazoparib-resistance in the treatment of triple-negative breast cancer (TNBC).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32017076", "sentence_id": 0, "text": "Herein, we investigated efflux pumps-mediated talazoparib-resistance in the treatment of triple-negative breast cancer (TNBC)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32017076\", \"sentence_id\": 1, \"text\": \"Furthermore, we produced a novel talazoparib-solid lipid nanoparticles (SLNs) and then explored in vitro therapeutic efficacy of talazoparib-SLNs to overcome talazoparib-resistance in TNBC cells.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32017076", "sentence_id": 1, "text": "Furthermore, we produced a novel talazoparib-solid lipid nanoparticles (SLNs) and then explored in vitro therapeutic efficacy of talazoparib-SLNs to overcome talazoparib-resistance in TNBC cells."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32017076\", \"sentence_id\": 2, \"text\": \"Talazoparib-SLNs formulation was produced and then characterized.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32017076", "sentence_id": 2, "text": "Talazoparib-SLNs formulation was produced and then characterized."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32017076\", \"sentence_id\": 3, \"text\": \"Calcein and Rho-123 were used to analyze the functional activity of drug efflux pumps in these cells.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32017076", "sentence_id": 3, "text": "Calcein and Rho-123 were used to analyze the functional activity of drug efflux pumps in these cells."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32017076\", \"sentence_id\": 4, \"text\": \"Additionally, RT-PCR, western blot and immunofluorescence analysis were used to detect the messenger RNA, and protein expression level, and cellular localization of the multidrug resistance (MDR1), breast cancer resistance protein (BCRP), and MRP1.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32017076", "sentence_id": 4, "text": "Additionally, RT-PCR, western blot and immunofluorescence analysis were used to detect the messenger RNA, and protein expression level, and cellular localization of the multidrug resistance (MDR1), breast cancer resistance protein (BCRP), and MRP1."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32017076\", \"sentence_id\": 5, \"text\": \"We found that talazoparib efflux was mediated by BCRP and MRP1 pumps in TNBC cells.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32017076", "sentence_id": 5, "text": "We found that talazoparib efflux was mediated by BCRP and MRP1 pumps in TNBC cells."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32017076\", \"sentence_id\": 6, \"text\": \"Talazoparib-SLNs could significantly enhance therapeutic efficacy of talazoparib.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32017076", "sentence_id": 6, "text": "Talazoparib-SLNs could significantly enhance therapeutic efficacy of talazoparib."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32017076\", \"sentence_id\": 7, \"text\": \"Furthermore, talazoparib-SLNs were more effective in the suppression of MDR1, BCRP, and MRP1 gene and protein expression levels than talazoparib.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32017076", "sentence_id": 7, "text": "Furthermore, talazoparib-SLNs were more effective in the suppression of MDR1, BCRP, and MRP1 gene and protein expression levels than talazoparib."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32017076\", \"sentence_id\": 8, \"text\": \"Consequently, this study suggests that talazoparib-SLNs formulation represents a promising therapeutic carrier to reverse MDR-mediated resistance in TNBC.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32017076", "sentence_id": 8, "text": "Consequently, this study suggests that talazoparib-SLNs formulation represents a promising therapeutic carrier to reverse MDR-mediated resistance in TNBC."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32004714\", \"sentence_id\": 0, \"text\": \"INTRODUCTION: BRCA1-associated protein-1 (BAP1), a nuclear deubiquitinase thought to be involved in DNA double-strand break repair, is frequently mutated in mesothelioma.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32004714", "sentence_id": 0, "text": "INTRODUCTION: BRCA1-associated protein-1 (BAP1), a nuclear deubiquitinase thought to be involved in DNA double-strand break repair, is frequently mutated in mesothelioma."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32004714\", \"sentence_id\": 1, \"text\": \"Because poly(adenosine diphosphate-ribose) polymerase inhibitors (PARPIs) induce synthetic lethality in BRCA1/2 mutant cancers, we evaluated whether BAP1 inactivating mutations confer sensitivity to PARPIs in mesothelioma and if combination therapy with temozolomide (TMZ) would be beneficial.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32004714", "sentence_id": 1, "text": "Because poly(adenosine diphosphate-ribose) polymerase inhibitors (PARPIs) induce synthetic lethality in BRCA1/2 mutant cancers, we evaluated whether BAP1 inactivating mutations confer sensitivity to PARPIs in mesothelioma and if combination therapy with temozolomide (TMZ) would be beneficial."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32004714\", \"sentence_id\": 2, \"text\": \"METHODS: A total of 10 patient-derived mesothelioma cell\u00a0lines were generated and characterized for BAP1 mutation status, protein expression, nuclear localization, and sensitivity to the PARPIs, olaparib, and talazoparib, alone or\u00a0in combination with TMZ.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32004714", "sentence_id": 2, "text": "METHODS: A total of 10 patient-derived mesothelioma cell\u00a0lines were generated and characterized for BAP1 mutation status, protein expression, nuclear localization, and sensitivity to the PARPIs, olaparib, and talazoparib, alone or\u00a0in combination with TMZ."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32004714\", \"sentence_id\": 3, \"text\": \"BAP1 deubiquitinase (DUB) activity was evaluated by ubiquitin with 7-amido-4-methylcoumarin assay.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32004714", "sentence_id": 3, "text": "BAP1 deubiquitinase (DUB) activity was evaluated by ubiquitin with 7-amido-4-methylcoumarin assay."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32004714\", \"sentence_id\": 4, \"text\": \"BAP1 knockout mesothelioma cell lines were generated by CRISPR-Cas9.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32004714", "sentence_id": 4, "text": "BAP1 knockout mesothelioma cell lines were generated by CRISPR-Cas9."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32004714\", \"sentence_id\": 5, \"text\": \"Because Schlafen 11 (SLFN11) and O\\nRESULTS: BAP1 mutations or copy-number alterations, or both were present in all 10 cell lines.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32004714", "sentence_id": 5, "text": "Because Schlafen 11 (SLFN11) and O\nRESULTS: BAP1 mutations or copy-number alterations, or both were present in all 10 cell lines."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32004714\", \"sentence_id\": 6, \"text\": \"Nonetheless, four cell lines exhibited intact DUB activity and two had nuclear BAP1 localization.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32004714", "sentence_id": 6, "text": "Nonetheless, four cell lines exhibited intact DUB activity and two had nuclear BAP1 localization."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32004714\", \"sentence_id\": 7, \"text\": \"Half maximal-inhibitory concentrations of olaparib and talazoparib ranged from 4.8 \u03bcM to greater than 50 \u03bcM and 0.039 \u03bcM to greater than 5 \u03bcM, respectively, classifying them into sensitive (two) or resistant (seven) cells, independent of their BAP1 status.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32004714", "sentence_id": 7, "text": "Half maximal-inhibitory concentrations of olaparib and talazoparib ranged from 4.8 \u03bcM to greater than 50 \u03bcM and 0.039 \u03bcM to greater than 5 \u03bcM, respectively, classifying them into sensitive (two) or resistant (seven) cells, independent of their BAP1 status."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32004714\", \"sentence_id\": 8, \"text\": \"Cell lines with BAP1 knockout resulted in the loss of BAP1 DUB activity but did not increase sensitivity to talazoparib.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32004714", "sentence_id": 8, "text": "Cell lines with BAP1 knockout resulted in the loss of BAP1 DUB activity but did not increase sensitivity to talazoparib."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32004714\", \"sentence_id\": 9, \"text\": \"Response to PARPI tended to be associated with high SLFN11 expression, and combination with temozolomide increased sensitivity of cells with low or no MGMT expression.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32004714", "sentence_id": 9, "text": "Response to PARPI tended to be associated with high SLFN11 expression, and combination with temozolomide increased sensitivity of cells with low or no MGMT expression."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32004714\", \"sentence_id\": 10, \"text\": \"CONCLUSIONS: BAP1 status does not determine sensitivity to PARPIs in patient-derived mesothelioma cell lines.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32004714", "sentence_id": 10, "text": "CONCLUSIONS: BAP1 status does not determine sensitivity to PARPIs in patient-derived mesothelioma cell lines."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"32004714\", \"sentence_id\": 11, \"text\": \"Combination of PARPI with TMZ may be beneficial for patients whose tumors have high SLFN11 and low or no MGMT expression.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "32004714", "sentence_id": 11, "text": "Combination of PARPI with TMZ may be beneficial for patients whose tumors have high SLFN11 and low or no MGMT expression."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31810230\", \"sentence_id\": 0, \"text\": \"Chondrosarcomas are chemo- and radiotherapy resistant and frequently harbor mutations in\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31810230", "sentence_id": 0, "text": "Chondrosarcomas are chemo- and radiotherapy resistant and frequently harbor mutations in"}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31770456\", \"sentence_id\": 0, \"text\": \"AIMS: In vitro data show that talazoparib is a substrate for P-glycoprotein (P-gp) and breast cancer resistance protein transporters.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31770456", "sentence_id": 0, "text": "AIMS: In vitro data show that talazoparib is a substrate for P-glycoprotein (P-gp) and breast cancer resistance protein transporters."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31770456\", \"sentence_id\": 1, \"text\": \"This open-label, 2-arm, drug-drug interaction Phase 1 study in patients with advanced solid tumours assessed the effect of a P-gp inhibitor (itraconazole) and a P-gp inducer (rifampicin) on the pharmacokinetics of a single dose of talazoparib.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31770456", "sentence_id": 1, "text": "This open-label, 2-arm, drug-drug interaction Phase 1 study in patients with advanced solid tumours assessed the effect of a P-gp inhibitor (itraconazole) and a P-gp inducer (rifampicin) on the pharmacokinetics of a single dose of talazoparib."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31770456\", \"sentence_id\": 2, \"text\": \"The safety and tolerability of a single dose of talazoparib with and without itraconazole or rifampicin were also assessed.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31770456", "sentence_id": 2, "text": "The safety and tolerability of a single dose of talazoparib with and without itraconazole or rifampicin were also assessed."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31770456\", \"sentence_id\": 3, \"text\": \"METHODS: Thirty-six patients were enrolled (Arm A [itraconazole], n = 19; Arm B [rifampicin], n = 17).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31770456", "sentence_id": 3, "text": "METHODS: Thirty-six patients were enrolled (Arm A [itraconazole], n = 19; Arm B [rifampicin], n = 17)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31770456\", \"sentence_id\": 4, \"text\": \"Patients in both arms received 2 single oral doses of talazoparib (0.5 mg, Arm A; 1 mg, Arm B) alone and with multiple daily oral doses of itraconazole (Arm A) or rifampicin (Arm B).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31770456", "sentence_id": 4, "text": "Patients in both arms received 2 single oral doses of talazoparib (0.5 mg, Arm A; 1 mg, Arm B) alone and with multiple daily oral doses of itraconazole (Arm A) or rifampicin (Arm B)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31770456\", \"sentence_id\": 5, \"text\": \"RESULTS: Coadministration of itraconazole and talazoparib increased talazoparib area under the plasma concentration-time profile from time 0 extrapolated to infinity by ~56% and maximum observed plasma concentration by ~40% relative to talazoparib alone.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31770456", "sentence_id": 5, "text": "RESULTS: Coadministration of itraconazole and talazoparib increased talazoparib area under the plasma concentration-time profile from time 0 extrapolated to infinity by ~56% and maximum observed plasma concentration by ~40% relative to talazoparib alone."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31770456\", \"sentence_id\": 6, \"text\": \"Coadministration of rifampicin and talazoparib increased talazoparib maximum observed plasma concentration by approximately 37% (geometric mean ratio 136.6% [90% confidence interval 103.2-180.9]); area under the curve was not affected relative to talazoparib alone (geometric mean ratio 102.0% [90% confidence interval 94.0-110.7]).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31770456", "sentence_id": 6, "text": "Coadministration of rifampicin and talazoparib increased talazoparib maximum observed plasma concentration by approximately 37% (geometric mean ratio 136.6% [90% confidence interval 103.2-180.9]); area under the curve was not affected relative to talazoparib alone (geometric mean ratio 102.0% [90% confidence interval 94.0-110.7])."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31770456\", \"sentence_id\": 7, \"text\": \"Talazoparib had an overall safety profile consistent with that observed in prior studies in which talazoparib was administered as a single dose.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31770456", "sentence_id": 7, "text": "Talazoparib had an overall safety profile consistent with that observed in prior studies in which talazoparib was administered as a single dose."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31770456\", \"sentence_id\": 8, \"text\": \"CONCLUSION: Coadministration of itraconazole increased talazoparib plasma exposure compared to talazoparib alone.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31770456", "sentence_id": 8, "text": "CONCLUSION: Coadministration of itraconazole increased talazoparib plasma exposure compared to talazoparib alone."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31770456\", \"sentence_id\": 9, \"text\": \"A reduced talazoparib dose is recommended if coadministration of potent P-gp inhibitors cannot be avoided.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31770456", "sentence_id": 9, "text": "A reduced talazoparib dose is recommended if coadministration of potent P-gp inhibitors cannot be avoided."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31770456\", \"sentence_id\": 10, \"text\": \"Similar exposure was observed when talazoparib was administered alone and with rifampicin suggesting that the effect of rifampicin on talazoparib exposure is limited.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31770456", "sentence_id": 10, "text": "Similar exposure was observed when talazoparib was administered alone and with rifampicin suggesting that the effect of rifampicin on talazoparib exposure is limited."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31732654\", \"sentence_id\": 0, \"text\": \"The significance of the phenotypic plasticity afforded by epithelial-mesenchymal transition (EMT) for cancer progression and drug resistance remains to be fully elucidated in the clinic.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31732654", "sentence_id": 0, "text": "The significance of the phenotypic plasticity afforded by epithelial-mesenchymal transition (EMT) for cancer progression and drug resistance remains to be fully elucidated in the clinic."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31732654\", \"sentence_id\": 1, \"text\": \"We evaluated epithelial-mesenchymal phenotypic characteristics across a range of tumor histologies using a validated, high-resolution digital microscopic immunofluorescence assay (IFA) that incorporates \u03b2-catenin detection and cellular morphology to delineate carcinoma cells from stromal fibroblasts and that quantitates the individual and colocalized expression of the epithelial marker E-cadherin (E) and the mesenchymal marker vimentin (V) at subcellular resolution (\\\"EMT-IFA\\\").\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31732654", "sentence_id": 1, "text": "We evaluated epithelial-mesenchymal phenotypic characteristics across a range of tumor histologies using a validated, high-resolution digital microscopic immunofluorescence assay (IFA) that incorporates \u03b2-catenin detection and cellular morphology to delineate carcinoma cells from stromal fibroblasts and that quantitates the individual and colocalized expression of the epithelial marker E-cadherin (E) and the mesenchymal marker vimentin (V) at subcellular resolution (\"EMT-IFA\")."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31732654\", \"sentence_id\": 2, \"text\": \"We report the discovery of \u03b2-catenin\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31732654", "sentence_id": 2, "text": "We report the discovery of \u03b2-catenin"}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31724813\", \"sentence_id\": 0, \"text\": \"PURPOSE: We conducted a phase 1/2 trial of the poly(ADP-ribose) polymerase 1/2 inhibitor talazoparib in combination with low-dose temozolomide (TMZ) to determine the dose-limiting toxicities (DLTs), recommended phase 2 dose (RP2D), and pharmacokinetics of this combination in children with recurrent/refractory solid tumors; and to explore clinical activity in Ewing sarcoma (EWS) (NCT02116777).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31724813", "sentence_id": 0, "text": "PURPOSE: We conducted a phase 1/2 trial of the poly(ADP-ribose) polymerase 1/2 inhibitor talazoparib in combination with low-dose temozolomide (TMZ) to determine the dose-limiting toxicities (DLTs), recommended phase 2 dose (RP2D), and pharmacokinetics of this combination in children with recurrent/refractory solid tumors; and to explore clinical activity in Ewing sarcoma (EWS) (NCT02116777)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31724813\", \"sentence_id\": 1, \"text\": \"METHODS: Talazoparib (400-600 \u00b5g/m\\nRESULTS: Forty patients, aged 4 to 25 years, were enrolled.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31724813", "sentence_id": 1, "text": "METHODS: Talazoparib (400-600 \u00b5g/m\nRESULTS: Forty patients, aged 4 to 25 years, were enrolled."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31724813\", \"sentence_id\": 2, \"text\": \"Talazoparib was increased to 600\u00a0\u00b5g/m\\nCONCLUSIONS: Talazoparib and low-dose TMZ are tolerated in children with recurrent/refractory solid tumors.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31724813", "sentence_id": 2, "text": "Talazoparib was increased to 600\u00a0\u00b5g/m\nCONCLUSIONS: Talazoparib and low-dose TMZ are tolerated in children with recurrent/refractory solid tumors."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31724813\", \"sentence_id\": 3, \"text\": \"Reversible neutropenia and thrombocytopenia were dose limiting.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31724813", "sentence_id": 3, "text": "Reversible neutropenia and thrombocytopenia were dose limiting."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31724813\", \"sentence_id\": 4, \"text\": \"The RP2D is talazoparib 600 \u00b5g/m\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31724813", "sentence_id": 4, "text": "The RP2D is talazoparib 600 \u00b5g/m"}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31714594\", \"sentence_id\": 0, \"text\": \"BACKGROUND: Poly(adenosine diphosphate ribose) polymerase (PARP) inhibitors exhibit promising activity against ovarian cancers, but their efficacy can be limited by acquired drug resistance.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31714594", "sentence_id": 0, "text": "BACKGROUND: Poly(adenosine diphosphate ribose) polymerase (PARP) inhibitors exhibit promising activity against ovarian cancers, but their efficacy can be limited by acquired drug resistance."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31714594\", \"sentence_id\": 1, \"text\": \"This study explores the role of autophagy in regulating the sensitivity of ovarian cancer cells to PARP inhibitors.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31714594", "sentence_id": 1, "text": "This study explores the role of autophagy in regulating the sensitivity of ovarian cancer cells to PARP inhibitors."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31714594\", \"sentence_id\": 2, \"text\": \"METHODS: Induction of autophagy was detected by punctate LC3 fluorescence staining, LC3I to LC3II conversion on Western blot analysis, and electron microscopy.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31714594", "sentence_id": 2, "text": "METHODS: Induction of autophagy was detected by punctate LC3 fluorescence staining, LC3I to LC3II conversion on Western blot analysis, and electron microscopy."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31714594\", \"sentence_id\": 3, \"text\": \"Enhanced growth inhibition and apoptosis were observed when PARP inhibitors were used with hydroxychloroquine, chloroquine (CQ), or LYS05 to block the hydrolysis of proteins and lipids in autophagosomes or with small interfering RNA against ATG5 or ATG7 to prevent the formation of autophagosomes.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31714594", "sentence_id": 3, "text": "Enhanced growth inhibition and apoptosis were observed when PARP inhibitors were used with hydroxychloroquine, chloroquine (CQ), or LYS05 to block the hydrolysis of proteins and lipids in autophagosomes or with small interfering RNA against ATG5 or ATG7 to prevent the formation of autophagosomes."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31714594\", \"sentence_id\": 4, \"text\": \"The preclinical efficacy of the combination of CQ and olaparib was evaluated with a patient-derived xenograft (PDX) and the OVCAR8 human ovarian cancer cell line.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31714594", "sentence_id": 4, "text": "The preclinical efficacy of the combination of CQ and olaparib was evaluated with a patient-derived xenograft (PDX) and the OVCAR8 human ovarian cancer cell line."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31714594\", \"sentence_id\": 5, \"text\": \"RESULTS: Four PARP inhibitors (olaparib, niraparib, rucaparib, and talazoparib) induced autophagy in a panel of ovarian cancer cells.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31714594", "sentence_id": 5, "text": "RESULTS: Four PARP inhibitors (olaparib, niraparib, rucaparib, and talazoparib) induced autophagy in a panel of ovarian cancer cells."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31714594\", \"sentence_id\": 6, \"text\": \"Inhibition of autophagy with CQ enhanced the sensitivity of ovarian cancer cells to PARP inhibitors.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31714594", "sentence_id": 6, "text": "Inhibition of autophagy with CQ enhanced the sensitivity of ovarian cancer cells to PARP inhibitors."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31714594\", \"sentence_id\": 7, \"text\": \"In vivo, olaparib and CQ produced additive growth inhibition in OVCAR8 xenografts and a PDX.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31714594", "sentence_id": 7, "text": "In vivo, olaparib and CQ produced additive growth inhibition in OVCAR8 xenografts and a PDX."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31714594\", \"sentence_id\": 8, \"text\": \"Olaparib inhibited PARP activity, and this led to increased reactive oxygen species (ROS) and an accumulation of \u03b3-H2AX.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31714594", "sentence_id": 8, "text": "Olaparib inhibited PARP activity, and this led to increased reactive oxygen species (ROS) and an accumulation of \u03b3-H2AX."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31714594\", \"sentence_id\": 9, \"text\": \"Inhibition of autophagy also increased ROS and \u03b3-H2AX and enhanced the effect of olaparib on both entities.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31714594", "sentence_id": 9, "text": "Inhibition of autophagy also increased ROS and \u03b3-H2AX and enhanced the effect of olaparib on both entities."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31714594\", \"sentence_id\": 10, \"text\": \"Treatment with olaparib increased phosphorylation of ATM and PTEN while decreasing the phosphorylation of AKT and mTOR and inducing autophagy.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31714594", "sentence_id": 10, "text": "Treatment with olaparib increased phosphorylation of ATM and PTEN while decreasing the phosphorylation of AKT and mTOR and inducing autophagy."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31714594\", \"sentence_id\": 11, \"text\": \"CONCLUSIONS: PARP inhibitor-induced autophagy provides an adaptive mechanism of resistance to PARP inhibitors in cancer cells with wild-type BRCA, and a combination of PARP inhibitors with CQ or other autophagy inhibitors could improve outcomes for patients with ovarian cancer.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31714594", "sentence_id": 11, "text": "CONCLUSIONS: PARP inhibitor-induced autophagy provides an adaptive mechanism of resistance to PARP inhibitors in cancer cells with wild-type BRCA, and a combination of PARP inhibitors with CQ or other autophagy inhibitors could improve outcomes for patients with ovarian cancer."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31669203\", \"sentence_id\": 0, \"text\": \"PARP1 inhibitor (Niraparib, Olaparib, Rucaparib) maintenance therapy improves progression-free survival in platinum sensitive sporadic epithelial ovarian cancers.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31669203", "sentence_id": 0, "text": "PARP1 inhibitor (Niraparib, Olaparib, Rucaparib) maintenance therapy improves progression-free survival in platinum sensitive sporadic epithelial ovarian cancers."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31669203\", \"sentence_id\": 1, \"text\": \"However, biomarkers of response to PARPi therapy is yet to be clearly defined.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31669203", "sentence_id": 1, "text": "However, biomarkers of response to PARPi therapy is yet to be clearly defined."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31669203\", \"sentence_id\": 2, \"text\": \"XRCC1, a scaffolding protein, interacts with PARP1 during BER and SSBR.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31669203", "sentence_id": 2, "text": "XRCC1, a scaffolding protein, interacts with PARP1 during BER and SSBR."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31669203\", \"sentence_id\": 3, \"text\": \"In a large clinical cohort of 525 sporadic ovarian cancers, high XRCC1 or high PARP1 protein levels was not only associated with aggressive phenotypes but was also significantly linked with poor progression-free survival (p\u202f=\u202f0.048 & p\u202f=\u202f0.001 respectively) and poor ovarian cancer-specific survival (p\u202f=\u202f0.020 & p\u202f=\u202f0.008 respectively).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31669203", "sentence_id": 3, "text": "In a large clinical cohort of 525 sporadic ovarian cancers, high XRCC1 or high PARP1 protein levels was not only associated with aggressive phenotypes but was also significantly linked with poor progression-free survival (p\u202f=\u202f0.048 & p\u202f=\u202f0.001 respectively) and poor ovarian cancer-specific survival (p\u202f=\u202f0.020 & p\u202f=\u202f0.008 respectively)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31669203\", \"sentence_id\": 4, \"text\": \"Pre-clinically, Olaparib and Talazoparib therapy were selectively toxic in XRCC1 deficient or knock-out platinum sensitive ovarian cancer cells in 2D and 3D models.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31669203", "sentence_id": 4, "text": "Pre-clinically, Olaparib and Talazoparib therapy were selectively toxic in XRCC1 deficient or knock-out platinum sensitive ovarian cancer cells in 2D and 3D models."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31669203\", \"sentence_id\": 5, \"text\": \"Increased sensitivity was associated with DNA double-strand break accumulation, cell cycle arrest and apoptotic cell accumulation.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31669203", "sentence_id": 5, "text": "Increased sensitivity was associated with DNA double-strand break accumulation, cell cycle arrest and apoptotic cell accumulation."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31669203\", \"sentence_id\": 6, \"text\": \"We conclude that XRCC1 deficiency predicts sensitivity to PARP inhibitor therapy.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31669203", "sentence_id": 6, "text": "We conclude that XRCC1 deficiency predicts sensitivity to PARP inhibitor therapy."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31669203\", \"sentence_id\": 7, \"text\": \"PARP1 targeting is a promising new approach in XRCC1 deficient ovarian cancers.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31669203", "sentence_id": 7, "text": "PARP1 targeting is a promising new approach in XRCC1 deficient ovarian cancers."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31625002\", \"sentence_id\": 0, \"text\": \"PARP (poly(ADP-ribose) polymerase) inhibitors represent a novel class of anti-cancer therapy; they take advantage of synthetic lethality and induce cell death by exploiting a defect in DNA repair.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31625002", "sentence_id": 0, "text": "PARP (poly(ADP-ribose) polymerase) inhibitors represent a novel class of anti-cancer therapy; they take advantage of synthetic lethality and induce cell death by exploiting a defect in DNA repair."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31625002\", \"sentence_id\": 1, \"text\": \"This class of medication was initially evaluated in patients with BRCA-associated tumors, but efficacy was also demonstrated in other populations.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31625002", "sentence_id": 1, "text": "This class of medication was initially evaluated in patients with BRCA-associated tumors, but efficacy was also demonstrated in other populations."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31625002\", \"sentence_id\": 2, \"text\": \"Since 2014, four PARP inhibitors have been approved in various indications: olaparib, niraparib, and rucaparib in high-grade serous ovarian cancer, and olaparib and talazoparib in metastatic breast cancer.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31625002", "sentence_id": 2, "text": "Since 2014, four PARP inhibitors have been approved in various indications: olaparib, niraparib, and rucaparib in high-grade serous ovarian cancer, and olaparib and talazoparib in metastatic breast cancer."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31625002\", \"sentence_id\": 3, \"text\": \"The exact indications and study populations vary slightly between the different approvals in both disease states but there is significant overlap.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31625002", "sentence_id": 3, "text": "The exact indications and study populations vary slightly between the different approvals in both disease states but there is significant overlap."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31625002\", \"sentence_id\": 4, \"text\": \"PARP inhibitors continue to be investigated in ongoing clinical trials.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31625002", "sentence_id": 4, "text": "PARP inhibitors continue to be investigated in ongoing clinical trials."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31625002\", \"sentence_id\": 5, \"text\": \"In line with other targeted therapies, benefit appears to be strongest in a distinct population of patients with BRCA mutations or other defects in homologous recombination repair.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31625002", "sentence_id": 5, "text": "In line with other targeted therapies, benefit appears to be strongest in a distinct population of patients with BRCA mutations or other defects in homologous recombination repair."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31625002\", \"sentence_id\": 6, \"text\": \"Combination therapies, which include anti-angiogenesis agents and immunotherapy, show promise as a strategy to broaden efficacy for unselected patients.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31625002", "sentence_id": 6, "text": "Combination therapies, which include anti-angiogenesis agents and immunotherapy, show promise as a strategy to broaden efficacy for unselected patients."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31625002\", \"sentence_id\": 7, \"text\": \"Initial studies of PARP inhibitors in combination with chemotherapy were limited by toxicity, but further studies are underway.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31625002", "sentence_id": 7, "text": "Initial studies of PARP inhibitors in combination with chemotherapy were limited by toxicity, but further studies are underway."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31625002\", \"sentence_id\": 8, \"text\": \"To date, head-to-head trials comparing various PARP inhibitors have not been conducted, so questions remain in terms of choosing a PARP inhibitor to administer when indications overlap, as well as how to sequence these medications.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31625002", "sentence_id": 8, "text": "To date, head-to-head trials comparing various PARP inhibitors have not been conducted, so questions remain in terms of choosing a PARP inhibitor to administer when indications overlap, as well as how to sequence these medications."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31625002\", \"sentence_id\": 9, \"text\": \"Here we review both completed and ongoing clinical trials involving PARP inhibitors and mechanisms of resistance to this class of drugs.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31625002", "sentence_id": 9, "text": "Here we review both completed and ongoing clinical trials involving PARP inhibitors and mechanisms of resistance to this class of drugs."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31553293\", \"sentence_id\": 0, \"text\": \"The standard treatment for advanced ovarian cancer is cytoreductive surgery followed by cytotoxic chemotherapy.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31553293", "sentence_id": 0, "text": "The standard treatment for advanced ovarian cancer is cytoreductive surgery followed by cytotoxic chemotherapy."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31553293\", \"sentence_id\": 1, \"text\": \"However, it has high risk of recurrence and poor prognosis.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31553293", "sentence_id": 1, "text": "However, it has high risk of recurrence and poor prognosis."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31553293\", \"sentence_id\": 2, \"text\": \"Poly(ADPribose) polymerase (PARP) inhibitors selectively target DNA double-strand breaks (DSBs) in tumor cells that cannot be repaired and induce the synthetic lethality of BRCA1/2 mutation cancers.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31553293", "sentence_id": 2, "text": "Poly(ADPribose) polymerase (PARP) inhibitors selectively target DNA double-strand breaks (DSBs) in tumor cells that cannot be repaired and induce the synthetic lethality of BRCA1/2 mutation cancers."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31553293\", \"sentence_id\": 3, \"text\": \"PARP inhibitors are clinically used to treat recurrent ovarian cancer and show significant efficacy in ovarian cancer patients with homologous recombination repair (HRR) pathway defects.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31553293", "sentence_id": 3, "text": "PARP inhibitors are clinically used to treat recurrent ovarian cancer and show significant efficacy in ovarian cancer patients with homologous recombination repair (HRR) pathway defects."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31553293\", \"sentence_id\": 4, \"text\": \"PARP inhibitors also have significant clinical benefits in patients without HR defects.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31553293", "sentence_id": 4, "text": "PARP inhibitors also have significant clinical benefits in patients without HR defects."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31553293\", \"sentence_id\": 5, \"text\": \"With the increasingly extensive clinical application of PARP inhibitors, the possibility of acquiring drug resistance is high.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31553293", "sentence_id": 5, "text": "With the increasingly extensive clinical application of PARP inhibitors, the possibility of acquiring drug resistance is high."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31553293\", \"sentence_id\": 6, \"text\": \"Therefore, clinical strategies should be adopted to manage drug resistance of PARP inhibitors.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31553293", "sentence_id": 6, "text": "Therefore, clinical strategies should be adopted to manage drug resistance of PARP inhibitors."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31553293\", \"sentence_id\": 7, \"text\": \"This study aims to summarize the indications and toxicity of PARP inhibitors, the mechanism of action, targeted treatment of drug resistance, and potential methods to manage drug-resistant diseases.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31553293", "sentence_id": 7, "text": "This study aims to summarize the indications and toxicity of PARP inhibitors, the mechanism of action, targeted treatment of drug resistance, and potential methods to manage drug-resistant diseases."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31553293\", \"sentence_id\": 8, \"text\": \"We used the term \\\"ovarian cancer\\\" and the names of each PARP inhibitor as keywords to search articles published in the Medical Subject Headings (MeSH) on Pubmed, along with the keywords \\\"clinicaltrials.gov\\\" and \\\"google.com/patents\\\" as well as \\\"uspto.gov.\\\" The FDA has approved olaparib, niraparib, and rucaparib for the treatment of recurrent epithelial ovarian cancer (EOC).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31553293", "sentence_id": 8, "text": "We used the term \"ovarian cancer\" and the names of each PARP inhibitor as keywords to search articles published in the Medical Subject Headings (MeSH) on Pubmed, along with the keywords \"clinicaltrials.gov\" and \"google.com/patents\" as well as \"uspto.gov.\" The FDA has approved olaparib, niraparib, and rucaparib for the treatment of recurrent epithelial ovarian cancer (EOC)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31553293\", \"sentence_id\": 9, \"text\": \"Talazoparib and veliparib are currently in early trials and show promising clinical results.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31553293", "sentence_id": 9, "text": "Talazoparib and veliparib are currently in early trials and show promising clinical results."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31553293\", \"sentence_id\": 10, \"text\": \"The mechanism underlying resistance to PARP inhibitors and the clinical strategies to overcome them remain unclear.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31553293", "sentence_id": 10, "text": "The mechanism underlying resistance to PARP inhibitors and the clinical strategies to overcome them remain unclear."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31553293\", \"sentence_id\": 11, \"text\": \"Understanding the mechanism of resistance to PARP inhibitors and their relationship with platinum resistance may help with the development of antiresistance therapies and optimization of the sequence of drug application in the future clinical treatment of ovarian cancer.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31553293", "sentence_id": 11, "text": "Understanding the mechanism of resistance to PARP inhibitors and their relationship with platinum resistance may help with the development of antiresistance therapies and optimization of the sequence of drug application in the future clinical treatment of ovarian cancer."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31439587\", \"sentence_id\": 0, \"text\": \"PURPOSE: In this study, we addressed the underlying mechanisms for the association between enzalutamide (ENZ) treatment and neuroendocrine prostate cancer (NEPC), and the critical involvement of MYCN, and loss of RB1 function in neuroendocrine differentiation (NED) of prostatic epithelial cells, and the development of NEPC.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31439587", "sentence_id": 0, "text": "PURPOSE: In this study, we addressed the underlying mechanisms for the association between enzalutamide (ENZ) treatment and neuroendocrine prostate cancer (NEPC), and the critical involvement of MYCN, and loss of RB1 function in neuroendocrine differentiation (NED) of prostatic epithelial cells, and the development of NEPC."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31439587\", \"sentence_id\": 1, \"text\": \"We further sought to determine whether PARP inhibition could suppress NEPC, and to identify molecular determinants of this therapeutic activity.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31439587", "sentence_id": 1, "text": "We further sought to determine whether PARP inhibition could suppress NEPC, and to identify molecular determinants of this therapeutic activity."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31439587\", \"sentence_id\": 2, \"text\": \"EXPERIMENTAL DESIGN: We used a novel prostate cancer patient-derived xenograft (PDX) treatment model, prostatic adenocarcinoma and NEPC cell lines, an NEPC organoid line, and NEPC xenograft models to address the mechanistic basis of ENZ-induced NED, and to analyze suppression of NED and NEPC growth by PARP inhibition.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31439587", "sentence_id": 2, "text": "EXPERIMENTAL DESIGN: We used a novel prostate cancer patient-derived xenograft (PDX) treatment model, prostatic adenocarcinoma and NEPC cell lines, an NEPC organoid line, and NEPC xenograft models to address the mechanistic basis of ENZ-induced NED, and to analyze suppression of NED and NEPC growth by PARP inhibition."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31439587\", \"sentence_id\": 3, \"text\": \"RESULTS: We identified an ENZ treatment-associated glucocorticoid receptor (GR)-MYCN-CDK5-RB1-E2F1 signaling pathway that drives NED in prostatic adenocarcinoma PDX and cell line models.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31439587", "sentence_id": 3, "text": "RESULTS: We identified an ENZ treatment-associated glucocorticoid receptor (GR)-MYCN-CDK5-RB1-E2F1 signaling pathway that drives NED in prostatic adenocarcinoma PDX and cell line models."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31439587\", \"sentence_id\": 4, \"text\": \"Mechanistically, long-term ENZ treatment transcriptionally upregulates signaling of the GR-MYCN axis, leading to CDK5R1 and CDK5R2 upregulation, Rb1 phosphorylation, and N-Myc-mediated and E2F1-mediated NED gene expression.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31439587", "sentence_id": 4, "text": "Mechanistically, long-term ENZ treatment transcriptionally upregulates signaling of the GR-MYCN axis, leading to CDK5R1 and CDK5R2 upregulation, Rb1 phosphorylation, and N-Myc-mediated and E2F1-mediated NED gene expression."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31439587\", \"sentence_id\": 5, \"text\": \"Importantly, olaparib (OLA) or talazoparib (TALA) suppressed these activities, and the combination of OLA and dinaciclib (DINA), an inhibitor of CDK2 and CDK5, which also inhibits Rb1 phosphorylation, suppressed NED and significantly improved therapeutic efficiency in NEPC cells\\nCONCLUSIONS: The results of our study indicate an important role of GR-MYCN-CDK5R1/2-RB1-NED signaling in ENZ-induced and PARP inhibitor-suppressed NEPC.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31439587", "sentence_id": 5, "text": "Importantly, olaparib (OLA) or talazoparib (TALA) suppressed these activities, and the combination of OLA and dinaciclib (DINA), an inhibitor of CDK2 and CDK5, which also inhibits Rb1 phosphorylation, suppressed NED and significantly improved therapeutic efficiency in NEPC cells\nCONCLUSIONS: The results of our study indicate an important role of GR-MYCN-CDK5R1/2-RB1-NED signaling in ENZ-induced and PARP inhibitor-suppressed NEPC."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31439587\", \"sentence_id\": 6, \"text\": \"We also demonstrated efficacy for OLA+DINA combination therapy in NEPC xenograft models.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31439587", "sentence_id": 6, "text": "We also demonstrated efficacy for OLA+DINA combination therapy in NEPC xenograft models."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31404966\", \"sentence_id\": 0, \"text\": \"The approval of upfront abiraterone for castration-sensitive prostate cancer and the approval of enzalutamide and apalutamide for non-metastatic castration-resistant prostate cancer have led to early utilization of potent androgen receptor (AR) signaling inhibitors in treating advanced prostate cancer.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31404966", "sentence_id": 0, "text": "The approval of upfront abiraterone for castration-sensitive prostate cancer and the approval of enzalutamide and apalutamide for non-metastatic castration-resistant prostate cancer have led to early utilization of potent androgen receptor (AR) signaling inhibitors in treating advanced prostate cancer."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31404966\", \"sentence_id\": 1, \"text\": \"There is an unmet need to develop novel therapies beyond targeting AR signaling for metastatic castration-resistant prostate cancer (mCRPC).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31404966", "sentence_id": 1, "text": "There is an unmet need to develop novel therapies beyond targeting AR signaling for metastatic castration-resistant prostate cancer (mCRPC)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31404966\", \"sentence_id\": 2, \"text\": \"Poly (ADP-ribose) polymerase inhibitors (PARPi) belong to a class of targeted agents being developed for the treatment of homologous recombination repair (HRR) deficient tumors.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31404966", "sentence_id": 2, "text": "Poly (ADP-ribose) polymerase inhibitors (PARPi) belong to a class of targeted agents being developed for the treatment of homologous recombination repair (HRR) deficient tumors."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31404966\", \"sentence_id\": 3, \"text\": \"Olaparib, rucaparib, niraparib, veliparib, and talazoparib were evaluated in early phase trials as a monotherapy for HRR-deficient mCRPC.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31404966", "sentence_id": 3, "text": "Olaparib, rucaparib, niraparib, veliparib, and talazoparib were evaluated in early phase trials as a monotherapy for HRR-deficient mCRPC."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31404966\", \"sentence_id\": 4, \"text\": \"Among them, olaparib and rucaparib have breakthrough designations for\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31404966", "sentence_id": 4, "text": "Among them, olaparib and rucaparib have breakthrough designations for"}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31218365\", \"sentence_id\": 0, \"text\": \"Genomic instability is a hallmark of cancer, and often is the result of altered DNA repair capacities in tumour cells.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31218365", "sentence_id": 0, "text": "Genomic instability is a hallmark of cancer, and often is the result of altered DNA repair capacities in tumour cells."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31218365\", \"sentence_id\": 1, \"text\": \"DNA damage repair defects are common in different cancer types; these alterations can also induce tumour-specific vulnerabilities that can be exploited therapeutically.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31218365", "sentence_id": 1, "text": "DNA damage repair defects are common in different cancer types; these alterations can also induce tumour-specific vulnerabilities that can be exploited therapeutically."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31218365\", \"sentence_id\": 2, \"text\": \"In 2009, a first-in-man clinical trial of the poly(ADP-ribose) polymerase (PARP) inhibitor olaparib clinically validated the synthetic lethal interaction between inhibition of PARP1, a key sensor of DNA damage, and BRCA1/BRCA2 deficiency.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31218365", "sentence_id": 2, "text": "In 2009, a first-in-man clinical trial of the poly(ADP-ribose) polymerase (PARP) inhibitor olaparib clinically validated the synthetic lethal interaction between inhibition of PARP1, a key sensor of DNA damage, and BRCA1/BRCA2 deficiency."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31218365\", \"sentence_id\": 3, \"text\": \"In this review, we summarize a decade of PARP inhibitor clinical development, a work that has resulted in the registration of several PARP inhibitors in breast (olaparib and talazoparib) and ovarian cancer (olaparib, niraparib and rucaparib, either alone or following platinum chemotherapy as maintenance therapy).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31218365", "sentence_id": 3, "text": "In this review, we summarize a decade of PARP inhibitor clinical development, a work that has resulted in the registration of several PARP inhibitors in breast (olaparib and talazoparib) and ovarian cancer (olaparib, niraparib and rucaparib, either alone or following platinum chemotherapy as maintenance therapy)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31218365\", \"sentence_id\": 4, \"text\": \"Over the past 10 years, our knowledge on the mechanism of action of PARP inhibitor as well as how tumours become resistant has been extended, and we summarise this work here.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31218365", "sentence_id": 4, "text": "Over the past 10 years, our knowledge on the mechanism of action of PARP inhibitor as well as how tumours become resistant has been extended, and we summarise this work here."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31218365\", \"sentence_id\": 5, \"text\": \"We also discuss opportunities for expanding the precision medicine approach with PARP inhibitors, identifying a wider population who could benefit from this drug class.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31218365", "sentence_id": 5, "text": "We also discuss opportunities for expanding the precision medicine approach with PARP inhibitors, identifying a wider population who could benefit from this drug class."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31218365\", \"sentence_id\": 6, \"text\": \"This includes developing and validating better predictive biomarkers for patient stratification, mainly based on homologous recombination defects beyond BRCA1/BRCA2 mutations, identifying DNA repair deficient tumours in other cancer types such as prostate or pancreatic cancer, or by designing combination therapies with PARP inhibitors.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31218365", "sentence_id": 6, "text": "This includes developing and validating better predictive biomarkers for patient stratification, mainly based on homologous recombination defects beyond BRCA1/BRCA2 mutations, identifying DNA repair deficient tumours in other cancer types such as prostate or pancreatic cancer, or by designing combination therapies with PARP inhibitors."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31128155\", \"sentence_id\": 0, \"text\": \"Schlafen 11 (SLFN11) sensitizes cells to a broad range of anti-cancer drugs including platinum derivatives (cisplatin and carboplatin), inhibitors of topoisomerases (irinotecan, topotecan, doxorubicin, daunorubicin, mitoxantrone and etoposide), DNA synthesis inhibitors (gemcitabine, cytarabine, hydroxyurea and nucleoside analogues), and poly(ADPribose) polymerase (PARP) inhibitors (olaparib, rucaparib, niraparib and talazoparib).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31128155", "sentence_id": 0, "text": "Schlafen 11 (SLFN11) sensitizes cells to a broad range of anti-cancer drugs including platinum derivatives (cisplatin and carboplatin), inhibitors of topoisomerases (irinotecan, topotecan, doxorubicin, daunorubicin, mitoxantrone and etoposide), DNA synthesis inhibitors (gemcitabine, cytarabine, hydroxyurea and nucleoside analogues), and poly(ADPribose) polymerase (PARP) inhibitors (olaparib, rucaparib, niraparib and talazoparib)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31128155\", \"sentence_id\": 1, \"text\": \"In spite of their different primary mechanisms of action, all these drugs damage DNA during S-phase, activate the intra-S-phase checkpoint and induce replication fork slowing and stalling with single-stranded DNA segments coated with replication protein A.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31128155", "sentence_id": 1, "text": "In spite of their different primary mechanisms of action, all these drugs damage DNA during S-phase, activate the intra-S-phase checkpoint and induce replication fork slowing and stalling with single-stranded DNA segments coated with replication protein A."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31128155\", \"sentence_id\": 2, \"text\": \"Such situation with abnormal replication forks is known as replication stress.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31128155", "sentence_id": 2, "text": "Such situation with abnormal replication forks is known as replication stress."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31128155\", \"sentence_id\": 3, \"text\": \"SLFN11 irreversibly blocks replication in cells under replication stress, explaining why SLFN11-positive cells are markedly more efficiently killed by DNA-targeting drugs than SLFN11-negative cells.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31128155", "sentence_id": 3, "text": "SLFN11 irreversibly blocks replication in cells under replication stress, explaining why SLFN11-positive cells are markedly more efficiently killed by DNA-targeting drugs than SLFN11-negative cells."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31128155\", \"sentence_id\": 4, \"text\": \"SLFN11 is inactivated in ~50% of cancer cell lines and in a large fraction of tumors, and is linked with the native immune, interferon and T-cells responses, implying the translational relevance of measuring SLFN11 expression as a predictive biomarker of response and resistance in patients.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31128155", "sentence_id": 4, "text": "SLFN11 is inactivated in ~50% of cancer cell lines and in a large fraction of tumors, and is linked with the native immune, interferon and T-cells responses, implying the translational relevance of measuring SLFN11 expression as a predictive biomarker of response and resistance in patients."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31128155\", \"sentence_id\": 5, \"text\": \"SLFN11 is also a plausible epigenetic target for reactivation by inhibitors of histone deacetylases (HDAC), DNA methyltransferases (DNMT) and EZH2 histone methyltransferase and for combination of these epigenetic inhibitors with DNA-targeting drugs in cells lacking SLFN11 expression.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31128155", "sentence_id": 5, "text": "SLFN11 is also a plausible epigenetic target for reactivation by inhibitors of histone deacetylases (HDAC), DNA methyltransferases (DNMT) and EZH2 histone methyltransferase and for combination of these epigenetic inhibitors with DNA-targeting drugs in cells lacking SLFN11 expression."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31128155\", \"sentence_id\": 6, \"text\": \"In addition, resistance due to lack of SLFN11 expression in tumors is a potential indication for cell-cycle checkpoint inhibitors in combination with DNA-targeting therapies.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31128155", "sentence_id": 6, "text": "In addition, resistance due to lack of SLFN11 expression in tumors is a potential indication for cell-cycle checkpoint inhibitors in combination with DNA-targeting therapies."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31113350\", \"sentence_id\": 0, \"text\": \"OBJECTIVE: In the present work, we report for the first time the therapeutic potential of talazoparib (BMN 673)-SLNs for the treatment of BRCA1 deficient Triple Negative Breast Cancer (TNBC).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31113350", "sentence_id": 0, "text": "OBJECTIVE: In the present work, we report for the first time the therapeutic potential of talazoparib (BMN 673)-SLNs for the treatment of BRCA1 deficient Triple Negative Breast Cancer (TNBC)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31113350\", \"sentence_id\": 1, \"text\": \"BMN 673-SLNs were produced by hot-homogenization technique and then characterized.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31113350", "sentence_id": 1, "text": "BMN 673-SLNs were produced by hot-homogenization technique and then characterized."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31113350\", \"sentence_id\": 2, \"text\": \"METHODS: The cytotoxic and apoptotic effects of BMN 673-SLNs compared with BMN 673 were determined on HCC1937BRCA1-/-, HCC1937-R resistant TNBC and MCF-10A control cell lines.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31113350", "sentence_id": 2, "text": "METHODS: The cytotoxic and apoptotic effects of BMN 673-SLNs compared with BMN 673 were determined on HCC1937BRCA1-/-, HCC1937-R resistant TNBC and MCF-10A control cell lines."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31113350\", \"sentence_id\": 3, \"text\": \"BMN 673- SLNs were found to have reduced particle size (219.5 \u00b1 1.45 nm) and thus more stable (-28.4 \u00b1 2.52 mV) than BMN 673 (1652 \u00b1 2.46 nm and -18.6 \u00b1 0.45 mV) at 4\u00b0C.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31113350", "sentence_id": 3, "text": "BMN 673- SLNs were found to have reduced particle size (219.5 \u00b1 1.45 nm) and thus more stable (-28.4 \u00b1 2.52 mV) than BMN 673 (1652 \u00b1 2.46 nm and -18.6 \u00b1 0.45 mV) at 4\u00b0C."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31113350\", \"sentence_id\": 4, \"text\": \"RESULTS: In vitro cell line studies demonstrated that BMN 673-SLNs showed significant cytotoxic effects on HCC1937 (29.8%) and HCC1937-R cells (35.7%) at 10 nM for 12 days compared with BMN 673 (HCC1937 cells: 34.0% and HCC1937-R cells: 93.8% at 10 nM for 12 days) (p<0.05).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31113350", "sentence_id": 4, "text": "RESULTS: In vitro cell line studies demonstrated that BMN 673-SLNs showed significant cytotoxic effects on HCC1937 (29.8%) and HCC1937-R cells (35.7%) at 10 nM for 12 days compared with BMN 673 (HCC1937 cells: 34.0% and HCC1937-R cells: 93.8% at 10 nM for 12 days) (p<0.05)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31113350\", \"sentence_id\": 5, \"text\": \"Additionally, BMN 673-SLNs (40.1%) reduced the toxicity of BMN 673 (53.1%) on MCF-10A control cells thanks to unique physical properties.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31113350", "sentence_id": 5, "text": "Additionally, BMN 673-SLNs (40.1%) reduced the toxicity of BMN 673 (53.1%) on MCF-10A control cells thanks to unique physical properties."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31113350\", \"sentence_id\": 6, \"text\": \"CONCLUSION: The apoptotic rates in the 10 nM BMN 673-SLNs treatment (88.78% and 85.56%) for 12 days were significantly higher than those in 10 nM BMN 673 (82.6% and 25.86%) for 12 days in HCC1937 and HCC1937-R cells, respectively (p<0.01).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31113350", "sentence_id": 6, "text": "CONCLUSION: The apoptotic rates in the 10 nM BMN 673-SLNs treatment (88.78% and 85.56%) for 12 days were significantly higher than those in 10 nM BMN 673 (82.6% and 25.86%) for 12 days in HCC1937 and HCC1937-R cells, respectively (p<0.01)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31113350\", \"sentence_id\": 7, \"text\": \"Furthermore, these effects were consistent with the findings of colony formation, wound healing and calcein accumulation analysis.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31113350", "sentence_id": 7, "text": "Furthermore, these effects were consistent with the findings of colony formation, wound healing and calcein accumulation analysis."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"31113350\", \"sentence_id\": 8, \"text\": \"In conclusion, the therapeutic potential of BMN 673-SLNs provides a promising chemotherapeutic strategy for the treatment of drugresistant TNBC.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "31113350", "sentence_id": 8, "text": "In conclusion, the therapeutic potential of BMN 673-SLNs provides a promising chemotherapeutic strategy for the treatment of drugresistant TNBC."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"30929564\", \"sentence_id\": 0, \"text\": \"Pharmacological inhibition of PARP is a promising approach in treating high grade serous ovarian carcinoma (HGSOC).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "30929564", "sentence_id": 0, "text": "Pharmacological inhibition of PARP is a promising approach in treating high grade serous ovarian carcinoma (HGSOC)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"30929564\", \"sentence_id\": 1, \"text\": \"PARP inhibitors (PARPi) are most active in patients with defects in DNA damage repair (DDR) mechanisms, such as alterations in expression/function of DNA repair and homologous recombination (HR) genes/proteins, including\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "30929564", "sentence_id": 1, "text": "PARP inhibitors (PARPi) are most active in patients with defects in DNA damage repair (DDR) mechanisms, such as alterations in expression/function of DNA repair and homologous recombination (HR) genes/proteins, including"}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"30806045\", \"sentence_id\": 0, \"text\": \"Nineteen topics were selected as major clinical research advances in gynecologic oncology in 2018.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "30806045", "sentence_id": 0, "text": "Nineteen topics were selected as major clinical research advances in gynecologic oncology in 2018."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"30806045\", \"sentence_id\": 1, \"text\": \"For cervical cancer, the importance of human papillomavirus (HPV) testing alone as primary cervical cancer screening method and negative survival impact of minimally invasive surgery in early-stage cervical cancer were addressed.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "30806045", "sentence_id": 1, "text": "For cervical cancer, the importance of human papillomavirus (HPV) testing alone as primary cervical cancer screening method and negative survival impact of minimally invasive surgery in early-stage cervical cancer were addressed."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"30806045\", \"sentence_id\": 2, \"text\": \"For ovarian cancer, cost-effectiveness of genetic testing to prevent cancer, use of analgesics and oral pill to reduce cancer risk, efficacy of secondary cytoreductive surgery and hyperthermic intraperitoneal chemotherapy, update in the use of poly (ADP-ribose) polymerase inhibitor, and efficacy of anti-angiogenic targeted treatments, including bevacizumab and tyrosine kinase inhibitors, were reviewed.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "30806045", "sentence_id": 2, "text": "For ovarian cancer, cost-effectiveness of genetic testing to prevent cancer, use of analgesics and oral pill to reduce cancer risk, efficacy of secondary cytoreductive surgery and hyperthermic intraperitoneal chemotherapy, update in the use of poly (ADP-ribose) polymerase inhibitor, and efficacy of anti-angiogenic targeted treatments, including bevacizumab and tyrosine kinase inhibitors, were reviewed."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"30806045\", \"sentence_id\": 3, \"text\": \"For corpus cancer, sentinel lymph node mapping technique, adjuvant therapy in high-risk endometrial cancer (PORTEC-3), and targeted therapy in recurrent disease were covered.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "30806045", "sentence_id": 3, "text": "For corpus cancer, sentinel lymph node mapping technique, adjuvant therapy in high-risk endometrial cancer (PORTEC-3), and targeted therapy in recurrent disease were covered."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"30806045\", \"sentence_id\": 4, \"text\": \"For the field of radiation oncology, survival outcomes of chemoradiation compared with chemotherapy alone in metastatic cervical cancer and new findings regarding the use of neoadjuvant chemotherapy in locally advanced cervical cancer were introduced.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "30806045", "sentence_id": 4, "text": "For the field of radiation oncology, survival outcomes of chemoradiation compared with chemotherapy alone in metastatic cervical cancer and new findings regarding the use of neoadjuvant chemotherapy in locally advanced cervical cancer were introduced."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"30806045\", \"sentence_id\": 5, \"text\": \"Lastly, for breast cancer, the use of talazoparib in patients with germline\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "30806045", "sentence_id": 5, "text": "Lastly, for breast cancer, the use of talazoparib in patients with germline"}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"30684797\", \"sentence_id\": 0, \"text\": \"Poly (ADP-ribose) Polymerase1 (PARP1) is a member of 17 membered PARP family having diversified biological functions such as synthetic lethality, DNA repair, apoptosis, necrosis, histone binding etc.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "30684797", "sentence_id": 0, "text": "Poly (ADP-ribose) Polymerase1 (PARP1) is a member of 17 membered PARP family having diversified biological functions such as synthetic lethality, DNA repair, apoptosis, necrosis, histone binding etc."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"30684797\", \"sentence_id\": 1, \"text\": \"It is primarily a chromatin-bound nuclear enzyme that gets activated by DNA damage.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "30684797", "sentence_id": 1, "text": "It is primarily a chromatin-bound nuclear enzyme that gets activated by DNA damage."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"30684797\", \"sentence_id\": 2, \"text\": \"It binds to DNA signal- and double-strand breaks, does parylation of target proteins (using NAD\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "30684797", "sentence_id": 2, "text": "It binds to DNA signal- and double-strand breaks, does parylation of target proteins (using NAD"}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"30621214\", \"sentence_id\": 0, \"text\": \"Therapeutic targeting of estrogen receptor-\u03b1 (ER\u03b1) by the anti-estrogen tamoxifen is standard of care for premenopausal breast cancer patients and remains a key component of treatment strategies for postmenopausal patients.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "30621214", "sentence_id": 0, "text": "Therapeutic targeting of estrogen receptor-\u03b1 (ER\u03b1) by the anti-estrogen tamoxifen is standard of care for premenopausal breast cancer patients and remains a key component of treatment strategies for postmenopausal patients."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"30621214\", \"sentence_id\": 1, \"text\": \"While tamoxifen significantly increases overall survival, tamoxifen resistance remains a major limitation despite continued expression of ER\u03b1 in resistant tumors.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "30621214", "sentence_id": 1, "text": "While tamoxifen significantly increases overall survival, tamoxifen resistance remains a major limitation despite continued expression of ER\u03b1 in resistant tumors."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"30621214\", \"sentence_id\": 2, \"text\": \"Previous reports have described increased oxidative stress in tamoxifen resistant versus sensitive breast cancer and a role for PARP1 in mediating oxidative damage repair.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "30621214", "sentence_id": 2, "text": "Previous reports have described increased oxidative stress in tamoxifen resistant versus sensitive breast cancer and a role for PARP1 in mediating oxidative damage repair."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"30621214\", \"sentence_id\": 3, \"text\": \"We hypothesized that PARP1 activity mediated tamoxifen resistance in ER\u03b1-positive breast cancer and that combining the antiestrogen tamoxifen with a PARP1 inhibitor (PARPi) would sensitize tamoxifen resistant cells to tamoxifen therapy.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "30621214", "sentence_id": 3, "text": "We hypothesized that PARP1 activity mediated tamoxifen resistance in ER\u03b1-positive breast cancer and that combining the antiestrogen tamoxifen with a PARP1 inhibitor (PARPi) would sensitize tamoxifen resistant cells to tamoxifen therapy."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"30621214\", \"sentence_id\": 4, \"text\": \"In tamoxifen-resistant vs.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "30621214", "sentence_id": 4, "text": "In tamoxifen-resistant vs."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"30621214\", \"sentence_id\": 5, \"text\": \"-sensitive breast cancer cells, oxidative stress and PARP1 overexpression were increased.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "30621214", "sentence_id": 5, "text": "-sensitive breast cancer cells, oxidative stress and PARP1 overexpression were increased."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"30621214\", \"sentence_id\": 6, \"text\": \"Furthermore, differential PARylation of ER\u03b1 was observed in tamoxifen-resistant versus -sensitive cells, and ER\u03b1 PARylation was increased by tamoxifen treatment.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "30621214", "sentence_id": 6, "text": "Furthermore, differential PARylation of ER\u03b1 was observed in tamoxifen-resistant versus -sensitive cells, and ER\u03b1 PARylation was increased by tamoxifen treatment."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"30621214\", \"sentence_id\": 7, \"text\": \"Loss of ER\u03b1 PARylation following treatment with a PARP inhibitor (talazoparib) augmented tamoxifen sensitivity and decreased localization of both ER\u03b1 and PARP1 to ER\u03b1-target genes.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "30621214", "sentence_id": 7, "text": "Loss of ER\u03b1 PARylation following treatment with a PARP inhibitor (talazoparib) augmented tamoxifen sensitivity and decreased localization of both ER\u03b1 and PARP1 to ER\u03b1-target genes."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"30621214\", \"sentence_id\": 8, \"text\": \"Co-administration of talazoparib plus tamoxifen increased DNA damage accumulation and decreased cell survival in a dose-dependent manner.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "30621214", "sentence_id": 8, "text": "Co-administration of talazoparib plus tamoxifen increased DNA damage accumulation and decreased cell survival in a dose-dependent manner."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"30621214\", \"sentence_id\": 9, \"text\": \"The ability of PARPi to overcome tamoxifen resistance was dependent on ER\u03b1, as lack of ER\u03b1-mediated estrogen signaling expression and showed no response to tamoxifen-PARPi treatment.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "30621214", "sentence_id": 9, "text": "The ability of PARPi to overcome tamoxifen resistance was dependent on ER\u03b1, as lack of ER\u03b1-mediated estrogen signaling expression and showed no response to tamoxifen-PARPi treatment."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"30621214\", \"sentence_id\": 10, \"text\": \"These results correlate ER\u03b1 PARylation with tamoxifen resistance and indicate a novel mechanism-based approach to overcome tamoxifen resistance in ER+ breast cancer.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "30621214", "sentence_id": 10, "text": "These results correlate ER\u03b1 PARylation with tamoxifen resistance and indicate a novel mechanism-based approach to overcome tamoxifen resistance in ER+ breast cancer."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"30563931\", \"sentence_id\": 0, \"text\": \"PURPOSE: To assess talazoparib activity in germline\\nPATIENTS AND METHODS: ABRAZO (NCT02034916) was a two-cohort, two-stage, phase II study of talazoparib (1 mg/day) in germline\\nRESULTS: We enrolled 84 patients (cohort 1,\\nCONCLUSIONS: Talazoparib exhibited promising antitumor activity in patients with advanced breast cancer and germline\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "30563931", "sentence_id": 0, "text": "PURPOSE: To assess talazoparib activity in germline\nPATIENTS AND METHODS: ABRAZO (NCT02034916) was a two-cohort, two-stage, phase II study of talazoparib (1 mg/day) in germline\nRESULTS: We enrolled 84 patients (cohort 1,\nCONCLUSIONS: Talazoparib exhibited promising antitumor activity in patients with advanced breast cancer and germline"}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"30518089\", \"sentence_id\": 0, \"text\": \"Inhibition of poly(ADP-ribose) polymerase (PARP) activity induces synthetic lethality in mutated BRCA1/2 cancers by selectively targeting tumor cells that fail to repair DNA double strand breaks (DSBs).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "30518089", "sentence_id": 0, "text": "Inhibition of poly(ADP-ribose) polymerase (PARP) activity induces synthetic lethality in mutated BRCA1/2 cancers by selectively targeting tumor cells that fail to repair DNA double strand breaks (DSBs)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"30518089\", \"sentence_id\": 1, \"text\": \"Clinical studies have confirmed the validity of the synthetic lethality approach and four different PARP inhibitors (PARPi; olaparib, rucaparib, niraparib and talazoparib) have been approved as monotherapies for BRCA-mutated or platinum-sensitive recurrent ovarian cancer and/or for BRCA-mutated HER2-negative metastatic breast cancer.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "30518089", "sentence_id": 1, "text": "Clinical studies have confirmed the validity of the synthetic lethality approach and four different PARP inhibitors (PARPi; olaparib, rucaparib, niraparib and talazoparib) have been approved as monotherapies for BRCA-mutated or platinum-sensitive recurrent ovarian cancer and/or for BRCA-mutated HER2-negative metastatic breast cancer."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"30518089\", \"sentence_id\": 2, \"text\": \"PARPi therapeutic efficacy is higher against tumors harboring deleterious germline or somatic BRCA mutations than in BRCA wild-type tumors.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "30518089", "sentence_id": 2, "text": "PARPi therapeutic efficacy is higher against tumors harboring deleterious germline or somatic BRCA mutations than in BRCA wild-type tumors."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"30518089\", \"sentence_id\": 3, \"text\": \"BRCA mutations or intrinsic tumor sensitivity to platinum compounds are both regarded as indicators of deficiency in DSB repair by homologous recombination as well as of favorable response to PARPi.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "30518089", "sentence_id": 3, "text": "BRCA mutations or intrinsic tumor sensitivity to platinum compounds are both regarded as indicators of deficiency in DSB repair by homologous recombination as well as of favorable response to PARPi."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"30518089\", \"sentence_id\": 4, \"text\": \"However, not all BRCA-mutated or platinum-responsive patients obtain clinical benefit from these agents.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "30518089", "sentence_id": 4, "text": "However, not all BRCA-mutated or platinum-responsive patients obtain clinical benefit from these agents."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"30518089\", \"sentence_id\": 5, \"text\": \"Conversely, a certain percentage of patients with wild-type BRCA or platinum-resistant tumors can still get benefit from PARPi.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "30518089", "sentence_id": 5, "text": "Conversely, a certain percentage of patients with wild-type BRCA or platinum-resistant tumors can still get benefit from PARPi."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"30518089\", \"sentence_id\": 6, \"text\": \"Thus, additional reliable markers need to be validated in clinical trials to select patients potentially eligible for PARPi-based therapies, in the absence of deleterious BRCA mutations or platinum sensitivity.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "30518089", "sentence_id": 6, "text": "Thus, additional reliable markers need to be validated in clinical trials to select patients potentially eligible for PARPi-based therapies, in the absence of deleterious BRCA mutations or platinum sensitivity."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"30518089\", \"sentence_id\": 7, \"text\": \"In this review, we summarize the mechanisms of action of PARPi and the clinical evidence supporting their use as anticancer drugs as well as the additional synthetic lethal partners that might confer sensitivity to PARPi in patients with wild-type BRCA tumors.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "30518089", "sentence_id": 7, "text": "In this review, we summarize the mechanisms of action of PARPi and the clinical evidence supporting their use as anticancer drugs as well as the additional synthetic lethal partners that might confer sensitivity to PARPi in patients with wild-type BRCA tumors."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"30506138\", \"sentence_id\": 0, \"text\": \"Talazoparib (TALZENNA\u2122) is an oral inhibitor of the polyadenosine 5'-diphosphoribose polymerase (PARP) enzymes, which play a critical role in repairing DNA single-strand breaks.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "30506138", "sentence_id": 0, "text": "Talazoparib (TALZENNA\u2122) is an oral inhibitor of the polyadenosine 5'-diphosphoribose polymerase (PARP) enzymes, which play a critical role in repairing DNA single-strand breaks."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"30506138\", \"sentence_id\": 1, \"text\": \"It has been developed by Pfizer and was recently approved in the USA for the treatment of adults with deleterious or suspected deleterious germline BRCA-mutated, human epidermal growth factor receptor 2 (HER2)-negative, locally advanced or metastatic breast cancer (as detected by a US FDA-approved assay).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "30506138", "sentence_id": 1, "text": "It has been developed by Pfizer and was recently approved in the USA for the treatment of adults with deleterious or suspected deleterious germline BRCA-mutated, human epidermal growth factor receptor 2 (HER2)-negative, locally advanced or metastatic breast cancer (as detected by a US FDA-approved assay)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"30506138\", \"sentence_id\": 2, \"text\": \"A regulatory assessment for talazoparib in this patient population is underway in the EU, with talazoparib also undergoing development for use in metastatic castration-resistant prostate cancer and various solid tumours, and as neoadjuvant therapy in early triple negative breast cancer.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "30506138", "sentence_id": 2, "text": "A regulatory assessment for talazoparib in this patient population is underway in the EU, with talazoparib also undergoing development for use in metastatic castration-resistant prostate cancer and various solid tumours, and as neoadjuvant therapy in early triple negative breast cancer."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"30506138\", \"sentence_id\": 3, \"text\": \"This article summarizes the milestones in the development of talazoparib leading to its first approval for the treatment of adults with deleterious or suspected deleterious germline BRCA-mutated, HER2-negative, locally advanced or metastatic breast cancer.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "30506138", "sentence_id": 3, "text": "This article summarizes the milestones in the development of talazoparib leading to its first approval for the treatment of adults with deleterious or suspected deleterious germline BRCA-mutated, HER2-negative, locally advanced or metastatic breast cancer."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"30297533\", \"sentence_id\": 0, \"text\": \": Targeting PARP1 for synthetic lethality is a new strategy for breast cancers harboring germline mutations in BRCA.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "30297533", "sentence_id": 0, "text": ": Targeting PARP1 for synthetic lethality is a new strategy for breast cancers harboring germline mutations in BRCA."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"30297533\", \"sentence_id\": 1, \"text\": \"However, these mutations are rare, and reactivation of BRCA-mediated pathways may result in eventual resistance to PARP1 inhibitor therapy.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "30297533", "sentence_id": 1, "text": "However, these mutations are rare, and reactivation of BRCA-mediated pathways may result in eventual resistance to PARP1 inhibitor therapy."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"30297533\", \"sentence_id\": 2, \"text\": \"Alternative synthetic lethality approaches targeting more common sporadic breast cancers and preinvasive ductal carcinoma\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "30297533", "sentence_id": 2, "text": "Alternative synthetic lethality approaches targeting more common sporadic breast cancers and preinvasive ductal carcinoma"}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"30255456\", \"sentence_id\": 0, \"text\": \"PURPOSE: The purpose of the study was to produce BMN 673 loaded solid lipid nanoparticles (SLNs) to improve its therapeutic index, to minimize toxicity and to overcome homologous recombination (HR)-mediated resistance.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "30255456", "sentence_id": 0, "text": "PURPOSE: The purpose of the study was to produce BMN 673 loaded solid lipid nanoparticles (SLNs) to improve its therapeutic index, to minimize toxicity and to overcome homologous recombination (HR)-mediated resistance."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"30255456\", \"sentence_id\": 1, \"text\": \"METHODS: Firstly, BMN 673-SLNs were characterized using Nano Zeta Sizer.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "30255456", "sentence_id": 1, "text": "METHODS: Firstly, BMN 673-SLNs were characterized using Nano Zeta Sizer."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"30255456\", \"sentence_id\": 2, \"text\": \"After treatment with different concentrations of BMN 673 and BMN 673-SLNs, cell viability of HCC1937\\nRESULTS: When compared with BMN 673, BMN 673-SLNs showed remarkably a decrease in HCC1937 and HCC1937-R cells with less damage to MCF-10A cells.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "30255456", "sentence_id": 2, "text": "After treatment with different concentrations of BMN 673 and BMN 673-SLNs, cell viability of HCC1937\nRESULTS: When compared with BMN 673, BMN 673-SLNs showed remarkably a decrease in HCC1937 and HCC1937-R cells with less damage to MCF-10A cells."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"30255456\", \"sentence_id\": 3, \"text\": \"BMN 673-SLNs significantly induced toxicity through double-stranded DNA breaks, G2/M cell cycle arrest and PARP cleavage in TNBC cells.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "30255456", "sentence_id": 3, "text": "BMN 673-SLNs significantly induced toxicity through double-stranded DNA breaks, G2/M cell cycle arrest and PARP cleavage in TNBC cells."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"30255456\", \"sentence_id\": 4, \"text\": \"Additionally, BMN 673-resistance was mediated by miR-107, miR-193b and miR-1255b targeting BRCA1 and RAD51 in HCC1937 and HCC1937-R cells.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "30255456", "sentence_id": 4, "text": "Additionally, BMN 673-resistance was mediated by miR-107, miR-193b and miR-1255b targeting BRCA1 and RAD51 in HCC1937 and HCC1937-R cells."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"30255456\", \"sentence_id\": 5, \"text\": \"However, BMN 673-SLNs treatment could overcome HR-mediated resistance in TNBC cells.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "30255456", "sentence_id": 5, "text": "However, BMN 673-SLNs treatment could overcome HR-mediated resistance in TNBC cells."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"30255456\", \"sentence_id\": 6, \"text\": \"CONCLUSIONS: As a result, our findings suggest that SLNs formulation strongly provides a synthetic lethal therapeutic potential in BRCA1 mutated sensitive and resistant TNBC cells.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "30255456", "sentence_id": 6, "text": "CONCLUSIONS: As a result, our findings suggest that SLNs formulation strongly provides a synthetic lethal therapeutic potential in BRCA1 mutated sensitive and resistant TNBC cells."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"30116283\", \"sentence_id\": 0, \"text\": \"Poly-ADP-ribose polymerase 1 (PARP-1) and PARP-2 are DNA damage sensors that are most active during S-phase of the cell cycle and that have wider-reaching roles in DNA repair than originally described.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "30116283", "sentence_id": 0, "text": "Poly-ADP-ribose polymerase 1 (PARP-1) and PARP-2 are DNA damage sensors that are most active during S-phase of the cell cycle and that have wider-reaching roles in DNA repair than originally described."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"30116283\", \"sentence_id\": 1, \"text\": \"BRCA1 and BRCA2 (Breast Cancer) proteins are involved in homologous recombination repair (HRR), which requires a homologous chromosome or sister chromatid as a template to faithfully repair DNA double-strand breaks.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "30116283", "sentence_id": 1, "text": "BRCA1 and BRCA2 (Breast Cancer) proteins are involved in homologous recombination repair (HRR), which requires a homologous chromosome or sister chromatid as a template to faithfully repair DNA double-strand breaks."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"30116283\", \"sentence_id\": 2, \"text\": \"The small-molecule NAD+ mimetics, olaparib, niraparib, rucaparib, veliparib, and talazoparib, inhibit the catalytic activity of PARP-1 and PARP-2 and are currently being studied in later-stage clinical trials.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "30116283", "sentence_id": 2, "text": "The small-molecule NAD+ mimetics, olaparib, niraparib, rucaparib, veliparib, and talazoparib, inhibit the catalytic activity of PARP-1 and PARP-2 and are currently being studied in later-stage clinical trials."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"30116283\", \"sentence_id\": 3, \"text\": \"PARP inhibitor clinical trials have predominantly focused on patients with breast and ovarian cancer with deleterious germline\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "30116283", "sentence_id": 3, "text": "PARP inhibitor clinical trials have predominantly focused on patients with breast and ovarian cancer with deleterious germline"}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"30067621\", \"sentence_id\": 0, \"text\": \"The poly(ADP-ribose) polymerases (PARPs) 1 and 2 are DNA-binding enzymes that play a critical role in the repair of DNA.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "30067621", "sentence_id": 0, "text": "The poly(ADP-ribose) polymerases (PARPs) 1 and 2 are DNA-binding enzymes that play a critical role in the repair of DNA."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"30067621\", \"sentence_id\": 1, \"text\": \"The use of PARP inhibitors is a rational therapeutic approach to selectively killing a subset of cancer cells with deficiencies in DNA repair pathways.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "30067621", "sentence_id": 1, "text": "The use of PARP inhibitors is a rational therapeutic approach to selectively killing a subset of cancer cells with deficiencies in DNA repair pathways."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"30067621\", \"sentence_id\": 2, \"text\": \"PARP inhibitors that have undergone clinical investigation in the treatment of breast cancer include olaparib, talazoparib, veliparib, niraparib, and rucaparib.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "30067621", "sentence_id": 2, "text": "PARP inhibitors that have undergone clinical investigation in the treatment of breast cancer include olaparib, talazoparib, veliparib, niraparib, and rucaparib."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"30067621\", \"sentence_id\": 3, \"text\": \"The antitumor activity of PARP inhibitors as single agents has been demonstrated in BRCA-associated metastatic breast cancer.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "30067621", "sentence_id": 3, "text": "The antitumor activity of PARP inhibitors as single agents has been demonstrated in BRCA-associated metastatic breast cancer."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"30067621\", \"sentence_id\": 4, \"text\": \"In 2018, olaparib became the first oral PARP inhibitor to receive approval in the United States for the treatment of advanced BRCA-mutated breast cancer, an approval that represents a major change in the treatment paradigm for this subtype of breast cancer.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "30067621", "sentence_id": 4, "text": "In 2018, olaparib became the first oral PARP inhibitor to receive approval in the United States for the treatment of advanced BRCA-mutated breast cancer, an approval that represents a major change in the treatment paradigm for this subtype of breast cancer."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"30067621\", \"sentence_id\": 5, \"text\": \"PARP inhibition plus chemotherapy and PARP inhibition plus immunotherapy are novel approaches undergoing extensive study in breast cancer.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "30067621", "sentence_id": 5, "text": "PARP inhibition plus chemotherapy and PARP inhibition plus immunotherapy are novel approaches undergoing extensive study in breast cancer."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"30067621\", \"sentence_id\": 6, \"text\": \"This review focuses on the clinical development of PARP inhibitors administered singly or in combination with other agents for early-stage and metastatic BRCA-mutated breast cancer.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "30067621", "sentence_id": 6, "text": "This review focuses on the clinical development of PARP inhibitors administered singly or in combination with other agents for early-stage and metastatic BRCA-mutated breast cancer."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"30049486\", \"sentence_id\": 0, \"text\": \"BACKGROUND: The intractability of castration-resistant prostate cancer (CRPC) is exacerbated by tumour heterogeneity, including diverse alterations to the androgen receptor (AR) axis and AR-independent phenotypes.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "30049486", "sentence_id": 0, "text": "BACKGROUND: The intractability of castration-resistant prostate cancer (CRPC) is exacerbated by tumour heterogeneity, including diverse alterations to the androgen receptor (AR) axis and AR-independent phenotypes."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"30049486\", \"sentence_id\": 1, \"text\": \"The availability of additional models encompassing this heterogeneity would facilitate the identification of more effective therapies for CRPC.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "30049486", "sentence_id": 1, "text": "The availability of additional models encompassing this heterogeneity would facilitate the identification of more effective therapies for CRPC."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"30049486\", \"sentence_id\": 2, \"text\": \"OBJECTIVE: To discover therapeutic strategies by exploiting patient-derived models that exemplify the heterogeneity of CRPC.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "30049486", "sentence_id": 2, "text": "OBJECTIVE: To discover therapeutic strategies by exploiting patient-derived models that exemplify the heterogeneity of CRPC."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"30049486\", \"sentence_id\": 3, \"text\": \"DESIGN, SETTING, AND PARTICIPANTS: Four new patient-derived xenografts (PDXs) were established from independent metastases of two patients and characterised using integrative genomics.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "30049486", "sentence_id": 3, "text": "DESIGN, SETTING, AND PARTICIPANTS: Four new patient-derived xenografts (PDXs) were established from independent metastases of two patients and characterised using integrative genomics."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"30049486\", \"sentence_id\": 4, \"text\": \"A panel of rationally selected drugs was tested using an innovative ex vivo PDX culture system.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "30049486", "sentence_id": 4, "text": "A panel of rationally selected drugs was tested using an innovative ex vivo PDX culture system."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"30049486\", \"sentence_id\": 5, \"text\": \"INTERVENTION: The following drugs were evaluated: AR signalling inhibitors (enzalutamide and galeterone), a PARP inhibitor (talazoparib), a chemotherapeutic (cisplatin), a CDK4/6 inhibitor (ribociclib), bromodomain and extraterminal (BET) protein inhibitors (iBET151 and JQ1), and inhibitors of ribosome biogenesis/function (RNA polymerase I inhibitor CX-5461 and pan-PIM kinase inhibitor CX-6258).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "30049486", "sentence_id": 5, "text": "INTERVENTION: The following drugs were evaluated: AR signalling inhibitors (enzalutamide and galeterone), a PARP inhibitor (talazoparib), a chemotherapeutic (cisplatin), a CDK4/6 inhibitor (ribociclib), bromodomain and extraterminal (BET) protein inhibitors (iBET151 and JQ1), and inhibitors of ribosome biogenesis/function (RNA polymerase I inhibitor CX-5461 and pan-PIM kinase inhibitor CX-6258)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"30049486\", \"sentence_id\": 6, \"text\": \"OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Drug efficacy in ex vivo cultures of PDX tissues was evaluated using immunohistochemistry for Ki67 and cleaved caspase-3 levels.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "30049486", "sentence_id": 6, "text": "OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Drug efficacy in ex vivo cultures of PDX tissues was evaluated using immunohistochemistry for Ki67 and cleaved caspase-3 levels."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"30049486\", \"sentence_id\": 7, \"text\": \"Candidate drugs were also tested for antitumour efficacy in vivo, with tumour volume being the primary endpoint.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "30049486", "sentence_id": 7, "text": "Candidate drugs were also tested for antitumour efficacy in vivo, with tumour volume being the primary endpoint."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"30049486\", \"sentence_id\": 8, \"text\": \"Two-tailed t tests were used to compare drug and control treatments.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "30049486", "sentence_id": 8, "text": "Two-tailed t tests were used to compare drug and control treatments."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"30049486\", \"sentence_id\": 9, \"text\": \"RESULTS AND LIMITATIONS: Integrative genomics revealed that the new PDXs exhibited heterogeneous mechanisms of resistance, including known and novel AR mutations, genomic structural rearrangements of the AR gene, and a neuroendocrine-like AR-null phenotype.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "30049486", "sentence_id": 9, "text": "RESULTS AND LIMITATIONS: Integrative genomics revealed that the new PDXs exhibited heterogeneous mechanisms of resistance, including known and novel AR mutations, genomic structural rearrangements of the AR gene, and a neuroendocrine-like AR-null phenotype."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"30049486\", \"sentence_id\": 10, \"text\": \"Despite their heterogeneity, all models were sensitive to the combination of ribosome-targeting agents CX-5461 and CX-6258.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "30049486", "sentence_id": 10, "text": "Despite their heterogeneity, all models were sensitive to the combination of ribosome-targeting agents CX-5461 and CX-6258."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"30049486\", \"sentence_id\": 11, \"text\": \"CONCLUSIONS: This study demonstrates that ribosome-targeting drugs may be effective against diverse CRPC subtypes including AR-null disease, and highlights the potential of contemporary patient-derived models to prioritise treatment strategies for clinical translation.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "30049486", "sentence_id": 11, "text": "CONCLUSIONS: This study demonstrates that ribosome-targeting drugs may be effective against diverse CRPC subtypes including AR-null disease, and highlights the potential of contemporary patient-derived models to prioritise treatment strategies for clinical translation."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"30049486\", \"sentence_id\": 12, \"text\": \"PATIENT SUMMARY: Diverse types of therapy-resistant prostate cancers are sensitive to a new combination of drugs that inhibit protein synthesis pathways in cancer cells.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "30049486", "sentence_id": 12, "text": "PATIENT SUMMARY: Diverse types of therapy-resistant prostate cancers are sensitive to a new combination of drugs that inhibit protein synthesis pathways in cancer cells."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29973717\", \"sentence_id\": 0, \"text\": \"The observation that BRCA1- and BRCA2-deficient cells are sensitive to inhibitors of poly(ADP-ribose) polymerase (PARP) has spurred the development of cancer therapies that use these inhibitors to target deficiencies in homologous recombination\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29973717", "sentence_id": 0, "text": "The observation that BRCA1- and BRCA2-deficient cells are sensitive to inhibitors of poly(ADP-ribose) polymerase (PARP) has spurred the development of cancer therapies that use these inhibitors to target deficiencies in homologous recombination"}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29895102\", \"sentence_id\": 0, \"text\": \"Epithelial ovarian cancer (EOC) accounts for 90% of all ovarian cancer.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29895102", "sentence_id": 0, "text": "Epithelial ovarian cancer (EOC) accounts for 90% of all ovarian cancer."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29895102\", \"sentence_id\": 1, \"text\": \"Initially, approaching 80% of EOC patients respond to standard therapeutic strategy, cytoreduction combining with postoperative auxiliary platinum-based chemotherapy.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29895102", "sentence_id": 1, "text": "Initially, approaching 80% of EOC patients respond to standard therapeutic strategy, cytoreduction combining with postoperative auxiliary platinum-based chemotherapy."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29895102\", \"sentence_id\": 2, \"text\": \"However, relapse is approximately inevitable because of drug-resistance for high-grade serous ovarian cancer (HGSOC).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29895102", "sentence_id": 2, "text": "However, relapse is approximately inevitable because of drug-resistance for high-grade serous ovarian cancer (HGSOC)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29895102\", \"sentence_id\": 3, \"text\": \"Recently, the nuclear enzyme poly (ADP-ribose) polymerase (PARP) represents a strikingly novel target in EOC treatment.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29895102", "sentence_id": 3, "text": "Recently, the nuclear enzyme poly (ADP-ribose) polymerase (PARP) represents a strikingly novel target in EOC treatment."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29895102\", \"sentence_id\": 4, \"text\": \"PARP inhibitors, currently mainly including Olaparib, Niraparib, Velaparib, Rucaparib, and Talazoparib, have demonstrated promising activity in EOC treatment.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29895102", "sentence_id": 4, "text": "PARP inhibitors, currently mainly including Olaparib, Niraparib, Velaparib, Rucaparib, and Talazoparib, have demonstrated promising activity in EOC treatment."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29895102\", \"sentence_id\": 5, \"text\": \"Especially, studies of Olaparib accelerated it to be approved in Europe and USA.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29895102", "sentence_id": 5, "text": "Especially, studies of Olaparib accelerated it to be approved in Europe and USA."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29895102\", \"sentence_id\": 6, \"text\": \"Here, this review focuses on the pre-clinical data, current clinical trials, the development of PARP inhibitors in the last decade and their future roles in clinical treatment for EOC patients.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29895102", "sentence_id": 6, "text": "Here, this review focuses on the pre-clinical data, current clinical trials, the development of PARP inhibitors in the last decade and their future roles in clinical treatment for EOC patients."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29748565\", \"sentence_id\": 0, \"text\": \"Although PARP inhibitors (PARPi) target homologous recombination defective tumours, drug resistance frequently emerges, often via poorly understood mechanisms.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29748565", "sentence_id": 0, "text": "Although PARP inhibitors (PARPi) target homologous recombination defective tumours, drug resistance frequently emerges, often via poorly understood mechanisms."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29748565\", \"sentence_id\": 1, \"text\": \"Here, using genome-wide and high-density CRISPR-Cas9 \\\"tag-mutate-enrich\\\" mutagenesis screens, we identify close to full-length mutant forms of PARP1 that cause in vitro and in vivo PARPi resistance.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29748565", "sentence_id": 1, "text": "Here, using genome-wide and high-density CRISPR-Cas9 \"tag-mutate-enrich\" mutagenesis screens, we identify close to full-length mutant forms of PARP1 that cause in vitro and in vivo PARPi resistance."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29748565\", \"sentence_id\": 2, \"text\": \"Mutations both within and outside of the PARP1 DNA-binding zinc-finger domains cause PARPi resistance and alter PARP1 trapping, as does a PARP1 mutation found in a clinical case of PARPi resistance.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29748565", "sentence_id": 2, "text": "Mutations both within and outside of the PARP1 DNA-binding zinc-finger domains cause PARPi resistance and alter PARP1 trapping, as does a PARP1 mutation found in a clinical case of PARPi resistance."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29748565\", \"sentence_id\": 3, \"text\": \"This reinforces the importance of trapped PARP1 as a cytotoxic DNA lesion and suggests that PARP1 intramolecular interactions might influence PARPi-mediated cytotoxicity.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29748565", "sentence_id": 3, "text": "This reinforces the importance of trapped PARP1 as a cytotoxic DNA lesion and suggests that PARP1 intramolecular interactions might influence PARPi-mediated cytotoxicity."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29748565\", \"sentence_id\": 4, \"text\": \"PARP1 mutations are also tolerated in cells with a pathogenic BRCA1 mutation where they result in distinct sensitivities to chemotherapeutic drugs compared to other mechanisms of PARPi resistance (BRCA1 reversion, 53BP1, REV7 (MAD2L2) mutation), suggesting that the underlying mechanism of PARPi resistance that emerges could influence the success of subsequent therapies.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29748565", "sentence_id": 4, "text": "PARP1 mutations are also tolerated in cells with a pathogenic BRCA1 mutation where they result in distinct sensitivities to chemotherapeutic drugs compared to other mechanisms of PARPi resistance (BRCA1 reversion, 53BP1, REV7 (MAD2L2) mutation), suggesting that the underlying mechanism of PARPi resistance that emerges could influence the success of subsequent therapies."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29664016\", \"sentence_id\": 0, \"text\": \"Poly(ADP-ribose) polymerase inhibitors (PARPis) are DNA-damaging agents that trap PARP-DNA complexes and interfere with DNA replication.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29664016", "sentence_id": 0, "text": "Poly(ADP-ribose) polymerase inhibitors (PARPis) are DNA-damaging agents that trap PARP-DNA complexes and interfere with DNA replication."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29664016\", \"sentence_id\": 1, \"text\": \"Three PARPis - olaparib, niraparib, and rucaparib - were recently approved by the FDA for the treatment of breast and ovarian cancers.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29664016", "sentence_id": 1, "text": "Three PARPis - olaparib, niraparib, and rucaparib - were recently approved by the FDA for the treatment of breast and ovarian cancers."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29664016\", \"sentence_id\": 2, \"text\": \"These PARPis, along with 2 others (talazoparib and veliparib), are being evaluated for their potential to treat additional malignancies, including prostate cancers.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29664016", "sentence_id": 2, "text": "These PARPis, along with 2 others (talazoparib and veliparib), are being evaluated for their potential to treat additional malignancies, including prostate cancers."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29664016\", \"sentence_id\": 3, \"text\": \"While lack of PARP-1 confers high resistance to PARPis, it has not been established whether or not the levels of PARP-1 directly correlate with tumor response.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29664016", "sentence_id": 3, "text": "While lack of PARP-1 confers high resistance to PARPis, it has not been established whether or not the levels of PARP-1 directly correlate with tumor response."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29664016\", \"sentence_id\": 4, \"text\": \"In this issue of the JCI, Makvandi and coworkers describe an approach to address this question using [18F]FluorThanatrace, an [18F]-labeled PARP-1 inhibitor, for PET.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29664016", "sentence_id": 4, "text": "In this issue of the JCI, Makvandi and coworkers describe an approach to address this question using [18F]FluorThanatrace, an [18F]-labeled PARP-1 inhibitor, for PET."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29664016\", \"sentence_id\": 5, \"text\": \"The tracer was taken up by patient tumor tissue and appeared to differentiate levels of PARP-1 expression; however, future studies should be aimed at determining if this tracer can be used to stratify patient response to PARPi therapy.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29664016", "sentence_id": 5, "text": "The tracer was taken up by patient tumor tissue and appeared to differentiate levels of PARP-1 expression; however, future studies should be aimed at determining if this tracer can be used to stratify patient response to PARPi therapy."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29660759\", \"sentence_id\": 0, \"text\": \"Individuals with breast and ovarian cancer susceptibility gene 1 (BRCA1) or BRCA2 germline mutations have a significantly increased lifetime risk for breast and ovarian cancers.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29660759", "sentence_id": 0, "text": "Individuals with breast and ovarian cancer susceptibility gene 1 (BRCA1) or BRCA2 germline mutations have a significantly increased lifetime risk for breast and ovarian cancers."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29660759\", \"sentence_id\": 1, \"text\": \"BRCA-mutant cancer cells have abnormal homologous recombination (HR) repair of DNA.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29660759", "sentence_id": 1, "text": "BRCA-mutant cancer cells have abnormal homologous recombination (HR) repair of DNA."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29660759\", \"sentence_id\": 2, \"text\": \"In these tumors, the base excision repair (BER) pathway is important for cell survival.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29660759", "sentence_id": 2, "text": "In these tumors, the base excision repair (BER) pathway is important for cell survival."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29660759\", \"sentence_id\": 3, \"text\": \"The poly(adenosine diphosphate-ribose) polymerase (PARP) enzymes play a key role in BER, and PARP inhibitors are effective in causing cell death in BRCA-mutant cells while sparing normal cells-a concept called synthetic lethality.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29660759", "sentence_id": 3, "text": "The poly(adenosine diphosphate-ribose) polymerase (PARP) enzymes play a key role in BER, and PARP inhibitors are effective in causing cell death in BRCA-mutant cells while sparing normal cells-a concept called synthetic lethality."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29660759\", \"sentence_id\": 4, \"text\": \"PARP inhibitors are the first cancer therapeutics designed to exploit synthetic lethality.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29660759", "sentence_id": 4, "text": "PARP inhibitors are the first cancer therapeutics designed to exploit synthetic lethality."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29660759\", \"sentence_id\": 5, \"text\": \"Recent clinical trials in BRCA-mutant, metastatic breast cancer demonstrated improved outcomes with single-agent PARP inhibitors (olaparib and talazoparib) over chemotherapy.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29660759", "sentence_id": 5, "text": "Recent clinical trials in BRCA-mutant, metastatic breast cancer demonstrated improved outcomes with single-agent PARP inhibitors (olaparib and talazoparib) over chemotherapy."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29660759\", \"sentence_id\": 6, \"text\": \"However, resistance to PARP inhibitors remains a challenge.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29660759", "sentence_id": 6, "text": "However, resistance to PARP inhibitors remains a challenge."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29660759\", \"sentence_id\": 7, \"text\": \"Primarily due to myelosuppression, the combination of PARP inhibitors with chemotherapy has been difficult.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29660759", "sentence_id": 7, "text": "Primarily due to myelosuppression, the combination of PARP inhibitors with chemotherapy has been difficult."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29660759\", \"sentence_id\": 8, \"text\": \"Novel combinations with chemotherapy, immunotherapy, and other targeted therapies are being pursued.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29660759", "sentence_id": 8, "text": "Novel combinations with chemotherapy, immunotherapy, and other targeted therapies are being pursued."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29660759\", \"sentence_id\": 9, \"text\": \"In this review, the authors discuss current knowledge of PARP inhibitors in BRCA-mutant breast cancer and potential future directions for these agents.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29660759", "sentence_id": 9, "text": "In this review, the authors discuss current knowledge of PARP inhibitors in BRCA-mutant breast cancer and potential future directions for these agents."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29660759\", \"sentence_id\": 10, \"text\": \"Cancer 2018;124:2498-506.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29660759", "sentence_id": 10, "text": "Cancer 2018;124:2498-506."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29660759\", \"sentence_id\": 11, \"text\": \"\u00a9 2018 American Cancer Society.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29660759", "sentence_id": 11, "text": "\u00a9 2018 American Cancer Society."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29644491\", \"sentence_id\": 0, \"text\": \"The single agent activity of PARP inhibitors (PARPi) in germline BRCA mutated (gBRCAm) breast and ovarian cancer suggests untapped potential for this new class of drug in breast cancer.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29644491", "sentence_id": 0, "text": "The single agent activity of PARP inhibitors (PARPi) in germline BRCA mutated (gBRCAm) breast and ovarian cancer suggests untapped potential for this new class of drug in breast cancer."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29644491\", \"sentence_id\": 1, \"text\": \"The US Food and Drug Administration has approved three PARPi (olaparib, rucaparib, and niraparib) so far to treat certain ovarian cancers, including those with gBRCAm and olaparib for treatment of gBRCAm breast cancers.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29644491", "sentence_id": 1, "text": "The US Food and Drug Administration has approved three PARPi (olaparib, rucaparib, and niraparib) so far to treat certain ovarian cancers, including those with gBRCAm and olaparib for treatment of gBRCAm breast cancers."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29644491\", \"sentence_id\": 2, \"text\": \"Several PARPi are now under clinical development for breast cancer in the various treatment settings.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29644491", "sentence_id": 2, "text": "Several PARPi are now under clinical development for breast cancer in the various treatment settings."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29644491\", \"sentence_id\": 3, \"text\": \"Recently, two phase III trials of olaparib (OlympiaD) and talazoparib (EMBRACA) demonstrated 3-month progression-free survival improvement with PARPi compared to physician's choice single agent chemotherapy in metastatic gBRCAm breast cancer.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29644491", "sentence_id": 3, "text": "Recently, two phase III trials of olaparib (OlympiaD) and talazoparib (EMBRACA) demonstrated 3-month progression-free survival improvement with PARPi compared to physician's choice single agent chemotherapy in metastatic gBRCAm breast cancer."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29644491\", \"sentence_id\": 4, \"text\": \"To date, PARPi seems less efficacious in metastatic breast cancer patients than those with BRCA mutated platinum-sensitive recurrent ovarian cancer, perhaps reflecting the biologic heterogeneity and low somatic BRCA mutation rate in breast cancer.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29644491", "sentence_id": 4, "text": "To date, PARPi seems less efficacious in metastatic breast cancer patients than those with BRCA mutated platinum-sensitive recurrent ovarian cancer, perhaps reflecting the biologic heterogeneity and low somatic BRCA mutation rate in breast cancer."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29644491\", \"sentence_id\": 5, \"text\": \"The use of PARPi is gradually evolving, including combination strategies with chemotherapy, targeted agents, radiotherapy, or immunotherapy in women with and without gBRCAm.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29644491", "sentence_id": 5, "text": "The use of PARPi is gradually evolving, including combination strategies with chemotherapy, targeted agents, radiotherapy, or immunotherapy in women with and without gBRCAm."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29644491\", \"sentence_id\": 6, \"text\": \"The role of predictive biomarkers, including molecular signatures and homologous recombination repair deficiency scores based on loss of heterozygosity and other structural genomic aberrations, will be crucial to identify a subgroup of patients who may have benefit from PARPi.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29644491", "sentence_id": 6, "text": "The role of predictive biomarkers, including molecular signatures and homologous recombination repair deficiency scores based on loss of heterozygosity and other structural genomic aberrations, will be crucial to identify a subgroup of patients who may have benefit from PARPi."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29644491\", \"sentence_id\": 7, \"text\": \"An improved understanding of the mechanisms underlying PARPi clinical resistance will also be important to enable the development of new approaches to increase efficacy.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29644491", "sentence_id": 7, "text": "An improved understanding of the mechanisms underlying PARPi clinical resistance will also be important to enable the development of new approaches to increase efficacy."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29644491\", \"sentence_id\": 8, \"text\": \"This is a field rich in opportunity, and the coming years should see a better understanding of which breast cancer patients we should treat with PARPi and where these agents should come in over the course of treatment.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29644491", "sentence_id": 8, "text": "This is a field rich in opportunity, and the coming years should see a better understanding of which breast cancer patients we should treat with PARPi and where these agents should come in over the course of treatment."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29593397\", \"sentence_id\": 0, \"text\": \"PARP-l is a DNA repair protein that plays a role in a number of repair pathways and also helps in transcriptional regulation; thus PARP inhibitors (PARPi), such as olaparib and BMN-673, act by inhibiting DNA damage repair.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29593397", "sentence_id": 0, "text": "PARP-l is a DNA repair protein that plays a role in a number of repair pathways and also helps in transcriptional regulation; thus PARP inhibitors (PARPi), such as olaparib and BMN-673, act by inhibiting DNA damage repair."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29593397\", \"sentence_id\": 1, \"text\": \"This leads to an accumulation of deleterious mutations leading to genetic instability as a result of a number of cell replications.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29593397", "sentence_id": 1, "text": "This leads to an accumulation of deleterious mutations leading to genetic instability as a result of a number of cell replications."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29593397\", \"sentence_id\": 2, \"text\": \"Currently, olaparib is only available in an oral form and has poor bioavailability, consequently leading to poor accumulation in the tumor due to first-pass metabolism.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29593397", "sentence_id": 2, "text": "Currently, olaparib is only available in an oral form and has poor bioavailability, consequently leading to poor accumulation in the tumor due to first-pass metabolism."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29593397\", \"sentence_id\": 3, \"text\": \"Therefore, in the present study, an injectable nanoparticle formulation of olaparib was created that offers a delivery route in which the drug would be fully bioavailable in the vasculature, suggesting greater tumor accumulation.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29593397", "sentence_id": 3, "text": "Therefore, in the present study, an injectable nanoparticle formulation of olaparib was created that offers a delivery route in which the drug would be fully bioavailable in the vasculature, suggesting greater tumor accumulation."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29593397\", \"sentence_id\": 4, \"text\": \"Our results illustrated that injectable nanoformulations of olaparib and BMN-673, a next generation PARPi, could be developed, and an efficacy test indicated that BMN-673 is a much more potent PARPi than olaparib.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29593397", "sentence_id": 4, "text": "Our results illustrated that injectable nanoformulations of olaparib and BMN-673, a next generation PARPi, could be developed, and an efficacy test indicated that BMN-673 is a much more potent PARPi than olaparib."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29593397\", \"sentence_id\": 5, \"text\": \"The success of these molecular inhibitors as a monotherapy in inhibiting colony formation suggests enhanced efficacy of these treatments in combination with other therapies, even in tumors which have developed resistance.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29593397", "sentence_id": 5, "text": "The success of these molecular inhibitors as a monotherapy in inhibiting colony formation suggests enhanced efficacy of these treatments in combination with other therapies, even in tumors which have developed resistance."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29512470\", \"sentence_id\": 0, \"text\": \"BACKGROUND: Treatment of Epithelial Ovarian Cancer (EOC), historically based on surgery and platinum doublet chemotherapy, is associated with high risk of relapse and poor prognosis for recurrent disease.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29512470", "sentence_id": 0, "text": "BACKGROUND: Treatment of Epithelial Ovarian Cancer (EOC), historically based on surgery and platinum doublet chemotherapy, is associated with high risk of relapse and poor prognosis for recurrent disease."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29512470\", \"sentence_id\": 1, \"text\": \"In this landscape, the innovative treatment with PARP inhibitors (PARPis) demonstrated an outstanding activity in EOC, and is currently changing clinical practice in BRCA mutant patients.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29512470", "sentence_id": 1, "text": "In this landscape, the innovative treatment with PARP inhibitors (PARPis) demonstrated an outstanding activity in EOC, and is currently changing clinical practice in BRCA mutant patients."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29512470\", \"sentence_id\": 2, \"text\": \"OBJECTIVES: The study aimed to highlight the mechanism of action, pharmacokinetics, clinical activity, indications and current strategies of development of Olaparib, Niraparib, Rucaparib, Talazoparib and Veliparib, the 5 most relevant PARPis.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29512470", "sentence_id": 2, "text": "OBJECTIVES: The study aimed to highlight the mechanism of action, pharmacokinetics, clinical activity, indications and current strategies of development of Olaparib, Niraparib, Rucaparib, Talazoparib and Veliparib, the 5 most relevant PARPis."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29512470\", \"sentence_id\": 3, \"text\": \"METHODS: We performed a review on Pubmed using 'ovarian cancer' and the name of each PARPi (PARP inhibitor) discussed in the review as Medical Subject Headings (MeSH) keywords.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29512470", "sentence_id": 3, "text": "METHODS: We performed a review on Pubmed using 'ovarian cancer' and the name of each PARPi (PARP inhibitor) discussed in the review as Medical Subject Headings (MeSH) keywords."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29512470\", \"sentence_id\": 4, \"text\": \"The same search was performed on \\\"clinicaltrial.gov\\\" to identify ongoing clinical trials and on \\\"google.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29512470", "sentence_id": 4, "text": "The same search was performed on \"clinicaltrial.gov\" to identify ongoing clinical trials and on \"google."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29512470\", \"sentence_id\": 5, \"text\": \"com/patents\\\" and \\\"uspto.gov\\\" for recent patents exploring PARPIs in ovarian cancer.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29512470", "sentence_id": 5, "text": "com/patents\" and \"uspto.gov\" for recent patents exploring PARPIs in ovarian cancer."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29512470\", \"sentence_id\": 6, \"text\": \"RESULTS: Olaparib, Niraparib and Rucaparib are already approved for the treatment of recurrent EOC and their indications are partially overlapping.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29512470", "sentence_id": 6, "text": "RESULTS: Olaparib, Niraparib and Rucaparib are already approved for the treatment of recurrent EOC and their indications are partially overlapping."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29512470\", \"sentence_id\": 7, \"text\": \"Talazoparib and Veliparib are promising PARPis, but currently under investigation in early phase trials.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29512470", "sentence_id": 7, "text": "Talazoparib and Veliparib are promising PARPis, but currently under investigation in early phase trials."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29512470\", \"sentence_id\": 8, \"text\": \"Several studies are evaluating PARPis in monotherapy or in associations, in a wide range of settings (i.e.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29512470", "sentence_id": 8, "text": "Several studies are evaluating PARPis in monotherapy or in associations, in a wide range of settings (i.e."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29512470\", \"sentence_id\": 9, \"text\": \"first line, neoadjuvant, platinum-sensitive and resistant disease).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29512470", "sentence_id": 9, "text": "first line, neoadjuvant, platinum-sensitive and resistant disease)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29512470\", \"sentence_id\": 10, \"text\": \"CONCLUSION: PARPis are valuable options in patients with recurrent ovarian cancer with promising activity in different stages of this disease.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29512470", "sentence_id": 10, "text": "CONCLUSION: PARPis are valuable options in patients with recurrent ovarian cancer with promising activity in different stages of this disease."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29512470\", \"sentence_id\": 11, \"text\": \"Further studies are required to better define optimal clinical settings, predictors of response beyond BRCA mutations and strategies to overcome secondary resistance of PARPis therapy in EOC.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29512470", "sentence_id": 11, "text": "Further studies are required to better define optimal clinical settings, predictors of response beyond BRCA mutations and strategies to overcome secondary resistance of PARPis therapy in EOC."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29483558\", \"sentence_id\": 0, \"text\": \"Despite continuous improvements in treatment of glioblastoma, tumor recurrence and therapy resistance still occur in a high proportion of patients.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29483558", "sentence_id": 0, "text": "Despite continuous improvements in treatment of glioblastoma, tumor recurrence and therapy resistance still occur in a high proportion of patients."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29483558\", \"sentence_id\": 1, \"text\": \"One underlying reason for this radioresistance might be the presence of glioblastoma cancer stem cells (GSCs), which feature high DNA repair capability.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29483558", "sentence_id": 1, "text": "One underlying reason for this radioresistance might be the presence of glioblastoma cancer stem cells (GSCs), which feature high DNA repair capability."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29483558\", \"sentence_id\": 2, \"text\": \"PARP protein plays an important cellular role by detecting the presence of damaged DNA and then activating signaling pathways that promote appropriate cellular responses.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29483558", "sentence_id": 2, "text": "PARP protein plays an important cellular role by detecting the presence of damaged DNA and then activating signaling pathways that promote appropriate cellular responses."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29483558\", \"sentence_id\": 3, \"text\": \"Thus, PARP inhibitors (PARPi) have recently emerged as potential radiosensitizing agents.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29483558", "sentence_id": 3, "text": "Thus, PARP inhibitors (PARPi) have recently emerged as potential radiosensitizing agents."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29483558\", \"sentence_id\": 4, \"text\": \"In this study, we investigated the preclinical efficacy of talazoparib, a new PARPi, in association with low and high linear energy transfer (LET) irradiation in two GSC cell lines.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29483558", "sentence_id": 4, "text": "In this study, we investigated the preclinical efficacy of talazoparib, a new PARPi, in association with low and high linear energy transfer (LET) irradiation in two GSC cell lines."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29483558\", \"sentence_id\": 5, \"text\": \"Reduction of GSC fraction, impact on cell proliferation, and cell cycle arrest were evaluated for each condition.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29483558", "sentence_id": 5, "text": "Reduction of GSC fraction, impact on cell proliferation, and cell cycle arrest were evaluated for each condition."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29483558\", \"sentence_id\": 6, \"text\": \"All combinations were compared with a reference schedule: photonic irradiation combined with temozolomide.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29483558", "sentence_id": 6, "text": "All combinations were compared with a reference schedule: photonic irradiation combined with temozolomide."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29483558\", \"sentence_id\": 7, \"text\": \"The use of PARPi combined with photon beam and even more carbon beam irradiation drastically reduced the GSC frequency of GBM cell lines in vitro.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29483558", "sentence_id": 7, "text": "The use of PARPi combined with photon beam and even more carbon beam irradiation drastically reduced the GSC frequency of GBM cell lines in vitro."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29483558\", \"sentence_id\": 8, \"text\": \"Furthermore, talazoparib combined with irradiation induced a marked and prolonged G2/M block, and decreased proliferation.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29483558", "sentence_id": 8, "text": "Furthermore, talazoparib combined with irradiation induced a marked and prolonged G2/M block, and decreased proliferation."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29483558\", \"sentence_id\": 9, \"text\": \"These results show that talazoparib is a new candidate that effects radiosensitization in radioresistant GSCs, and its combination with high LET irradiation, is promising.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29483558", "sentence_id": 9, "text": "These results show that talazoparib is a new candidate that effects radiosensitization in radioresistant GSCs, and its combination with high LET irradiation, is promising."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29274141\", \"sentence_id\": 0, \"text\": \"With increasing uses of poly(ADP-ribose) polymerase (PARP) inhibitors (PARPi) for cancer therapy, understanding their resistance is becoming urgent.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29274141", "sentence_id": 0, "text": "With increasing uses of poly(ADP-ribose) polymerase (PARP) inhibitors (PARPi) for cancer therapy, understanding their resistance is becoming urgent."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29274141\", \"sentence_id\": 1, \"text\": \"However, acquired PARPi resistance in the phosphatase and tensin homolog (PTEN)-deficient background is poorly understood.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29274141", "sentence_id": 1, "text": "However, acquired PARPi resistance in the phosphatase and tensin homolog (PTEN)-deficient background is poorly understood."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29274141\", \"sentence_id\": 2, \"text\": \"We generated 3 PARPi-resistant PTEN-deficient glioblastoma U251 variants separately with olaparib (U251/OP), talazoparib (U251/TP) and simmiparib (U251/SP).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29274141", "sentence_id": 2, "text": "We generated 3 PARPi-resistant PTEN-deficient glioblastoma U251 variants separately with olaparib (U251/OP), talazoparib (U251/TP) and simmiparib (U251/SP)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29274141\", \"sentence_id\": 3, \"text\": \"These variants displayed consistent resistance (2.46-71.78-fold) to all 5 PARPi, including niraparib and rucaparib, and showed higher degrees of resistance to the PARPi to which the parental cells were more sensitive.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29274141", "sentence_id": 3, "text": "These variants displayed consistent resistance (2.46-71.78-fold) to all 5 PARPi, including niraparib and rucaparib, and showed higher degrees of resistance to the PARPi to which the parental cells were more sensitive."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29274141\", \"sentence_id\": 4, \"text\": \"The resistance was characteristic of fast emergence and high stability.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29274141", "sentence_id": 4, "text": "The resistance was characteristic of fast emergence and high stability."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29274141\", \"sentence_id\": 5, \"text\": \"However, the resistance acquirement did not cause an increasingly aggressive phenotype.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29274141", "sentence_id": 5, "text": "However, the resistance acquirement did not cause an increasingly aggressive phenotype."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29274141\", \"sentence_id\": 6, \"text\": \"The resistance was not correlated to various factors, including PTEN mutations.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29274141", "sentence_id": 6, "text": "The resistance was not correlated to various factors, including PTEN mutations."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29274141\", \"sentence_id\": 7, \"text\": \"The PARPi-treated variants produced less \u03b3H2AX and G2/M arrest.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29274141", "sentence_id": 7, "text": "The PARPi-treated variants produced less \u03b3H2AX and G2/M arrest."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29274141\", \"sentence_id\": 8, \"text\": \"Consistently, loss of 53BP1 occurred in all variants and its compensation enhanced their sensitivity to PARPi by approximately 76%.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29274141", "sentence_id": 8, "text": "Consistently, loss of 53BP1 occurred in all variants and its compensation enhanced their sensitivity to PARPi by approximately 76%."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29274141\", \"sentence_id\": 9, \"text\": \"The variants revealed slightly different cross-resistance profiles to 13 non-PARPi anticancer drugs.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29274141", "sentence_id": 9, "text": "The variants revealed slightly different cross-resistance profiles to 13 non-PARPi anticancer drugs."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29274141\", \"sentence_id\": 10, \"text\": \"All were resistant to Ara-C (6-8-fold) but showed differential resistance to 5-fluorouracil, gemcitabine and paclitaxel.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29274141", "sentence_id": 10, "text": "All were resistant to Ara-C (6-8-fold) but showed differential resistance to 5-fluorouracil, gemcitabine and paclitaxel."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29274141\", \"sentence_id\": 11, \"text\": \"Almost no resistance was observed to the rest drugs, including cisplatin.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29274141", "sentence_id": 11, "text": "Almost no resistance was observed to the rest drugs, including cisplatin."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29274141\", \"sentence_id\": 12, \"text\": \"SAMHD1 was overexpressed in all the variants and its knockout completely restored their sensitivity to Ara-C but did not affect their PARPi sensitivity.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29274141", "sentence_id": 12, "text": "SAMHD1 was overexpressed in all the variants and its knockout completely restored their sensitivity to Ara-C but did not affect their PARPi sensitivity."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29274141\", \"sentence_id\": 13, \"text\": \"The present study demonstrates a consistent resistance profile to PARPi and a unique cross-resistance profile to non-PARPi drugs in different PARPi-resistant U251 cells and reveals 53BP1 loss and SAMHD1 overexpression as the primary mechanisms responsible for their resistance to PARPi and Ara-C, respectively.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29274141", "sentence_id": 13, "text": "The present study demonstrates a consistent resistance profile to PARPi and a unique cross-resistance profile to non-PARPi drugs in different PARPi-resistant U251 cells and reveals 53BP1 loss and SAMHD1 overexpression as the primary mechanisms responsible for their resistance to PARPi and Ara-C, respectively."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29274141\", \"sentence_id\": 14, \"text\": \"These effects probably result from heritable gene change(s) caused by persistent PARPi exposure.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29274141", "sentence_id": 14, "text": "These effects probably result from heritable gene change(s) caused by persistent PARPi exposure."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29173760\", \"sentence_id\": 0, \"text\": \"SCLC accounts for 15% of lung cancer worldwide.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29173760", "sentence_id": 0, "text": "SCLC accounts for 15% of lung cancer worldwide."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29173760\", \"sentence_id\": 1, \"text\": \"Characterised by early dissemination and rapid development of chemo-resistant disease, less than 5% of patients survive 5 years.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29173760", "sentence_id": 1, "text": "Characterised by early dissemination and rapid development of chemo-resistant disease, less than 5% of patients survive 5 years."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29173760\", \"sentence_id\": 2, \"text\": \"Despite 3 decades of clinical trials there has been no change to the standard platinum and etoposide regimen for first line treatment developed in the 1970's.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29173760", "sentence_id": 2, "text": "Despite 3 decades of clinical trials there has been no change to the standard platinum and etoposide regimen for first line treatment developed in the 1970's."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29173760\", \"sentence_id\": 3, \"text\": \"The exceptionally high number of genomic aberrations observed in SCLC combined with the characteristic rapid cellular proliferation results in accumulation of DNA damage and genomic instability.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29173760", "sentence_id": 3, "text": "The exceptionally high number of genomic aberrations observed in SCLC combined with the characteristic rapid cellular proliferation results in accumulation of DNA damage and genomic instability."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29173760\", \"sentence_id\": 4, \"text\": \"To flourish in this precarious genomic context, SCLC cells are reliant on functional DNA damage repair pathways and cell cycle checkpoints.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29173760", "sentence_id": 4, "text": "To flourish in this precarious genomic context, SCLC cells are reliant on functional DNA damage repair pathways and cell cycle checkpoints."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29173760\", \"sentence_id\": 5, \"text\": \"Current cytotoxic drugs and radiotherapy treatments for SCLC have long been known to act by induction of DNA damage and the response of cancer cells to such damage determines treatment efficacy.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29173760", "sentence_id": 5, "text": "Current cytotoxic drugs and radiotherapy treatments for SCLC have long been known to act by induction of DNA damage and the response of cancer cells to such damage determines treatment efficacy."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29173760\", \"sentence_id\": 6, \"text\": \"Recent years have witnessed improved understanding of strategies to exploit DNA damage and repair mechanisms in order to increase treatment efficacy.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29173760", "sentence_id": 6, "text": "Recent years have witnessed improved understanding of strategies to exploit DNA damage and repair mechanisms in order to increase treatment efficacy."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"29173760\", \"sentence_id\": 7, \"text\": \"This review will summarise the rationale to target DNA damage response in SCLC, the progress made in evaluating novel DDR inhibitors and highlight various ongoing challenges for their clinical development in this disease.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "29173760", "sentence_id": 7, "text": "This review will summarise the rationale to target DNA damage response in SCLC, the progress made in evaluating novel DDR inhibitors and highlight various ongoing challenges for their clinical development in this disease."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"28886696\", \"sentence_id\": 0, \"text\": \"BACKGROUND: Phosphatase and Tensin homolog (PTEN) is a tumor suppressor gene.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "28886696", "sentence_id": 0, "text": "BACKGROUND: Phosphatase and Tensin homolog (PTEN) is a tumor suppressor gene."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"28886696\", \"sentence_id\": 1, \"text\": \"Loss of its function is the most frequent genetic alteration in endometrioid endometrial cancers (70-80%) and high grade tumors (90%).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "28886696", "sentence_id": 1, "text": "Loss of its function is the most frequent genetic alteration in endometrioid endometrial cancers (70-80%) and high grade tumors (90%)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"28886696\", \"sentence_id\": 2, \"text\": \"We assessed the sensitivity of endometrial cancer cell lines to PARP inhibitors (olaparib and BMN-673) and a PI3K inhibitor (BKM-120), alone or in combination, in the context of their PTEN mutation status.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "28886696", "sentence_id": 2, "text": "We assessed the sensitivity of endometrial cancer cell lines to PARP inhibitors (olaparib and BMN-673) and a PI3K inhibitor (BKM-120), alone or in combination, in the context of their PTEN mutation status."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"28886696\", \"sentence_id\": 3, \"text\": \"We also highlighted a direct pathway linking PTEN to DNA repair.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "28886696", "sentence_id": 3, "text": "We also highlighted a direct pathway linking PTEN to DNA repair."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"28886696\", \"sentence_id\": 4, \"text\": \"METHODS: Using endometrial cancer cellular models with known PTEN status, we evaluated their homologous recombination (HR) functionality by RAD51 foci formation assay.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "28886696", "sentence_id": 4, "text": "METHODS: Using endometrial cancer cellular models with known PTEN status, we evaluated their homologous recombination (HR) functionality by RAD51 foci formation assay."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"28886696\", \"sentence_id\": 5, \"text\": \"The 50% Inhibitory concentration (IC50) of PI3K and PARP inhibitors in these cells was assessed, and western blotting was performed to determine the expression of proteins involved in the PI3K/mTOR pathway.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "28886696", "sentence_id": 5, "text": "The 50% Inhibitory concentration (IC50) of PI3K and PARP inhibitors in these cells was assessed, and western blotting was performed to determine the expression of proteins involved in the PI3K/mTOR pathway."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"28886696\", \"sentence_id\": 6, \"text\": \"Moreover, we explored the interaction between RAD51 and PI3K/mTOR by immunofluorescence.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "28886696", "sentence_id": 6, "text": "Moreover, we explored the interaction between RAD51 and PI3K/mTOR by immunofluorescence."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"28886696\", \"sentence_id\": 7, \"text\": \"Next, the combination effect of PI3K and PARP inhibitors on cell proliferation was evaluated by a clonogenic assay.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "28886696", "sentence_id": 7, "text": "Next, the combination effect of PI3K and PARP inhibitors on cell proliferation was evaluated by a clonogenic assay."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"28886696\", \"sentence_id\": 8, \"text\": \"RESULTS: Cells with mutated PTEN showed over-activation of the PI3K/mTOR pathway.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "28886696", "sentence_id": 8, "text": "RESULTS: Cells with mutated PTEN showed over-activation of the PI3K/mTOR pathway."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"28886696\", \"sentence_id\": 9, \"text\": \"These cells were more sensitive to PARP inhibition compared to PTEN wild-type cells.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "28886696", "sentence_id": 9, "text": "These cells were more sensitive to PARP inhibition compared to PTEN wild-type cells."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"28886696\", \"sentence_id\": 10, \"text\": \"In addition, PI3K inhibitor treatment reduced RAD51 foci formation in PTEN mutated cells, and sensitized these cells to PARP inhibitor.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "28886696", "sentence_id": 10, "text": "In addition, PI3K inhibitor treatment reduced RAD51 foci formation in PTEN mutated cells, and sensitized these cells to PARP inhibitor."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"28886696\", \"sentence_id\": 11, \"text\": \"CONCLUSION: Targeting both PARP and PI3K might lead to improved personalized therapeutic approaches in endometrial cancer patients with PTEN mutations.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "28886696", "sentence_id": 11, "text": "CONCLUSION: Targeting both PARP and PI3K might lead to improved personalized therapeutic approaches in endometrial cancer patients with PTEN mutations."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"28886696\", \"sentence_id\": 12, \"text\": \"Understanding the complex interaction of PTEN mutations with DNA repair in endometrial cancer will help to better select patients that are likely to respond to some of the new and costly targeted therapies.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "28886696", "sentence_id": 12, "text": "Understanding the complex interaction of PTEN mutations with DNA repair in endometrial cancer will help to better select patients that are likely to respond to some of the new and costly targeted therapies."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"28450426\", \"sentence_id\": 0, \"text\": \"Approximately 20% of metastatic prostate cancers harbor mutations in genes required for DNA repair by homologous recombination repair (HRR) such as\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "28450426", "sentence_id": 0, "text": "Approximately 20% of metastatic prostate cancers harbor mutations in genes required for DNA repair by homologous recombination repair (HRR) such as"}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"28316110\", \"sentence_id\": 0, \"text\": \"Poly (ADP-ribose) polymerase 1 (PARP1) is an enzyme involved in DNA repair under investigation as a chemotherapeutic target.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "28316110", "sentence_id": 0, "text": "Poly (ADP-ribose) polymerase 1 (PARP1) is an enzyme involved in DNA repair under investigation as a chemotherapeutic target."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"28316110\", \"sentence_id\": 1, \"text\": \"Current randomized phase three trials of PARPi in metastatic breast cancer are limited to patients with documented BRCA1/2 mutations and no biomarker of PARPi beyond BRCA status is available.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "28316110", "sentence_id": 1, "text": "Current randomized phase three trials of PARPi in metastatic breast cancer are limited to patients with documented BRCA1/2 mutations and no biomarker of PARPi beyond BRCA status is available."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"28316110\", \"sentence_id\": 2, \"text\": \"In an effort to identify novel biomarkers for PARP inhibition, we created a cell line (HCC1187/TALRES) resistant to the PARP1 inhibitor talazoparib.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "28316110", "sentence_id": 2, "text": "In an effort to identify novel biomarkers for PARP inhibition, we created a cell line (HCC1187/TALRES) resistant to the PARP1 inhibitor talazoparib."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"28316110\", \"sentence_id\": 3, \"text\": \"Herein we show by array-CGH that HCC1187/TALRES has a selective loss of the proteasome ubiquitin receptor PSMD4 amplicon resulting in significant down-regulation of PSMD4.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "28316110", "sentence_id": 3, "text": "Herein we show by array-CGH that HCC1187/TALRES has a selective loss of the proteasome ubiquitin receptor PSMD4 amplicon resulting in significant down-regulation of PSMD4."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"28316110\", \"sentence_id\": 4, \"text\": \"Conversely, we find that breast cancer cell lines that have copy number gain or amplification for PSMD4 are significantly more sensitive to talazoparib.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "28316110", "sentence_id": 4, "text": "Conversely, we find that breast cancer cell lines that have copy number gain or amplification for PSMD4 are significantly more sensitive to talazoparib."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"28316110\", \"sentence_id\": 5, \"text\": \"Functional studies reveal that knock-down of PSMD4 in amplified breast cancer cells and loss of the PSMD4 amplicon result in knock-down of PARP1 protein.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "28316110", "sentence_id": 5, "text": "Functional studies reveal that knock-down of PSMD4 in amplified breast cancer cells and loss of the PSMD4 amplicon result in knock-down of PARP1 protein."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"28316110\", \"sentence_id\": 6, \"text\": \"We show that PSMD4 is amplified and overexpressed in breast cancer and its overexpression correlates with poor survival.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "28316110", "sentence_id": 6, "text": "We show that PSMD4 is amplified and overexpressed in breast cancer and its overexpression correlates with poor survival."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"28316110\", \"sentence_id\": 7, \"text\": \"Knock-down of PSMD4 results in a significant decrease in cell growth.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "28316110", "sentence_id": 7, "text": "Knock-down of PSMD4 results in a significant decrease in cell growth."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"28316110\", \"sentence_id\": 8, \"text\": \"We provide evidence that PSMD4 is a proteasomal amplification target in breast cancer that PSMD4 amplification confers sensitivity to PARP inhibition, and that PSMD4 amplification is lost in the process of acquiring resistance to PARPi.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "28316110", "sentence_id": 8, "text": "We provide evidence that PSMD4 is a proteasomal amplification target in breast cancer that PSMD4 amplification confers sensitivity to PARP inhibition, and that PSMD4 amplification is lost in the process of acquiring resistance to PARPi."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"28316110\", \"sentence_id\": 9, \"text\": \"Finally, this study shows not only that PSMD4 copy number correlates with PARPi sensitivity, but also, that it may be a better predictor of sensitivity to PARPi than BRCA1/2 mutation.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "28316110", "sentence_id": 9, "text": "Finally, this study shows not only that PSMD4 copy number correlates with PARPi sensitivity, but also, that it may be a better predictor of sensitivity to PARPi than BRCA1/2 mutation."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"27708213\", \"sentence_id\": 0, \"text\": \"Poly(ADP-ribose) polymerase inhibitors (PARPIs) kill cancer cells by trapping PARP1 and PARP2.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "27708213", "sentence_id": 0, "text": "Poly(ADP-ribose) polymerase inhibitors (PARPIs) kill cancer cells by trapping PARP1 and PARP2."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"27708213\", \"sentence_id\": 1, \"text\": \"Talazoparib, the most potent PARPI inhibitor (PARPI), exhibits remarkable selectivity among the NCI-60 cancer cell lines beyond BRCA inactivation.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "27708213", "sentence_id": 1, "text": "Talazoparib, the most potent PARPI inhibitor (PARPI), exhibits remarkable selectivity among the NCI-60 cancer cell lines beyond BRCA inactivation."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"27708213\", \"sentence_id\": 2, \"text\": \"Our genomic analyses reveal high correlation between response to talazoparib and Schlafen 11 (SLFN11) expression.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "27708213", "sentence_id": 2, "text": "Our genomic analyses reveal high correlation between response to talazoparib and Schlafen 11 (SLFN11) expression."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"27708213\", \"sentence_id\": 3, \"text\": \"Causality was established in four isogenic SLFN11-positive and -negative cell lines and extended to olaparib.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "27708213", "sentence_id": 3, "text": "Causality was established in four isogenic SLFN11-positive and -negative cell lines and extended to olaparib."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"27708213\", \"sentence_id\": 4, \"text\": \"Response to the talazoparib-temozolomide combination was also driven by SLFN11 and validated in 36 small cell lung cancer cell lines, and in xenograft models.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "27708213", "sentence_id": 4, "text": "Response to the talazoparib-temozolomide combination was also driven by SLFN11 and validated in 36 small cell lung cancer cell lines, and in xenograft models."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"27708213\", \"sentence_id\": 5, \"text\": \"Resistance in SLFN11-deficient cells was caused neither by impaired drug penetration nor by activation of homologous recombination.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "27708213", "sentence_id": 5, "text": "Resistance in SLFN11-deficient cells was caused neither by impaired drug penetration nor by activation of homologous recombination."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"27708213\", \"sentence_id\": 6, \"text\": \"Rather, SLFN11 induced irreversible and lethal replication inhibition, which was independent of ATR-mediated S-phase checkpoint.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "27708213", "sentence_id": 6, "text": "Rather, SLFN11 induced irreversible and lethal replication inhibition, which was independent of ATR-mediated S-phase checkpoint."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"27708213\", \"sentence_id\": 7, \"text\": \"The resistance to PARPIs by SLFN11 inactivation was overcome by ATR inhibition, mechanistically because SLFN11-deficient cells solely rely on ATR activation for their survival under PARPI treatment.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "27708213", "sentence_id": 7, "text": "The resistance to PARPIs by SLFN11 inactivation was overcome by ATR inhibition, mechanistically because SLFN11-deficient cells solely rely on ATR activation for their survival under PARPI treatment."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"27708213\", \"sentence_id\": 8, \"text\": \"Our study reveals that SLFN11 inactivation, which is common (~45%) in cancer cells, is a novel and dominant resistance determinant to PARPIs.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "27708213", "sentence_id": 8, "text": "Our study reveals that SLFN11 inactivation, which is common (~45%) in cancer cells, is a novel and dominant resistance determinant to PARPIs."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"27447864\", \"sentence_id\": 0, \"text\": \"We recently discovered mutation signatures reminiscent of BRCA deficiency in the vast majority of a set of primary osteosarcomas (OS).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "27447864", "sentence_id": 0, "text": "We recently discovered mutation signatures reminiscent of BRCA deficiency in the vast majority of a set of primary osteosarcomas (OS)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"27447864\", \"sentence_id\": 1, \"text\": \"In the current study, we therefore investigated the sensitivity of a panel of OS cell lines to the poly(ADP)-ribose polymerase (PARP) inhibitor talazoparib alone and in combination with several chemotherapeutic drugs (i.e.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "27447864", "sentence_id": 1, "text": "In the current study, we therefore investigated the sensitivity of a panel of OS cell lines to the poly(ADP)-ribose polymerase (PARP) inhibitor talazoparib alone and in combination with several chemotherapeutic drugs (i.e."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"27447864\", \"sentence_id\": 2, \"text\": \"temozolomide (TMZ), SN-38, doxorubicin, cisplatin, methotrexate (MTX), etoposide/carboplatin).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "27447864", "sentence_id": 2, "text": "temozolomide (TMZ), SN-38, doxorubicin, cisplatin, methotrexate (MTX), etoposide/carboplatin)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"27447864\", \"sentence_id\": 3, \"text\": \"Here, we identified an association between homologous recombination (HR) repair deficiency and the response of OS cell lines to talazoparib.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "27447864", "sentence_id": 3, "text": "Here, we identified an association between homologous recombination (HR) repair deficiency and the response of OS cell lines to talazoparib."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"27447864\", \"sentence_id\": 4, \"text\": \"All OS cell lines with molecular features characteristic of BRCA1/2 mutant tumors (so-called \\\"BRCAness\\\"), such as disruptive gains in PTEN or FANCD2 and/or losses of ATM, BAP1, BARD1 or CHEK2, were susceptible to talazoparib-induced reduction of cell viability (i.e.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "27447864", "sentence_id": 4, "text": "All OS cell lines with molecular features characteristic of BRCA1/2 mutant tumors (so-called \"BRCAness\"), such as disruptive gains in PTEN or FANCD2 and/or losses of ATM, BAP1, BARD1 or CHEK2, were susceptible to talazoparib-induced reduction of cell viability (i.e."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"27447864\", \"sentence_id\": 5, \"text\": \"MG63, ZK-58,, SaOS-2 and MNNG-HOS).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "27447864", "sentence_id": 5, "text": "MG63, ZK-58,, SaOS-2 and MNNG-HOS)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"27447864\", \"sentence_id\": 6, \"text\": \"Consistent with their high sensitivity to talazoparib, MG63 and ZK-58 cells scored positive in a DNA-based measure of genomic instability (i.e.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "27447864", "sentence_id": 6, "text": "Consistent with their high sensitivity to talazoparib, MG63 and ZK-58 cells scored positive in a DNA-based measure of genomic instability (i.e."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"27447864\", \"sentence_id\": 7, \"text\": \"homologous recombination deficiency (HRD)-loss of heterozygosity (LOH) score).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "27447864", "sentence_id": 7, "text": "homologous recombination deficiency (HRD)-loss of heterozygosity (LOH) score)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"27447864\", \"sentence_id\": 8, \"text\": \"In contrast, U2OS cells that carry a heterozygous BRCA2 mutation and therefore most likely have one intact BRCA2 allele left proved to be resistant to talazoparib.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "27447864", "sentence_id": 8, "text": "In contrast, U2OS cells that carry a heterozygous BRCA2 mutation and therefore most likely have one intact BRCA2 allele left proved to be resistant to talazoparib."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"27447864\", \"sentence_id\": 9, \"text\": \"Furthermore, we identified TMZ as the most potent chemotherapeutic drug together with talazoparib to synergistically reduce cell viability, as confirmed by calculation of combination index (CI) values, and to suppress long-term clonogenic survival.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "27447864", "sentence_id": 9, "text": "Furthermore, we identified TMZ as the most potent chemotherapeutic drug together with talazoparib to synergistically reduce cell viability, as confirmed by calculation of combination index (CI) values, and to suppress long-term clonogenic survival."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"27447864\", \"sentence_id\": 10, \"text\": \"Mechanistically, talazoparib and TMZ cooperated to induce apoptotic cell death, as demonstrated by activation of BAX and BAK, loss of mitochondrial membrane potential (MMP), caspase activation, DNA fragmentation and caspase-dependent cell death.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "27447864", "sentence_id": 10, "text": "Mechanistically, talazoparib and TMZ cooperated to induce apoptotic cell death, as demonstrated by activation of BAX and BAK, loss of mitochondrial membrane potential (MMP), caspase activation, DNA fragmentation and caspase-dependent cell death."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"27447864\", \"sentence_id\": 11, \"text\": \"Genetic silencing of BAX and BAK or pharmacological inhibition of caspases by zVAD.fmk significantly rescued OS cells from talazoparib/TMZ-induced apoptosis.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "27447864", "sentence_id": 11, "text": "Genetic silencing of BAX and BAK or pharmacological inhibition of caspases by zVAD.fmk significantly rescued OS cells from talazoparib/TMZ-induced apoptosis."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"27447864\", \"sentence_id\": 12, \"text\": \"These findings have important implications for the development of novel treatment strategies using PARP inhibitors alone or together with chemotherapy in a subset of OS with features of BRCAness.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "27447864", "sentence_id": 12, "text": "These findings have important implications for the development of novel treatment strategies using PARP inhibitors alone or together with chemotherapy in a subset of OS with features of BRCAness."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"27440269\", \"sentence_id\": 0, \"text\": \"PURPOSE: PARP inhibitors (PARPi) are a novel class of small molecule therapeutics for small cell lung cancer (SCLC).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "27440269", "sentence_id": 0, "text": "PURPOSE: PARP inhibitors (PARPi) are a novel class of small molecule therapeutics for small cell lung cancer (SCLC)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"27440269\", \"sentence_id\": 1, \"text\": \"Identification of predictors of response would advance our understanding, and guide clinical application, of this therapeutic strategy.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "27440269", "sentence_id": 1, "text": "Identification of predictors of response would advance our understanding, and guide clinical application, of this therapeutic strategy."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"27440269\", \"sentence_id\": 2, \"text\": \"EXPERIMENTAL DESIGN: Efficacy of PARP inhibitors olaparib, rucaparib, and veliparib, as well as etoposide and cisplatin in SCLC cell lines, and gene expression correlates, was analyzed using public datasets.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "27440269", "sentence_id": 2, "text": "EXPERIMENTAL DESIGN: Efficacy of PARP inhibitors olaparib, rucaparib, and veliparib, as well as etoposide and cisplatin in SCLC cell lines, and gene expression correlates, was analyzed using public datasets."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"27440269\", \"sentence_id\": 3, \"text\": \"HRD genomic scar scores were calculated from Affymetrix SNP 6.0 arrays.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "27440269", "sentence_id": 3, "text": "HRD genomic scar scores were calculated from Affymetrix SNP 6.0 arrays."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"27440269\", \"sentence_id\": 4, \"text\": \"In vitro talazoparib efficacy was measured by cell viability assays.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "27440269", "sentence_id": 4, "text": "In vitro talazoparib efficacy was measured by cell viability assays."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"27440269\", \"sentence_id\": 5, \"text\": \"For functional studies, CRISPR/Cas9 and shRNA were used for genomic editing and transcript knockdown, respectively.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "27440269", "sentence_id": 5, "text": "For functional studies, CRISPR/Cas9 and shRNA were used for genomic editing and transcript knockdown, respectively."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"27440269\", \"sentence_id\": 6, \"text\": \"Protein levels were assessed by immunoblotting and immunohistochemistry (IHC).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "27440269", "sentence_id": 6, "text": "Protein levels were assessed by immunoblotting and immunohistochemistry (IHC)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"27440269\", \"sentence_id\": 7, \"text\": \"Quantitative synergy of talazoparib and temozolomide was determined in vitro In vivo efficacy of talazoparib, temozolomide, and the combination was assessed in patient-derived xenograft (PDX) models.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "27440269", "sentence_id": 7, "text": "Quantitative synergy of talazoparib and temozolomide was determined in vitro In vivo efficacy of talazoparib, temozolomide, and the combination was assessed in patient-derived xenograft (PDX) models."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"27440269\", \"sentence_id\": 8, \"text\": \"RESULTS: We identified SLFN11, but not HRD genomic scars, as a consistent correlate of response to all three PARPi assessed, with loss of SLFN11 conferring resistance to PARPi.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "27440269", "sentence_id": 8, "text": "RESULTS: We identified SLFN11, but not HRD genomic scars, as a consistent correlate of response to all three PARPi assessed, with loss of SLFN11 conferring resistance to PARPi."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"27440269\", \"sentence_id\": 9, \"text\": \"We confirmed these findings in vivo across multiple PDX and defined IHC staining for SLFN11 as a predictor of talazoparib response.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "27440269", "sentence_id": 9, "text": "We confirmed these findings in vivo across multiple PDX and defined IHC staining for SLFN11 as a predictor of talazoparib response."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"27440269\", \"sentence_id\": 10, \"text\": \"As temozolomide has activity in SCLC, we investigated combination therapy with talazoparib and found marked synergy in vitro and efficacy in vivo, which did not solely depend on SLFN11 or MGMT status.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "27440269", "sentence_id": 10, "text": "As temozolomide has activity in SCLC, we investigated combination therapy with talazoparib and found marked synergy in vitro and efficacy in vivo, which did not solely depend on SLFN11 or MGMT status."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"27440269\", \"sentence_id\": 11, \"text\": \"CONCLUSIONS: SLFN11 is a relevant predictive biomarker of sensitivity to PARP inhibitor monotherapy in SCLC and we identify combinatorial therapy with TMZ as a particularly promising therapeutic strategy that warrants further clinical investigation.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "27440269", "sentence_id": 11, "text": "CONCLUSIONS: SLFN11 is a relevant predictive biomarker of sensitivity to PARP inhibitor monotherapy in SCLC and we identify combinatorial therapy with TMZ as a particularly promising therapeutic strategy that warrants further clinical investigation."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"27440269\", \"sentence_id\": 12, \"text\": \"Clin Cancer Res; 23(2); 523-35.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "27440269", "sentence_id": 12, "text": "Clin Cancer Res; 23(2); 523-35."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"27440269\", \"sentence_id\": 13, \"text\": \"\u00a92016 AACR.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "27440269", "sentence_id": 13, "text": "\u00a92016 AACR."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"27087632\", \"sentence_id\": 0, \"text\": \"Rucaparib camsylate (CO-338; 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one ((1S,4R)-7,7-dimethyl-2-oxobicyclo[2.2.1]hept-1-yl)methanesulfonic acid salt) is a PARP1, 2 and 3 inhibitor.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "27087632", "sentence_id": 0, "text": "Rucaparib camsylate (CO-338; 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one ((1S,4R)-7,7-dimethyl-2-oxobicyclo[2.2.1]hept-1-yl)methanesulfonic acid salt) is a PARP1, 2 and 3 inhibitor."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"27087632\", \"sentence_id\": 1, \"text\": \"Phase I studies identified a recommended Phase II dose of 600 mg orally twice daily.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "27087632", "sentence_id": 1, "text": "Phase I studies identified a recommended Phase II dose of 600 mg orally twice daily."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"27087632\", \"sentence_id\": 2, \"text\": \"ARIEL2 Part 1 established a tumor genomic profiling test for homologous recombination loss of heterozygosity quantification using a next-generation sequencing companion diagnostic (CDx).\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "27087632", "sentence_id": 2, "text": "ARIEL2 Part 1 established a tumor genomic profiling test for homologous recombination loss of heterozygosity quantification using a next-generation sequencing companion diagnostic (CDx)."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"27087632\", \"sentence_id\": 3, \"text\": \"Rucaparib received US FDA Breakthrough Therapy designation for treatment of platinum-sensitive BRCA-mutated advanced ovarian cancer patients who received greater than two lines of platinum-based therapy.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "27087632", "sentence_id": 3, "text": "Rucaparib received US FDA Breakthrough Therapy designation for treatment of platinum-sensitive BRCA-mutated advanced ovarian cancer patients who received greater than two lines of platinum-based therapy."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"27087632\", \"sentence_id\": 4, \"text\": \"Comparable to rucaparib development, other PARP inhibitors, such as olaparib, niraparib, veliparib and talazoparib, are developing CDx tests for targeted therapy.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "27087632", "sentence_id": 4, "text": "Comparable to rucaparib development, other PARP inhibitors, such as olaparib, niraparib, veliparib and talazoparib, are developing CDx tests for targeted therapy."}}
{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"27087632\", \"sentence_id\": 5, \"text\": \"PARP inhibitor clinical trials and CDx assays are discussed in this review, as are potential PARP inhibitor combination therapies and likely resistance mechanisms.\"}]"}], "response_format": {"type": "json_object"}, "metadata": {"pmid": "27087632", "sentence_id": 5, "text": "PARP inhibitor clinical trials and CDx assays are discussed in this review, as are potential PARP inhibitor combination therapies and likely resistance mechanisms."}}
